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Chapter 1 
GENERAL INTRODUCTION 
In the past decade pioneering research in the field of N-hydroxy amino acids -by amongst others the 
Nijmegen group1,2- showed the biogenetic as well as the synthetic relevance of this class of 
compounds. In particular N-hydroxytryptophan (1) was studied in some detail.2 In approaches to 
several natural products, e.g. sporisdesmins, neoechinulins and fumitremorgins it appeared that 1 is an 
excellent precursor for a-functionalized-, α,β-functionalized- as well as α,β-dehydro-tiyptophan 
derived compounds. 
It was also demonstrated that N-hydroxytryptophan can be converted into ß-carbolines in two ways 
(Scheme I). A Pictet-Spengler reaction of 1 with acetáis provides the 1,3-disubstituted 
N(2)-hyclroxy-l,2,3,4-tetrahydro-ß-carbolines (2).2d A modified Bischler-Napieralski reaction of 1 
with trimethylorthoformate gives N(2)-oxo-3,4-dihydro-ß-carboline (3) of which the nitrone function 
can undergo 1,3-dipolar cycloaddition reactions with alkenes26 and nitriles2f, providing the 
isoxazolidine (4) and the A4-l,2,4-oxadiazoline (5) annulated tetrahydro-ß-carbolines, respectively. 
Both approaches gave an entrance to a new class of compounds, the N-oxy-ß-carbolines. 
This thesis describes the in depth continuation of this research, with emphasis on substituted 
tryptamines. Further research on this topic was considered to be of interest because of the following 
reasons: 
i) Secondary metabolites occur featuring a N-hydroxylated tryptophan moiety e.g. Astechrome3 (6) 
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or containing the skeleton of N-hydroxytryptamine e.g. Geneserine4 (7). Moreover, the secondary 
metabolites belonging to the class of the Eudistomins (8) (Scheme II) are a synthetic challenge. 
ii) Previously, the N-O functionality of N-hydroxytryptophan has been used for the synthesis of 
a-fiinctionalized-, α,β-functionalized- and α,β-dehydro-tryptophan derivatives.1,2 We now wondered 
whether transposition of the N-O-functionality towards other positions of a molecule would be 
feasible. For instance, we reasoned that the isoxazolidine 9 might be a suitable precursor for the 
fumitremorgin series (i.e. 10, Scheme Ш) 
Scheme III 
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Hi) ß-Carbolines and tetrahydro-ß-carbolines10 have a broad and interesting pharmalogical profile. 
Harman-like ß-carbolines, e.g. 11 (Scheme IV) have shown affinities for the tryptamine11"15 and 
Scheme IV 
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serotonin16"18 receptors and the 3-carboxylated ß-carbolines (e.g. 12) bind with high affinities to the 
benzodiazepine receptor.19"37 Moreover, the therapeutic activity of several indole alkaloids which 
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contain the tetrahydro-ß-carboline fragment such as yohimbine- (e.g. 13), and corynatheine-like (e.g. 
14) derivatives has been demonstrated.38 
Chemical modification of ß-carbolines and tryptamines -which form the backbone of the 
ß-carbolines- continues to be the object of intensive study in order to find new drugs. The relatively 
Scheme V 
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unknown N-oxy-tryptamines and N-oxy-ß-carbolines (e.g. 15-17, Scheme V) constitute an interesting 
new line in this pharmacological field. As the pharmacodynamic interaction of the basic nitrogen 
plays a key-role at the receptor level, it might be valuable to study the influence of an electronegative 
oxygen adjacent to this nitrogen in these structures. Alterations in basicity, nucleofilicity, polarization, 
steric hindrance and additional Η-bridge formation might be considered in this context. Obviously, the 
information obtained will lead to more insight on the molecular level concerning the critical 
parameters involved in receptor affinity and consequently to the development of new 
pharmacotherapeutics. 
Finally, of special interest are also the above-mentioned eudistomins (8). They display potent 
antiviral activity5"9 against Herpes simplex Type 1 (HSV-1) and Polio vaccine Type 1 viruses and 
antitumour activity.8·9 
Outline of this Thesis 
In this thesis the following topics are discussed: 
The synthesis of new N-oxy-tryptamines and an approach to optically pure 
N-hydroxy-tryptophan derivatives. 
Οσ 
HNOR, 
The synthesis of ß-carboline nitrones and the study of the mechanism and scope of the 
nitrone-nitrile 1,3-dipolar cycloaddition. 
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The first total syntheses of fumitremorgin С and vemiculogen TR-2 starting from 
N-oxo-ß-carbolines. 
JA 
-Me 
Fumitremorgin С 
М О 
Verruculogen TR-2 
The synthesis of several substituted N-hydroxy(alkoxy)-tetrahydro-ß-carbolines using the 
intermolecular Pictet-Spengler reaction of N-hydroxy(alkoxy)-tTyptamines and -tryptophans 
with aldehydes and the study of the influence of the N-0 substituent on the stereoselectivity of 
this reaction. 
R4CHO ( f V H j Σ^Ζ r il πι ί + L J1 ι 
Ι
 Ί
 Ι 1 ^ Ι г Ί 
R1 R1 R^ R1 R^ 
The synthesis of tetracyclic N-oxo-ß-carbolines having structural resemblances to eudistomins 
or corynanthe-like alkaloids by a novel, intramolecular Pictet-Spengler reaction of N-alkoxy-
tryptamine or -tryptophan derivatives. 
R 
"'XX HN. corynanthe-like 
eudistomins 
The structure-activity relationship (SAR) study of N-oxy-tryptamines and -ß-carbolines with 
respect to the benzodiazepine, serotonin and tryptamine receptors and the SAR study of 
eudistomins and analogues with respect to their antitumour and antiviral activity. 
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Introduction to the chapters 
In chapter 2 an efficient route to N-hydroxytryptophan (1) and -tryptamine (20: R2=H, Me, Ph) 
derivatives is described proceeding via the corresponding nitro compounds 19 prepared from the 
easily accessible gramine 18 and nitromethanc derivatives39 (Scheme VI, Route A). Reduction of the 
nitro group with Al-amalgam gives the N-hydroxy compounds in high yields. 
Scheme VI 
NMe. 
Route A: R2=H, CH3, Ph, COOEt 
Route B: R2-Ph, COOEt, COO(R*) 
A second route features the well-known approach via the oxime compounds 23, which are prepared 
by a cycloaddition reaction of indole derivatives (21) and nitroso olefins (22) (Scheme VI, Route B).2 
Reduction of the oxime double bond is accomplished with borane-trimethylamine complex 
(МезМ.ВНз) under acidic conditions. This route seems to be only efficiently applicable if strongly 
electron-withdrawing groups R2 are present in the nitroso-olefm 22 (e.g. R2=COOEt). 
N-Alkoxy-tryptamines (24; R2=H, Me) and -tryptophans (24; R2=COOEt) can be conveniently 
prepared by the selective N-protection of 1 or 20 with 2-(trimethylsilyl)ethyl chloroformate, followed 
by O-alkylation and removal of the TEOC group (Scheme VI, Route A'). N-Alkoxytryptophans (24; 
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R2=COOEt) can also be obtained by a regioselective O-alkylation of oxime 23 followed by reduction 
with MejN.BHj (Scheme VI, Route B"). 
Subsequendy, an approach to optically active N-hydroxytryptophan derivatives is described. 
Diastereoselecuve reduction of the oxime functionality in the chiral substituted menthol ester 
derivatives (23; R2=COO(-)-8-phenylmenthyl and COO-(-)-8-naphthylmenthyl) is achieved leading to 
a derivative of 1 in which the ethyl group is replaced by the corresponding chiral auxiliary (Scheme 
VI, Route B). Unfortunately, subsequent removal of the chiral auxiliary failed so far. 
Chapter 3 deals with the synthesis of nitrones (25: R1=COOEt, CH3, H and R2=H or R1=CH3, 
R2=Ph) from the corresponding N-hydroxy compounds (see Scheme П). Subsequently, the 
Scheme VII 
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1,3-dipolar cycloaddition of these nitrones 25 with nitriles is discussed. In general, the cycloaddition 
seemes to be controlled by a HOMO(nitrone)-LUMO(nitrile) interaction, to give 
A4-l,2,4-oxadiazolines (26) with complete regioselectivity. However, a cross-over in the orbital 
control is observed with strongly electron donating groups R3. Kinetic studies taking into account 
solvent polarity and substituent effects (R3=aryl, Hammett equation) demonstrate that mechanistically 
this new nitrone-nitrile cycloaddition is consistent with the well-known nitrone-alkene cycloaddition. 
In chapter 4 the employment of the isoxazolidine 27 -obtained by cycloaddition of the corresponding 
nitrone and isobutene in a complete regio- and stereoselective fashion- in the total synthesis of 
fumitremorgin С (28) is highlighted (Scheme ІП). Key-step in this approach is the epimerization of 
the C(3) carbon to give compounds with a di-relationship {e.g. 28) between the C(l) and C(3) 
substituents. By completing the synthesis of all four possible stereoisomers -by varying the chirality at 
C(8) and C(14a) in 28- we unambiguously determined the configuration at C(14a) of fumitremorgin С 
as depictet in Scheme VIII (14a(S)). At the onset of our studies the relative stereochemistry at carbon 
atom 14a of the natural product was unknown. 
The second half of this chapter deals with the total synthesis of veiruculogen TR-2 (31). This 
synthesis features the formal dehydrogenation of tetrahydro-ß-carbolines to 3,4-dehydro-ß-carbolines 
{e.g. 30). This conversion was achieved via the intermediacy of the 3-alkoxyindolenines 29, which 
under acidic conditions, rearranged to 30. The alkene moiety was then converted into a cii-diol 
functionality employing osmium tetroxide. 
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Scheme Vili 
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In chapter 5 the synthesis of a wide range of new N-oxo-ß-carbolines is reported. The influence of 
the substituents RpRj in the N-oxy-tryptophan and -tryptamine derivatives 1, 20 and 24 on their 
reactivity in the intermolecular Pictet-Spengler reaction with aldehydes (R4CHO) to give cis- (33) and 
trans-ß-carbolines (34) is studied (Scheme K) . Attention was also paid to the influence of these 
CO R.CHO 0
* 3 
1,20,24 
α 
Scheme IX 
cççc cca: 
32 33: 34: trans 
substituents on the stereochemical outcome of this reaction. The increased electrophilic character of 
the C=N double bond in the intermediate 32 -due to the oxygen substituent on the nitrogen- increases 
its reactivity and alters the stereoselectivity, with respect to the deoxy analogues. 
Chapter 6 deals with the syntheses of tetracyclic N-oxo-ß-carbolines 35 (R=H, CH3, COOEt), 
analogues of the corynantheine indole alkaloids.These target molecules could be obtained by a novel 
intramolecular Pictet-Spengler reaction employing 36 (Scheme X). This crucial intermediate 36 
represents a N-alkoxytryptamine derivative having an aldehyde function or a masked derivative 
thereoff in δ-position of the alkoxy chain. Three approaches were studied towards 36. Route A 
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Scheme X 
35 
features a selective reduction of the O-alkylated oxime function present in 37. In route В a selective 
O-alkylation of the N-hydroxy compounds 1 and 20 with a properly functionalized four carbon 
substrate is carried out. Route С consists of a selective reduction of the ester function in 38, generated 
from 20. The most effective approaches are routes В and C, whereas route A gave poor results. 
In chapter 7 the application of the intramolecular Pictet-Spengler reaction in the total synthesis of 
eudistomin analogues 39 is described. First, model-studies resulted in the the synthesis of the 
Scheme XI 
'XXfX 
У н Y 
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eudistomin skeleton 39 (R1=R2=H). Intramolecular Pictet-Spengler reaction of N-alkoxytryptamines 
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40 (R1=R2=H, Y=CH(OMe)2 or Y=COOMe) -derived from 20 and the chloromethylsulfide derivative 
41- gives 39. 
In the second half of this chapter the syntheses of all four stereoisomers of the eudistomins 39 
(R2=NH2 an<^ Ri=H o r OMe) are described. In this case the intramolecular Pictet-Spengler reaction is 
only feasible when the ester 40 (Y=COOMe) is used as in-situ precursor for the aldehyde (route C, 
Scheme X). 
Chapter 8 deals with structure-activity relationship studies. In the first part the affinities of the 
previously described N-hydroxy(alkoxy)-tryptophans and -tryptamines (chapter 2), the 3,4-dihydro-
N-oxo-ß-carbolines (chapter 3), the N-oxo-tetrahydro-ß-carbolines (chapter 5) and the tetracyclic 
N-oxo-tetrahydro-ß-carbolines (chapter 6) for the tryptamine-, serotonin- and 
benzodiazepine-receptors are given. In general the N-oxo substituent abolishes the affinity, though 
within some N-oxo derivatives a rather selective profile is observed. These receptor studies were 
performed in Duphar Research Laboratories, Weesp. 
The second half of this chapter deals with the structure-activity relationships of several eudistomin 
analogues with regard to their antitumour and antiviral activity. These antitumour assays were 
performed by Peter Lelieveld (TNO-CIVO institutes, Zeist) and the antiviral assays by Prof. E. 
DeClercq (Rega institute, Leuven). 
Antiviral activities 
This preliminary SAR study focusses on the influence of the stereochemistry at C(l) and C(13b) and 
of small alterations of essential structural moieties on the activity. 
Seven eudistomin analogues 39 were evaluated on their inhibitory effects on the replication of a 
variety of viruses including the human immunodefiency virus Ш -l and HIV-2. 
In general we observed with respect to the antiviral activities other than the anti-HIV-1 and -2 
activity that i) only those stereoisomers are active that have the same configuration at C(l) and C(13b) 
as the natural products ii) the presence of the amino function at C(l) is of importance Hi) substitution 
in the indole nucleus alters the potency of the compound. 
The results of this preliminary SAR study are summarized in Scheme XII. 
Scheme XII. Antiviral and antitumour activity of eudlstomln-analogues. 
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Antitumour activity 
Four of the prepared eudistomin analogues are assayed against tumour cells (P388 leukemie) in an in 
vitro clonogenic assay. The preliminary results indicate that the antitumour activity of the compounds 
tested parallels their antiviral activity as far as the influence of structural parameters is concerned 
(Scheme ΧΠ). 
The most potent compound is 39 in which R1=OMe and R2=NH2. This analogue is five times more 
active in the assays studied than the well-known antitumour compound adriamycine. 
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CHAPTER 2 
Syntheses of N-hydroxy(alkoxy)-tryptophan and 
-tryptamine derivatives. 
Route A 
R2=H, CH3, Ph, COOEt, COO(R·) | 
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Chapter 2.1 
SYNTHESES OF N-HYDROXY(ALKOXY)-TRYPTOPHAN AND -TRYPTAMINE 
DERIVATIVES. 
This chapter intends to provide a survey of the syntheses of N-hydroxy(alkoxy)-tiyptophan (Scheme 
I, A, R2=CCX)R) and -tryptamine (R2=H) derivatives. For two reasons we are interested in these 
compounds. The first has a pharmacological background. The target compounds are derivatives of the 
neurotransmitters tryptamine and serotonin (5-HT), and it is interesting to study the influence of the 
N-oxy substitution upon the interaction with the biological receptors. Furthermore, ß-carbolines 
-which can be prepared from tryptophan and tryptamine derivatives1- show a broad pharmacological 
profile. For instance they act as monoamine oxidase inhibitors, 5-HT reuptake inhibitors or they 
possess strong affinities for the benzodiazepine receptor.2 Second, the synthetic utility of the title 
compounds is of importance. N-Hydroxy amino acids in general3*, and N-hydroxytryptophan3b,c in 
particular not only deserve attention as possible biosynthetic intermediates but also as synthons in the 
preparation of natural products.3·4 Natural products containing the N-oxytryptamine moiety such as 
Geneserine5 or Eudistomins6·7 are of special interest in this respect. 
The most obvious synthetic method for the N-oxo derivatives (A) would be direct oxidation of the 
amine function in (B). However the vulnerability of the indole nucleus towards (eleetrophilie) 
oxidating agents precludes this possibility. Since the indole nucleus is relatively stable towards 
Schemel .^^ ^ ^ ^ ^ 
NORj <ΚΓ£. 
^ ^ ^ Я, * a 
oxidation ^ \ ^ ^ ^ ^ ? "· JU к ^ * W HNOR3 С 
η, 
η, 
В А 
'<Kft 
η, 
D 
reducing agents, we considered the reduction of oxim derivatives (C) and nitro derivatives (D). 
N-Hydroxy derivatives (Scheme Π). The syntheses of N-hydroxytryptophan derivatives like 23 via 
oxim derivatives (Route A) are well documented3·4. Cycloaddition8 of the nitroso-olefin 5 -prepared 
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in situ from ethyl a-(hydroxyimino)-ß-bromopropanoate- with an excess of 1 gives an adduct which 
after ring opening and rearomatization affords 7. Subsequent reduction of the oxime double bond of 7 
with borane-trimethylamine complex under acidic conditions gives 23. In an analogous fashion 
conjugate addition of 4-chloroindole (3) or 5-chloroindole (4) to 5 gave the oximes 8 and 9 in 67% and 
70% yield, respectively. Reduction with borane-trimethylamine complex afforded 24 (73%) and 
25(94%). 
By the same procedure oxime 12 is obtained, from 1 and б9 in only 20% yield. The poor yield is a 
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result of the lower reactivity of the nitroso-olefin 6 compared with 5 due to the less 
electron-withdrawing ability of the phenyl group.9·10 Reduction of the oxime double bond of 12 failed 
with borane-trimethylamine complex or Al-amalgam. However, reduction with sodium cyano 
borohydride in acidic solvent gave the N-hydroxy tryptamine derivative 27 in 95% yield.11 
Since Route A seems to be only efficiendy applicable if strongly electron-withdrawing R2 groups are 
present in the nitroso-olefin we studied an alternative route. Heath-Brown et.al.12 prepared the nitro 
compound 20 0*2=СНз) from gramine (13) and nitroethane (14) by treatment with dimethylsulfate 
and base. Following the same procedure with α-nitrotoluene (15)13 and nitromethane (16) we isolated 
the nitro compounds 18 (R2=Ph) and 19 (R2=H) in 63% and 86% yield, respectively. In the latter case 
a large excess of nitromethane was necessary in order to suppress the formation of the bisindole 
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compound 31, which has not been reported before. Reduction of the nitro functionality of 18-20 into 
CKTCXO 
I I 
H H 
31 
the hydroxylamine group proceeded smoothly with Al-amalgam in ethyl acetate saturated with water 
to give 27-29 in high to excellent yields.14 This method appeared to be also suited for the preparation 
of 23. By simple heating 13 and ethyl nitroacetate (17) in xylene (KXPC) the nitro compound 22 was 
obtained in 90% yield,15 which by reduction with Al-amalgam afforded 23 in 92% yield.16 Thus, 
Route В is a general and a simple approach to both N-hydroxytryptophan and tryptamine derivatives. 
We also investigated the preparation of the two indole nitrogen substituted compounds 26 and 30. 
The synthesis of 26 has been described (Route A, 2—»10—»ll—»26).3b In Route В it was possible to 
protect the nitrogen of indole with rm-butyloxycarbonyl (BOC) in the nitro-stage, following the 
procedure of Grehn.17 Reaction of 20 with di-fm-butyl dicarbonate in the presence of triethylamine 
and 4-dimethylaminopyridme in acetonitrile gave 21 in 83% yield and subsequent reduction of the 
nitro group with Al-amalgam gave 30 in 54% yield. 
N-AIkoxy derivatives (Scheme ΠΙ). One of the approaches we explored for the synthesis of 
N-alkoxytiyptophan derivatives starts with the oxime 7. (Route A') Alkylation of oximes is known to 
occur both on oxygen and on nitrogen to give mixtures of oxime ethers and nitrons, respectively.18 
Selective O-alkylation of oximes has been reported using phase transfer conditions18*, but these 
conditions failed with 7.19 In our hands the method of choice for selective O-alkylation encompasses 
DMSO as solvent, potassium rm-butoxide as base and an alkyl chloride20 as alkylating agent and 
50oC as reaction temperature. Under these conditions reaction of 7 with benzylchloride, 
2-chloropropane, l-chlorobutane and chloromethylthiomethyl gave 32-35 in 68, 76, 77% and 48% 
yield, respectively. In the case of the O-methyl derivative 36 we applied a general method18* for the 
preparation of methyloxime ethers -viz. reaction of 7 with methyliodide in acetone in the presence of 
suspended Ag20 (86% yield ). Reduction of the oxime ethers was accomplished under standard 
conditions. Treatment of 32-36 with borane-trimethylamine complex afforded the target compounds 
45-49 in 56-91% yield. 
N-Hydroxytryptamine derivatives were not efficiently accessible via the oxime approach (vide 
supra) and therefore we explored an alternative approach towards the N-alkoxy derivatives, from the 
corresponding N-hydroxy compounds. (Route B', Scheme III). The problem we faced was the 
selective O-alkylation of the N-mono substituted hydroxylamine function. In general 
Ν,Ο-disubstituted hydroxylamines are prepared by O-alkylation of N-hydroxyurethanes followed by 
acidic hydrolysis.21 By a careful choice of the protective group this method could be made suitable for 
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our goal. The protective group not only has to be easily incorporated and removed but also has to 
survive the alkylation conditions. The trichloroethoxycarbonyl (ТЮС) group satisfied the first two 
criteria but failed with respect of the last one. The protective group of choice which met all of the 
criteria was the 2-(trimethylsilyl)ethoxycarbonyl (TEOC) group.22 Treatment of 23, 28 and 29 with 
2-(trimethylsilyl)ethylchloroformate in dichloromethane / dioxane23 at room temperature gave 37, 38 
and 39 in 96%, 91% and 80%, respectively. 
The reaction conditions for the O-alkylation of these TEOC-protected compounds depend on the 
α-substituent in the tryptamine moiety. A N-acyl-N-hydroxytryptophan derivative such as 37 is 
sensitive to elimination reactions under basic conditions. In the absence of a nucleophile, 
reairangement to the corresponding enamine ester derivative has been reported3b,4g. Indeed we found 
that alkylation attempts of 37 with benzylbromide using DMSO/KOtBU or DME/NaH yielded the 
dehydro ester 53 almost quantitatively. With K2CO3 as the base in DMSO at 450C the desired 40 was 
obtained in 67% yield. In an analogous fashion reaction of 37 with methyliodide and l-bromopropane 
gave 41 and 42 in 69% and 71% yield, respectively. The TEOC-protective group of 40-42 was 
removed with tetrabutylammonium fluoride (BU4NF) in THF to give the N-alkoxytryptophan 
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derivatives 45,46 and 50 in 84%, 89%, and 91% yield, respectively. Since 38 and 39 are less prone to 
undergo this elimination reaction these compounds could be smoothly converted into 43 and 44 
respectively using methyliodide and NaH in DME at room temperature. These compounds were not 
purified, but immediately deprotected with BU4NF in THF yielding the compounds 51 and 52 in an 
overall yield of 68% and 70%, respectively. 
Secondary alkylhalides like 2-bromopropane failed to undergo alkylation with 37-39. So by this 
approach (Route B') compound 47 was not accessible in contrast to the oxime approach (Route A'). 
Conclusions 
An efficient route to N-hydroxy-tryptophan and -tryptamine derivatives has been described via the 
corresponding nitro compounds (18-22) prepared from gramine (13) and nitromethane derivatives 
(14-17). Reduction of the nitro group with Al-amalgam gives the N-hydroxy compounds 23 and 27-30 
in high yields (Scheme II, route B). 
N-Alkoxytryptophans can be conveniently prepared by a regioselective O-alkylation of oxime 7 
followed by reduction with МезМ.ВНз (Scheme III, route A'). N-Alkoxy-tryptamines and 
-tryptophans have been prepared by selective N-protection of hydroxylamines 23, 28 and 29 with 
2-(trimethylsilyl)ethyl chlorofomiate providing 37-39, and subsequent O-alkylation and removal of 
the TEOC-group. (Scheme ΙΠ, route B'). 
Experimental Section 
Melting points were taken on a Koefler hot stage (Leitz-Wetzlar) and are uncorrected. Ultraviolet 
spectra were measured with a Perkin Elmer spectrometer, Model lambda 5. Proton magnetic 
resonance spectra were measured on a Braker WH-90 or on a Bruker AM 400 spectrometer. 
Chemical shifts are reported as δ-values relative to tetramethylsilane as an internal standard; 
deuteriochloroform was used as solvent unless stated otherwise. Mass spectra were obtained with a 
double-focusing VG 7070E spectrometer. Thin-layer chromatography (TLC) was carried out by 
using silica gel F-254 plates (thickness 0.25 mm). Spots were visualized with a UV hand lamp, 
iodine vapor, or CI2-TDM.24 For column chromatography Merck silica gel (type 60H) was used. 
Ethyl a-(Hydroxyimino)-ß-(4-chloroindol-3-yl)propanate (8), Ethyl a-hydroxyimino-
-ß-bromopropanoate (2.3 g., 11 mmol) in CH2CI2 (40 mL) was added dropwise to a stirred solution 
of 3 (5.0 g., 33 mmol) and a suspension of Na2C03 (2.4 g., 23 mmol) in CH2CI2 (30 mL) at room 
temperature under argon. Stirring was continued at room temperature for 22h. The mixture was then 
filtered through a thin layer silica gel (60) and concentrated to dryness. The residue was subjected to 
column chromatography (silica gel 60H, EtOAc/n-hexane,l/2,v/v) to yield 6.3 g. of crystalline 8, 
67%. It was recrystallized from CH2c l2/n-hcxane : mP 166-1710C; Rf 0.35 (solvent system C); UV 
(MeOH) Xmax 224, 284 nm, λπύη 253 nm; EIMS (70 eV) m/z 282 ([M+2]+, 12%)· 280 (M+, 34%), 
265 ([Μ+2-ΟΗΓ, 21%), 263 ([M-OH]+,56%), 192 ([C10H7N2C1]+, 28%), 190 ([C1()H7N2C1]+, 81%), 
166 ([C9H7NC1]+, 33%), 164 ([CofyNCir, 100%); Ή NMR δ 8.76 (br s, IH, NH), 7.27-6.98 (m, 
3H, indole C(5)-C(7)H), 6.84 (s, IH, indole C(2)H), 4.45 (s, 2H, indole C(3)-CH2), 4.26 (q, 2Н, 
ОСН2СНз), ^ З (t, ЗН, OCHjCHj); Anal.Calc. for CuH^Cll^Oj (MW 280.713): С, 55.62; 
Н,4.67; N. 9.98. Found: С, 55.25; H, 4.67; Ν, 9.91. 
Ethyl a-(Hydroxyimino)-ß-(5-chloroindol-3-yl)-propanoate (9). Identical procedure with 
5-choroindole 4 gave 9, yield 70%. Recrystallized from C^Cyn-hexane: mp 164-1660C; Rf 0.30 
(solvent system C); UV (MeOH) Xm« 224, 290 nm, Um 253 nm; EIMS (70 eV) m/z 282 ([M+2]+, 
14%)· 280 (M+, 41%), 265 ([M+2-OH]+, 22%), 263 ([M-OH]+,64%), 192 ([C10H7N2C1]+, 34%), 190 
([C10H7N2C1]+, 77%), 166 ([0,Η 7Να]+, 34%), 164 ([C9H7NC11+, 100%); lH NMR (CDCI3 / 
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СВзОО,95/5, / ) δ 7.70 (d, IH, indole C(7)H), 7.30-6.98 (m, 3H, indole C(2)H,C(4)H and C(6)H), 
4.23 (q, 2H, O C H J C H J ) , 3.98 (s, 2H, indole C(3)-CH2), 1.27 (t, 3H, ОСН2СНз); Anal.Calc. for 
С ^ Н ^ С ^ О з (MW 280.713): С, 55.62; Н,4.67; Ν, 9.98. Found: С, 55.42; Η. 4.67; Ν, 9.95. 
3-(2-Hydroxyimino-2-phenyIethyl)indoIe(12) 
A solution of a-(hydroxyiimno)-a-phenyl-ß-bromoethane' (21.4 g, 100 mmol) in dry 
dichloromethane (400 mL) was added dropwise in 4 hours to a solution of indole (1) (35.1 g, 300 
mmol) and КагСОз (21.1 g, 200 mmol) in dry dichloromethane (250 mL). Stirring was continued for 
40 hours at room temperature in an argon atmosphere. The reaction mixture was filtered and 
subsequently washed with 0.1 N HCl and brine. The organic layer was dried (N32804) and the 
solvent evaporated in vacuo. The residue was subjected to column chromatography (CF^C^/MeOH, 
98/2, v/v) to give 5 g (20%) of 12: mp 167-1710C; Rf 0.29 (CH2Cl2/MeOH, 98/2, v/v) : EIMS (70 
eV) m/z (relative intensity) 250 (M+, 48), 233 ([M-OH]+, 13), 130 ([Ο,Η,,ΝΓ, 100); Ή NMR δ 
8.22-7.00 (m, ЮН, С(4)-С(7)Н, indole NH and QHs), 6.89 (m, IH, C(2)H), 4.27 (s, 2Н, indole 
С(3)-СН2); Anal.Calcd. for C 1 6 H 1 4 N 2 0 (Mw 250.303): C, 76.78; H, 5.64; N, 11.19. Found: C, 
76.78; H, 5.60; N, 10.96. 
3-(2-Nitro-2-phenylethyl)indole(18) 
Following the same procedure as described by Heath-Brown12 for 20, with gramine (5.8 g, 30 
mmol), sodium (0.76 g, 33 mmol) and dimethylsulfate (7.56 g, 60 mmol) in ethanol (25 mL) and 
α-nitrotoluene (15)13 (5.1 g, 37 mmol) gave after column chromatography (CHCWn-hexane, 70/30, 
v/v) 5.0 g (63%) of 18. Recrystallized from O^CU/n-hexane: mp 98-100oC; Rf 0.58 (CHCI3); 
EIMS (70 eV) m/z (relative intensity) 266 (M+, 29), 220 ( [ C ^ ^ N ] * , 100), 130 ([CoHgN]4·, 36); Ή 
NMR δ 8.00 (br s, IH, NH), 7.56-7.04 (m, 9H, indole C(4)-C(7)H and QHs), 6.91 (d, IH, indole 
C(2)H), 5.77 (X part of ABX spectrum, IH, J=5.5Hz, J=9.3Hz, OLCHNOj), 3.95 and 3.47 (AN 
part of ABX spectrum, 2H, 2J=14.7Hz, J=5.5Hz, J=9.3Hz, CHjCHNO^; Anal.Calcd. for 
C16H14N202 ( M w 266.302): C, 72.16; H, 5.30; N, 10.52. Found: C, 71.80; H, 5.24; N, 10.36. 
3-(2-Nitroethyl)indole (19) and 3-[2-Nitro-2(3-indolyl-methyl)ethyl]indole (31) 
This synthesis is a modification of Heath-Brown's procedure.12 
Sodium methoxide which was freshly prepared from 4.35 g (189 mmol) sodium in dry methanol 
(300 mL) was added to a stirred solution of gramine (13) (30 g, 172 mmol) and dimethylsulfate (43.4 
g, 344 mmol) in nitromethane/methanol, 1/1, v/v (500 mL). The reaction mixture was stirred for 24h. 
After the solution had been concentrated to near dryness, the residue was dissolved in 
dichloromethane and subsequently washed with 5% NH3 and IN HCl and brine. The organic layer 
was dried (Na2S04) en the solvent evaporated in vacuo. The crystalline residue was subjected to 
column chromatography (CHClj/n-hexane, 75/25, v/v) to yield 28g (86%) of 19 and 2.8g (5%) of 31. 
Compound 19: Spectrocopic data are identical with earlier published results.7"·'1 
Compound 31: Recrystallized from CH2Cl2/MeOH/n-hexane: mp 213-214
0C; Rf 0.29 (CHC13); 
EIMS (70 eV), m/z (relative intensity) 319 (M#, 67), 272 ([M-HNOJ"1-, 22), 130 ([0,Η8Ν]+, 100); Ή 
NMR (DMSO-d6) δ 10.96 (br s, 2H, 2xNH), 7.60-6.92 (m, ЮН, 2x indoleC(2)H and 
2xindoleC(4)-C(7)H), 5.22 (X part of ABX spectrum, IH, CHNO2), 3.50 (AB part of ABX 
spectrum, 4H, 2х indoleC^-CHj); Anal Caled, for С 1 9 Н 1 7 ^ 0 2 (Mw 319.364): С, 71.46; H, 5.37; 
Ν, 13.16. Found: С, 71.21; Η, 5.32; Ν, 12.97. 
N(l)[(/ert-Butyloxy)carbonyl]-3-(2-Nitropropyl)indoIe(21) 
To a stirred solution of 201 2 (204 mg, 1 mmol) and DMAP (12.2 mg, 0.1 mmol) in dry acetonitrile 
(3 mL) was added di-rm-butyloxyearbonate (260 mg, 1.2 mmol). After completion of the reaction as 
was monitored by TLC (СНСІз/МеОН, 99/1, v/v) the reaction mixture was diluted with ethyl acetate 
and subsequently washed with 10% NH3, water and brine. The organic layer was dried (MgSC^ and 
the solvent evaporated in vacuo. The residue was subjected to column chromatography 
(C^Cyn-hexane, 90/10, v/v) to give 250 mg (83%) of 21. Recrystallized from CHjClj/n-hexane; 
mp 117-1190C; Rf 0.82 (CHCI3); UV (MeOH) Xmax 225, 257, 262.5, 273 (sh), 284.5, 292.5 nm; 
EIMS (70 eV) m/z (relative intensity) 304 (M+, 34), 248 (16), 201 (38), 157 ([^,Η,ιΝΓ, 54), 57 
([C4H9]+, 100); Ή NMR δ 8.07 (m, IH, C(2)H), 7.51-7.12 (m, 4Н, С(4)-С(7)Н), 4,86 (m, IH, 
СН2СНСНз), 3.43 and 3.12 (AB part of ABX spectrum, 2H, 2J=14.7Hz, J=6.3Hz, J=5.4Hz, indole 
C(3)-CH2), 1.67 (s, 9H, С(СНз)з), 1.60 (d, 3H, J=6.3Hz, CHCH3); Anal.Cald. for C16H20N2O4 (Mw 
304.349): C, 63.14; H, 6.62; N, 9.20. Found: C, 63.24; H, 6.59; N, 9.13. 
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Ethyl a-(Hydroxyaimno)-ß-(indol-3-yl)propanoate (23) 
Procedure A: Reduction of oxime 7 as described earlier. 
Procedure B: This synthesis is a modification of Cohen's procedure.14 To a stirred solution of 2215 
(524 mg, 2 mmol) in ethyl acetate (saturated with water) (100 mL) was added portionwise at 0oC 
freshly prepared Al(Hg) untili the starting material was consumed. The reaction mixture was filtered 
and the filtrate dried (MgS04) and the solvent evaporated in vacuo. The residue was subjected to 
column chromatography (СНСІз/МеОН, 98/2, v/v) to give 455 mg (92%) of 23. Spectroscopic data 
are identical with earlier published results.3 
Ethyl a-(Hydroxyamino)-ß-(4-chloroindoI-3-yl)-propanoate (24). A solution of HCl in ethanol 
(13 mL of a 7N solution) was added dropwise to a stiired solution of 8 (2.0 g., 7.2 mmol) and 
(СНз)зМ.ВНз (Aldrich Chemical Co; 590 mg, 8.1 mmol) in EtOH (25 mL) at room temperature and in 
argon atmosphere. Stirring was continued for 2.5 h. The mixture was then concentrated to near 
dryness. The residue dissolved in CH2CI2. This solution was neutralized with NaHCOß and filtered. 
The filtrate was washed with 0.1 N HCl and dried over Na2S04. Evaporation of the solvent in vacuo 
and recrystallization of the residue from CfyC^/MeOH/n-hexane gave 1.48 g. 24 (73%): mp 
m-UOPC; Rf 0.25 (solvent system D); UV (MeOH) Xmax 224, 289 nm, Uin 251 nm; EIMS (70 eV) 
m/z 284 ([M+2]+, 0.5%)· 282 (M+, 1.7%), 166 ([CoH-jNCl]-'-, 34%), 164 ( [ С о Н ^ а Г , 100%); •H 
NMR (СТ>С1з/СВзСЮ,95/5, / ) δ 7.35-7.00 (m, 4H, indole C(2)H,C(5)H- C(7)H), 4.17 (q, 2H,JJ 7.1 
Hz, OCH2CH3), 4.01 (X part of ABX spectrum, 1H,3J 5.3 Hz, 3J 8.9 Hz, indole C(3)-CH2-CH),3.40 
and 3.23 (AB part of ABX spectrum, 2H,2J 14.2 Hz, 3J 5.3 Hz, 3J 8.9 Hz, indole CQyCHJ, 1.19 (t, 
3H, OCHjCHj). 
Ethyl a-(Hydroxyamino)-ß-(5-chloroindol-3-yl)-propanoate (25). Identical procedure with 9 
gave 25, yield 94%. Recrystallized from CfyCb/MeOH/n-hexane:
 m p 188-190°^ Rf 0.26 (solvent 
system D); UV (MeOH) Xm« 224, 289 nm, Xmin 251 nm; EIMS (70 eV) m/z 284 ([M+2]+, 1.3%)· 282 
(M+, 4.7%), 166 ([C9H7NC1]+, 31%), 164 ([C9H7NC1]+, 100%); Ή NMR (CDCÙCT^OD^S/S.v/v) δ 
11.34 (br s, IH, NH), 7.61-7.04 (m, 4H, indole C(2)H,C(4)H and C(6)-C(7)H), 4.28 (X part of ABX 
spectrum, 1H,3J 3.9 Hz, 3J 9.6 Hz, indole COVCHU-CH), 4.07 (q, 2H,3J=7.1 Hz, OCHjOL), 3.46 and 
3.23 (AB part of ABX spectrum, 2H,2J 14.4 Hz, ^ 3.9 Hz, 3J 9.6 Hz, indole CpVCHj), 0.97 (t, 3H, 
3
і=7.1Нг,ОСН2СНз). 
3-(2-Hydroxyam¡no-2-phenylethyl)indole (27) 
Procedure A: To a solution of 12 (1.63 g, 6.5 mmol) in dry methanol (150 mL) was added 5 mL of 
a solution of NaCN.BH3 (4 g, 63.7 mmol in 50 mL dry methanol). By adding slowly a solution of 
HCl in ethanol (7N) the mixture was kept at pH 1~2 (electronic pH-meter) untili the pH did not 
change anymore. Another 5mL of the NaCNBH3 solution was than added and again the pH was 
adjusted to pH 1-2 with the ethanolic HCl solution. This process was repeated untili the total 
NaCN.BH3 soltution (50 mL) was added (48 hours). The reaction mixture was filtered and the 
residue concentrated to dryness. The residue was dissolved in ethylacetate/water, 1/1, v/v. The 
aqueous layer was washed again with ethyl acetate. The combined organic layers were subsequently 
washed with a saturated NaHCC^ solution and brine. The organic layer was dried (MgS04) and the 
solvent evaporated in vacuo. Recrystallization from Q^C^/n-hexane gave 1.6 g (95%) of 27.: mp 
112-1150C; Rf 0.75 (EtOAc/n-hexane, 9/1, v/v); Ή NMR δ 7.93 (br s, IH, NH), 7.71-6.95 (m, 
9H,indole C(4)-C(7)H and C6H5), 6.82 (d, IH, C(2)H), 4.64 (br s, 2H, HNOH), 4.27 (X part of ABX 
spectrum, IH, J=14.1Hz, indole C(3)CH2CH), 3.17 and 3.05 (AB part of ABX spectrum, 2H, 
2J=14.4Hz, J=6.0Hz, J=8.6Hz, indole C(3)CH2CH); Anal.Calcd. for C16H16N20 (Mw 252.319): C, 
76.16; H, 6.39: N, 11.10. Found: C, 76.18; H, 6.42; N, 10.86. 
Procedure B: : The same procedure was followed as was described for 23. Reaction of 18 (2.14 g, 
8 mmol) with Al(Hg) gave after column chromatography (CHClj/MeOH, 98/2, v/v) 1.54 g (76%) of 
3-(2-Hydroxyaininoethyl)indole(28) 
Procedure В was followed as described for 23. Reaction with 19 (1.5 g, 7.9 mmol) gave after 
evaporation of the solvent crude 28. The residue was not purified because of the instability of the 
compound. Spectroscopic data are identical with earlier published results.7 
Chapter 2.1 33 
3-(2-Hydroxyaminopropyl)indole(29) 
The same procedure was followed as described for 23. Reaction with 20 (8,23 g, 40.3 mmol) gave 
after column chromatography (CHCiyMeOH, 96/4, v/v) 7.5 g (98%) of 29. Spectroscopic data are 
identical with earlier published results.12b 
N(l)-[(teri-Butyloxy)carbonyl]-3-(2-HydroxyaminopropyI)indoIe (24) 
The same procedure was followed as described for 23. reaction with 21 (145 mg, 0.48 mmol) gave 
after column chromatography (CHCli/MeOH, 99/1, v/v) 74 mg (54%) of 30. Rf 0.20 (CHClj/MeOH, 
97/3, v/v); EIMS (70 eV) m/z (relative intensity) 290 (M+, 21), 189 (38), 130 ([Ο,ΗβΝΓ,ΙΟΟ); lH 
NMR δ 8.17 (m, IH, C(2)H), 7.67-7.19 (m, 4H, C(4)-C(7)H), 6.21 (br s, 2H, ΗΝΟΗ), 3.31 (m, IH, 
СН2СНСНз), 2.85 (t, 2H, indole C(3)-CH2), 1.68 (s, 9H, CXCHj^), 1.15 (d, 3H, CHCHj). 
Ethyl a-(2-propyloximino)-ß-(indoI-3-yl)propanoate (33) 
To a stirred solution of 73·4 (375 mg, 1.52 mmol) and 2-chloropropane (235 mg, 3 mmol) in DMSO 
(7 ML) at SCPC was added portionwise KOtBu (188 mg, 1.68 mmol). After completion of the 
reaction (3 hours) as was monitored by TLC (СНСІз/МеОН, 97/3, v/v) the reaction mixture was 
diluted with dichloromethane (50 mL) and successively washed with water (3x) an4 brine. The 
organic layer was dried (NajSC^) and the solvent evaporated in vacuo. The residue was subjected to 
column chromatography (CHCI3) to give 330 mg (76%) of 33. Oil; Rf 0.37 (СНСІз/МеОН, 97/3, 
v/v); EIMS (70 eV) m/z (relative intensity) 288 (M+, 32), 229 ([Μ-ΟΟ,Η-,Γ, 51), 155 (100), 130 
([C9H8N]+, 93); 'H NMR δ 8.12 (br s, IH, NH), 7.90-7.79 (m, IH, indole (4)H), 7.34-7.06 (m, 4H, 
indole C(2)H and C(5)-C(7)H), 4.68 (m, IH, NOCHtOtyj), 4.27 (q, 2H, ОСЩСЩ), 4.07 (s, 2H, 
indole C(3)CH2), 1.40 (d, 6H, NOCHiCHj)^, 1.29 (t, 3H, OCHjCHj). 
Ethyl a-(l-butyloximino)-ß-(indoI-3-yl)propanoate (34) 
The same procedure was followed as described for 33. Reaction with 73·4 (984 mg, 4 mmol), 
l-chlorobutane (1.2 g, 12 mmol) and KOtBu (0.5 g, 4.4 mmol) in DMSO at SCPC gave after column 
chromatography (CHCL) 930 mg (77%) of 34. Oil; Rf 0.83 (CHClj/MeOH, 97/3, v/v); EIMS (70 
eV) m/z (relative intensity) 302 (M+, 30), 229 ([M-COOEt]+, 60), 155 (100), 130 ([C^HgNr, 80); Ή 
NMR δ 8.09 (br s, IH, indole NH), 7.76-7.03 (m, 5H, C(2)H and C(4)-C(7)H), 4.30 (t, IH, 
ЖЭСНЛДгі (q, 2H, ОСН2СНз), 4.02 (d, 2H, indole C(3)CH2), 1.88-1.13 (m, 4H, 
ОСН2СН2СН2СНз), 1.24 (t, 3H, ОСН2СНз), 0.92 (t, 3H, ОСН2СН2СН2СНз). 
Ethyl a-(methylthiomethyloximino)-ß-(indol-3-yI)propanoate (35) 
The same procedure was followed as described for 33. Reaction with 73·4 (984 mg, 4 mmol), 
cc-chloromethylmethylsulfide (580 mg, 6 mmol) and KOtBu (493 mg, 4.4 mmol) in DMSO at room 
temperature gave after column chromatography (CHCI3) 586 mg (48%) of 35. Oil; Rf 0.80 
(CHCWMeOH, 97/3, v/v); EIMS (70 eV) m/z (relative intensity) 306 (M+, 43), 259 ( [ Ο ^ Η ^ Ν ^ Γ , 
15), 130 ([GjHgNr, 100); Ή NMR δ 7.98 (br s, IH, NH), 7.79-7.02 (m, 5H, indole C(2)H and 
C(4)-C(7)H), 5.34 (s, 2H, OCH2S), 4.24 (q, 2H, ОСН2СНз), 4.07 (s, 2H, C(3)-CH¿, 2.21 (s, 3H, 
SCH3), 1.27 (t, 3H, ОСН2СНз). 
Ethyl a-(methyloximino)-ß-(indoI-3-yl)propanoate (36) 
To a stirred solution of V·4 (246 mg, 1 mmol) and methyliodide (1 mL) in aceton (3 mL) was 
added Ag20 (250 mg, 1.08 mmol). After completion of the reaction (30 minutes) as was monitored 
by TLC (СНСІз/МеОН, 97/3, v/v) the reaction mixture was filtered and the filtrate evaporated in 
vacuo. The residue was subjected to column chromatography (CHCI3) to give 224 mg (86%) of 36. 
Oil; Rf 0.67 (СНСІз/МеОН, 97/3, v/v); EIMS (70 eV) m/z (relative intensity) 260 (M+, 46), 229 
( [ С . з Н ^ О г Г , 55), 155 ÜC,0H7N2]+, 100), 130 ([0,Η8Ν]+, 100); 'Η NMR δ 8.03 (br s, IH, NH), 
7.69-7.00 (m, 5H, C(2)H and C(4)-C(7)H), 4.25 (q, 2H, ОСН2СНз), 4.13 (s, 3H, OCH3), 4.04 (s, 2H, 
C(3)-CH2), 1.31 (t, 3H, ОСН2СНз). 
Ethyl a-[NJS-(2-(trimethylsilyl)ethyloxycarbonyl, hydroxy)amino]-ß-(indol-3-yl)propanoate 
(37) 
2-(Trimethylsilyl)ethylchloroformate22 (1.08 g, 6 mmol) was added dropwise to a stirred solution 
of 233·4 (1.0 g, 4 mmol) in CH2Cl2/dioxane, 1/1, v/v (25 mL). The reaction was monitored by TLC. 
Stirring was continued for 2 hours. The reaction mixture was concentrated to near dryness, dissolved 
in CH2C12 and subsequently washed with saturated NaHC03 and brine and dried with Na2S04. 
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Evaporation of the solvent gave a crystalline material which was subjected to column 
chromatography (CHCWn-hexane, 99.5/0.5, v/v) to yield 1.51 g. (96%) of 37. Crystallization from 
СНлСІг/п-Ьехапе: mp 101-102.5 0C; Rf 0.45 (CHClj/MeOH, 93/7, v/v); UV (MeOH) Xmax 224, 
274(sh), 281, 289 nm; CIMS (100 eV) m/z (relative intensity) 393 ([M+l]+, 9), 392 (M+, 23), 365 
(28), 349 (49), 321 (27), 247 ( [ М - О Д з С ^ Г , 11), 231 (53), 216 (67), 215 (95), 130 ([CçHgN]*, 
Ì00)M NMR δ 8.23 (br s, IH, NH), 7.77-7.19 (m, 5H, indole C(2) and C(4)-C(7)H), 6.53 (br s, IH. 
NOH), 5.11 (t, IH, J=7.8 Hz, HCCOOEt), 4.37 (q, 2H, OCH2CH3), 3.91 (m, 2H, OO^ObSi) , 3.51 
(d, 2H, J=7.8 Hz, Indole C(3)CH2), 1.39 (t, 3H, OCH2CH3), 0.71 (m, 2H, CH2Si), 0.0 (s, 9H, 
8і(СНз)з); Anal.Calcd. for C^HjgNjOjSi (Mw 392.531): C, 58.14; H, 7.19; N, 7.14. Found: С, 
57.83; H, 7.14; Ν, 7.16. 
3-[2-(N,N-(2-(Trimethylsil}1)ethyloxycarbonyl, hydroxy )aniino)ethyl]indole (38) 
The same procedure was followed as described for 37. 2-(Trimethylsilyl)ethylchlorofonnate22 (675 
mg, 3.75 mmol) and 28 (440 mg, 2,5 mmol) gave after column chromatography (EtOAc/n-hexane, 
40/60, v/v) 750 mg (91%) of 38. Crystallization from EtOAc/n-hexane: mp 95-970C; Rf 0.39 
(CHClj/MEOH, 97/3, v/v)); UV (MeOH) Xmax 224, 274(sh), 281, 289 nm; EIMS (70 eV) m/z 
(relative intensity) 320 (M+, 1), 157 ( [ ^ ο Η , ^ Γ , И), 130 ([0>Η8Ν]+, 100); Ή NMR δ 8.02 (br s, 
IH, NH), 7.70-7.04 (m, 5H, indole C(2) and C(4)-C(7)H), 6.25 (br s, IH, NOH), 4.11-3.87 (m, 2H, 
OCH,CH2Si), 3.90 (t, 2H, CH2N), 3.13 (t, 2H, Indole C(3)CH2), 0.89-0.68 (m, 2H, CH2Si), 0.0 (s, 
9H, 5і(СНз)з); Anal.Calcd. for C ^ H ^ N ^ S i (Mw 320469): C, 59.97; H, 7.55; N, 8.74. Found: 
C,59.91;H,7.62;N,8.70. 
3-[2-(N,N-(2-(Trmiethylsilyl)ethyloxycarbonyl, hydroxy )amino)propyl]indole (39) 
The same procedure was followed as described for 37. 2-(Trimethylsilyl)ethylchloroformate22 
(1625 mg, 9 mmol) and 29 (1.14 g, 6 mmol) gave after column chromatography (CHCU/n-hexane, 
99/1, v/v) 1.61 g (80%) of 39. Crystallization from CHClj/n-hexanemp 122-125 0C; Rf 0.29 
(CHClj/MeOH, 97/3, v/v); UV (MeOH) Xmax 224, 274(sh), 281, 289 nm; CIMS (100 eV) m/z 
(relative intensity) 334 (M+, 2), 291 (14), 230 (9), 158 ([C
n
H 1 2N]+, 100), 130 ([CçHgNr, 85), 73 ([8і(СНз)з]+, 100); •H NMR δ 8.07 (br s, IH, NH), 7.68-7.07 (m, 5H, indole C(2) and C(4)-C(7)H), 
6.20 (br s, IH, NOH), 4.53 (m, IH, HCCH3), 3.84 (m, 2H, OCH2CH2Si)( 3.18 and 2.94 (AB part of 
ABX spectrum, 2H, 2J=14.3 Hz, J=8.1 Hz, J=6.0 Hz, indole C(3)CH2), 1.36 (d, 3H, J=7.0Hz, 
HCCH3), 0.63 (m, 2H, CH2Si), 0.0 (s, 9H, 8і(СНз)з); Anal.Calcd. for C n H ^ N ^ S i (Mw 334.494): 
C, 61.04; H, 7.83; N, 8.37. Found: С, 60.83; H, 7.93; Ν, 8.16. 
Ethyl a-(benzyloxamino)-ß-(indol-3-yl)propanoate (45) 
Procedure A: A solution of HCl in ethanol (5 mL of a 7N solution) was added to a stirred solution 
of 323 (672 mg, 2.0 mmol) and borane-trimethylamine complex (TMA.B^Aldrich Chemical Co., 
210 mg, 2.9 mmol) in ethanol (5 mL) at room temperature. Stirring was continued for 24h at room 
temperature. The reaction mixture was then concentrated to dryness in vacuo. The residue was 
dissolved in dichloromethane and subsequently washed with saturated NaHCOs, water and brine. 
The organic layer was dried (Na2S04) and the solvent evaporated in vacuo. The residue was 
subjected to column chromatography (CHCyMeOH, 98/2, ν/) to give 566 mg (84%) of 45. 
Spectroscopic data are identical with results published earlier.3 
Procedure В: К2СОз (168 mg, 1.22 mmol) was added portionwise to a stirred solution of 37 (480 
mg, 1.22 mmol), benzylbromide (415 mg, 2.44 mmol) in DMSO (12 mL). After completion of the 
reaction (2 days) as was monitored by TLC (СНОз/МеОН, 99/1, v/v) the reaction mixture was 
diluted with dichloromethane (50 mL) and washed with water and brine. The organic layer was dried 
(Na2S04) a n d the solvent evaporated in vacuo. The residue was subjected to column chromatography (CHClj/MeOH, 98/2, v/v) to give 394 mg (67%) of 40. The product was immediately deprotected by 
addition of tetrabutylammoniumfluoride (TBAF) (1.7 mL of a IN solution on THF) to a stirred 
solution of 40 in dry THF (5 mL). Stirring was continued for 5h after which the reaction mixture was 
washed with water and brine. The organic layer was dried (MgSOJ and the solvent evapoarted in 
vacuo. The residue was subjected to column chromatography (EtOAc/n-hexane, 25/75, v/v) to give 
232 mg (84%) of 45. 
Ethyl a-(methyloxamino)-ß-(indol-3-yl)propanoate (46) 
Procedure A: The same procedure was followed as described for 45. Reaction with 36 (624 mg, 
2.4 mmol) and TMA.BH3 (210 mg, 2.9 mmol) gave after column chromatography (СНСІз/МеОН, 
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98/2, ν/) 456 mg (73%) of 46. Oil; Rf 0.20 (CHClj/MeOH, 97/3, v/v); EIMS (70 eV) m/z (relative 
intensity) 262 (M+, 41), 189 ([C
u
H 1 3 N 2 0] + , 18), 130 ([0,Η8Ν]+, 100); ХЯ NMR δ 8.12 (br s, IH, 
indole NH), 7.66-7.07 (m, 5H, C(2)H and С(4)-С(7)Н), 4.78 (br s, IH, HNOMe), 4.11 (q, 2H, 
OCH2CH3), 4.02 (t, IH, CHCOOEt), 3.49 (s, 3H, OCHj), 3.09 (d, 2H, C(3)CH2CH), 1.14 (t, 3H, 
ОСН2СНз). 
Procedure В: The same procedure was followed as described for 45. With 37 (392 mg, 1 mmol), 
Mel (156 mg, 1.1 mmol) and K2CO3 (138 mg, 1 mmol) in DMSO gave after column 
chromatography (CHCI3) 280 mg (69%) of 41. Deprotection with BU4NF gave 161 mg (89%) of 46. 
Ethyl a-(2-propyIoxamino)-ß-(indol-3-yl)propanoate (47) 
Procedure A was follwoed as described for 45. Reaction with 33 (1008 mg, 3.5 mmol) and 
TMA.BH3 (281 mg, 3.85 mmol) gave after column chtomatography (CHCVMeOH, 99/1, v/v) 673 
mg (74%) of 47. Oil; Rf 0.27 (CHCVMeOH, 99/1, v/v); EIMS (70 eV) m/z (relative intensity) 290 
(M+, 53), 217 ([C13H17N20]+, 22), 130 ([0,Η8Ν]+, 100); •Η NMR δ 8.03 (br s, IH, indole NH), 
7.66-7.02 (m, 5H, C(2)H and С(4)-С(7)Н), 4.11 (q, 2Н, 0СН2СНз), 4.03-3.3.74 (m, 2Н, ОСЩМе^ 
and CHCOOEt), 3.09 (d, 2H, С(3)СН2СН), 1.14 (t, ЗН, ОСН2СНз), 1.10 (d, 6Н, СН(СНз)2. 
Ethyl a-(l-butyloxamino)-ß-(indol-3-yl)propanoate (48) 
Procedure A was followed as described for 45. Reaction with 34 (900 mg, 3.0 mmol) and 
TMA.BH3 (460 mg, 6.3 mmol) gave after column chtomatography (CHC13) 833 mg (91%) of 48. 
Oil; Rf 0.35 (СНСІз/МеОН, 99/1, v/v); EIMS (70 EV) m/z (relative intensity) 304 (M+, 52), 231 
([M-COOEt]+, 24), 130 ([CnHgN]*, 100); Ή NMR δ 8.06 (br s, IH, indole NH), 7.67-7.04 (m, 5H, 
C(2)H and C(4)-C(7)H), 4.14 (q, 2H, ОСН2СНз), 4.01 (t, IH, CHCOOEt), 3.70 (t, IH, NOCH2), 
3.10 (d, 2H, C(3)CH2CH), 1.62-1.13 (m, 4H, ОСН2СН2СН2СНз), 1.13 (t, ЗН, ОСН2СНз), 0.89 (t, 
ЗН, ОСН2СН2СН2СНз). 
Ethyl a-(methylthiomethyloxainino)-ß-(indol-3-yl)propanoate (49) 
Procedure A was followed as described for 45. Reaction with 35 (520 mg, 1.7 mmol) and 
TMA.BH3 (620 mg, 8.5 mmol) gave after column chtomatography (CHCI3) 377 mg (72%) of 49. 
Oil; Rf 0.24 (CHCWeOH, 99/1, v/v); EIMS (70 eV) m/z (relative intensity) 308 (M+, 15), 190 
(22), 130 ([C9H8Nr, 100); λΗ NMR δ 8.03 (br s, IH, indole NH), 7.62-7.00 (m, 5H, C(2)H and 
C(4)-C(7)H), 4.77 (s, 2H, OCH2S), 4.11 (q, 2H, ОСН2СНз), 4.08 (t, IH, CHCOOEt), 3.13 (d, 2H, 
C(3)CH2CH), 1.14 (t, ЗН, ОСН2СНз). 
Ethyl a-(l-propyloxamino)-ß-(indoI-3-yl)propanoate (50) 
Procedure В was followed as described for 45. Reaction with 37 (480 mg, 1.22 mmol), 
1-bromopropane (300 mg, 2.44 mmol) and К2СОз (168 mg, 1.22 mmol) in DMSO (12 mL) gave 
after column chromatography (CHCI3) 376 mg (71%) of 42. Oil; RfíHS (CHClj/MeOH, 99/1, v/v); 
EIMS (70 eV) m/z (relative intensity) 434 (M+, 4), 215 (40), 130 ([0)Η8Ν]+, 100); 1П NMR δ 8.06 (br s, IH, indole NH), 7.72-7.12 (m, 5H, C(2)H and C(4)-C(7)H), 5.01 (X part of ABX spectrum, 
IH, CHCOOEt), 4.27 (q, 2H, OCH2CH3), 4.12-3.92 (m, 2H, OCH2CH2Si), 3.82 (t, IH, NOCH2), 
3.46 (m, 2H, C(3)CH2CH), 1.62 (m, 2H, OCH2CH2CH3), 1.33 (t, 3H, OCH2CH3), 0.92 (t, 3H, 
OCH2CH2CH3), 0.93-0.64 (m, 2H, CH2Si), 0.00 (s, 9H, Si(CH3)3). Deprotection with Bu4NF (1.7 
mL of a IN solution on THF) gave 225 mg (91%) of 50. Oil; Rf 0.73 (СНСІз/МеОН, 97/3, v/v); 
EIMS (70 eV) m/z (relative intensity) 290 (M+, 32), 217 ([C1 3Hi7N20]+, 20), 130 ([CgHgNr, 100); 
'H NMR δ 8.06 (br s, IH, indole NH), 7.69-7.08 (m, 5H, C(2)H and С(4)-С(7)Н), 5.85 (br s, IH, 
HNO), 4.14 (q, 2H, ОСН2СН3), 4.02 (t, IH, CHCOOEt), 3.67 (t, IH, NOCH2), 3.10 (d, 2H, 
C(3)CH2CH), 1.54 (m, 2H, OCH2CH2CH3), 1.17 (t, ЗН, ОСН2СНз), 0.89 (t, 3H, OCH2CH2CH3). 
3-(2-MethyIoxaminoethyl)indole (51) 
Sodium hydride (58 mg, 2.42 mmol) was added to a a cooled (-10oC) stirring solution of 38 (700 
mg, 2.2 mmol) in dry DME (10 mL) in an argon atmosphere. The reaction mixture was allowed to 
warm to room temperature by which H2-evolution occurred. Methyliodide (625 mg, 4.4 mmol) was 
added to the resulting clear solution. The alkylated product 43 was not isolated but after overnight 
stirring BU4NF (4.4 mL, IN solution in THF) was added. The reaction mixture was stirred for an 
additional 8 hours, after which the reaction mixture was diluted with EtOAc (25 mL) and 
subsequently washed with a saturated NaHC03 and a IN HCl and brine solution. The organic layer 
was dried (MgSO j^) and the solvent evaporated in vacuo. The residue was subjected to column 
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chromatography (EtOAc/n-hexane, 25/75, v/v) 305 mg (68%) of 51. Oil; Rf 0.38 (СНСІз/МеОН, 
97/3, v/v); EIMS (70 eV) m/z (relative intensity) 204 (M+, 4), 131 (100), 130 ([C9H8N]+, 59); Ή 
NMR δ 8.03 (br s, IH, indole NH), 7.67-7.03 (m, 5H, C(2)H and C(4)-C(7)H), 3.56 (s, 3H, NOCH3), 
3.48-3.20 (m, IH, CHCH3), 2.89 (t, 2H, indole C(3)CH2), 1.13 (d, 3H, CH3). 
3-(2-Methyloxaminopropyl)indole (52) 
Sodium hydride (66 mg, 2.75 mmol) was added to a a cooled (-10oC) stirring solution of 39 (835 
mg, 2.5 mmol) in dry DME (10 mL) in an argon atmosphere. The reaction mixture was allowed to 
warm to room temperature by which Hj-evolution occurred. Methyliodide (625 mg, 4.4 mmol) was 
added to the resulting clear solution. The alkylated product 44 was not isolated but after overnight 
stirring BU4NF (5 mL, IN solution in THF) was added. The reaction mixture was stiired for an 
additional 8 hours, after which the reaction mixture was diluted with EtOAc (25 mL) and 
subsequently washed with a saturated NaHC03 and a IN HCl and brine solution. The organic layer 
was dried (MgSO,^ and the solvent evaporated in vacuo. The residue was subjected to column 
chromatography (CHCWn-hexane, 60/40, v/v) to give 330 mg (70%) of 52. Oil; Rf 0.34 
(CHClj/MeOH, 97/3, v/v); EIMS (70 eV) m/z (relative intensity) 190 (M+, 20), 130 ([CçHgNr, 
100); Ή NMR δ 8.00 (br s, IH, indole NH), 7.68-7.05 (m, 5H, C(2)H and С(4)-С(7)Н), 3.57 (s, ЗН, 
NOCHj), 3.36-2.93 (m, 4H, indole C(3)CH2CH2), 1.78 (br s, IH, HNO). 
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Chapter 22 
AN APPROACH TO OPTICALLY ACTIVE N-HYDROXYTRYPTOPHAN BY 
ASYMMETRIC REDUCTION OF THE OXIME DOUBLE BOND. 
Although there is strong evidence for a role of N-hydroxytryptophan (1) as intermediate in the 
biosynthesis of several natural products1, this N-hydroxy-amino acid has still not been obtained in 
the optically pure form neither by synthesis nor by isolation. It has been demonstrated that 1 can be 
employed as a building block for chiral natural products such as 42 and in general for 
1,3-disubstituted 1,2,3,4-tetrahydro-ß-carbolines3 {e.g. 5). In order to obtain a complete 
α 
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stereoselective total synthesis of these compounds it is most advantageous to start with optically 
active N-hydroxytryptophan. 
So far, Feenstra et.al. developed three different approaches to homochiral N-hydroxy-a-amino acid 
derivatives. The first one features a substitution reaction involving triflates of α-hydroxy esters and 
hydroxylamine or derivatives thereof.4 The second approach is based on the selective N-oxidation of 
derivatives of optically active amino acids5 and the third one is based on the enzymatic resolution of 
N-benzyloxy-amino acid ethyl esters.6 These approaches failed however when tryptophan was 
involved, mainly due to the reactivity of the indole nucleus. 
Consequently an alternative approach was searched for, employing one of the two routes to 
N-hydroxytryptophan described in Chapter 2.1 (Scheme I, Routes A and B).7 We reasoned that an 
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asymmetric reduction of the oxime double bond in Route A might be an attractive avenue to 
optically active N-hydroxytryptophan. The chirality can be transferred either from a chiral auxiliary 
group present in the oxime derivative or from a chiral reducing agent. We chose to study the first 
alternative and for obvious reasons the ester group was considered as a suitable function to introduce 
chirality. (Scheme II). As chiral auxiliaries the alcohols (-)-menthol, (-)-8-phenylmenthol and 
Scheme II 
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6: R*=(-)-memhyl 9: R*=(-)-menthyl 
7: R|=(-)-e-phenylmenthyl 10: R[-(-)-8-phenylmenthyl 
8: R'=(-)-8-(P-naphtyl)menthyl 11 : R*-(-)-8-(p-naphtyl)menthyl 
(-)-8-(ß-naphtyl)menthol were examined. The latter two chiral inductors originally prepared by 
Corey and Ensley8 are known to be remarkably efficient, giving excellent asymmetric induction in 
several types of reactions.9 
Results 
Transesterfication of oxime 2 by a mild method10 using titanium (IV) isopropoxide and an excess 
of (-)-menthol (5 equiv.) in dioxane at 850C gave б in 85% yield (Scheme ІП). This method failed 
however when the more bulky alcohols 8-phenyl- and 8-(ß-naphtyl)menthol were used. Therefore, 
the direct coupling between the alcohol and an activated carboxylic acid derivative was studied. 
Saponification of 2 with 2N NaOH in dioxane gave the carboxylic acid 12 (Scheme ПІ) in 70% 
yield. Activation of the latter with dicyclohexylcarbodiimide (DCC) and 4-dimethylaminopyridine 
(DMAP) in the presence of (-)-menthol failed to give the coupling product 6, but instead 
3-indolylacetonitrile (13) was obtained. We reasoned that decomposition of 12 in the activation step 
could be circumvented by the protection of the oxime function. Tsuji11 introduced the O-allyl ether 
as a convenient protective group for oximes, which can be deprotected easily by the 
palladium-catalyzed reaction with triethylammonium formate. We obtained the O-allyl ether 14 in 
85% yield by treatment of 2 with KOrBu and allylbromide in DMSO. Saponification of 14 under 
standard conditions gave the carboxylic acid 15 in 96% yield. Activation of the latter with DCC and 
DMAP in the presence of (-)-menthol, (-)-8-phenylmenthol or (-)-8-(ß-naphtyl)menthol in 
acetonitnle gave the coupling products 16, 17 and 18 in yields of 90, 77 or 78%, respectively. The 
deprotection of the allylic ethers was carried out in refluxing aqueous acetonitnle in the presence of 
Pd(OAc)2 (0.01 equiv.), triphenylphosphine (0.04 equiv.) and triethylammonium formate (3 equiv.) 
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 16: R*=(-)-menthyl 
17: R*«(-)-8-phenylmenthyl 
18: R*=(-)-8-(ß-naphtyl)menthyl 
i) Ti(0-i-C3H7)4l (-)-menlhol, dioxane 85°C, ii) 2N NaOWdioxane Ш) DCCIDMAPI R*OH iv) ailyl bromdelKOtBu, DMSO 
v) Pd(OAc)21 PPh31 HCOONHEl3,80% aq.CHjCN, reflux 
to give 6,7 and 8 in 89,96 and 100% yield, respectively. 
Reduction of the oxime double bond was accomplished by treatment of 6-8 with 
trimethylamine-borane complex in dioxane in the presence of hydrochloric acid to give 9-11 
(Scheme П). The chemical yields and diastereomeric excesses (de) of the reduction are given in 
Table I. Reduction of the menthyl derivative 6 (entry 1) gave no induction and a 1/1 mixture of the 
Table I 
entry chem.y¡elda de(%)a 
1 
2 
3 
(-)-menthyl 
(-)-8-phenylmemhyl 
(-)-8-(ß-naphtyl)menthyl 
85 
72 
89 
0 
49 
69 
a) Based on isolated compounds 
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diastereomers of 9 were isolated12; they could not be separated. Although a significant improvement 
in the level of induction was obtained with 8-phenylmenthyl ester (entry 2), the de is still moderate. 
We observed a further increase in the induction level by using (-)-8-(ß-naphtyl)menthyl (entry 3). 
However, a complete diastereofacial control could not be achieved. The two diastereomers of the 
mixtures 10 and 11 could be readily separated by column chromatography. 
The stereochemical outcome can be rationalized with the "π-stacking" model previously proposed 
by Oppolzer14. The aryl group of the inductor shields one face of the oxime double bond, thereby 
directing the addition of the hydride to the other face. This interpretation is strongly supported by a 
comparative Ή NMR study that indicates that the shielding of the indole C(3)-CH2 protons of 6 is 
identical to that observed for 2, while these protons in the 8-phenyl- and the 8-(ß-naphtyl)menthyl 
oximes 7 and 8 gave separated signals. In the latter two compounds these diastereotopic protons are 
shifted upfield (0.5-0.6 ppm (Ha) and 0.1-0.2 ppm (Hb) for 7 and 0.9-1.0 ppm (Ha) and 0.5-0.6 ppm 
(Hb) for 8 (Chart I). These observations are a firm indication that the "π-stacked" conformation, as 
1
Η NMR δ (ppm) 
Ha Hb 
4.20 4.20 
4.09 4.09 
3.57 3.97 
3.22 3.60 
I 
Η 
depicted in Chart I, exists in solution. It is reasonable to assume that protonation of the oxime 
nitrogen prior to the attack of the hydride does not affect this conformation. 
Unfortunately, the target molecules could not be prepared because the chiral auxiliaries (8-phenyl-
and 8-(ß-naphtyl)menthol) could not be removed from the hydroxylamine derivatives 10 and 11. 
Chart! 
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Various transesterfication methods such as MeOH/fySC^, reflux; Ті(ОіСзН7)4/ЕЮН, reflux; 
MeOH/HCl gave starting material or unidentified products. 
Moreover, it was also impossible to establish the absolute configuration of both diastereoisomers 
of 10 and 11 by X-ray analysis as all crystallization attempts failed. However, according to the 
models as depicted in Chart I attack on the re face of the oxime unit has to be expected, resulting in 
an S-configuration at the α-carbon atom of the major isomer. 
In conclusion, the asymmetric reduction of the oxime double bond is feasible. However, it has not 
yet yielded an approach to optically pure N-hydroxytryptophan as removal of the chiral auxiliary has 
not been achieved so far. The excellent asymmetric induction recently observed by Corey in the 
reduction of ketones with borane in the presence of a catalytic amount of chiral oxazaborolidines15 
makes a study of the approach via chiral reducing agents (vide supra) more worthwhile. 
Experimental Section 
Melting points were taken on a Koefler hot stage (Leitz-Wetzlar) and are uncorrected. Ultraviolet 
spectra were measured with a Perkin Elmer spectrometer. Model lambda 5. Proton magnetic 
resonance spectra were measured on a Bruker WH-90 or on a Bruker AM 400 spectrometer. 
Chemical shifts are reported as δ-values relative to tetramethylsilane as an internal standard; 
deuteriochloroform was used as solvent unless stated otherwise. Mass spectra were obtained with a 
double-focusing VG 7070E spectrometer. Thin-layer chromatography (TLC) was carried out by 
using silica gel F-254 plates (thickness 0.25 mm). Spots were visualized with a UV hand lamp, 
iodine vapor, or CI2-TDM.16 For column chromatography Merck silica gel (type 60H) was used. 
a-(Hydroxyiniino)-ß-indol-3-ylpropanoate (12) 
A solution of 2N NaOH (8 mL) was added to a stirred solution of 21 (2.48 g, 10 mmol)in dioxane 
(20 mL). Stirring was continued aEBt room temperature under argon for 3 days after which the 
reaction mixture was neutralized with 4N HCl and washed with ethyl acetate. The organic layer was 
washed with brine, dried (MgSO,^ ) and concentrated to dryness. The residue was crystallized from 
MeOH/H20 to give 1.05 g (70%) of 12. mp 151-1530C; Rf 0.00 (CHClj/MeOH, 93/7, v/v); EIMS (70 eV) m/z (relative intensity) 218 (M+, 20), 201 ([M-OH]+, 8), 156 ([C1QHgN2]+, 80), 155 ([C10H7N2]+, 100); Ή NMR (CDCU/CDjOD) δ 8.93 (br s, IH, ΜΗ), 7.80-6.97 (m, 4Η, indole 
С(4)-С(7)Н), 7.00 (s, IH, indole C(2)H)m 4.06 (s, 2H, indole C(3)CH2); Anal. Caled, for 
CiiH i0N2 o3 (Mw 218.215) :C, 60.55; H, 4.62; N, 12.84. Found: С, 59.97; H, 4.56; Ν, 12.64. 
Ethyl a-(3-propeneoximino)-ß-indol-3-ylpropanoate (14) 
To a stirred solution of 21 (5 g, 20 mmol) and allylbromide (5g, 40 mmol) in DMSO 50 mL) was 
added portionwise KOrBu (2.46 g, 22 mmol) at room temperature. After completion of the reaction 
(2d.) as was monitored by TLC (CHCyMeOH, 99/1, v/v) dichloromethane was added (150 mL). 
The reaction mixture was washed with water (3x 200 mL) and IN HCl. The organic layer was 
washed with brine, dried (N32804) and concentrated to dryness. The residue was subjected to 
column chromatography (CHCI3) to give 4.9 g (85%) of 14. Oil; Rf 0.64 (CHClj/MeOH, 99/1, v/v); 
EMS (70 eV) m/z (relative intensity) 286 (M+, 26), 229 ([М-СзН50]+, 32), 155 (71), 130 ([C9H8N]+, 100); Ή NMR δ 8.06 (br s, IH, NH), 7.77-6.98 (m, 5H, indole C(4)-C(7)H and C(2)H), 
6.29-5.84 (m, IH, OCH2CH=), 5.43-5.18 (m, 2Н, СН=СН2), 4.81 (dd, 2Н, NOCHj), 4.27 (q, 2Н, 
ОСН2СН3), 4.09 (s, 2Н, indole С(3)СН2), 1.26 (t, ЗН, ОСН2СН3). 
a-(3-propeneoximino)-ß-indol-3-ylpropanoate (15) 
The same procedure was followed as described for 12. Reaction of 14 (2.33 g, 8.1 mmol) gave after 
column chromatography (СНСІз/МеОН/НОАс, 87/10/3, v/v/v) 2.1 g (96%) of 15. Oil; Rf 0.47 
(CHClj/MeOH/HOAc, 87/10/3, v/v/v); EIMS (70 eV) m/z (relative intensity) 258 (M+, 29), 201 
([М-СзНзОГ, 15), 155 (92), 130 ([C9HgN]+, 100); Ή NMR δ 8.04 (br s, IH, NH), 7.81-7.04 (m, 5H, 
indole C(4)-C(7)H and C(2)H), 6.27-5.82 (m, IH, OCHjCH^, 5.47-5.26 (m, 2H, O^CHj), 4.82 
(dd, 2H, NOCH2), 4.33 (br s, IH, OH), 4.08 (s, 2H, indole C(3)CH2). 
Chapter 2.2 43 
(-)-Menthyl a-(3-propeneoximino)-ß-indol-3-ylpropanoate (16) 
To a stirred solution of 15 (45 mg, 0.17 mmol), (-)-menthol (27 mg, 0.17 mmol) and DMAP (0.1 
equiv.) in acetonitrile (5 mL), DCC (36 mg, 0.17 mmol) was added at room temperature under argon 
atmosphere. After completion of the reaction (24h) as was monitored by TLC (EtOAc/n-hexane, 
35/65, v/v) the reaction mixture was filtered and the filtrate concentrated to dryness. The residue was 
subjected to column chromatography (EtOAc/n-hexane, 10/90, v/v) to give 61 mg (90%) of 16. Oil; 
Rf 0.62 (EtOAc/n-hexane, 35/65, v/v); CIMS (100 eV) m/z (relative intensity) 357 ([M+l]+, 14), 396 
(M+, 12), 341 (16), 201 (79), 130 ([C9H8N]+, 100); rH NMR δ 7.97 (br s, IH, NH), 7.78-7.03 (m, 
4H, indole С(4)-С(7)Н), 7.10 (s, IH, indole C(2)H), 6.27-5.95 (m, IH, OCH2CH=), 5.40-5.18 (m, 
2H, CH=CH2), 4.98-4.73 (m, IH, menthol C(l)H), 4.10 (s, 2H, indole C(3)CH2), 2.10-1.00 (m, 9H, 
menthol C(2)H, C(3)H2- C(4)H2, C(5)H, C(6)H2 and C(8)H), 0.90 (d, 3H, J=6.1Hz, С(8)СНз), 0.81 (d, 3H, J=6.8Hz, С(8)СНз), 0.68 (d, 3H, J=6.7Hz, С(5)СНз) 
(-)-8-Phenylmenthyl a-(3-propeneoximino)-ß-indol-3-ylpropanoate (17) 
The same procedure was followed as described for 16. Reaction of 15 (500 mg, 1.94 mmol), 
(-)-8-phenylmenthol (Aldrich: 494 mg, 2.13 mmol), DCC (439 mg, 2.13 mmol) and DMAP (24 mg, 
0.2 mmol) gave after column chromatography (n-hexane/EtOAc, 90/10, v/v) 708 mg (77%) of 17. 
Oil; Rf 0.48 (n-hexane/EtOAc, 2/1, v/v); [а] й р +1052 (c=1.55, methanol); EIMS (70 eV) m/z 
(relative intensity) 472 (M+, 31), 201 (71), 155 (52), 130 ([0)Η8Ν]+, 100); 'Η NMR δ 7.97 (br s, IH, 
NH), 7.70-6.96 (m, ЮН, indole C(4)-C(7)H, С(2)Н and С6Н5), 6.28-5.85 (m, IH, ОСН2СН=), 
5.43-5.21 (m, 2Н, СН=СН2), 4.87 (dt, IH, menthol C(l)H), 4.78 (dd, 2H, NOCH^, 3.92 and 3.46 (AB spectrum, 2H, 2J=14.0Hz, indole C(3)CH2), 2.11 (br t, Ш, menthol C(2)H), 1.78-0.60 (m, 7H, 
menthol C(3)-C(4)H2, C(5)H and С(6)Н2), 1.23 (s, 6Н, С(8)(СНз)2), 0.69 (d, ЗН, С(5)СНз). 
(-)-8-(ß-Naphtyl)menthyl a-(3-propeneoximino)-ß-indol-3-ylpropanoate (19) 
The same procedure was followed as described for 16. Reaction of 15 (500 mg, 1.94 mmol), 
(-)-8-(ß-naphtyl)menthol8 (551 mg, 1.95 mmol), DCC (439 mg, 2.13 mmol) and DMAP (24 mg, 0.2 
mmol) gave after column chromatography (n-hexane/EtOAc, 90/10, v/v) 795 mg (78%) of 18. Oil; 
Rf 0.33 (EtOAc/n-hexane, 1/4, v/v); EIMS (70 eV) m/z (relative intensity) 522 (M+, 20), 201 (24), 
169 ([СнНиГ, 100), 155 ([C 1 2 H n ] + , 60). 141 ([СпЩ]+, 34), 130 ([C^gNr, 44); Ή NMR 7.91 (br s, IH, NH), 7.80-6.87 (m, 12H, indole C(4)-C(7)H, C(2)H and ß-naphtyl), 6.18-5.76 (m, IH, 
OCH2CH=), 5.36-5.16 (m, 2H, CH=CH2), 4.98 (dt, IH, menthol C(l)H), 4.59 (dd, 2H, NOCH,), 
3.54 and 3.13 (AB spectrum, 2H, 2J=14.9Hz, indole C(3)CH¿, 2.17 (dt, IH, menthol C(2)H), 
1.78-0.69 (m, 7H, menthol C(3)-C(4)H2, C(5)H and C(6)HJ, 1.36 and 1.29 (2xs, 6H, С(8)(СНз)2), 
0.80 (d, ЗН, С(5)СНз). 
(-)-Menthyl a-(hydroxyiinino)-ß-indol-3-ylpropanoate (6) 
Procedure A: Titanium(IV)isopropoxide (734 mg, 2.6 mmol) was added to a stirred solution of 21 
(4.92 g, 20 mmol) and (-)-menthol (15.6 g, 100 mmol) in dioxane (1.5 mL) at 850C under an argon 
atmosphere. After completion of the reaction (24 h) as was monitored by TLC (n-hexane/EtOAc, 
70/30, v/v) the solvent was evaporated in vacuo. The residue was dissolved in dichloromethane and 
washed successively with In HCl, 0.1 N №НСОз and brine. The organic layer was dried (Na2S04) 
and concentrated to dryness. The residue was subjected to column chromatography 
(n-hexane/EtOAc, 20/80, v/v) to give 6.09 g (85%) of 6. Crystallized from CH^CU/n-hexane: mp 
151-1520C; Rf 0.52 (n-hexane/EtOAc, 70/30, v/v); [a]2 2n -59° (c=2.3, methanol); CIMS (100 eV) 
m/z (relative intensity) 357 ([M+l]+, 14), 356 (M+, 22), 341 (16), 219 (79), 130 ([CoHgNr, 100); Ή 
NMR δ 7.99 (br s, IH, NH), 7.80-7.02 (m, 4H, indole C(4)-C(7)H), 7.10 (s, IH, indole C(2)H), 
4.98-4.70 (m, IH, menthol C(l)H), 4.09 (s, 2H, indole C(3)CH2), 2.10-1.00 (m, 9H, menthol C(2)H, 
C(3)H2- C(4)H2, C(5)H, C(6)H2 and C(8)H), 0.91 (d, 3H, J=6.1Hz, С(8)СНз), 0.79 (d, 3H, J=6.8Hz, 
С(8)СНз), 0.65 (d, 3H, J=6.7Hz, С(5)СНз); Anal. Caled, for C ^ H ^ O j (Mw 356.468): C, 69.74; 
H, 7.92; N, 7.86. Found: С, 69.81; H, 7.84; Ν, 7.73. 
Procedure В: A solution of 16 (50 mg, 0.125 mmol), Pd(OAc)2 (0.28 mg, 0.00125 mmol), РРІіз (1.3 mg, 0.005 mmol) and HCOONHEt3 (160 mg, 0.375 mmol) in 80% aqueous acetonitrile was 
refluxed. After completion of the reaction (Ih) as was monitored by TLC (СНСІз/МеОН, 97/3, v/v) 
the reaction mixture was diluted with ethyl acetate and subsequently washed with brine. The organic 
layer was dried (MgSO,,) and the solvent evaporated in vacuo. The residue was subjected to column 
chromatography (CHClj/MeOH, 97/3, v/v) to give 40 mg (89%) of 6. 
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(.).8-PhenyImenthyI a-(hydroxyimino)-ß-indol-3-ylpropanoate (7) 
Procedure В was followed as described for 6. Reaction of 17 (500 mg, 1.06 mmol), Pd(OAc)2 (2.37 
mg, 0.0106 mmol), PPhj (11 mg, 0.0424 mmol) and HCOONHEt, (1.3 mg, 3.18 mmol) gave after 
column chromatography (EtOAc/n-hexane, 20/80, v/v) 440 mg (96%) of 7. White solid material. 
Crystallization attempts failed. Rf 0.26 (EtOAc/n-hexane, 1/2, v/v), [a ] 2 2 D +863 (c=1.75, methanol); 
EIMS (70 eV) m/z (relative intensity) 432 (M+, 45), 218 (39), 201 (94), 155 (37), 130 ([Ο,Η,,ΝΓ, 
100); Ή NMR δ 7.98 (br s, IH, NH), 7.81-7.00 (m, ЮН, indole C(4)-C(7)H, С(2)Н and СЛ^), 4.98 
(dt, IH, menthol C(l)H), 3.97 and 3.57 (AB spectrum, 2H, 2J=14.1Hz, indole C(3)CH2), 2.05 (br t, 
IH, menthol C(2)H), 1.91-0.70 (m, 7H, menthol C(3)-C(4)H2, C(5)H and C(6)H2), 1.24 and 1.19 (2x8,6H, СХвКаад, 0.80 (d, 3H, С(5)СНз). 
(-)-8-(ß-NaphtyI)menthyI a-(hydroxyimino)-ß-indol-3-ylpropanoate(8) 
Procedure В was followed as described for 6. Reaction of 18 (740 mg, 1.41 mmol), Pd(OAc)2 (6.3 
mg, 0.028 mmol), PPhj (30 mg, 0.11 mmol) and НСООМНЕіз (1.8 mg, 4.16 mmol) gave after 
column chromatography (EtOAc/n-hexane, 20/80, v/v) 680 mg (100%) of 8. White solid material. 
Crystallization attempts failed. Rf 0.81 (EtOAc/n-hexane, 1/1, v/v); EIMS (70 eV) m/z (relative 
intensity) 482 (M+, 16), 202 (28), 201 (27), 169 ([C^H^r, 100), 155 ([СиНцГ, 48), 141 
([СцНдГ, 24), 130 ([CoHgN]-·-, 50); ХП NMR 7.92 (br s, IH, NH), 7.79-6.96 (m, 12H, indole 
C(4)-C(7)H, C(2)H and ß-naphtyl), 5.04 (dt, IH, menthol C(l)H), 3.60 and 3.22 (AB spectrum, 2H, 
2J=14.0Hz, indole C(3)CH2), 2.16 (dt, IH, menthol C(2)H), 1.78-0.69 (m, 7H, menthol C(3)-C(4)H2, 
C(5)H and С(6)Н2), 1.36 and 1.29 (2x8, 6Н, С(8)(СНз)2), 0.84 (d, ЗН, С(5)СНз)· 
(-)-Menthyl a-(hydroxyamino)-ß-indol-3-ylpropanoate (9) 
A solution of HCl in dioxane (37 mL of a 7N solution) was added dropwise to a stirred solution of 
б (5.43 g, 15.3 mmol) and Με?Ν.ΒΗ3 (1.22 g, 16.8 mmol) in dioxane (60 mL) at room temperature 
under an argon atmosphere. Sarring was continued for 2h. The reaction mixture was concentrated to 
dryness; the residue dissolved in dichloromethane; the solution was neutralized with 0.1 N NaHCC^ 
, washed with brine and dried with Na2S04. The residue obtained after evaporation of the solvent in 
vacuo, was subjected to column chromatography iCHCl2/MeOH, 98.5/1.5, v/v) to give 4.66 g (85%) 
of 9. The two diastereomers in a ratio of 1/1l2 could not be separated. White solid. Rf 0.43 
(СНСІз/МеОН, 93/7, v/v); CIMS (100 eV) m/z (relative intensity) 359 ([M+l]+, 39), 343 ([M-OH]+, 
60), 221 (54), 130 ([C9HgN]+, 100); 'H NMR of the mixture of diastereomers δ 8.05 (br s, IH, NH), 
7.67-7.05 (m, 5H, indole C(2)H and indole C(4)-C(7)H), 5.29 (br s, IH, HNOH of diastreomer a), 
5.19 (br s, IH, HNOH of diastereomer b), 4.91-4.59 (m, IH, menthol C(l)H), 3.97 (X part of ABX 
spectrum, IH, indole C(3)CH2CH), 3.18-3.05 (AB part of ABX spectrum, 2H, 2J=14.4Hz, J=4.4Hz, 
J=8.9Hz, indole C ^ C H ^ , 2.10-1.00 (m, 9H, menthol C(2)H, C(3)-C(4)H2, C(5)H ,C(6)H2 and 
C(8)H), 0.89-0.62 (m, 9H, menthol С(5)СНз and С(8)(СНз)2). 
(-)-8-Phenylmenthyl a-(hydroxyamino)-ß-indol-3-ylpropanoate (10) 
The same procedure was followed as described for 9. Reaction of 7 (385 mg, 0.89 mmol) and 
Мез^ВНз (65 mg, 0.9 mmol) gave after column chromatography (EtOAc/n-hexane, 1/2, v/v) 71 mg 
(18%) of diastereomer a and 206 mg (54%) of diastereomer b. 
Diastereomer a: White solid. Crystallization attemps failed. Rf 0.63 (EtOAc/n-hexane, 1/1, v/v); 
EIMS (70 eV) m/z (relative intensity) 434 (M+, 4), 416 ([Μ-Η2θ]+, 10), 202 (40), 130 ([ά)Η8Ν]+, 
100), 119 ([CçH,!]-1-, 94); 'H NMR δ 8.67 (br s, IH, NH), 7.54-6.89 (m, ЮН, indole C(Í)H and 
C(4)-C(7)H and С6Н5), 6.71 (br s, 2H, HNOH), 4.91 (dt, IH, menthol C(l)H), 3.55 (br t, IH, indole 
C(3)CH2CH), 3.04 (br d, 2H, indole C(3)CH2), 2.13-1.00 (m, 8H, menthol C(2)H, C(3)-C(4)H2, 
С(5)Н and С(6)Н2), 1.24 and 1.13 (2xs, 6Н, С(8)(СНз)2), 0.86 (br d, ЗН, С(5)СНз). 
Diastereomer b: White solid. Crystallization attemps failed. Rf 0.52 0.63 (EtOAc/n-hexane, 1/1, 
v/v); [a] 2 2 D +55 (c=2.2, methanol); EIMS (70 eV) m/z (relative intensity) 434 (M+, 2), 416 ([Μ-Η2θ]+, 6), 202 (26), 130 ([α,Η8Ν]+, 100), 119 {[0<μηΫ, 59); ХЯ NMR δ Ή NMR δ 8.43 (br s, 
IH, NH), 7.49-6.99 (m, ЮН, indole C(2)H and C(4)-C(7)H and С Щ, 6.53 (br s, 2H, HNOH), 4.80 
(dt, IH, menthol C(l)H), 3.46 (br t, IH, indole C^CHjCH), 2.93 (br d, 2H, indole C(3)CH2), 
2.11-0.61 (m, 8H, menthol C(2)H, C(3)-C(4)H2, C(5)H and ОДНг), 1.31 and 1.21 (2xs, 6H, 
С(8)(СНз)2), 0.83 (br d, ЗН, С(5)СНз). 
(-)-8-(ß-Naphtyl)menthyl a-(hydroxyamino)-ß-indol-3-ylpropanoate(ll) 
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The same procedure was followed as described for 9. Reaction of 8 (700 mg, 1.45 mmol) and 
МезМ.ВНз (210 mg, 2.92 mmol) gave after column chromatography (CHClj/MeOH, 99/1, v/v) 86 
mg (12%) of diastereomer a and 463 mg (66%) of diastereomer b. 
Diastereomer a: White solid. Crystallization attemps failed. Rf 0.21 (EtOAc/n-hexane, 1/2, v/v); 
[a] 2 2 D -274 (c=1.9, methanol); EIMS (70 eV) m/z (relative intensity) 466 (M+, 5), 277 (15), 202 (43), 
169 ([С^НізГ, 71); 155 ([С^НцГ, 37), 141 ([С
п
Щ]+. 18), 130 ([CçHgNr, 100); Ή NMR δ 7.96 
(br s, IH, NH), 7.80-7.01 (m, ПН, indole C(2)H and C(4)-C(7)H and ß-naphtyl), 6.72 (d, IH, 
naphtyl otH), 5.00 (dt, IH, menthol C(l)H), 3.23 (X paît of a ABX spectium, IH, indole 
C(3)CH2CH), 2.87 and 2.77 (AB paît of ABX spectrum, 2H, 2J=14.4Hz, J=4.3 Hz, J=10.0 Hz, 
indole C(3)CH2), 2.21 (dt, IH, menthol C(2)H), 2.04-0.61 (m, 7H, menthol C(3)-C(4)H2, C(5)H and 
C(6)H2), 1.38 and 1.26 (2xs, 6H, С(8)(СНз)2), 0.88 (d, 3H, С(5)СНз). 
Diastereomer b: White solid. Crystallization attemps failed. Rf 0.16 (EtOAc/n-hexane, 1/2, v/v); 
[a]2 2n -36 (c=1.95, methanol); EMS (70 eV) m/z (relative intensity) 466 (M+, 17), 202 (53), 169 
аСиНиГ, 69); 155 ([СцНцГ, 36), 141 ([СцНоГ, 20), 130 ([CÇHRN]*, 100); •H NMR δ 7.93 (br s, 
IH, NH), 7.82-7.02 (m, 1 IH, indole C(2)H and C(4)-C(7)H and ß-naphtyl), 6.65 (d, IH, naphtyl 
αΗ), 4.91 (dt, IH, menthol C(l)H), 3.08 (X part of a ABX spectrum, IH, indole C^CHjCH), 2.77 
and 2.70 (AB part of ABX spectrum, 2ΗΛ=14.7Ηζ, J=5.7 Hz, J=8.3 Hz, indole С(Ъ)СЩ, 2.18 (dt, 
IH, menthol C(2)H), 1.91-0.60 (m, 7H. menthol C(3)-C(4)H2, C(5)H and С(6)Н2), 1.44 and 1.29 (2xs, 6H, С(8)(СНз)2), 0.84 (d, ЗН, С(5)СНз). 
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CHAPTER 3 
Syntheses of 3,4-dihydro-ß-carboline nitrones from 
N-hydroxy-tryptophan and -tryptamine derivatives 
and their 1,3-dipolar cycloaddition with nitriles. 
O o ^ - G X C — OciOC"' 
H H Rj H N = / 
"1,3-Dipolar Cycloaddition of Nitrones with Nitriles. Scope and Mechanistic Study" 
Pedro H.H. Hermkens, Jan H. v. Maarseveen, Chris G. Kruse, Hans W. Scheeren, 
Tetrahedron (1989), 30, 5009. 
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Chapter 3.1 
INTRODUCTION 
Compounds containing the ß-carboline structure have aroused considerable interest in 
neuropharmacology. For two reasons we wanted to investigate the N(2)-oxo-3,4-dihydro-p-carbolines 
(Scheme I, e.g. 1). The first is the in vitro affinity of these compounds towards the benzodiazepine 
receptor1. The second reason is that the nitrone functionality of these compounds can undergo [3+2] 
cycloaddition reactions with a variety of dipolarophiles2. The result would be a 5-membered ring 
containing two (N-O) or more hetero atoms annulated with the ß-carboline fragment (Scheme I, e.g. 
2). Compounds having the general structure 2 might well have a biological activity due to their 
structural similarity with several classes of active indole alkaloids. 
Scheme I 
O J C C — CtXX' 
1 2 * 
Recently, we demonstrated that the 1,3-dipolar cyloaddition of the nitrone 1 (Rj=COOEt) with 
alkenes3 and nitriles4 proceeds with high or complete regio- and stereoselectivity resulting in 
isoxazolidines and A4-l,2,4-oxadiazolines, respectively. In chapter 4 the application of this 
cycloaddition to yield an isoxazolidine in the total synthesis of natural products of the 
fumitremorgin-veiruculogen group is reported. 
In chapter 3.2 the syntheses of 3,4-dihydro-ß-carboline nitrones is described and in chapter 3.3 the 
cycloaddition of some of these nitrones with nitriles is discussed in more detail. 
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Chapter 3.2 
SYNTHESES OF N-OXO-3,4-DIHYDR0-^-CARBOUNES FROM 
N-HYDROXY-TRYPTOPHAN AND -TRYPTAMINE DERIVATIVES. 
As part of synthetic studies on N-hydroxytryptophan derivatives it was found that 1 can be converted 
into the N-hydroxy-tetrahydro-ß-carboline 6 (Scheme I).1·2 In addition, it was described1 that the 
nitrone 8 could be prepared either by DDQ oxidation of 6 or -more efficiently- in a single step from 1 
by acid-catalyzed condensation with trimethyl orthoformate. 
Scheme I 
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Following the latter procedure the N-hydroxy compounds 2-5 (chapter 2.1) were converted into the 
C(l) unsubstituted mtrones 9-12 in 75%, 67%, 90% and 31%3, respectively. 
The C(l) substituted derivative 13 was prepared from l-phenyl-2-hydroxy-3-methyl-1,2,3,4-
tetrahydro-ß-carboline (7) -derived from 4 and benzaldehyde in the presence of TFA4- by DDQ 
oxidation. A draw-back of this approach is that not only 13, but also 14(18%) and 15(6%) were 
formed as a result of overoxidation (partly accompanied by dehydrogenation (Chart I)). 
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Chart I 
H Ph H Ph 
14 15 
Experimental Section 
Melting points were taken on a Koefler hot stage (Leitz-Wetzlar) and are uncorrected. Ultraviolet 
spectra were measured with a Perkin Elmer spectrometer, Model lambda 5. Proton magnetic 
resonance spectra were measured on a Bruker WH-90 or on a Bruker AM 400 spectrometer. 
Chemical shifts are reported as δ-values relative to tetramethylsilane as an internal standard; 
deuteriochloroform was used as solvent unless stated otherwise. Mass spectra were obtained with a 
double-focusing VG 7070E spectrometer. Thin-layer chromatography (TLC) was carried out by using 
silica gel F-254 plates (thickness 0.25 mm). Spots were visualized with a UV hand lamp, iodine vapor, 
or CI2-TDM.5 For column chromatography Merck silica gel (type 60H) was used. 
2-Oxo-3-(ethoxycarbonyl)-5-chloro-3,4-dihydro-ß-carboline (9). Trifluoracetic acid (0.45 mL) 
was added dropwise to a stirred solution of 2 (1.0 g., 3.6 mmol) in НС(ОМе)з (10 mL) at room 
temperature and in argon atmosphere. Stirring was continued for 2.5 h. The solution was then 
concentrated to near dryness, dissolved in CH2CI2 and concentrated again. The residue was dissolved 
in CH2CI2 and washed with NaHC03 and water and dried over N32804. Evaporation of the solvent 
gave crystalline 9, which was recrystallized (C^C^/MeOH/n-hexane) to yield 0.78 g. (75%) 9: mp 
1730C (decomposes); Rf 0.28 (solvent system D); UV (MeOH) Xm« 218, 362, 367 nm, Xmin; EIMS 
(70 eV) m/z 294 (fM+2]+, 16%)· 292 (M+, 27%), 276 ([СнНцСІМгОг]*, 8%), 274 
([C14Hi1ClN202]+,14%), 221 ([CnHgClNjOr. 41%), 219([C11H8C1N20J+, 72%), 204 ([C
n
H7N2Cl]+, 46%), 202 ( [ С ц Н ^ С І Г , 100%); Ή NMR (СВС1з/СОзОО,95/5, / ) δ 8.01 (s, IH, 
C(l)H), 7.32-7.00 (m, 3H, indole C(6)-C(8)H), 4.88 (X part of ABX spectrum, 1H,3J 3.2 Hz, 3J 8.2 
Hz, C(3)H), 4.22 (q, 2H,3J=7.1 Hz, ОСН,СНз), 4.11-3.72 (AB part of ABX spectrum, 2H,2J 17.7 Hz, 
3J 3.2 Hz, 3J 8.2 Hz, C(4)H), 1.21 (t, 3H, 4 7.1 Hz, OCH2CH3). 
2-oxo-3-(ethoxycarbonyl)-6-chloro-3,4-dihydro-ß-carboIine (10). The same procedure was 
followed as described for 9. Reaction of 3 (1.0 g, 3.6 mmol) in НС(ОМе)з (10 mL) and TFA (0.5 
mL) gave after column chromatography (СНСІз/МеОН, 93/7, v/v) in 67% yield 10. Recrystallized 
from CHjClj/MeOH/n-hexane: mp 208oC (decomposes); Rf 0.19 (solvent system D); UV (MeOH) 
Xmax 218, 362, 367 nm, Xmn; EIMS (70 eV) m/z 294 ([M+2]+, 16%)· 292 (M+, 27%), 276 
([C14H11C1N202]+, 8%), 274 ([C14HnClN202]+,14%), 221 ([CUH8C1N20]+, 41%), 
219([C11H8C1N20]+, 72%), 204 ([C11H7N2Cl]+,46%), 202 ( [ С ц Н ^ С І ] * 100%); lH NMR (СоС1з/СОзОВ,95/5, / ) δ 7.96 (s, IH, C(l)H), 7.44-7.09 (m. 3H, indole C(5)H and C(7)-C(8)H), 
4.94-4.82 (X part of ABX spectrum, IH, C(3)H), 4.21 (q, 2НДг 7.1 Hz, ОСН2СНз), 3.59-3.53 (AB 
part of ABX spectrum, 2H, C(4)H), 1.24 (t, 3H, 3J 7.1 Hz, ОСЩСЩ). 
2-oxo-3-methyl-3,4-dihydro-ß-carboline (11) 
The same procedure was followed as described for 9. Reaction of 4 (2 g, 10.5 mmol) in НС(ОМе)з 
(25 mL) and TFA (1.5 mL) gave after column chromatography (СНСІз/МеОН, 93/7, v/v) 1.9 g (90%) 
of 11. Recrystallized from CH2Cl2/n-hexane: mp 214-216
0C; Rf 0.21 (CHClj/MeOH, 93/7, v/v); UV 
(methanol) Xmax 212, 262, 351 nm; EIMS (70 eV) m/z (relative intensity) 200 (M+, 100), 183 
([M-OH]+, 37), 169 ([CUH9N2)+, 29); Ή NMR δ 9.58 (br s, IH, NH), 7.81 (s, IH, C(l)H), 7.50-7.03 (m, 4H, C(5)-C(8)H), 4.30 (m, IH, C(3)H)), 3.38 and 2.94 (AB part of ABX spectrum, 2H, 2J-17.0Hz, 
J=6.8Hz, J=4.5Hz, C(4)H2), 1.56 (d, 3H, С(З)НСНз). 
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2-oxo-3,4-dihydro-ß-carboHne(12) 
The same procedure was followed as described for 9. Reaction of 3 (1 g, 5.67 mmol) in НС(ОМе)з 
(25 mL) and TFA (6.5 g, 56.7 mmol) gave after column chromatography (CHClj/MeOH, 93/7, v/v) 
330 mg (31%) of 9. Crystallization attempts failed. Rf 0.24 (CHClj/MeOH, 90/10, v/v); CIMS (100 
eV) m/z (relative intensity) 187 ([M+l]+, 33), 170 ( [ С ц Н ^ г Г , 100), 169 ( [ С ц Н , ^ * , 75); Ή 
NMR δ 9.00 (br s, IH, NH), 7.80 (s, IH, C(l)H), 7.54-7.09 (m, 4H, C(5)-C(8)H), 4.26 (t, 2H, J=1.9 
Hz, C(3)H2), 3.21 (t, 2H, J=1.9Hz, C(4)H2). 
l-phenyl-2-oxo-3-methyl-3,4-dihydro-ß-carboline (13); l-phenyl-3-methyl-ß-carboline (14); 
l-phenyl-2-oxo-3-methyl-ß-carbolinc (15) 
To a stirred solution of 74 (2.58 g, 9.3 mmol) in dichloromethane (100 mL) was added at room 
temperature dropwise a solution of DDQ (2.1 g, 9.3 mmol) in dichloromethane (100 mL). After 
completion of the reaction (Ih.) as was monitoreid by TLC (СНСІз/МеОН, 93/7, v/v) the reaction 
mixture was washed with 0.1 N NaOH and brine. The organic layer was dried (NajSC^) and the 
solvent evaporated in vacuo. The residue was subjected to column chromatography (СНОз/МеОН, 
99/1, v/v) to give 430 mg (18%) of 14, 1.62 g (63%) of 13 and 160 mg (6%) of IS. 
Compound 13: Recrystallized from CHjClj/n-hexane: mp 243-2450C; Rf 0.21 (CHClj/MeOH, 
93/7, v/v); UV (methanol) Xmax 212, 255, 281, 352 nm; EIMS (70 eV) m/z (relative intensity) 276 
(M+, 100), 259 ([M-OH]+, 31), 245 ([С.уН^КгГ, 20); 'H NMR δ 7.83-7.09 (m, ЮН, NH, 
С(5)-С(8)Н and QHs), 4.44 (m, Ш, С(З)Н), 3.53 and 2.97 (AB part of ABX spectrum, 2H, 
2J=16.5Hz, J=7.0Hz, J=4.3Hz, C(4)H2), 1.61 (d, 3H, С(З)НСНз); Anal. Caled, for C 1 8 H 1 6 N 2 0 (Mw 
276.341): C, 78.24; H, 5.84; N, 10.14. Found: C, 78.21; H, 5.79; N, 10.04. 
Compound 14: Recrystallized from CH^CWn-hexane: mp 178-1790C; Rf 0.48 (CHCVMeOH, 
93/7, v/v); UV (methanol) ληΐ3χ 220, 236, 2$5, 295, 356, 365 nm; EIMS (70 eV) m/z (relative 
intensity) 258 (M+, 100); Ή NMR δ 8.33 (br s, IH, NH), 8.14-7.16 (m, ЮН, QH«, C(5)-C(8)H and 
C(4)H), 1.64 (s, 3H, C(3)CH3); Anal. Caled, for QgH^Nj (Mw 258.326): С, 83.69; H, 5.46; Ν, 10.84. 
Found: С, 83.21; Η, 5.44; Ν, 10.76. 
Compound 15: Recrystallized from CH2Cl2/n-hexane: mp 210-212
oC; Rf 0.11 (СНСІз/МеОН, 
93/7, v/v); UV (methanol) λιη3χ 234, 260, 322, 348 nm; EIMS (70 eV) m/z (relative intensity) 274 
(M+, 62), 257 ([M-OH]+, 100); Ή NMR δ 8.20 (br s, IH, NH), 8.00-7.12 (m, ЮН, QHj, C(5)-C(8)H 
and C(4)H), 1.69 (s, ЗН, С(З)СНз) 
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Iß-DIPOLAR CYCLOADDITION OF NITRONES WITH NITRILES. 
SCOPE AND MECHANISTIC STUDY. 
The [3+2] cycloaddition reactions of nitriles with 1,3-dipoles containing an orthogonal double bond 
(nitrilium betaines, diazonium betaines) are well documented1 and afford useful synthetic routes to a 
variety of five-membered heterocyclic ring systems. In contrast, relatively few examples of the 
cycloaddition of nitriles to 1,3-dipoles lacking a double bond (the class of azomethinium betaines) are 
known.1 Recently we reported2 that 1, a nitrone derived from N-hydroxytryptophane as well as several 
other nitrones undergo cycloaddition to geminai dinitriles with complete regioselectivity to give 
Δ4-1,2,4-oxadiazolines. 
In general, the knowledge and understanding of the reaction scale of 1,3-dipoles and dipolarophiles 
are intimately connected with mechanistic questions. It is generally accepted that 1,3-dipolar 
cycloadditions of nitrones to alkenes are single-step, concerted, four-center reactions.3 However, it has 
been suggested1 that polarized dipolarophiles (e.g. nitriles) may undergo concerted, but not 
necessarily synchronous cycloadditions. We now report an extensive investigation of the scope as well 
as a mechanistic study of the nitrone-nitrile cycloaddition. 
Synthetic Scope 
The nitrones 1-6 were used as 1,3-dipoles in this investigation. The synthesis of nitrones 3 and 4 has 
CO-. r^ ° 
Ph 
5 6 
been described in chapter 3.2 and the nitrones I2, 22, S4 and 65 were prepared according to known 
procedures. 
A survey of the nitriles used in this study is given in Table I. They are divided into three classes 
based on structural characteristics, viz., 2-substituted-2-cyanopropanes (7), ylidenemalononitriles (8) 
and directly substituted cyano derivatives (9). The results of the cycloaddition reactions of the nitrones 
О El 
1 : R 1 = R 2 = R 3 = H 
2 : R 1 = R 2 = K R 3 - O M e 
3 : R 1 = C I , R 2 = R 3 . H 
4 : R 1 = R 3 = H , R 2 =CI 
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Table I. Survey of nitri les divided into three classes. 
М :
^ С Н з 
Анз 
7 
a 
b 
с 
d 
e 
Y 
N 0 2 
CN 
COOEt 
Ph 
Me 
Ref. 
6 
7 
8 
9 
10 
Ν > < Χ · 
Ν Ξ Ξ / X 2 
в 
a 
b 
с 
d 
e 
Χι 
Η 
Η 
Η 
Ph 
SMe 
χ2 
Ph 
p-CI-C6H4 
2-furanyl 
Ph 
SMe 
Ref. 
11 
12 
11 
11 
11 
R — = N 
9 
a 
b 
с 
d 
e 
R 
CCI3 
COOEt 
N(Me)2 
Ph 
Me 
1-4, 5 and 6 with the nitriles 7-9 to give the cycloadducts 10, 11 and 12, respectively, are listed in 
Table II. 
Reactivity scale of nitriles. 
Within the series of reactions of 1 with nitriles 7-9 (entries 1-9 and 13-23) it is possible to study the 
reactivity scale of the nitriles. In the series of 2-substituted-2-cyanopropanes (7) (entries 1-8) we 
studied exclusively the inductive influence of the substituent on the reactivity of the nitrile function. 
Under thermal conditions the nitriles 7a and 7b2 react smoothly to give the cycloadducts 10a and 10b 
in nearly quantitative yields (entries 1 and 2), whereas the nitriles 7c-e react sluggishly giving lOc-e in 
low yields (entries 3,5 and 7). The yield of the reaction leading to 10e (entry 7) could be improved by 
the use of a ten-fold excess of the dipolarophile. Acceptable yields of lOc-e were accomplished, when 
high pressure conditions (12 kbar) were used (entries 4, 6 and 8). It is apparent that the reactivity of 
the nitriles decreases with decreasing electron withdrawing ability of the substituent e.g. N02~CN > 
COOEt > C6H5~alkyl. 
Monosubstituted ylidene malononitriles 8a-c react easily with 1 (entries 9, 13 and 14). Remarkable 
is the higher reactivity of 8b and с versus 8a. The disubstituted ylidene malononitrile 8d reacted very 
sluggishly under thermal conditions and gave cycloadduct 101 in a low yield (entry 15). Reaction of 
the disubstituted ylidene malononitriles 8d and 8e under high pressure conditions however, solved this 
problem and in high yields the adducts 101 and lOm were isolated (entries 16 and 17). 
For the directly substituted cyano derivatives 9, the reactivity decreases in the order 9a>9b>9c>9d 
(entries 18-21). Nitrile 9e did not react under thermal or under high pressure conditions (entries 22 and 
23). These results demonstrate that both electron withdrawing and strongly electron donating groups 
facilitate the reaction. 
Cycloaddition reactions of nitriles with nitrones 1-4 proceeded with complete stereoselectivity -VJZ. 
C(5) and C(llb) substituents have an trans orientation- which is similar to earlier observed 
cycloadditions of these nitrones.2 This was judged on account of the chemical shift values of the H(5) 
and H(llb) protons, which are not very different13 from analogous shift values of the corresponding 
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Table II. Reactions of nitrones (1-6) with nitriles (7-9) (1.5 equivalents) in toluene. 
Entry 
1 
2 
3 
4 
5 
6 
7 
β 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
'S 
^ 
Ri 
Η 
Η 
Η 
R 1 
Χ 
Ι 
Η 
1-4 
R2 R3 
Η Η 
Η Η 
OMe 
CI Η 
Η CI 
Η Η 
R 
0 
• V ^ ^ V ^ O E t 
Τ τ 
" ^ ч ^ · x 0
 — 
R4 
С(ЫОг)Ме2 
C(CN)Me2 
C(COOEt)Me2 
C(Ph)Me2 
С(Ме)з 
C(CN)=CHPh 
C(CN)=CH(p-C6H4CI) 
С(СМ)=СН(2-С4НзО) 
C(CN)=C(Ph)2 
C(CN)=C(SMe)2 
CCI3 
COOEt 
N(Me)2 
Ph 
Me 
ГУ^
 R 
^ * Ч ^
м >
ж о 
5 
C(CN)Me2 
CCI3 
Ph 
R 
O H , 
Ph 
6 
C(CN)Me2 
ouig 
Ph 
R 1 
V - = N ^ ^ Х . 
^ X J T 
Rg ^ N 
1 
H 
Reaction conditions 
80oC, 2h. 
e0oC, 1.5h. 
80oC, 70. 
50oC, 12kbar,28h.c 
800C, 7d. 
50oC, 12kbar,2d.c 
800C, 6d. 
бО^.ігкЬаг.За.
0 
80oC, 33 h. 
600C,7h. 
800C, 7h. 
800C, 7h. 
80oC, 3h. 
800C, 1.5h. 
800C, 1d. 
RT, 12kbar, 1d.c 
RT, 12kbar, 1d.c 
80oC, 2 minutes 
80oC, 1.5h. (80oC, 0.5h.d) 
80oC, 20h., (80oC, 3.5h.d) 
80oC, 2d. 
refluxing acetomtrile 
RT,12kbar,3d.c 
7
-
9_N
. [ Γ Υ ^ 1 \ ί ^ 4 ^ - Ν 
H 0 
^LK* C» 
H* Ñ=/ 
10 R4 
Product 
10a 
10bb 
10c 
10d 
10e 
10fb 
I0gb 
10h 
10i 
lOj 
10k 
101 
101 
10m 
10n 
100 
10p 
10q 
no reaction 
no reaction 
4o 
11 N 
100oC, Ih. 
100oC, 2 minutes 
1000C. 5d. 
с н
э R — = N | э 
12 R 
110oC, 10d. 
110oC, 2 minutes 
110oC, 10d. 
R 
11a 
11b 
11c 
12ab 
12b 
12c 
Yield8 (%) 
97 
99 
26 
75 
11 
56 
1 2 ( 4 8 ) d 
87d 
78 
95 
72 
72 
97 
100 
11 
84 
78 
100 
85 (98) d 
93 (100) d 
ВТ
0 
100d 
100d 
56d 
85d 
100d 
57 d 
a) based on isolated products b) see reference 2 с) reaction m DMF d) ten-fold excess of dipolarophile 
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protons of the trans compounds 10b and lOf (see reference 2). The trans orientation of the C(5) and 
C(llb) substituents is ascribed to steric influence of the ethoxycarbonyl function in the transition 
state. Furthermore, in the case of the ylidenemalononitriles 8a-c, only the less sterically hindered of 
the two diastereotopic nitrile functions adds to the 1,3-dipole, which is in agreement with earlier 
results.2 Confirmation of the influence of steric hindrance was found in the low reactivity of the 
disubstituted ylidenemalononitriles 8d and e. 
As mentioned earlier2, the ß-carboline carboxyethylester 13 (ß-CCE) was formed up to 10% yield 
when the cycloaddition reactions were allowed to stand for days under thermal conditions. We found 
that cycloaddition product lOq partially decomposed to give 13 and benzamide (14) (Scheme I) when 
Scheme I 
OE1 
+
 PhCONHj 
14 
it was kept under cycloaddition reaction conditions for 2 days. This problem could be overcome by the 
use of a ten-fold excess of dipolarophile or high pressure conditions, (see Table Π) 
Reactivity scale ofnitrones. 
The nitrones 1-4 made it possible to study the influence of indole substitution on the reactivity of the 
1,3-dipole in cycloaddition to nitriles. Reaction of nitrile 8a with 1-4 (entries 9-12) clearly 
demonstrates that 2 is the most reactive nitrone as a result of the electron donating effect of the 
methoxy substituent.2 The chloro substituents of 3 and 4 showed no clear effect on the reactivity with 
regard to the unsubstituted nitrone 1. With regard to nitrones S and 6, nitrone 1 is more reactive as 
shown by reaction of 5 and 6 with some nitriles (entries 24-29). With the highly reactive nitrile 9a it is 
not possible to make a distinction between the reactivity of these nitrones. However, the less reactive 
nitriles 7b and 9d demonstrate that the order of reactivity is 1 > 5 > 6, which is in agreement with our 
earlier observations.2 
Kinetics 
Pseudo-first-order reaction rates were determined in 2-methoxyethanol, by using nitrone 1 and a 
tenfold excess of the dipolarophile; the reaction was monitored with a dilatometer.14 The results are 
presented in Table III. 
We studied the reactivity of 7b and ethyl crotonate in order to compare the nitrile cycloaddition with 
the well-known analogous cycloaddition of alkenes (Table 3, entries 1 and 2). Only a small difference 
in rate (kethyi crotonate / kdimeihyima]ononimic=2.7) was found. Extrapolation for the k2-value of ethyl 
OB toluene 
eo0c 
1
 Н*
% X
 / H H N = ^ Ph 
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Table III. Dilatometrie k2-values for cycloadditions of 1 with dipolarophiles in 2-methoxyethanol. 
Entry 
1 
2 
3 
4 
5 
6 
7 
8 
9 
dipolarophile 
dimethylmalononitrile (7b) 
ethyl crotonate 
p-nitrobenzonitrile 
p-cyanobenzaldehyde 
p-cyanobenzoic acid 
p-chlorobenzonltrile 
benzonitrile 
p-tolunitrile 
anisonitrile 
в50С 
564 
21.2 
9.20 
628 
5.35 
3.02 
2.60ь 
2 03b 
105k2 (l/mol.sec) 
90oC 100oC 
553 
1517a 
4.48 8.52 
1100C 
21.10 
17.60 
14.00 
Product 
10b 
15 
10Г 
10s 
10t 
10U 
10q 
10V 
10w 
a) Extrapolation from 8 5 0 C to 100oC, with cofrecbon (actor 2 7 (Huisgen, see ret 3b) 
b) Extrapolation from 1100C to 8S°C, lüoentroptc {AS*—23 β cal/mol deg) 
crotonate from 8 5 ^ to ΙΟΟ'Ό was done isoentropicalfy.15 Noteworthy is the complete regio- and 
stereoselectivity of the cycloaddition of ethyl crotonate with 1 to give isoxazolidine 15. Structure 
ι 
H 
E 
О 
15 
assignment was made in analogy with other cycloadditions of I, 1 6 viz., the C(5) and C(llb) 
substituents have an /ranï-orientation (vide-supra), electron withdrawing substituents on C(l) favours 
endo-17 and alkyl substituents on C(2) eu»-orientation. The proton coupling constant Jiib,i=9.9 Hz 
also supports the relative stereochemistry as depicted in IS.17·18 
The reaction of para-substituted benzonitnles was studied in order to determine a Hammett plot 
(Table Ш , entries 3-9). The reactivity differences made it necessary to determine the reaction rates at 
two temperatures. The more reactive nitriles (entries 3-7) were measured at 850C, and the remaining 
nitriles (entries 8 and 9) at 1 КУС. Extrapolation of the k2-values of the nitriles of entries 8 and 9 from 
IKPC to 850C occurred isoentropically. The necessary activation parameters are obtained from 
benzonitrile, i.e. entry 7 (д8*=-23.6 cal/mol.deg and дН'=20.1 kcal/mol). The Hammett plot showed 
an excellent linear correlation between the log k-values and the substituent constants (σ-values)19, viz., 
p=0.96 (corr.coeff. = 0.995) (Figure I). 
Because of the insolubility of nitrone 1 in most solvents we studied the influence of solvent polarity 
upon the reaction rate with the better soluble though less reactive 5. The reaction of 5 with 
dimethylmalononitrile (7b) was studied at KXPC in three solvents covering a wide range of Bj· 
values20 (Table Г ). We observed a notoriously small effect of solvent polarity. In agreement with 
Huisgen's30 study of the cycloaddition of nitrones with alkenes we found an inverse influence of 
logfkjj + e 
t -
-
-
-
-
-
• 
-
' 
• 
Me 
MeOjy 
9 / 
-02 
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Rgure I. Hammett Plot 
Table IV. Rates in various solvents for reaction ot 5 with 
TbatlOtTC 
solvent 
toluene 
phenetole 
2-methoxyethanol 
103k2 
Vmol sec. 
15.1 
11.5 
1.44(1.38)a 
ET 
kcal/mol 
33.9 
36 4 
52.3 
a) normal second-order expenment 
Solvent polarity (ktoluene/k2-methoxyetfunol=10.5). 
Discussion 
The regioselective formation of the 44-l,2,4-oxadiazoline ring in the cycloaddition of nitriles 7-9 
with nitrones 1-6, can be rationalized by using Frontier Molecular Orbital (FMO) theory.21 In our 
previous report2 we suggested that the regioselectivity of the reaction depends on a favourable 
HOMO(nitrone)-LUMO(nitrile) interaction. This would imply that the reactivity will increase if 
nitrones become more electron-rich and nitriles more electron-deficient.2 The results of the study at 
hand are in line with this assumption. 
A measure for the electron richness of conjugated nitrones is the weighted average of the first two 
ionization potentials. The values for I 2 · 1 6 ,5 2 2 and б 2 2 are 8.40, 8.46 and 8.56 eV, respectively. This is 
in agreement with the reactivity order 1>5>6. The enhanced reactivity of 2 as compared with that of 1 
suggests an average IP-value lower than 8.40 eV. This must be the result of the electron donating 
effect of the methoxy substituent. 
In the case of 2-substituted-2-cyanopropanes 7 and direcdy substituted cyano derivatives 9 we found 
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an increas in reactivity of the nitrile function with increasing electron withdrawing ability of the 
substituent, viz., the reaction order for 7; N02~CN>COOEt>C6Hj~CH3 and that for 9; 
саз>схюЕс>с6Н5. 
In the 1,3-dipolar cycloadditions with ylidenemalononitriles 8 the nitrones add selectively to the 
nitrile function23, whereas the reactivity still strongly depends on the nature of the ß-substiment. The 
influence of ß-substituents has already been demonstrated in [2+2]24 cycloadditions of the alkene 
moiety of 8. Generally, electron withdrawing substituents will decrease the conjugate resonance 
stabilization (Scheme II) and consequently make the alkene function more reactive. Although the 
Scheme II 
- N 
N = H N = H Ч С н IH — =И* — н 
N = H N S ' H
 H ^ \ 
A B C 
nitrile function is further away from the ß-substituent, we observed a similar, and even stronger 
substituent effect. This may be attributed to the diminished contribution of resonance structure С in 
the order 2-furanyl«4-Cl-C6H4«C6H5. 
The reactivity of the nitrile 9c with the strongly electron donating dimethylamino group is the result 
of a crossover in the frontier orbital control, so that the regiochemistry will now depend on a 
favourable HOMO(nitrile)-LUMO(nitrone) interaction. This is in agreement with the classification by 
Sustmann25 that nitrone cycloadditions are type Π processes, in which both HOMO-LUMO 
interactions contribute to the stabilization of the transition-state. A U-shaped reactivity curve of 
dipolarophiles is a necessary consequence. In both HOMO-LUMO interactions, overlap of orbitals 
with comparable terminal coefficients, i.e. orbitals of the nitrogen and carbon atoms of the nitrile with 
the carbon and oxygen of the nitrone, respectively will lead to the 44-l,2,4-oxadiazoline ring. 
The inverse influence of the solvent polarity is an indication of a slight decrease of the polarity in the 
transition state (TS) versus the polarity of the reactants. This supports the concerted nature of this 
1,3-dipolar cycloaddition and is in agreement with an early TS. 
The term concerted does not necessarily imply that the two new σ-bonds are developed in the TS to 
precisely the same extent. If in the TS of cycloaddition of nitrones with a polarized dipolarophile 
-such as the nitrile- the making of one bond lays behind the closure of the other σ-bond, partial 
charges at the centers of the weak incipient bond can be stabilized. Therefore, a Hammett plot of the 
cycloaddition of nitrone 1 with p-substituted benzonitiiles has been determined. The excellent linear 
correlation between the log k-values and substituent constants (σ-values)19 shows that all the 
p-substituted benzonitriles are far away from the crossover in the U-shape reactivity curve. The 
observed valu for p=0.96 is slightly higher than the analogous value found by Huisgen3b (p=0.77) in 
the cycloaddition of the nitrone 6 with p-subtituted styrènes. This higher p-value is not necessarily a 
result of a more polar transition state for the nitrile cycloadditions. It may also be a reflection of a 
Chapter 33 59 
smaller energy gap between the HOMO(nitrone) and LUMO(nitrile) compared to the HOMO(nitrone) 
and LUMO(alkene).26 
In conclusion, the results of this study are consistent with Huisgen's3b kinetic study of the 
1,3-dipolar cycloaddition of nitrones with alkenes. Consequently, it can be concluded that 
nitrone-nitrile cycloadditions should not be considered mechanistically different from nitrone-alkene 
cycloadditions. 
Experimental Section 
Melting points were taken on a Koefler hot stage (Leitz-Wetzlar) and are uncorrected. Ultraviolet 
spectra were measured with a Perkin-Elmer spectrometer, Model Lambda 5. Proton magnetic 
resonance spectra were measured on a Bruker WH-90 spectrometer. Chemical shifts are reported as 
δ-values relative to tetramethylsilane as an internal standard; deuteriochloroform was used as solvent 
unless stated otherwise. Mass spectra were obtained using a double-focusing VG 7070E spectrometer. 
Thin-layer chromatography (TLC) was carried out using silica gel F-254 plates (thickness 0.25 mm). 
Spots were visualized with a UV hand lamp, iodine vapor, or CI2-TDM.27 For high-performance 
liquid column chromatography (Jobin Yvon) Merck silica gel H (type 60) was used. Solvent systems 
used are. A: (MeOH/CHClj, 1/99, v/v), B: (MeOH/CHClj, 3/97, v/v), С:(МеОН/СНС1з, 5/95, v/v), D: 
(МеОН/СНСІз, 7/93, v/v) 
General Procedure Cycloadditions. 
Thermal Reaction Conditions. A stirred solution of nitrone (0.5 mmol) and nitrile (0.75 mmol) in 
dry toluene (10 mL) was allowed to react under the conditions given in Table П. The reaction was 
monitored by TLC. The mixture was then concentrated in vacuo and the resultant residue subjected to 
column chromatography to yield compounds 10, 11 or 12(Table Π). Recrystallization was always 
accomplished from CH2CI2 / MeOH / n-hexane. Spectroscopic data for these derivatives are recorded 
in Table V. 
High-Pressure Reaction Conditions. The nitrone (0.5 mmol) and the nitrile (0.75 mmol) were 
dissolved in dry DMF (1.5 mL) and brought into a Teflon high-pressure vessel, which was placed in a 
high-pressure apparatus. Pressure was raised to 12 kbar and to the appropriate temperature (see Table 
II). The mixture was then concentrated in vacuo and the resultant residue subjected to column 
chromatography to yield compounds 10c, d, e, 1, and m (Table Π). Recrystallization was always 
accomplished from CH2CI2 / MeOH / n-hexane. Spectroscopic data for these derivatives are recorded 
in Table V. 
Decomposition of cycloadduct lOq 
A solution of lOq (361 mg, 1.0 mmol) in dry toluene (15 mL) was kept at SCPC for two days under 
argon atmosphere. After evaporation of the solvent the residue was subjected to flash chromatography 
(silica gel 60H, eluens CHCWMeOH, 99/1, v/v) to give 310 mg (86%) of lOq, 34 mg (14%) of 13 
and 18 mg (14%) of benzamide (14). 
Compound 20: Spectroscopical data are identical with earlier published results.16 
Kinetic Experiments. 
Equipment.Thc dilatometer was made according to a literature method.28 The important features of 
this design are: a) The coil had a capacity of about 20 ml. b) The precision capillary was 25 cm long 
and its inner diameter was 0.35 mm. A microprocessor controlled constant temperature bath Tamson 
TMV 70, filled with ethylene glycol (70 L) was used. Temperature fluctuations in the bath were less 
than 0.004oC. 
ExecuriOH.-Although all the reactions obeyed the second-order rate law, pseudo-first-order reaction 
rates were determined, by using a tenfold excess of dipolarophile.14 The concentration of nitrone was 
in all the experiments 0.116M. Further, standard procedure was followed.3b Rate constants were 
calculated on a IBM XT personal computer, using a non-linear regression fit program based on the 
Gauss method.29 Second-order rate constants were reproducible within 5%. 
Table V. Spectrosco 
prod 
10a a 
IOC 
10d 
10e a 
10h a 
101a 
ЮГ 
mp 
Cc) 
176-181 
141-144 
Oll 
169-172 
172-174 
179-182 
177-180 
Rf 
<8<*3уч 
0 62 
(А) 
0 5 5 
(А) 
0 5 3 
(А) 
0 78 
(В) 
0 66 
(А) 
0 67 
(А) 
0 73 
(А) 
эіс data of с 
UV(MeOH) 
λ max(nm 
222,277 
222. 274 
220, 272 
260 (sh) 
289 (sh) 
220,272 
280 (sh) 
289 (sh) 
225, 300, 306 
228,303 
221,293(sh) 
318 
^cloadducts 1 0 , 1 1 , 1 2 and 15. 
IR 
vícm·') 
1732 (C=0) 
1675 (C=N) 
1556 (N02) 
1740 (C-O) 
1665 ( C N ) 
3400 (NH) 
1740 (C-O) 
1660 (C-N) 
3370 (NH) 
1735 (C=0) 
1660 (C=N) 
2236 (mtnle) 
1730(C=O) 
1640 (C=N) 
2230 (mtnle) 
1730(C=O) 
1640 (C=N) 
2238 (mtnle) 
1717 (C=0) 
1642 (C-N) 
Mas· Spectrum 
EIMS (70 eV) m/z 372 (M*, 21%), 
258 ([0 1 4 Η 1 4 Ν 2 θ3Γ, 25%), 185 
( [ C 1 1 H 1 0 N 2 ] M 0 0 % ) , 169(59%) 
CIMS (100 eV) m/z 400 ([Μ+1Γ, 12%). 
2 4 3 a C 1 4 H l 4 N 2 0 2 + i r , 2 2 % ) , 1 4 2 ( [ C 7 
H ) 1 N O 2 + i r , 7 3 % ) , 1 1 4 ( [ C e H 1 0 O 2 l * , 
100%) 
EIMS ( 70 eV) m/z 403 (M*, 7%), 330 
([M-COOEtr, 2%), 258 ( [ ^ „ N j O J * 
68%),185([C 1 1 H 1 0 N 2 Or,86%), 
71 (100%) 
EIMS (70 eV) m/z 341 (M*, 12%), 284 
( [ С 1 5 Н 1 4 ^ О з ] \ 22%), 258 ([C 1 4 H, 4 N 2 
OJ*. 40%), 241 ttC^jNjCy. 11%), 
1 8 5 ( [ C 1 ) H l 0 N 2 O r , 1 0 0 % ) , 1 6 9 ( [ C 1 1 
Η 1 0 Ν 2 Γ,38%) 
EIMS ( 70 eV) m/z 448 ([М+2Г,0 9%), 
446 (M*,! 6%), 294 « C M H ^ C I N J O J * . 
5%), 292 ( ^ „ H ^ C I N j O J * . 14%), 204 
( ( Ο , , Η ^ Ι Ν / , 46%), 202 ([C^HjCINj]* 
100%) 
EIMS (70 eV) m/z 448 ([Mt2]*, 0 1%), 
446 (M*. 0 3%). 294 ( [ C ^ H ^ C I N j O / . 
2%), 292 (6%), 276 ( ^ „ H J J C I N J O J * , 
8%), 274(21%), 204 ([Ο,,Η,ΟΙΝ^*, 
35%), 202 (100%) 
FABMS (7 kV at 1 4 mA) m/z 449 ЦМ+ 
31*. 2%), 447 (ΙΜ+ΙΓ, 4%), 243 ([C,4 
H 1 4 N 2 o 2 + i r , 100%) 
Ή NMR 
S(ppm) 
6 36 (br s, 1H, NH), 7 52-7 02 (m, 4H, C(7)-C(10)H), 6 19 (s, 1H, C(11b)H), 4 31 and 
4 29 (2q, 2H,dastBreotopre protons, ОСН2СНз), 3 93 (X part of ABX spectrum, 1H, 3 J 
3 6 Hz, 3 J 11 8 Hz, C(5)H), 3 20 and 3 01 (AB part of ABX spectrum, 2H, 2 J 1 5 6 Hz, 
3 J 3 6 Hz, 3 J 11 8 Hz, C(6)H2), 1 88 (s, 6H, 2хСНэ), 1 32(t, 3H. OCHJZHJ 
8 98 (brs, 1H, NH), 7 4 9 - 7 0 0 (m, 4H, C(7)-C(10)H), 6 14 (s, I H . С(11Ь)Н), 4 31 (q, 2H, 
Hz, 3J 12 3 Hz, C(5)H), 3 17 and 3 00 (AB part of ABX spectrum, 2H, 2 J 15 4 Hz, 3 J 
3 9 Hz, 3 J 12 3 Hz, C(6)H2), 1 50 (s, 6H, 2KCH3), 1 34 (t, ЗН, ОСНгСН^, 1 23 (1, ЭН, 
ОСН2СНз) 
8 80(brs, IH, NH), 7 4 « 96 (m, 9H, С(7)-С(10)Н and Ph), 6 1 1 (ε, I H , C(llb)H), 4 17 
(q, 2H, ОСН2СНз), 3 61 (X part of ABX spectrum, I H , 3 J 2 6 Hz, 3J 12 3 Hz, C(5)H), 
3 08 and 2.95 (AB part of ABX spectrum, 2H, 2 J 15 6 Hz, 3 J 2 6 Hz, 3 J 12.3 Hz, 
C(6)H2), 1 61 (s, 6H, 2хСНэ). 1 21 (t, 3H, ΟΟΚ,ΟΗ.,) 
в93(Ьг8,1H,NH).7 52-7 00(m.4H, C(7)-C(10)H), 6 10 (s, I H , C(11b)H), 4 36 and 
4 34 (2q, 2H, OCHjCH^, 3 76 (X part of ABX spectrum, 1 H, 3J 3 3 Hz, 3 J 1 2 0 Hz, 
C(5)H), 3 15 and 3 04 (AB part of ABX spectrum, 2H, 2 J 1 5 5 Hz, 3 J 3 3 Hz, 3 J 12 0 
Hz, 0 ( 6 ) ^ ) , 1 36(t, 3H, CXÎHjCHg), 1 25 (s, 9H, C{CHJJ 
9 03(br s, 1H, NH), 7 98-7 01 (m, 9H, С(8И;(10)Н, CHPh. Ph), 6 46 (s, IH, С(11Ь)Н), 
4 40 (q, 2H, ОСН2СНз), 3 92 (X part of ABX гресйит, 1 H, 3 J 3 7 Hz, 3J 11 2 Hz, 
C(5)H), 3 72 and 3 27 (AB part of ABX 8pectnim, 2H, ' j 15 7 Hz, 3 J 3 7 Hz, 3 J 11 2 
Hz, C(6)H2), 1 36 (t, ЗН, СХ5Н2СНз) 
8 80 (br ε, 1 H, NH), 7 98-7 82 (m, 3H, C(9)C(10)H and C-CH-Ph), 7 53-7 11 (m, 6H, 
C(7)H and Ph) 6 41 (s, IH, C(11b)H), 4 37 (q, 2H, OCHjCHj), 3 89 (X part of ABX 
spectrum, IH, 3 J 2 7 Hz, 3 J 11 1 Hz C(5)H), 3 17 and 3 04 (AB part of ABX spectrum, 
2H, 2J 16 4 Hz, 3 J 2 7 Hz , 3 J 11 1 Hz. С(6)Н
г
). 1 36 (t ЗН, OCHjCHj) 
8 40 (brs, I H , NH), 791-7 11 (m, 9H, C(7)-C(10)H and C=CH-, and CeH4CI), 6 36 (s, 
1H, C(11b)H), 4 36 (q, 2H, ОСН2СНз), 3 88 (X part of ABX spectnim, IH, 3J 4 0 Hz, 
3 J 9 9 Hz, C(5)H), 3 23 and 3 06 (AB part of ABX spectrum, 2H, 2 J 1 5 1 Hz, 3 J 4 0 
Hz, 3J 9 9 Hz, C(6)H2), 1 37 (t, ЭН, OCH2CHj 
a) Satisfactory micro analysis were obtained for these compounds (C+0 5%, H ± 0 2%, N ± 0 4%) 
Table V. Spectroscopic data of cycloadducts 10,11,12 and 15. 
Prod 
10k1 
10la 
Ют" 
Юп» 
ІОо» 
10ρ· 
lOq' 
a) Satufi 
mp 
CO 
167-171 
148-152 
143-146 
159-162 
84-88 
73-77 
174-176 
ictory mi 
Rf 
(SotïSy«) 
0 51 
(В) 
029 
(A) 
0 72 
(В) 
0 75 
(В) 
067 
(В) 
038 
(В) 
0 69 
(А) 
сгоапаіу 
UV(MeOH) 
222, 282. 
345 
209,221 
273(sh). 
282,290, 
319 
222,283 
339 
209 (sh) 
223,273 
280 (sh) 
289 (sh) 
204 (sh) 
220, 272 
280 (sh) 
289 (sh) 
208 (sh) 
223, 273 
280 
289 (sh) 
318 
207(sh) 
222, 269, 
273(sh), 
281(sh) 
290(sh) 
sisforthes« 
IR 
vlcm') 
2235 (nitnle) 
1730 (СжО) 
1650 (C-N) 
2220 (rumie) 
1742(C=0) 
1655 (C=N) 
2220 (minie) 
1710(C-O) 
1620 (C-N) 
3359 (NH) 
1720 (CO) 
1666 (C=N) 
3320 (NH) 
1745 (C=0) 
170в(С=О) 
1654 (CN) 
1738(C=0) 
1665 (СЛ) 
3290 (NH) 
1734 (C-O) 
1652 (CN) 
s compounds 
Mass Spectrum 
EIMS (70 eV) m/z 402 (M*. 1 5%), 258 
<[014Η14Ν2θ3ΐ\ 35%). 144([CeH4N2Or 
,100%) 
EIMS (70 eV) m/z 468 (M*. 1%). 258 
([С
м
Н
м
М
г
ОэГ. 11%), 240([С14Н1гМ2 
О / , 38%). 168(100%) 
EIMS (70 eV) m/z 428 (M\ 7%). 355 
([M-COOEt, 12%), 258 ([С14Н14МгОэ 
Г. 23%), 240 ([Ο,,Η,ϋ^Ο/, 35%). 
185(34%), ^OdCjHgNjSjl, 100%), 
169 (56%) 
EIMS (70 eV) m/z 405 QM^f. 1 2%). 
403 ([М+2Г, 3 3%), 401 (M*. 3 5%), 
284 ([C15H,4N303r, 13%), 240 (7%), 
185 (11%), 168 (43%), 108 (97%), 44 
(100%) 
EIMS (70 eV) m/z 357 (M*. 1%), 284 
((C15H14N30/. 2%), 240(1С14Н12^О. 
Г, 2%), 185 ((Ο,,Η,ο^ΟΓ. 5%), 169 
([Ο,,ΗβΝ^, 16%), 54 (100%) 
EIMS (70 eV) πΛ 328 (M*, 65%), 284 
( [ C ^ H . ^ O / . 100%), 258 0C14H14N2 
О / , 15%), 210 ([CjjH^jOjl*. 95%), 
185(42%), 168(30%) 
EIMS (70 eV) miz 361 (M*, 6%), 288 
([Ο,,Η,ΛΟΓ. 5%), 258 (|C14H14N203l 
\ 10%), 240 ([C14H12N202r, 7%), 185 
[21%), 168 (38%), 103 ([C7HsNr, 100% 
were obumed (C±0 J%. H±0^%, N±0 
'H NMR 
δ (ppm) 
200 MHz 8 54 (s. 1H, NH). 7 75 (d, 1H.C(a')H). 7 63 (s. IH, -CH-), 7 50 (d, IH. C(7)H), 
7 40 (d, IH, C(10)H. 7 35 (d. IH, C(ß)H), 7 24 and 7 14 (2xm, 2H, С( ) and С(9)Н). 6 67 
(dd, 1Н,С(Р')Н), 6 38 (s, 1Н, С(11Ь)Н), 4 39 and 4 36 (2q, 2Н, OCHjCHj), 3 86 (X part 
of ABX spectrum, 1 H,3J 3 0 Hz, 3J 11 1 Hz, C(5)H). 3 22 and 3 06 (AB part of ABX 
spectrum, 2H, 2J 15 9 Hz, 3J 3 0 Hz, 3J11 1 Hz, C(6)H2), 1 38 (t, 3H, OCH2CH^ 
8 69 (brs, 1H, NH), 755-707(m, 14H, C(7)-C(10)H and 2xPh), 6 06 (s, IH, C(11b)H), 
4 18 (q, 2H, ОСН2СНэ), 3 80 (X part of ABX spectrum, 1H, 3J 3 8 Hz, 3J10 9 Hz.C(5)H) 
3 18 aid 2 94 (AB part ol ABX spectrum, 2H, 2J 15 5 Hz, 3J 3 8 Hz, 3J 109 Hz. C(6) 
H2), іг9(1,ЗН,ОСН2СНз) 
8 46 (br s, 1H, NH), 7 53-704 (m, 4H, C(7)-C(10)H), 6 32 (s, 1H, C(1 lb), 4 35 (q, 2H, 
OCHjCH,), 3 92 (X part ol ABX spectrum, 1H, 3J 3 7 Hz, 3J 11 6 Hz, C(5)H), 3 20 and 
3 05 (AB part ol ABX spectrum, 2H, 2J 15 7 Hz, 3J 3,7 Hz, 3J11 6 Hz, C(6)H2,2 69 
(s, 3H ЗСНз), 2 57 (s, 3H. SCHj), 1 30 (t. ЗН, ОСН
г
СНз) 
8 46 (br s, 1 H, NH), 7 56-7 04 (m. 4Н, С(7), С(10)Н, 6 44 (s. 1 H, С(11Ь(Н), 4 36 and 
4 34 (2q, 2H, OCHjCH,), 4 01 (X part of ABX specdum, 1H. ! J 3 6 Hz, 3J 11 0 Hz, 
C(5)H). 3 26 and 3,06 (AB part of ABX spectrum, 2H, 2J 15 4 Hz, 3J 3 6 Hz. 3J 11 0 
Hz, C(6)H2). 1 35 (t, 3H, OCH2CHJ 
8 63 (br s, 1H, NH), 753-702 (m, 4H, C(7)-C(10)H), 6 40 (s, IH, C(11b)H), 4 38 (q, 2H, 
ОСН2СНз), 4 33 (q, 2H, OCI^CH,). 3 95 (X part of ABX spectrum, IH, 3J 6 6 Hz, 3J 
8 1 Hz, C<5)H), 3 24 aid 3 03 (AB part of ABX spectrum, 2H, 2J 15 4 Hz, 3J 6 6 Hz, 3J 
8 1 Hz, 0(6)^), 1 33 (2X1, 6h, 2хОСН2СНз) 
9 71 (br s, 1H, NH), 7 61-6 96 (m, 4H, C(7)-C(10)H), 6 21 (s, 1H, C(11 b)H), 4 33 (q, 2H, 
OCHjCHj), 4 07 )X part of ABX spectmm. 1H, C(5)H), 3 47-2 90 (AB part of ABX spec­
trum, 2H. qejHj). 2.90 (s. 6H, N C C H ^ ) . 1.36 (t, ЗН, осн
г
сн^ 
8 81(br β, 1 Η, NH), 7 96-7 85 (m, 2Η, C(2)-Pfl-onho-H), 7 54-7 04 (m, 7H, C(7)-C(10)H 
and C(2)Ph-meta,para-H), 6 38 (s, 1 H, C(11Ь)Н), 4 40 (q, 2H, OCHjCH^), 3 94 (X part 
of ABX spectrum, 1 H, 3J 2 5 Hz, 3J 11 8 Hz, C(5)H), 3 22 and 3 11 (AB pat of ABX 
spectrum, 2H, ZJ 15 5 Hz, 3J 2 5 Hz, 3J 11 8 Hz, C(6)H2), 1 40 (ζ ЗН, OCHjCHj) 
.4%). 
Table V. Spectroscopic data of cycloadducts 10,11,12 and IS. 
product 
Юг« 
I O S ' 
lOf·" 
l O u ' 
lOV 
lOW 
11a 
mp 
CC) 
168-172 
165-169 
167-170 
164-167 
164-168 
178-182 
oil 
Rf 
(SoKSy.) 
0 32 
(A) 
0 49 
(A) 
0 71 
(B) 
0 78 
(A) 
0 42 
(A) 
(A) 
0 75 
(B) 
UV(MeOH) 
Xmn(nm) 
222 
276 
220,267 
280 (sh) 
289 (sh) 
220,253 
282 (sh) 
289.(sh) 
219 
249 
222 
247 
267 
216 
270 
214 
258 (sh) 
264,271 
286. 
307 (sh) 
IR 
vtcm·') 
1730 (C=0) 
1650 (C=N) 
1354 (N0 2 ) 
3260 (NH) 
1742 (C-O) 
1700 (C=0) 
1650 (C-N) 
3370 (NH) 
1731 (C=0) 
1715 (C=0) 
1653 (C-N) 
3395 (NH) 
1 7 5 0 ( C ^ ) 
1645 (C=N) 
1738(C-0) 
1658 (C=N) 
1733 ( С Ю ) 
1657 (C=N) 
2240 (nitrite) 
1669 (C=N) 
М а м Spectrum 
EIMS (70 eV) m/z 406 (M*. 1%), 333 
( [ Ο , , Η ^ Ν , Ο / , 1%), 258 ([C 1 4 H 1 4 N 2 03 
Г, 8%), 240 ( [ C ^ H . j N j C y . 12%). IBS 
(16%), 168 ( [ Ο , , Η , Ν / , 81%), 148 ([C7 
^ N j O j l * . 100%) 
EIMS (70 eV) m/z 389 (M*, 1%), 316 
( ( Ο , , Η , ^ Ο , Γ , 1%), 258(20%), 240 
(31%). 185 (42%), 169 (100%), 131 
([CeH5NO]*.5e%) 
EIMS (70 eV) m/Z 419 (M*, 1%), 346 
([M-COOEtr, 1%), 258 (7%), 240 
(13%). 161 ( P y ^ N O J * . 100%) 
EIMS (70 eV) m/z 397 ([M+2]*, 3%), 
395 (M*. 9%), 324 (M+2-COOEtr. 5%), 
322 ([M-COOEt]*, 14%), 2 5 8 ( [ C 1 4 H U N 2 
Of, 21%), 240 ( [ C „ H , 2 N 2 O j r , 14%), 
185 ( Ι Ο , , Η , ο ^ Ο Γ . 44%). 168 (100%) 
EIMS (70 eV) m/z 375 ([M*, 8%), 302 
( [ M ^ O O E t r , 8%), 258 ( [ ( ^ „ N j Q J * . 
24%). 169([C 1 1 H, 0 N 2 r ,29%). 117 
(100%) 
EIMS (70 eV) m/z 391 (M*, 9%), 318 
([M-COOEt]*, 7%), 258 aC 1 4 H 1 4 N 2 03l*. 
36%), 185 ([Ο,,Η,,,^ΟΙ*, 61%), 169 
«Ο,,Η,, ,Ν/. 44%). 133 ([C e H 7 NOr, 
100%) 
EIMS (70 eV) m/z 241 (M*, 4%), 173 
( [ С 1 0 Н ^ 2 Г . 1 4 % ) , 1 4 7 ( [ С д Н ^ О Г . 
100%) 
' H N M R 
6(ppm) 
8 23 and В 02 (AB spectrum, 4H, 3J9 4 Hz, C e H 4 N0 2 ) , 7 57-7 09 (m, 4H, C(7)-C(10)H), 
6 41 (s, 1H, Ci 11 Ь)Н), 4 40 (q, 2H, ОСН
г
СН^, 3 91 (X part of ABX spflrtram, 1 H, 3 J 
2 9 Hz, 3 J 11 9 Hz, C(5)H, 3 23 and 3 11 (AB part of ABX spectrum, 2H, 2 J 1 5 6 Hz, 3 J 
2 9 Hz. 3 J 1 1 9 Hz, С(в)Н2), 1 38 (t, ЗН, OCHjCHj) 
10 06 (s, IH, CHO), 8 74 (br s, 1H, NH), 8 05 and 7 93 (AB spectrum, 4H, 3 J 8,4 Hz. 
CeH4CHO). 7 56-700 (m, 4H, C(7-)C(10)H), 6 40 (s, I H , C(11b)H), 4 39 (q, 2H, OCH 2 
CKj), 3,92 (X p a t of ABX spectrum, IH, 3 J 2 5 Hz. 3 J 12 8 Hz, C(5)H). 3 21 and 3 11 
(AB part of ABX spectrum, 2H. 2 J 15 7 Hz, 3 J 2 5 H z , 3 J 12.8 Hz, 0 ( 6 ) ^ ) , 1 39(t ,3H, 
O C H J C H J ) 
8 6 0 ( b r s , 1 H , N H ) , 8 1 2 a n d e 0 0 ( A B spectrum, 4H, 3 J 9 2 Hz. C J H ^ C C O C H J ) , 7 59-
7 09 (m, 4Н, C(7)-C(10)H), 6 40 (6, 1H, C(11b)H), 4 41 (q, 2H, OCI^CHj) . 3 95 (s, ЗН, 
OCHj), 3 93 (X part of ABX spectrom. I H , 3 J 2 5 Hz. 3 J 1 3 1 Hz. C(5)H). 3 23 and 3 13 
(AB part of ABX spednim. 2H. 2 J 1S 5 Hz. 3 J 2 5 Hz, 3 J 1 3 1 Hz. С(6)Н
г
), 1 35 (t, ЭН, 
OCHjCH,) 
8 62 (br s, 1H, NH), 7 87-7 03 (m, BH, C(7)C(10)H and C,H4CI), 6 35 (s, 1H. C(11 b)H), 
4 40 (q, 2H, ОСН2СНз), 3 91 (X part of ABX spectrum, 1H, 3 J 3 0 Hz, 3 J 12 0 Hz, C(S)H) 
3 22 and 3 10 (AB part of ABX spectrum, 2H, г Л 5 6 Hz, 3 J 3 0 Hz, 3 J 1 2 0 Hz, C(6)H2) 
1 38 (t, ЗН, ОСН2СНз) 
8 86 (br s, I H , NH), 784-704 (m, BH, C(7)C(10) and С
в
Н4-СНз), 6 36 (s, I H , C(11b)H), 
4 39 (q. 2H, OCH3CH2) 3,91 (X part of ABX spectrum, IH, 3 J 1 9 Hz, 3 J 12 4 Hz, C(5) 
H), 3 19 and 3 09 (AB part of ABX spectrum, 2H, 2 J 15 1 Hz, 3 J 1 9 Hz, 3 J 12 4 Hz. C(6) 
H2), 238 (s, ЗН, СвН4-СНз), 1 39 (t, ОСНэСН2) 
9 27 (br s, 1 H, NH), 7 84 and 6 89 (AB spectrum, 4H, 3 J 9 0 Hz, С(2)-С
в
Н4-ОСНз), 7 55-
7 02 (m, 4H, C(7)C(10)H), 6 37 (s, 1 H, С(11Ь)Н). 4 40 (q, 2Н, ΟΟΗ,,ΟΗ,), 3 93 (Xpart of 
ABX spectrum, 3 J 2 4 Hz, 3 J 12 4 Hz, C(5)H), 3 81 (s, ЗН. С
в
Н4-ОСНз), 3 21 and 3 11 
(AB part of ABX spnctrum, 2H, *J 15 6 Hz. 3 J 2 4 Hz, 3 J 1 2 4 Hz, C(6)H2), 1 39 (t, 3H, 
ОСН2СНз) 
7 55-7 03 (m, 4H, C(7)-C(10)H), 5 96 (e, I H , С(10Ь)Н), 3 48-2 63 (m, 4H, С(5)-С(6)Н
г
), 
167(8, 6H, 2хСНз) 
в) Satisfactory micro analysis were obtained for these compounds (C±0.5%, H±0 2%, N±0.4%) b) Esterfied to methoxycarbonyl with thionyl chlonde m methanol. 
Table V. Spectroscopic data of cycloadducts 10,11,12 and 15 
product 
11b 
l i e 
12b 
12c 
15a 
mp 
co 
oil 
oil 
oil 
oil 
187-189 
Rt 
(Sol»S)»0 
086 
(B) 
0 82 
(B) 
090 
(B) 
076 
(B) 
0 26 
(B) 
UVtMeOH) 
Хтвж(пгл) 
214, 256 
(sh), 263, 
270, 286 
307 (sh) 
205 237, 
263 (sh), 
271 (sh) 
204 
238 
204 
238 
222. 273 
280 
290 (sh) 
IR 
vlcm1) 
1660 (C=N) 
1645 (C=N) 
1662 (C=N) 
1660 (CN) 
3200 (NH) 
1740 (C=0) 
1721 (C=0) 
Mass Spectrum 
EIMS (70 eV) m/z 296 ([Μ+6Γ. 0 3%), 
294 ([Μ+4Γ. 2 8%), ([Μ+2Γ, 8 4%), 290 
(M*. 8 4%), 173 ([С10НвМгО1*, 20%), 
147 ((Ο,Η,ΝΟΓ, 100%) 
EIMS (70 ) m/Z 250 (M*, 6%), 173 
<[С10Н,МгОГ, 10%), 147([C|,H,NOr, 
100%), 77 (58%) 
EIMS (70 eV) m/z 284 ([М+6Г. 0 3%), 
282 ([Mt4|*, 3 1%), 280 ([М+г]*, 9 2%) 
, 278 (M*, 9 6%), 161 ([C9H,N20]*, 
5%), 134 ([CjHjNOf. 100%), 77 (33%) 
EIMS (70 eV) m/z 238 (M*, 24%), 193 
([C)4H„N]',5%), 135([СаНвМОГ, 
100%),77([С
в
Н5Г,60%) 
EIMS (70 eV) m/z 372 (M*, 39%), 299 
([М-СООЕГ,38%), ΙβδΚΟ,,Η,,,Ν^* 
,100%),169([Cl1HgN2r,42%) 
Ή NMR 
5(pPm) 
7 61-7 06 (m, 4H, C(7)-C(10)H), 6 20 (s, 1 H, C(10b)H), 3 60-2 67 (m, 4H, С(5)-С(6)Н
г
) 
В 02-7 90 (m, 2H, C(2)Ph-ortho-H-s), 7 68-7 07 (m, 7H, C(7)-C(10)H and C(2)Ph-mela, 
para-H), 6 13 (s. 1H. C(10b)H), 3 74-2 67 (m. 4H, C<5)-C(6)H2) 
7 34 (s, 5H, Ph), 5 73 (s, IH, C<3)H), 2 97 (s, 3H. N-CHJ 
8 04-7 93 (m, 2H. C(5)-Ph-ortho-H's). 7 50-7 24 (m, BH, C(3)-Ph and C(5)-Ph-metB,para-
H's), 5 77 (s, 1H, C(3)H), 2 96 (s, 3H, N-CHj) 
8 03 (br s, 1 H, NH), 7 48-6 98 (m, 4H, C(7)-C(10)H), 5 11 (d, IH, 3J-9 9 Hz, C(11b)H), 
4 93 aid 4 85 (2xq, IH. 3J 73 Hz, 3J 8 0 Hz. C(2)H), 4 43 (X part of ABX spectrum, IH, 
3J 6 6 Hz, 3J 6 8 Hz, C(5)H), 4 27 (q, 2H, OCH^CHJ. 3 83 (q, 2H, <ХН
г
СН^, 3 76 
(2xd, IH, 3J 7 3 Hz oíd 3J 9 9 Hz, C<1)H), 3 61 and 3 52 (AB part of ABX Rpoctnim, 2H 
,
 2J 15 3 Hz, 3J 6 6 Hz, 3J 6 8 Hz, C(6)H2), 1 35 (d, 3H. 3J 8 0 Hz, C(2)CHJ, 1 33 (t, ЭН 
. ОСа.СНз), 0 87 (t. 3H, OCHjCHj) 
a) Satisfactory micro analysis were obtained for these compounds (<І0 S%, H+0.2%, NÌ0.4%). 
ON 
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CHAPTER 4 
Application of an Isoxazolidine in the Stereoselective 
Synthesis of Fumitremorgin С and Verruculogen TR-2 
Verruculogen TR-2 
"First Total Synthesis of Fumitremorgin C", Pedro H.H. Hermkens, Ralf Plate.Harrie C.J. 
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"First Total Synthesis of Verruculogen TR-2", Pedro H.H. Hermkens, Ralf Plate, Harrie C.J. 
Ottenheijm, Tetrahedron Letters (1988), 29, 1323. 
"Stereoselective synthesis of verruculogen TR-2. A new oxidation method to dehydro-ß-
carbolines.", Pedro H.H. Hermkens, Chris G. Kruse, Hans W. Scheeren, Hanie C.J. 
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INTRODUCTION 
Increased research on mycotoxins has led to the discovery of fungal metabolites that induced 
neurological manifestations in vertebrate animals that include sustained or intermittent tremors.1'12 
Fungi capable of producing tremorgic metabolites can be found on a variety of important agricultural 
commodities. The fungal tremorgens can be classified into six groups based on chemical relationship.9 
The compounds of one of these groups-the fumitremorgin-verruculogen group- are biochemically 
derived from tryptophan, proline and one or more mevalonic acid moieties.6 Seven members of this 
group are at the moment isolated and identified, including in most cases their stereochemistry (three 
members are given in Scheme I). In efforts to determine the mode of action of fungal tremorgens, it 
has become apparent thet they provide usefull tools in the study of central nervous system functions. 
In general, they interfere in the mechanisms resposible for the release of CNS neurotransmitters.13"18 
Although particular molecular features responsible for the tremorgenic activity in the 
fumitremorgin-verruculogen group have not been completely identified, there are indications that the 
conformation and configuration of the dioxopiperazine moiety affects this tremorgenic activity16. 
We became interested in the fumitremorgins as attractive synthetic targets because of their biological 
activity. The first target we setded upon was fumitremorgin С (l)2·3·6·8·9 a mycotoxin isolated from 
Scheme I 
1 : Fumitremorgin С 2: Verruculogen TR-2 
он о 
3: Verruculogen TR-1 
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Aspergillus Fumigatus. An earlier approach19 via an isoxazolidine (e.g. 5) -derived from 
N-hydroxytryptophan (4)- demonstrated that the this was an efficient route to the skeleton of the 
fumitremorgins i.e. 6 (Scheme II). A further study of this route is discussed in chapter 4.2, which 
Scheme II 
eventually resulted in the total synthesis of fumitremorgin С 
The second target was the more functionalized verruculogen TR-2 (2)3·6·8·9·11, a mycotoxin initially 
isolated from Aspergillus Fumigatus (Chapter 4.3). 
Over the last years other members of the fumitremorgin-verruculogen class of mycotoxins have been 
targets for total synthesis.· 
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Chapter 42 
TOTAL SYNTHESIS OF (-)-FUMITREMORGIN С 
The structure of fumitremorgin C, as first reported m 1977,,a contains three chiral carbon atoms. The 
absolute configuration at C(5a) and C(8) is as depicted in formula la.1 The stereochemistry at C(14a) 
has not been ascertained2. Thus, the total synthesis of fumitremorgin С is desirable -amongst others-
to confirm the assigned structure and to determine the precise stereochemistry. 
Recendy, we reported the first stereoselective approach to tetrahydro-ß-carbolines (cf. 7) having a 
masked C(l) 2-hydroxy-2-methylpropyl side chain moiety.3 Subsequent to the development of this 
efficient, N-hydroxytryptophan mediated synthesis of these tetrahydro-ß-carbolines, one of our goals 
has been the synthesis of the skeleton of fumitremorgins.4 Through the synthesis of the fumitremorgin 
С analog 2b, we became evidence -though inconclusive- that this compound is not the skeleton of 
fumitremorgin С (la) but a C(14a) epimer. 
,ΧΧΧΧΡ 
ι u-4 H Η 
la Fumitremorgin С a: 
l b b: 
2a,biC(l4a)-epimer) '— 
3a,b (C(8)-epimer) 
4a,b (C(8) and C(14a)-epimer) 
R=OCH, R-H 3 
Unfortunately, our approach to 2b employing the cycloadduct 7b invariably led to compounds 
having a frans-relationship between the tetrahydro-ß-carbolines C(l) and C(3) substituents (Scheme 
I). So the problem we faced was a selective epimerisation at the carbon atom C(3) of 7 or one of its 
successors. 
In this chapter a straight-forward synthesis of the optically pure tremogenic mycotoxin 
fumitremorgin С (la) and it isomers 2a-4a is presented. 
Results 
Nitrone 6a (Scheme I) was prepared by a known procedure3,4·5 from 5a. 1,3-Dipolar cycloaddition of 
isobutene with 6a proceeded regio- and stereoselecüvely to give quantitatively the frans-adduct 7a. 
The desired cleavage of the isoxazolidine N-0 bond was accomplished by treatment of 7a with zinc 
dust in acetic acid.6 
Surprisingly7, this procedure gave a diastereomenc mixture of 8a (trans) and 9a (eis) in 98% yield. 
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Scheme I 
OEl 4OEt 
5a: R=OMe 
b:R.H 
7a,b 
OEt 
9a 
i)HC(OMe)31H+ üfisobuleneinloluenefntfC.Sbar) ¡ü)ZnlHOAc 
8a,b 
The ratio 8a/9a varied from 12.5/1 to 25/1. We have not established unambiguously whether this 
epimensation at C(3) occurs with 7a or with 8a, mainly because the efficiency of this process was too 
low to be of synthetic value. We rather preferred to study the epimensation of 8a and its progeners. 
Epimerisation 
In our hands the isoxazolidine tetrahydro-ß-caibolines 7 could not be epimerised. Treatment with 
base (NaH or tBuOK in dimethoxyethane) gave 12 in 75% yield. (Scheme II) Therefore we selected 
the N(2) amides as target molecules for epimerisation studies. As a model compound we selected the 
N(2) sulfonamide derivative 10, which was prepared in 82% yield by treatment of 8b2 with TosCl in 
pyridine. 
An efficient method for epimerisation of 10 was only found after several unsuccesful attempts. No 
isomerisation occured when 10 was treated with Et3N in dichloromethane. Employment of the 
stronger base NaOEt in ethanol led to the undesired ß-carboline 12 as the main product.8The method 
of choice for the anticipated epimerisation appeared to be treatment of 10 with DBU in 
dichloromethane at room temperature. The cis/trans equilibrium ratio of this reaction was estimated as 
11/10=8.5/1.0. Minute quantities (5%) of 12 as side product were observed.9 
The epimerisation occurred selectively at the C(3) carbon since reaction of 10 with DBU in a 
mixture of CD3OD and dichloromethane led to deuterium incorporation at the C(3) carbon 
exclusively. 
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Scherno II 
Encouraged by these results we selected the diastereomeric amides 14 and 15 (Scheme III) as targets 
for epimerisation. These compounds were prepared in the following manner. Treatment of the racemic 
amine 8a with the acid chloride of TrOC-L-proline (13) at -2ÇPCX0 in the presence of triethylamine 
provided in 77% yield the amides 14 and 15 (diastereomeric ratio 1/1.5), which were separated by 
column chromatography. When the experiment was carried out without triethylamine a complete 
kinetic resolution was observed leading to the exclusive formation of diastereomer 15. Subsequent 
addition of the base resulted in formation of 14 from the residual 8a and 13. 
Isomerisation of the key intermediate 14 into its epimer 16 was achieved as follows. When 14 was 
treated with DBU in chloroform for 2 days at 450C an equilibrium ratio of 14/16=1/1 was observed. 
Fortunately, this procedure afforded no oxidized ß-carbolines. Subsequently, 15 was treated in the 
same manner to give an equilibrium ratio of 15/17=2/3. These diastereomeric mixtures could easily be 
separated by column chromatography where upon the trans compounds were subjected again to this 
epimerisation proces. In this way the trans compounds 14 and 15 could be converted nearly 
completely into the corresponding cis compounds 16 and 17, respectively. 
The proline amine functions of the compounds 14-17 were deprotected by means of zinc dust in 
refluxing methanol to give the amines 18-21 which -under these conditions- cyclized to give the 
pentacyclic compounds 22-25. We noticed that the trans compounds 22 and 23 were obtained 
quantitatively within 10 minutes, whereas the cis compounds 24 and 25 were obtained in 63% and 
45% yield, respectively only after prolonged reaction of 3 days. 
Comparison of CPK models revealed that in 24 and 25 there is considerable steric hindrance 
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20 R=H 
29 R=CBz 
+ 
17 R=TrOC, H(1)P, Η(3)β 
21 R-H 
30 R=CBz 
MeO 
22 R.CH2C(Me)2OH, H(8)a, H(14a)ß 
Ів R=CH»C(Me)2 
31 R=CH2-C(Me)=CH2 
35 R=CH2C(Me)2CI 
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MeO' •ААг^ 
Ι „ Λ η Η 
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24 Н-СН
г
С(Ме)2ОН, Η(8)α, Η(14β)α 
1а Р=СН=С(М ) 2 
33 R-CH2-C(Me).CH2 
23 R-CHjCfMe)^, Η(8)Ρ, H(14a)a 
За R=CH~C(Me)2 
32 R=CH2-C(Me)=CH2 
36 R=CH2-C(Me)2CI 
25 R-CH2C(Me)2OH, H(8)ß, H(14a)ß 
4α R=CH=C(Me)2 
34 R=.CH2-C(Me)>CH2 
between the side-chain and the proline moiety. This observation might rationalise the rather sluggish 
dioxopiperazine formation in the cis-series. 
Alternatively, the four pentacycles 22-25 could be prepared -though less efficiently in the case of 24 
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and 25- from the isomers 8a and 9a (vide supra). Thus coupling of 8a and 9a with CBz-L-proline acid 
chloride (26) (Scheme III) provided the amides 27 and 28 (ratio 1/1.25) in 79% and 29 and 30 (ratio 
1/1.15) in 71% yield, respectively. Again kinetic resolution was observed. Chromatographic 
separation of the diastereomers, followed by deprotection by catalytic hydrogénation and subsequent 
ring closure of the intermediates 18-21 afforded again the pentacyclic dioxopiperazines 22 (100%), 
23 (100%), 24 (10%) and 25 (10%), respectively. The yields again are indicating that ring closure of 
the cis compounds is less favourable. 
That no racemisation had taken place in the proline moiety during the coupling procedure was 
secured with the chiral shift reagens tris[3-((heptafluoropropyl)hydroxymethylene)camphorato]-
europium (Ш) as described earlier.4 Stereochemical structure assignments are made by extending our 
previous results4 assuming that no deviant behaviour is caused by the methoxy moiety on the indole 
nucleus. 
For obvious reasons we finally subjected the pentacyclic compounds 22 and 23 to DBU in CHCI3 at 
60PC (vide supra) as well as to NaOEt in ethanol at 60PC. However, no epimerisation was observed. 
Finally, transformation of the alcohol functions of 22-25 into the alkene functions of la-4a was 
accomplished by means of SOCI2 in pyridine at -40oC.2 The desired alkenes la-4a were accompanied 
by products due to Hofmann eliminations and -in some cases- by the corresponding chlorides. Thus 24 
gave la (4%) and 33 (44%) and 22 gave 2a (65%), 31 (11%) and 35 (7%) and 23 gave 3a (28%), 32 
(13%) and 36 (12%) and 25 gave 4a (5%) and 34 (16%). It was discouraging to observe that in the cis 
series the dehydration afforded mainly the undesired products of Hofmann elimination. A tentative 
rationale comes from studying the CPK models; the proton participating in the desired Saytzeff 
elimination is sterically more hindered than the corresponding proton in the trans series. Attempts to 
isomerize the olefins 31-34 into la-4a by means of catalytic amounts of acid (H2SO4 or TFA) or a 
metal complex (PdC^, ЯЬС1(РРЬз)з failed.11 Upon completion of this synthesis of fumitremorgic C, 
Nakagawa et.al12 reported that isomerization of comparable olefins was possible employing the 
transition metal catalyst Рез(СО)і2. 
Of the four pentacycles la-4a only the product la possessed spectral characteristics identical to 
those reported for fumitremorgin C.4 This comparison completed the first total synthesis of this 
natural product.13 From this result we concluded that the product 2b we reported earlier4 is indeed the 
C(14a) epimeric analog of the natural product. 
Discussion 
The synthesis of fumitremorgin С (la) as well as the developed method to achieve the desired 
tetrahydro-ß-carboline having a eis relationship of the C(l), C(3) substituents demonstrates the utility 
of N-hydroxytryptophan in the synthesis of indole alkaloids. 
Epimerisation at the C(3) carbon in 1,3-disubstituted-tetrahydro-ß-carbolines was accomplished only 
when N(2) amides were used and steric interactions absent. 
A draw-back of the synthetic route was that in the cis series the dehydration afforded mainly the 
undesired products of a Hofmann elimination. Nakagawa et.al13 demonstrated later on that a better 
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position in the reaction sequence for this elimination reaction is in the stage before ring closure (e.g. 
compounds 16 and 17). 
Experimental Section 
Melting points were taken on Koefler hot stage (Leitz-Wetzlar) and are uncorrected. Ultraviolet 
spectra were measured with a LKB spectrophotometer. Model 4050. Proton magnetic resonance 
spectra were measured on a Bruker WH-90 spectrometer. Chemical shifts are reported as δ values 
(parts per million) relative to tetramethylsilane as an internal standard. As a chiral reagent we used 
tris[3-((heptafluoropropyl) hydroxy-methylene)-d-camphorato]europium(ni) (Janssen Chimica, 
Belgium). Mass spectra were obtained using a double focusing VG 7070E spectrometer. Thin layer 
chromatography (TLC) was carried out using Merck precoated silicagel F-254 plates (thickness, 0.25 
mm). Spots were visualized with a UV hand lamp, iodine vapor, CI2-TDM.14 For column 
chromatography Merk silicagel 60H was used. Solvent systems used were as follows: system A: 
СНС1з/МеОН,93/7, / ; system В: СНС1з/МеОН,97/3, v/v; system CEtOAc; system 
0:СНС1з/МеОН,99/1, / . 
2,2-Dimethyl-5-(ethoxycarbonyl)-9-methoxy-4^,6,llb-tetrahydro-isoxazolidin[2,3-a]-ß-carbo-
line (7a) 
Thermal reaction conditions: A stirred solution of 6a5 (2.04 g, 7.06 mmol) in dry toluene (75 mL) 
and isobutene (50 mL) was heated for 4h at IIWC in a 250 mL pressure vessel. The pressure 
increased up to 9 bar. Filtration of the mixture gave 1.99 g (82%) product. Evaporation of the filtrate 
and recrystallisation of the residue (CT^CM gave additional 0.3 g (12%) of 7a. Total yield (94%); mp 
263-2650C ; Rf 0.57 (solvent system A); UV (methanol) Xmax 226,265, 269, 297 nm, λτηιη 250, 280 
nm; EIMS (70 eV) m/z (relative intensity), 344 (M+, 73%), 271 [C^H^lsLOJ-1-, 100%), 198 
([C12H10N2O]+, 55%), exact mass for C l 9 H 2 4 N 2 0 4 caled. 344.1736, found 344.1731;% NMR δ 7.89 (br s, IH, NR), 7.37-6.70 (m, 2H, С(7)-С(8)Н), 6.81 (s, IH, C(IO)H), 4.85 (X part of ABX spectrum, 
IH, C(llb)H), 4.29 and 4.24 (2 q from diastereotopic protons, 2H, ОСН2СНз), 4.09 (t, IH, 3J=7.0 Hz, 
C(5)H), 3.78 (s, 3H, OCH,), 3.02 (d. 2H, 3J=7.0 Hz, C(6)H), 2.42 and 2.23 (AB part of ABX 
spectrum, 2H, 2J=12.3 Hz, yJ=6.7 Hz, 3J=11.1 Hz, C(1)H2), 1.42 and 1.31 (2xs, 6H, 2x CH,), 1.28 (t, 
3H, OCH2CH3); Anal. Caled, for C ^ H ^ N ^ (MW 344.412) : С, 66.26; H, 7.02; Ν, 8.13. Found: С, 
66.11; Η, 7.02; Ν, 8.12. 
High-Pressure reaction conditions: The nitrone 6a (288 mg, 1 mmol) and isobutene (3 mL) were 
dissolved in 4 mL DMF and brought into a teflon high-pressure vessel, which was placed in a 
high-pressure apparatus. After 20h at 12 kbar the reaction was completed as monitored by TLC. 
Filtration of the mixture gave 255 mg (75%) product. Evaporation of the filtrate and recrystallisation 
of the residue gave additional 40 mg (11%) of 7a. Total yield 86%. 
l-(2,-Hydroxy-methylpropyl)-3-(ethoxycarbonyl)-7-methoxy-l,2^,4-tetrahydro-ß-carboline 
(trans 8a, cis 9a) 
Activated zinc dust was added portionwise to a stirred solution of 7a (750 mg, 2.2 mmol) in 100 mL 
glacial acetic acid. The reaction mixture was kept at 40oC for 7 h and during that time argon was 
bubbled through the solution. The reaction was monitored by TLC (solvent system A). The reaction 
mixture was filtered and washed with CH2CI2, the filtrate concentrated to dryness and the residue 
dissolved in CH2CI2. This solution was washed successively with saturated КаНСОз, brine, and dried 
over N32804. The solvent was evaporated in vacuo and the residue subjected to flash chromatography 
(CHClj/MeOH, 98/2. v/v) to yield 32 mg (4%) of 9a and 706 mg (94%) of 8a. These products resisted 
crystallisation attempts. 
cis-product 9a: Rf 0.30 (solvent system B); EIMS (70 eV) m/z (relative intensity) 346 (M+, 20%), 
273 ([CjeHjiNjO,]4, 100%), 199 ([С^Нц^ОГ, 25%); exact mass for C19H26N204 caled. 346.1893, 
found 346.1892; Ή NMR δ 8.86 (br s, IH, N(9)H), 7.38-6.72 (m, 2H, C(5)-C(6)H), 6.81 (s, IH, 
C(8)H), 4.44-4.08 (X part of ABX spectrum, IH, C(l)H), 4.26 (q, 2H, OCH2CH3), 3.83 (s, 3H. 
OCH3), 3.78 (X part of ABX spectrum, IH, C(3)H), 3.04 and 2.77 (AB part of ABX spectrum, 2H, 
2J=15.3 Hz, 3J=4.0 Hz, 3J=11.5 Hz, C^Hj), 2.29 (br s, 2H, N(2)H and OH), 2.11 and 1.84 (AB part 
of ABX spectrum, 2H, 2J=14.7 Hz, 3J=6.0 Hz, 3J=6.0 Hz, C(1)-CH2), 1.39 (s, 6H, 2хСНз), 1.33 (t, 3H, 
OCH2CH3). 
trans-product 8a: Rf 0.27 (solvent system B); EIMS (70 eV) m/z (relative intensity) 346 (M+, 39%), 
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273 (100%), 199 (40%); exact mass for C 1 9 H 2 6 N 2 0 4 caled. 346.1893, found 346.1889; lH NMR δ 
7.83 (br s, IH, N(9)H), 7.40-6.73 (m, 2H, С(5)-С(6)Н), 6.82 (s, IH, С(8)Н), 4.51 (X part of ABX 
spectrum, IH, C(l)H), 4.23 (q, 2H, ОСН2СНз), 3.93 (X part of ABX spectrum, IH, С(З)Н), 3.83 (s, 
3H, OCHj), 3.10 and 2.74 (AB part of ABX spectrum, 2H, 2J=15.6 Hz, 3J=4.8 Hz, 3J=10.0 Hz, 
CWH,), 1.95 and 1.72 (AB part of ABX spectrum, 2H, 2J=14.5 Hz, 3J=5.1 Hz, 3J=12.3 Hz, 
C(1)-CH2), 1.40 and 1.25 (2xs, 6H, 2хСНз), 1.31 (t, 3H, OCH2CH3). 
l-(2'-Hydroxy-methjrlpropyl)-2-(tosyl)-3-(ethoxycarbon)'l)-7-methoxy-l^,3,4-tetrahydro-
-ß-carboline (10) 
To a stirring solution of 8b2 (1.24 g, 4 mmol) in dry pyridine (10 mL) at 0°C in an argon atmosphere 
was added dropwise tosyl chloride (840 mg, 4.4 mmol) in dry pyridine (5 mL). The solution was 
allowed to warm to room temperature. The reaction was completed within one hour. After dilution 
with CH2C12 (100 mL) the solution was succesively washed with, 2N aqueous HCl, brine and dried 
with Na2S04. Evaporation of the filtrate gave 1.52 g (82%) of 10, which was crystallized from 
CCVEtp; mp 165-1680C; Rf 0.75 (solvent system A); UV (methanol) Xmax 220, 264, 269, 275, 281, 
287 nm, λπύη 257 nm; ¿IMS (100 eV) m/z (relative intensity) 471 ([M+l]+, 14%), 453 
( [ C ^ H ^ N ^ S r , 60%), 413 ( [ C ^ H ^ N ^ S r , 100%), 397 ( [ C ^ H ^ N ^ S r , 51%), 315 
( [ C . g H ^ N ^ r , 35%); exact mass for C ^ . N ^ S caled. 471.195, found 471.193; lH NMR δ 8.54 
(br s, IH, N(9)H), 7.80-7.00 (m, 8H, C(5)-C(è)H and C6H4), 5.20 (t, IH, 3J=6.1 Hz, C(l)H), 4.40 (q, 
2H, ОСН2СНз), 4.33 (X part of ABX spectrum, IH, С(З)Н), 3.20 and 2.97 (AB part of ABX 
spectrum, 2Н.^=16.2 Hz, 3J=12.0 Hz, 3J=4.4 Hz, C(4)H2), 2.58 (br s, IH, OH), 2.22 (s, 3H, p-CHj), 
2.08 (d, 2H, 3J=6.1 Hz, C(1)-CH2), 1.42 (t, 3H, ОСН2СНз), 1.26 (s, 6H, 2хСНз); Anal. Caled, for 
с25нз<Л058 (MW 470.589): С, 63.81; H, 6.43; Ν, 5.95. Found: С, 63.19; Η, 6.52; Ν, 5.99. 
Epimerisation of N(2)-sulfonamide 10 
A solution of sulfonamide 10 (108 mg, 0.23 mmol) and DBU (35 mg, 0.23 mmol) in dry CH2C12 (10 
mL) was stirred at room temperature in an argon atmosphere for 24 h. The reaction mixture was 
washed with 0.1N aqueous HCl and brine, and dried with N82804. Evaporation of the solvent and 
subsequent flash chromatography (n-hexane/EtOAc, 75/25, v/v) of the residue gave the epimerized 
product 11 (85%), starting material (10%) and aromatised product 12 (5%).2 
Compound 11: This product resisted crystallisation attempts.Rj 0.90 (solvent system A); EIMS (70 
eV) m/z (relative intensity) 470 (M+, 35%), 397 (100%), 169 (90%); exact mass for C^fygN^S 
caled. 470.1875, found 470.1878; lH NMR δ 9.98 (br s, IH, N(9)H), 7.78-7.00 (m, 8H, С(5)-С(8)Н 
and СбН4), 5.22 (br d, 2Н, С(1)Н and С(З)Н), 4.05 and 4.03 (2q from diastereotopic protons, 2H, 
ОСН2СНз), 3.44-3.28 (A part of ABX spectrum, IH, C(4)Ha), 2.73-2.18 (m, 3H, C(4)Hb and 
C(1)-CH2), 2.33 (s, 3H, Р-СН3), 2.09 (br s, IH, OH), 1.61 and 1.36 (2xs, 6H, 2хСНз), 1.16 (t, 3H, 
ОСН2СНз). 
Deuterium incorporation at C(3)-position of 10. 
A solution of 10 (106 mg, 0.2 mmol) and DBU in СН2С12/СОзОО, 8/2, v/v (4 mL) was stirred at 
room temperature in an argon atmosphere for 24 h. The solvent was evaporated and the residue 
subjected to flash chromatography (CHCI3) to yield 140 mg (80%) C(3)-deuterated 11: EIMS (70 eV) 
m/z (relative intensity) 471 (M+, 22%), 398 ( [ C ^ H ^ D N ^ S r , 100%), 170 ([СцНвО^Г, 69%); Ή 
NMR δ 9.96 (br s, IH, N(9)H), 7.72-6.98 (m, 8H, C(5)-C(8)H and С6Н4), 5.19 (br d, IH, C(l)H), 4.05 (q, 2H, ОСН2СНз), 3.44-3.24 (A part of AB spectrum, IH. C(4)Ha), 2.71-1.90 (В part of AB 
spectrum, IH, C(4)Hb and AB part of ABX spectrum, 2H, C(1)-CH2), 2.33 (s, 3H, p-CHj), 1.86 (br s, 
IH, OH), 1.60 and 1.36 (2xs, 6H, 2хСНз), 1.15 (t, 3H, ОСН2СНз). 
8-(2'-Hydroxy-2'-niethylpropyl)-7,8,14,14a-tetrahydro-pyrrolidino-[l^-c]-piperazino-[r,6'-
-2,3]-ß-carboHne-(5aHa, 8Ηα, 14aHß)-l,6-dione (22) and 8-(2'-Hydroxy-2'-methylpropyl)-
-7,8,14,14a-tetrahydro-pyrroIidino-[l^-cbpiperazino-[r,6'-2,3]-ß-carboline-(5aHa, 8Hß, 
14aHa).l,6-dione (23) 
Method a: A solution of 8a (680 mg, 1.97 mmol) and Et?N (200 mg, 1.98 mmol) in dry CH2C12 (10 
mL) was added dropwise to a cooled (-20oC) stirring solution of L-TrOC-Pro-Cl15 (2.43 mmol) in dry 
CH2C12 (20 mL) in an argon atmosphere. The reaction mixture was allowed to warm to room 
temperature and was monitored by TLC (solvent system A; 15 Rf 0.53.; 14 Rf 0.49). After one hour 
the reaction was completed, and the reaction mixture was washed succesively with 0.1 N aqueous 
HCl, 0.1 N NaHC03 and brine and dried with Na2S04. Evaporation of the solvent in vacuo gave a 
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crystalline material, which was subjected to flash chromatography (СНСІз/МеОН, 99.7/0.3, v/v) to 
yield 527 mg (43%) of 15 and 415 mg (34%) of 14. Removal of the N-protecting group was 
accomplished quantitatively by refluxing the dipeptides in methanol (50 mL) with zinc dust for 10 
minutes. Filtration and evaporation of the solvent gave 336 mg (43%) of 23 and 266 mg (34%) of 22. 
Yields are based on 8a. 
Method b: Coupling of 8a (840 mg, 2.43 mmol) with L-CBz-Pro-Cl2 as described above and 
subsequently flash chromatography (CHClj/MeOH, 99.25/0.75, v/v) gave 610 mg (44%) of 28 (Rf 
0.62, solvent system A) and 492 mg (35%) of 27 (Rf 0.53, solvent system A). Of these N-protected 
dipeptides the CBZ-group was removed by catalytic hydrogénation using Pd-C in ethanolic solution 
at atmospheric pressure. Filtration and evaporation of the solvent gave 403 mg (44%) of 23 and 320 
mg (32%) of 22. 
Compound 22: Rf 0.26 (solvent system B); mp 270-271oC (CHClj/n-hexane); [afo22 +112 (c=1.25, 
methanol); UV (methanol) Xmax 225, 267, 297 nm, Xmin 251, 281 nm; EIMS (70 eV) m/z (relative 
intensity) 397 (M+, 46%), 379 (8%), 324 (100%), 199 (42%); exact mass for C22H27N3O4 caled. 
397.2002, found 397.2003: Ή NMR δ 8.69 (br s, IH, NH), 7.33-6.68 (m, 2H, C(12)-C(13)H), 6.81 (s, 
IH, C(IO)H), 5.93 (t, IH, Ь=5Л Hz, C(8)H), 4.36 (X part of ABX spectrum, IH, C(14a)H), 4.24-3.97 
(m, IH, C(5a)H), 3.85-3.51 (m, 2H, C(3]H2), 3.82 (s, 3H, OCH3), 3.30 and 2.89 (AB part of ABX 
spectrum, 2H, 2J=15.3 Hz, 3J=3.9 Hz, 3J=11.7 Hz, C(14)H2), 2.60-1.68 (m, 7H, C(4)HrC(5)H2, 
C(8)-C(1')H2 and OH), 1.43 and 1.34 (2xs, 6H, 2хСНз). Addition of the chiral shift reagent 
tris[3-((heptÍFluoropropyl)hydroxymethylene)-¿-camphorato]europium (III) to the CDCI3 solution of 
22 did not cause splitting of signals. Anal. Caled, for С 2 2 Н 2 7 ^04 . 0.4СНСІЗ (Mw 445.229): C, 60.43; 
H, 6.20; N, 9.44. Found: C, 60.28; H, 6.17; N, 9.43. 
Compound 23: Rf 0.26 (solvent system B); mp 234-2360C (CHCyn-hexane); [α]ο 2 2 -159 (c=2.0, 
methanol); UV (methanol) Xmax 225, 267, 297 nm, Xxmn 250, 278 nm; EHIMS (70 eV) m/z (relative 
intensity) 397 (M+, 36%), 379 ([C^H^NjOj]^ 5%), 324 (С1 8Н ] (^зОз]+, 100%), 199 (38%); exact 
mass for C ^ H ^ O ^ caled. 397.2002, found 397.1996; •Η NMR δ 9.09 (br s, IH, NH), 7.40-6.71 
(m, 2H, C(12)-C(13)H), 6.82 (s, IH, C(10)H, 6.00-5.87 (X paît of ABX spectrum, IH, C(8)H), 4.40 
(X part of ABX spectrum, IH, C(14a)H), 4.23-3.33 (m, 3H, C(5a)H and C(3)H2), 3.83 (s, 3H, OCH3), 
2.95-1.73 (m, 9H, 2x AB part of ABX spectrum C(14)H2 and C(8)-C(1')H2, C(4)H2-C(5)H2 and OH), 
1.53 and 1.35 (2xs, 6H, 2хСНз). Addition of the chiral shift reagent 
tris[3-((heptafluoropropyl)hydroxymethylene)-d-camphorato]europium (III) to the CDCI3 solution of 
23 did not cause splitting of signals. Anal. Caled, for C ^ H ^ O ^ 0.8 CHC13 (Mw 492.981) : C, 
55.55; H, 5.68; N, 8.52. Found: C, 55.28; H, 5.64; N, 8.48. 
8-(2'-Hydroxy-2'-methylpropyl)-7,8,14,14a-tetrahydгo-pyгrolidίno-[l,2-c]-pîperazino-[1^6,-
-2,3]-ß-carboline-(5aHa, 8Ηα, 14aHa)-l,6-dione (24) and 8-(2'-Hydroxy-2'-methylpropyl)-
-7,8,14,14a-tetrahydro-pyrrolidino-[l^-c]-piperazino-[l',6,-2,3]-ß-carboline-(5aHa, 8Hß, 
14aHß)-l,6-dione (25) 
Method a: Compound 9a (155 mg, 0.45 mmol) was coupled with L-CBz-Pro-Cl (0.56 mmol) as 
described for the preparation of 22 abd 23. This procedure gave 75 mg (29%) of 29 and 110 mg (42%) 
of 30. The N-protecting group of these dipeptides was removed by catalytic hydrogénation using Pd-C 
in ethanolic solution at room temperature and atmospheric pressure to yield 20 and 21, respectively. 
Cyclisation to the corresponding dioxopiperazines did not occur under these conditions. This was 
achieved by refluxing a solution of the amines 20 and 21 in ethanol to give 18 mg (10%) of 24 and 18 
mg (10%) of 25. 
Method b (Epimerisation of N-protected dipeptides 14 and 15): A solution of 14 or 15 (325 mg, 
0.53 mmol) and DBU (85 mg, 0.53 mmol) in dry CHCI3 was stirred at 450C in an argon atmosphere. 
Monitoring of the reaction by TLC showed that after 48 h. the equilibrium was reached. The reaction 
mixture was washed with 0.1 N aqueous HCl, brine and dried with N32804. After evaporation of the 
solvent the residue was subjected to flash chromatography (СНСІз/МеОН, 99.5/0.5, v/v) to yield 162 
mg (50%) of 16 (Rf 0.42, solvent sytem B) and 162 mg starting material 14 (or 217 mg (67%) of 17 (Rf 0.40, solvent system B) and 108 mg starting material 15). Removal of the N-protecting group and 
cyclisation to the diketopiperazines 24 and 25 was accomplished by refluxing a solution of 16 or 17 in 
a methanol (5 mL) with zinc dust for 3 days. After filtration and evaporation of the solvent, the residue 
was subjected to flash chromatography (СНСІз/МеОН, 99.5/0.5, v/v) to yield 65 mg (63%) of 24 (or 
63 mg (45%) of 25). 
Compound 24: Crystallisation attempts were unsuccesful. Rf 0.34 (solvent system Β); [a]22!) -62.5 
(c=3.8, methanol); UV (methanol) Xmax 226, 267, 297 nm, Xmin 250, 280 nm; EIMS (70 eV) m/z 
76 Chapter 4.2 
(relative intensity) 397 (M+, 42%), 279 (6%), 324 (100%), 199 (38%); exact mass for C J Í ^ N J O , , 
caled. 397.2002, found 397.1998; lH NMR δ 8.81 (br s, IH, NH), 7.43-6.67 (m, 2H, С(12)-С(13)Н), 
6.85 (s, IH, C(IO)H), 5.67 (X part of ABX spectrum, IH, C(8)H), 4.20-4.00 (m, 2H, C(5a)H and Χ 
part of ABX spectrum C(14a)H), 3.80 (s, 3H, OCH3), 3.72-2.93 (m, 4H, C(3)H2 and AB part of ABX 
spectrum С{ЩЩ, 2.49-1.64 (m, 7H, C(4)H
r
C(5)H2, AB part of ABX spectrum CW-CíHHj and 
OH), 1.38 and 1.13 (2xs, 6H, 2XCH3). 
Compound 25: Crystallisation attempts were unsuccesful. Rf 0.34 (solvent system Β); [ a ] 2 ^ +30 
(c=4.3, methanol); UV (methanol) Xmax 225, 267, 297 nm, Xmin 249, 281 nm; EIMS (70 eV) m/z 
(relative intensity) 397 (M+, 40%), 479 (7%), 324 (100%), 199 (45%); exact mass for C Í Í H ^ N J C ^ 
caled. 397.2002, found 397.2000; Ή NMR δ 9.56 (br s, IH, NH), 7.35-6.71 (m, 2H, C(12)-C(13)H), 
6.81 (s, IH, C(10)H), 4.94-4.73 (X part of ABX spectrum, IH, C(8)H), 4.34-3.98 (m, 2H, C(5a)H and 
X part of ABX spectrum C(14a)H), 3.82 (s, 3H, OCH3), 3.84-1.71 (m, 1 IH, C(3)H2, AB part of ABX 
spectrum C(14)H2, AB part of ABX spectrum C(8)-C(1')H2, C(4)H2-C(5)H2 and OH), 1.45 and 1.41 (2xs, 6H, 2хСНз). 
Dehydration of 22-25 
General method: To a stirred and cooled (-40oC) solution of the alcohol in dry pyridine (1 mL per 
0.1 mmol of alcohol) was added freshly distilled thionyl chloride (1.5 equivalents) in an argon 
atmosphere. The reaction was monitored by TLC (solvent system C). The solution was allowed to 
warm to room temperature. After dilution with СН2СІ2 the resulting mixture was washed with 2 N 
aqueous HCl, brine and dried with Na2S04. Evaporation of the solvent gave a mixture of reaction 
products, which were separated by flash chromatography. 
Reaction of 22 (100 mg, 0.25 mmol) with SOCl2 (44mg, 0.375 mmol) gave after flash 
chromatography (EtOAc/n-hexane, 60/40, v/v) 7 mg (7%) of 35, 10 mg (11%) of 31 and 62 mg (65%) 
of 2a. 
8-(2'-methyl-l'-propenyl)-7,8,14,14a-tetrahydro-pyrrolidino-[l, 2-c]-piperazino-[l',6'-2,3]-
-ß-carboline-(5aHa, 8Ha, 14aHß)-l,6-dione (2а): Rf 0.42 (solvent system C); mp 261-2630C (EtOAc/n-hexane); [a] 2 2 D +250 (c=0.9, methanol); UV (methanol) λπΐ3χ 230, 268, 297 nm, Xmin 255, 
282 nm; EIMS (70 eV) m/z (relative intensity) 379 (M+, 82%), 324 (37%), 281 (100%), 199 (20%); 
Ή NMR δ 7.76 (br s ,1H, NH), 7.32 (br d, IH, C(13)H), 6.82 (s, IH, C(IO)H), 6.76 (m, IH, C(12)H), 
6.44 (d, IH, 3J=9.3 Hz, C(8)H), 5.34 (d, IH, 3J=9.3 Hz, С(Г)Н), 4.40 (X part of ABX spectrum, IH, 
C(14a)H), 4.27-3.98 (m, IH, C(5a)H), 3.82 (s, ЗН, ОСН3), 3.82-3.50 (m, 2Н, С Р ) ^ ) , 3.27 and 2.87 
(AB part of ABX spectrum, 2H, 2J=15.0 Hz, 3J=3.9 Hz, 3J=11.7 Hz, C(14)H2), 2.51-1.98 )m, 4H, 
C(4)H2-C(5)H2), 1.96 and 1.75 (2xs, 6H, 2хСНз); Anal. Caled, for C ^ ^ N j O j (Mw 379.463): C, 
69.64; H, 6.64; N, 11.07. Found: C, 69.49; H, 6.69; N, 10.92. 
8-(2'-methyl-2'-propenyl)-7,8,14,14a-tetrahydro-pyrrolidino-[l, г-сІ-рірегагіпо-ЕІ'^'^]-
-ß-carboIine-(5aHa, 8Ηα, 14aHß)-l,6-dione (31): Rf 0.46 (solvent system С); oil; EIMS (70 eV) 
m/z (relative intensity) 379 (M+, 13%), 324 (100%), 199 (29%); lH NMR δ 7.86 (br s, IH, NH), 
7.39-6.74 (m, 2H, C(12)-C(13)H), 6.83 (s, IH, C(10)H), 5.90 (t, IH, 3J=7.2 Hz, C(8)H), 4.93 (br d, 
2H, 2J=7.8 Hz, СОІЩ, 4,42 (X part of ABX spectrum, IH, C(14a)H), 4.20-4.03 (m, IH, C(5a)H), 
3.83 (s, ЗН, OCHj), 3.83-3.53 (m, 2Н, С(3)Н2), 3.32 and 2.88 (AB part of ABX spectrum, 2H, 2J=15.3 Hz, 3J=3.3 Hz, 3J=12.0 Hz, C(14)H2), 2.54 (d, 2H, 3J=7.2 Hz, С(Г)Н2), 2.54-1.68 (m, 4H, 
C(4)-C(5)H2), 1.91 (s, ЗН, CHj). 
8-(2'-chloro-2'-methylpropyl)-7,8,14,14a-tetrahydro-pyrrolidino -[l,2-c]-piperazino-[l',6'-2,3]-
-ß-carboHne-(5aHa, 8Ηα, 14aHß)-l,6-dione (35): Rf 0.52 (solvent system С); oil, FABMS (7 kV 
at 1.4 mA) m/z (relative intensity) 418 ([M+3]+, 2.5%), 416 ([M+l]+, 6.6%), 185 (100%); Ή NMR δ 
8.80 (br s, IH, NH), 7.37-6.74 (m, 2H, C(12)-C(13)H), 6.83 (s, IH, C(10)H), 6.09 (t, IH, 3J=4.5 Hz, 
C(8)H), 4.40 (X part of ABX spectrum, IH, C(14a)H), 4.23-4.02 (m, IH, C(5a)H), 3.87-3.57 (m, 2H, 
C(3)H2), 3.83 (s, ЗН, OCH,), 3.27 and 2.87 (AB part of ABX spectrum, 2H, 2J=15.0 Hz, 3J=3.8 Hz, 3J=11.4 Hz, C(14)H2), 2.60-1.60 (m, 4H, C(4)-C(5)H2), 2.60 (d, 2H, 3J=4.5 Hz, Cd^Hz), 1.72 and 
1.68(2х5,6Н,2хСНз). 
Reaction of 23 (100 mg, 0.25 mmol) and SOCl2 (44 mg, 0.375 mmol) gave after flash 
chromatography (EtOAc/n-hexane, 55/45, v/v) 12 mg (12%) of 36, 12 mg (13%) of 32 and 27 mg 
(28%) of 3a. 
8-(2'-methyl-l'-propenyl)-7,844,14a-tetrahydro-pyrroIidino-[l, 2-c]-piperazino-[l',6'-2,3]-
-ß-carboline-(5aHa, 8Hß, 14aHa)-l,6-dione (За): Rf 0.37 (solvent system C); mp 259-2690C 
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(EtOAc/n-hexane); [al 2 2 D -327 (c=0.8, methanol); UV (methanol) Xmax, 225, 270, 297 nm, λιηϊη 254, 
281 nm; EMS (70 eV) m/z (relative intensity) 379 (M+, 98%), 324 (100%), 199 (46%); 'H NMR δ 
7.68 (br s, IH, NH), 7.36 (br d, IH, C(13)H), 6.83 (s, IH, C(10)H), 6.83-6.73 (m, IH, C(12)H), 6.38 
(d, IH, 3J=9.8 Hz, C(8)H), 5.23 (2, IH, 3J=9.8 Hz, C(V)H), 4.44 (X part of ABX spectrum, IH, 
C(14a)H), 4.22-4.00 (m, IH, C(5a)H), 3.95-3.33 (m, 2H, C(3)H2), 3.82 (s, 3H, OCH3), 3.09-1.90 (m, 
6H C(4)-C(5)H2 and AB part of ABX spectrum C(14)H2), 2.03 and 1.76 (2xs, 6H, 2хСНз); Anal. 
Caled, for СггН^ЫзОз (Mw 379.463): С, 69.64; H, 6.64; Ν, 11.07. Found: С, 69.33; Η, 6.68; Ν, 
10.88. 
8-(2,-methyl-2'-propenyl)-7,8,14,14a-tetrahydro-pyrrol¡dino-[l, 2-с]-рірегагіпо-[Г,6'-2,3]-
-ß-carboline-(5aHa, 8Hß, 14aHa)-l,6-dione (32):Rf 0.42 (solvent system С); oil; EIMS (70 eV) 
m/z (relative intensity) 379 (M+, 15%), 324 (100%), 199 (35%); •Η NMR δ 7.96 (br s, IH, NH), 
7.42-6.75 (m, 2H, C(12)-C(13)H), 6.84 (s, IH, C(10)H), 5.92 (t, IH, 3J=6.6 Hz, C(8)H), 4.91 (d, 2H, 
2J=7.5 Hz, C(3')H2), 4.44 (X part of ABX spectrum, IH, C(14a)H), 4.24-4.00 (m, IH, C(5a)H), 
3.94-3.33 (m, 2H, C(3)H2), 3.84 (s, ЗН, OCHj), 3.04-1.62 (m, 6H, C(4)-C(5)H2 and AB part of ABX 
spectrum 0 ( 1 4 ) ^ , 2.55 (d, 2H, 3J=6.6 Hz, С(Г)Н2), 1.89 (s, ЗН, СЩ). 
8-(2'-chloro-2'-methyIpropyl)-7,8,14,14a-tetrahydro-pyrrolidino -[l,2-c]-piperazïno-[r,6'-2,3]-
-ß-carboIine-(5aHa, 8Hß, 14aHa)-l,6-dione (36): Rf 0.48 (solvent system С); oil; FABMS (7 kV 
at 1.4 mA) m/z (relative intensity) 418 ([M+3]+, 2%), 416 ([M+l]+, 5%), 185 (100%); •H NMR δ 8.23 
(br s, IH, NH), 7.37-6.74 (m, 2H, C(12)-C(13)H), 6.83 (s, IH, C(10)H), 6.23 (t, IH, 3J=5.4 Hz, 
C(8)H), 4.49 (X part of ABX spectrum, IH, C(14a)H), 4.28-4.00 (m, IH, C(5a)H), 3.94-3.31 (m, 2H, 
C(3)H2), 3.83 (s, ЗН, OCHj), 3.3-1.91 (m, 6H, C(4)-C(5)H2 and AB part of ABX spectrum C(14)H2), 
2.31 (d, 2H, 3J=5.4 Hz, C(l ')H2), 1.71 (s, 6H, 2xCH3). 
Reaction of 24 (50 mg, 0.12 mmol) and SOCI2 (19 mg, 0.185 mmol) gave after flash 
chromatography (EtOAc/n-hexane, 50/50, v/v) 20 mg (44%) of 33 and 2 mg (4%) of la. 
Fumitremorgin С (la). Rf 0.13 (solvent system D); oil; [a] 2 2 D -9 (methanol c=0.65); UV (methanol) Xmax 225, 270, 296 nm Дтіп 255, 280 nm; EIMS (70 eV) m/z (relative intensity) 379 
(M+, 72%), 324 (100%), 199 (52%);^ NMR (200 MHz) δ 7.66 (br s, IH, NH), 7.44 (d, IH, C(13)H), 
6.86-6.79 (m, 2H, C(10)H and C(12)H), 5.98 (d, IH, 5J=9.6 Hz, C(8)H), 4.91 (dt, IH, 3J=9.6 Hz, 
4J=1.5 Hz, C(l')H), 4.23-4.08 (m, 2H, C(14a)H and C(5a)H), 3.84 (s, 3H, OCH3), 3.68-3.60 (m, IH, 
C(3)H2), 3.51 and 3.10 (AB part of ABX spectrum, 2H, 3J=6.3 Hz, 3J=12.3 Hz, 2J=18.0 Hz, C(14)H2), 
2.46-1.91 (m, 4H, C(4)-C(5)H2), 2.00 (d, 3H, 4J=1.5 Hz, CH3), 1.66 (d, 3H, 4J=1.5 Hz, CH3). 
8-(2'-methyl-2'-propenyl)-7,8,14,14a-tetrahydro-pyrroIidino-[l, 2-c]-pip€razino-[l',6'-2,3]-
-ß-carbo]ine-(5aHa, 8Ηα, 14aHa)-l,6-dione (33): Rf 0.14 (solvent system D);EIMS (70 eV) m/z (relative intensity) 379 (M+, 14%), 324 (100%), 199 (42%); lH NMR δ 8.00 (br s, IH, NH), 7.42 (d, 
IH, C(13)H), 6.84 (s, IH, C(IO)H), 6.78 (d, IH, C(12)H), 5.40 (X part of ABX spectrum, IH, C(8)H), 
4.64 (br d, 2H, 2J=22.0 Hz, C(3')H2), 4.20-3.97 (m, 2H, C(5a)H and C(14a)H), 3.84 (s, ЗН, OCH3), 
3.67-1.73 (m, 10H, C(3)H2, C(14)H2> C(1')H2 and C(4)-C(5)H2), 1.64 (s, ЗН, CH3). 
Reaction of 25 (40 mg, 0.1 mmol) and SOCU (18 mg, 0.15 mmol) gave after flash chromatography 
(EtOAc/n-hexane, 60/40, v/v) 6 mg (16%) of 34 and 2 mg (5%) of 4a. 
8-(2'-niethyI-l'-propenyl)-7,8,14,14a-tetrahydro-pyrrolidino-[l, 2-c]-piperazino-[l\6'-2,3]-
-ß-carboline-(5aHa, 8Hß, 14aHß)-l,6-dione (4a): Rr 0.13 (solvent system D); EIMS (70 eV) m/z 
(relative intensity) 379 (M+, 83%), 324 (100%), 199 (35%); 'H NMR δ 7.85 (br s, IH, NH), 7.42 (d, 
IH, C(13)H), 6.85 (s, IH, C(10)H), 6.73 (d, IH, C(12)H), 5.54 (d, IH, 3J=9.0 Hz, C(8)H), 4.95 (d, 
1H,3J=9.0 Hz, C(l')H), 4.31-4.01 (m, 2H, C(14a)H and C(5a)H), 3.85 (s, ЗН, OCH3), 3.84-2.74 (m, 
4H, C(3)H2 and С(14)Щ, 2.45-1.75 (m, 4H, C(4)-C(5)H2), 1.92 and 1.82 (2xs, 6H, 2хСНз). 
8-(2'-niethyl-2'-propenyl)-7,8,14,14a-tetrahydro-pyrroIidino-[l, 2-c]-p¡perazino-[l',6'-2,3]-
-ß-carboline-(5aHa, 8Hß, 14aHß)-l,6-dione (34): Rf 0.16 (solvent system D); EIMS (70 eV) m/z (relative intensity) 379 (M+, 21%), 324 (100%), 199 (54%); Ή NMR δ 8.26 (br s, IH, NH), 7.37 (m, 
IH, C(13)H), 6.83 (s, IH, C(10)H), 6.77 (m, IH, C(12)H), 5.10-4.85 (m, IH, C(8)H), 4.96 (br d, 
1H,2J=8.1 Hz, C(T)U2), 4.33-4.00 (m, 2H, C(14a)H and C(5a)H), 3.83 (s, 3H, OCH3), 3.79-2.81 (m, 
4H, C(3)H2 and C(14)H2), 2.53-1.67 (m, 6H, С(Г)Н2 and C(4)-C(5)H2), 1.80 (s, ЗН, CH3). 
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STEREOSELECTIVE SYNTHESIS OF (-)-VERRUCULOGEN TR-2. 
In the previous chapter the total synthesis of the tremorgenic mycotoxin fumitremorgin С and three 
of its epimers has been presented.1 The next target we settled upon was a more-functionalized member 
of the same class of natural products, i.e. verruculogen TR-2 (I).2 So far a synthesis of this mycotoxin 
has not been reported. 
Willingale et.al.3 demonstrated by a labeling experiment that verruculogen TR-2 is biosynthetically 
derived from tryptophan, proline, methionine and mevalonate. Recently, it was suggested4 that the 
biogenetic relationship between tryptophan on one hand and α-substituted- and 
a.ß-dehydro-tryptophan derivatives on the other hand might proceed via N-hydroxytryptophan 
derivatives. Moreover, it was demonstrated4 that N-hydroxytryptophan derivatives deserve attention 
as synthons in the preparation of natural products having α-functionalized- and 
α,β-dehydro-tryptophan as structural elements. 
Based on these experiences we wondered whether the N-hydroxytryptophan derivative 3 could be 
converted into the α,β-dehydrotryptophan moiety present in 2. This conversion might well be an 
avenue to the title compound, as the hydroxylation of α,β-dehydrotryptophan derivatives into the 
corresponding rij-diols has been reported before by others58. 
Scheme I 
он о О О 
Verruculogen TR-2 
Strategy 
So the problem we faced here was the conversion of 3 into 2. This is not a trivial reaction, as 
1,2-dihydro-ß-carbolines are relatively unstable and prone to undergo base-induced aromatization to 
give ß-carbolines9. 
Starting from a tetrahydro-ß-carboline we reasoned that two, fundamentally different approaches 
might yield a selective, formal conversion of 3 into 2 (Scheme 11). 
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Initially, we studied the base-catalyzed elimination of the alkoxy group in N(2)-alkoxy derivatives 
(e.g. 4) to give -after isomerization of the double bond- the dehydro ß-carboline 5 (route A, Scheme 
II). Acylation of the amine function might then give the desired dehydro-ß-carboline 6. 
Our second approach (route B) deviated from route A in that first the N-O bond was cleaved by 
reduction to yield a ring-opened amino alcohol of which the amino group was acylated to provide 7. 
Subsequently several methods were studied for the formal dehydrogenation of the latter to give 6. 
Firstly we studied a selective dehydrogenation of 7 with the oxidizing reagent DDQ (route В!). A 
second method (route B¿) features the introduction of a leaving group at the 3-position of indole 
providing the indolenine 8, which -after elimination of the leaving group and rearrangement- should 
give the dehydro compound 6 (route B^). A third method (route B3) has been explored successfully by 
Boyd9, who introduced the benzeneseleninic function at the ß-carboline C(3) position to yield 9 
(LG=SeOPh) and subsequently eliminated this function to give 6. 
Initially, routes A, B! and B2 were explored with a more readily available analogue of 3 lacking the 
methoxy substituent in the indole moiety. The most suitable approach to 2 was found to be route B2, 
which was subsequently successfully applied in the total synthesis of 1. 
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Results 
Route A. In chapter 4.2 it is mentioned10 that treatment of the isoxazolidine tetrahydro ß-carboline 
10 with base (NaH or KOtBu in dimethoxyethane) gave the aromatized ß-carboline 14 instead of the 
desired dihydro compound (Scheme III). In a related reaction Harrison11 has shown that this 
aromatization can be prevented by acylation of the NH function. We therefore set out to prepare the 
proline amides 16 and 17 anticipating that the proline ester moiety might capture intramolecularly the 
NH formed in the dihydro-ß-carboline moiety to give the desmethoxy analogue of 2. Firstly, the 
isoxazolidine fragment 10 had to be coupled with L-proline methyl ester. This coupling could be 
achieved by employing the acid chloride 13, which was prepared from 10 in three steps. The first one 
was transesterfication of 10 by a mild method12 using titanium (IV) isopropoxide in an excess of 
i)Ti(OiCsH7)4IBnOH u)H2.PdlC ш) (COClfy DMFICH2CI2 iv)NaHIDME v) EtjN / СЩС^ vi) Zn I HO Ac, 6CPC 
vit) DBUICH2CI2 vui)DDQ/CH2Cl2 
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benzylalcohol to give the benzyl ester 11 (yield 92%). Chemoselective removal of the benzyl group 
was achieved by hydrogénation in the presence of catalytic Pd/C to give 12 quantitatively.13 The 
carboxylic acid was converted into the acid chloride 13 by using oxalyl chloride in dichloromethane in 
the presence of a catalytic amount of DMF. 
In order to retain the homo-chirality of 13 during the coupling procedure a solution of L-proline 
methyl ester 15 and triethylamine were added together and dropwise to a cooled (-2QPC) solution of 
13. This procedure provided (76% yield) the amides 16 and 17 in a ratio of 1:1, which were easily 
separated by column chromatography. In order to assign the relative stereochemistry of 16 and 17 
these compounds were converted into the known pentacycles 18 and 1914. 
Unfortunately, conversion of 16 and 17 to the α,β-dehydro-compound 5 failed. Treatment with 
several bases (MeOH/NaOMe, KOtBu/MeOH, NaH/DME, DBU/THF, pyridine, KOtBu/O^Clj) or 
acids (HjSOyMeOH, HCl(g)/dioxane, TiCyCI^Cl^ TMSI/CH3CN) gave only untractable reaction 
mixtures or starting material. This failure blocked the -in our opinion- most elegant approach for the 
conversion 3—»2. 
Route B]. Attempted selective dehydrogenation of the pentacycles 18 and 19 with DDQ failed to 
give the corresponding 14,14a-dehy(lro derivative, i.e. the desmethoxy analogue of 2. Reaction of 18 
or 19 with DDQ (1 equiv.) in dichloromethane gave in stead 50% starting material and 50% of the 
N(2)-acyl-ß-carboline anhydro base 20 (Scheme III). Subsequent addition of a second equivalent 
DDQ to the reaction mixture gave quantitatively 20. The desired dehydro derivative 6 is probably an 
intermediate in this reaction. Attempts to prevent the over-oxidation (i.e. 6—»20) by temperature 
control or by the use of other solvents or by a milder oxidation reagent -such as p-chloranil- failed. 
Route В2. Electrophiles are easily incorporated at the 3-position of the indole unit of a 
tetrahydro-ß-carboline15. Our initial investigation concerned the sulfonamide derivative 211 as a 
model compound and 2,3,4,5,6,6-hexachlorocyclohexadien-l-one (22) as a mild Cl+-donor16. The 
selectivity and mildness of this latter reagent is based on its ability to form a donor-acceptor complex 
and to form a hydrogen bond which leads to a well defined 'recognition' between this reagent and a 
substrate. It has however, not been studied so far in substitution reactions at an indole nucleus. 
Suprisingly, we found that reaction of 21 in dichloromethane/methanol, 1/1, v/v with 22 at room 
temperature gave not the expected 3-chloroindolunine, but the 3-methoxyindolenine 23 in quantitative 
yield (Scheme Г ). Reaction of 21 with 22 under identical conditions but now in a 
dichloromethane/ethanol or a dimethoxyethane/water mixture gave the 3-ethoxyindolenine 24 (80%) 
and the 3-hydroxyindolenine 25 (78%), respectively. Although examples of the introduction of a 
nucleophile at this position are extremely rare17, we could not escape the conclusion that the above 
described conditions cause incorporation of a nucleophile at C(3) of the indole nucleus. Whereas this 
reaction proceeds with complete stereoselectivity we did not establish -for obvious reasons- the 
stereochemistry at C(4a) of the alkoxy indolenines 23-25. 
These findings can be rationalized as follows. Initially, 22 reacts with 21 to form a donor-acceptor 
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Scheme IV 
2 1 23: R-ОМ 
24: R-OEt 
25: R-OH 
complex, directed by a H-bridge between the indole NH proton and the oxygen of 22. This is followed 
by the formation of pentachlorophenol and the N-chloro substituted intermediate X, which is now 
Chart! 
prone to undergo a nucleophilic attack at the indole C(3)-positìon (Chart I). The observed complete 
stereoselectivity renders a SN1 type reaction less likely. It is also unlikely that first a 
3-chloroindolenine is generated which subsequendy undergoes nucleophilic substitution of the 
chlorine by ROH as neutral conditions are employed, whereas strongly alkaline150 or acidic15f 
conditions are reported to be required for this conversion. 
Application of this methodology to the pentacycle 261 -a precursor of one of the epimers of 
fumitremorgin С (see chapter 4.2)- gave the 3-methoxyindolenine 27 (73%) with complete 
stereoselectivity (Scheme V). Subsequently, a solution of 27 in dichloromethane and a few drops of 
trifluoroacetic acid was stirred at room temperature to give the dehydrodipeptide 2 (46%), together 
with the aromatized product 28 (6%) and recovered starting material 27 (43%). This mixture was 
separated easily by column chromatography whereupon the starting material 27 was treated again with 
TFA. This led to 80% overall yield of 2. 
Treatment of 26 with 22 in ethanol (neat) at room temperature gave directly the dehydrogenated 
product 2 in 37% yield. However, formation of the side-product 28 in up to 23% yield made this route 
less attractive. 
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Next our strategy employed the transformation of the C(14)-C(14a) alkene moiety of key 
intermediate 2 into the ct'i-diol of the natural product 1. Thus, based on literature procedures8 using 
Os04 in pyridine, followed by a reductive work up with sodium bisulfite, 2 was converted into 1 in 
22% yield (Scheme V). The spectroscopical data of 1 are identical to those of the natural verruculogen 
TR-l*. 
Recently, the synthesis of desmethoxy TR-2 has been reported8. However, we are puzzled about the 
Ή NMR spectrum of the compound reported in that study. It differs substantially from the spectrum 
we observed for 1. Moreover, the sign of the specific rotation we measured for 1 ([a]D-450) is opposite 
to that reported by Boyd and Thompson ([a]D+1160). Therefore we are tempted to conclude that these 
authors described the synthesis of one of the isomers of demethoxy TR-2. 
Conclusion 
Our approach to 1 constitutes the first total synthesis of verruculogen TR-2 and provides definite 
proof of its structure. Reaction of 26 with 22 in dichloromethane/methanol provides the 
methoxyindolenine 27, which in the presence of TFA rearranges to the dehydrodipeptide 2. This 
compound was elaborated to 1 employing osmium tetroxide followed by reductive work up. 
Experimental Section 
Melting points were taken on Koefler hot stage (Leitz-Wetzlar) and are uncorrected. Ultraviolet 
spectra were measured with a Perkon Elmer spectrophotometer, Model lambda 5. Proton magnetic 
resonance spectra were measured on a Bruker WH-90 or on a Bruker AM 200 spectrometer. Chemical 
shifts are reported as δ values (parts per million) relative to tetramethylsilane as an internal standard. 
Mass spectra were obtained with a double focusing VG 7070E spectrometer. Thin layer 
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chromatography (TLC) was carried out by using Merck precoated silicagel F-254 plates (thickness, 
0.25 mm). Spots were visualized with a UV hand lamp, iodine vapor, CLj-TDM.18 For column 
chromatography Merk silicagel 60H was used. 
2,2-Dimethyl-5-(benzoxycarbonyl)-4^,6,llb-tetrahydro-isoxazondino[2,3-a]-ß-carboIine(ll) 
A solution of 1010 (3.7 g, 11.8 mmol), benzylalcohol (20 mL) and 0.3 equivalent 
titanium(IV)isopropoxide (Aldrich Chemical Co. 1.0 g, 3.5 mmol) in dioxane (30 mL) was kept for 
18h at ÌOCPC and argon atmosphere. The reaction was monitored by TLC (СНСІз/МеОН, 99/1, v/v). 
After dilution with CH2CI2 (100 mL) the mixture was washed with 1 N HCl. The troubled organic 
layer was filtered and the filtrate was washed with brine and dried with ЫагЗОд and evaporated. 
Crystallization from CHCiyn-hexane gave 2.5 g (57%) of 11. Removing of the benzylalcohol by 
vacuum destination and crystallization of the resulting residue gave an extra 1.15 g (26%) product. 
Total yield 83%. ; mp 210-212oC (CHCI3); Rf 0.64 (CHCtyMeOH, 93/7, v/v); CIMS (100 eV) m/z (relative intensity) 377 ([M+l]+, 100%), 241 (ГС^Нп^ОГ, 91%), 91 ([C7H7]+, 72%); exact mass for 
C23H25N2O3 caled. 377.187, found 377.189; Ή NMR (CDCU) δ 7.95 (br s, IH, NH), 7.60-7.18 (m, 
9H, С(7)-С(10)Н and Ph), 5.45 and 5.30 (AB spectrum, 2H, 4=14 Hz, OCHj), 5.03 (X part of ABX 
spectrum, IH, C(llb)H), 4.28 (t, IH, J=6.6 Hz, C(5)H), 3.21 (d, 2H, J=6.6 Hz, C(6)H2), 2.60 and 2.38 (AB part of ABX spectrum, 2H, 2J=21.3 HZ, J=6.3 Hz, J=9.9 Hz, C(1)H2), 1.53 and 1.50 (2xs, 6H, 
2хСНз); Anal.Calcd. for С^Н^ЩОу С, 73.38; Η, 6.43; Ν, 7.44. Found: С, 73.03; Η, 6.41; Ν, 7.32. 
Compound 16 and Compound 17 
Hydrogénation of 11 (1.28g, 3.4 mmol) in EtOH/CHjClj, 95/5, v/v (200 mL) using catalytic Pd-C at 
room temperature and atmospheric pressure gave 996 mg (100%) 12 as a crystalline material. As a 
solid and kept under argon it was stable. Rf=0.12 (СНСІз/МеОН, 93/7, v/v); CIMS (100 eV) m/z 287 
([M+l]+, 2%), 285 ([M-l]+, 4%), 269 ([M-OH]+, 3%), 241 ([M-COOH]+, 20%), 183([C12H11N2]+, 
24%), 169([Ci1H9N2]+, 19%), 59(100%); Ή NMR (DMSO-d6) δ 10.97 (br s, IH, NH), 7.50-6.88 (m, 
4H, С(7)-С(10)Н)> 4.79 (X part of ABX spectrum, IH, C(l lb)H), 4.30 (X part of ABX spectrum, IH, 
C(5)H), 3.19-2.78 (AB part of ABX spectrum, 2H, C(6)H2), 2.67-1.94(AB aprt of ABX spectrum, 2H, 
COiHj), 1.34 (s, 6H, 2хСНз). To a cooled (-г^С) and stirring mixture of 12 in dry СН2СІ2 (100 mL) 
and a few drops of DMF was added dropwise oxalylchloride (475 mg, 3.75 mmol). The reaction 
mixture became clear while CO and C02-evolution occurred. After completion of the reaction a 
solution of (L)-Pro-OMe (485 mg, 3.75 mmol) and Et3N (760 mg, 7.52 mmol) in dry CH2CI2 was 
added dropwise to the cooled stirring solution in an argon atmosphere. The reaction mixture was 
allowed to warm to room temperature. After completion of the reaction (1 h.) as was monitored by 
TLC (СНСІз/МеОН, 93/7, v/v) the reaction mixture was successively washed with 0.1 N NaHCC^, 
0.1 N HCl and brine. The organic layer was dried (N32804) and the solvent was evaporated in vacuo. 
The residue was subjected to column chromatography (СНСІз/МеОН, 98.5/1.5, v/v) to give 530 mg 
(39%) of 16 and 498 mg (37%) of 17. 
Compound 16: Crystallized from MeOH/CHClj: mp 263-2650C; Rf 0.46 (CHClj/MeOH, 93/7, 
v/v); [a]2 2 D+42 (c=2.6, methanol); EIMS (70 eV) m/z (relative intensity) 397 (M+, 2), 382 ([М-СН3Г, 
8), 338 ([M-COOMe]+, 6), 241 ( [ С ^ Н ^ О Г , 100), 183 ([Ο,,Η,,^Γ, 82); lH NMR δ 8.16 (br s, 
IH, NH), 7.48-7.00 (m, 4H, C(7)-C(10)H), 4.81 (t, IH, C(llb)H), 4.57 (t, IH, C(5)H), 4.32 (t, IH, 
Са'ЭНСООМе), 3.94 (br t, 2H, QS*)!^), 3.71 (s, 3H, OCH3), 3.08 (d, 2H, C(6)H2), 2.60-1.82 (m, 
6H, C(1)H2 and C(3,)H2-C(4,)H2), 1.36 (s, 6H, 2хСНз); Anal. Caled, for C22H27N3O4 (Mw 397.496): 
С, 66.48; H, 6.85; Ν, 10.57. Found: С, 66.80; Η, 6.72; Ν, 10.30. 
Compound 17: Crystallized from CH2Cl2/n-hexane: mp 286-288
0C; Rf 0.43 (CHCtyMeOH, 93/7, 
v/v); [аро-Зб 1 (c=1.6, methanol); EIMS (70 eV) m/z (relative intensity) 397 (M+, 2), 241 
([C1 5H1 7N20]+, 75), 183 ([Ci 2HnN 2]+, 100); 'H NMR δ 7.87 (br s, IH, NH), 7.54-7.07 (m, 4H, 
C(7)-C(10)H), 4.96 (t, IH, C(llb)H), 4.67 (t, IH, C(5)H), 4.37 (t, IH, C(2')HCOOMe), 3.89-3.58 (m, 
2H, C(5')H2), 3.64 (s, 3H, OCH3), 3.11 (d, 2H, C(6)H2), 2.67-1.92 (m, 6H, C(1)H2 and 
C(3,)H2-C(4f)H2), 1.39 and 1.32 (2x8, 6H, 2хСНз); Anal. Caled, for С 2 2 Н 2 7 ^ 0 4 (Mw 397.496): С, 
66.48; H, 6.85; Ν, 10.57. Found: С, 66.12; Η, 6.75; Ν, 10.41. 
pentacyclic skeleton 18 and 19 
To a warmed (50oC) stirring solution of 16 (or 17) (40 mg, 0.1 mmol) in acetic acid was added 
activated zink dust. After completion of the reaction (30 minutes) as was monitored by TLC 
(СНСІз/МеОН, 93/7, v/v) the reaction mixture was filtered and the filtrate was evaporated in vacuo. 
The residue was dissolved in dichloromethane and successively washed with 0.1N NaHC03 ^ d brine. 
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The organic layer was dried (N32804) and concentrated to dryness. The residue was disolved in dry 
dichloromethane and DBU (1 equiv.) was added. After completion of the reaction (3 days) as was 
monitored by TLC (CHCLj/MeOH, 93/7, v/v) the reaction mixture was washed with IN HCl and 
brine. The organic layer was dried (N32804) and evaporation of the solvent in vacuo gave 35 mg 
(95%) of crystalline 18 (or 19). Spectroscopical data are identical with earlier published results14. 
Oxidation attempt of 18 (or 19) with DDQ. 
Compound 20 
To a stirred solution of 18 (or 19) (92 mg, 0.25 mmol) in dry dichloromethane (5 mL) was added 
dropwise DDQ (125 mg, 0.55 mmol) in dichloromethane (10 mL). After completion of the reaction (1 
h.) as was monitored by TLC (СНОз/МеОН, 93/7, v/v) the reaction mixture was washed with 0.1N 
NaOH and brine. The organic layer was dried (N32804) and concentrated to dryness. The resisue was 
subjected to column chromatography (CHClj/MeOH, 99/1, v/v) to give 86 mg (95%) of 20; Rf 0.56 
(СНСІз/МеОН, 93/7, v/v); UV (MeOH) Xmax 210, 237, 271, 285(sh), 304(sh), 316(sh), 335, 350 nm; 
EIMS (70 eV) m/z (relative intensity) 363 (M+, 15), 222 (100); Ή NMR δ 8.37 (s, IH, C(14)H), 7.92 
(d, IH, C(IO)H), 7.47 (m, IH, C(13)H), 7.31-7.05 (m, 2H, C(11)-C(12)H), 4.11 (m, IH, C(5a)H), 
3.90-3.60 (m, 2H, ОДНг), 3.44 and 3.28 (AB spectrum, 2H, 2J=16.0 Hz, C(15)H2), 2.22-1.76 (m, 4H, 
C(4)H2-C(5)H2), 1.60 and 1.13 (2xs, 6H, 2хСНз). 
General procedure to 3-alkoxy-indolemnes 
A solution of 2,3,4,5,6,6-hexachloro-2,4-cyclohexandien-l-one (22; Janssen Chimica; 33 mg, 0.11 
mmol) in dichloromethane (2 mL) was added dropwise to a stirred solution of 211 (53 mg, 0.1 mmol) 
in CH2CI2/ROH, 1/1, v/v (8 mL). After completion of the reaction (2-4 h.) as was monitored by TLC 
(EtOAc/n-hexane, 40/60, v/v) the reaction mixture was washed with IN NaOH and brine. The organic 
layer was dried (N37804) and concentrated to dryness. The residue was subjected to column 
chromstography (CHCI3) to give the 3-alkoxy indolenines 23-25. 
Compound 23 (R=Me): Yield 56 mg (100%); oil; Rf 0.48 (EtOAc/n-hexane, 40/60, v/v); UV 
(MeOH) Xmax 205, 231 nm; EIMS (70 eV) m/z (relative intensity) 562 (M+, 14), 407 
([M-S02C7H7]+, 34), 91 ([C7H7]+, 100); 1Я NMR δ 7.78 (d, 2H, р-С6На2НЬ2(СНз)), 7.41-6.93 (m, 
9Н, С6Н5, р-С6На2НЬ2(СНз) and С(6)-С(7)Н), 6.78-6.40 (m, 2Н, С(5)Н and С(8)Н), 4.74 (X part of 
АВХ spectrum, IH, C(l)H), 4.56 and 4.27 (AB spectrum, 2H, 2J=12.4 Hz, OCHjPh), 4.21 (br t, IH, 
C(3)H), 3.11 (s, 3H, OCH3), 2.70-1.75 (m, 4H, C(4)H2 and CiDCHj), 2.42 (s, 3H, р-С6Н4(СНз)), 
1.58 (br s, IH, OH (exchangeable)), 1.34 and 1.28 (2xs, 6H, 2хСНз) 
Compound 24 (R=Et): Yield 46 mg (80%); oil; Rf 0.58 (EtOAc / n-hexane, 40/60, v/v); UV 
(MeOH) Xmax 207, 231 nm; EIMS (70 eV) m/z (relative intensity) 576 (M+, 4), 421 ([M-S02C7H7]+, 
11), 91 ([C7H7]+, 100); •H NMR δ 7.73 (d, 2H, р-С6На2НЬ2(СНз)), 7.32-6.90 (m, 9Н, QHc, 
р-С6На2НЬ2(СНз) and С(6)-С(7)Н), 6.73-6.38 (m, 2Н, С(5)Н and С(8)Н), 4.69 (X part of АВХ 
spectrum, IH, J=3.3Hz, J=5.9Hz, C(l)H), 4.50 and 4.34 (AB spectrum, 2H, 2J=12.3 Hz, OCfyPh), 
4.18 (X part of АВХ spectrum, IH, J=6.9Hz, J=11.7Hz, C(3)H), 3.30 (m, 2H, OCH2CH3), 2.76-1.71 
(m, 4H, C(4)H2 and С{\)СЩ, 2.38 (s, ЗН, р-С6Н4(СНз)), 1.60 (br s, IH, OH (exchangeable)), 1.33 
and 1.27 (2xs, 6H, 2хСНз) 
Compound 25 (R=H): Instead of dichloromethane, dimethoxyethane was used as the solvent in this 
experiment. Yield 43 mg (78%); oil; Rf 0.41 (EtOAc/n-hexane, 40/60, v/v); UV (MeOH) Xmax 205, 
231 nm; EIMS (70 eV) m/z (relative intensity) 548 (M+, 69), 413 ([M-COOC7H7]+, 4), 393 ([M-S02C7H7r, 37), 337 (25), 230 (30), 91 ([C7H7]+, 100); Ή NMR δ 7.77 (d, 2H, 
р-С6На2НЬ2(СНз)), 7.36-6.97 (m, 9Н, QHs, -СМаМЬ^СЩ) and С(6)-С(7)Н), 6.81-6.44 (m, 2Н, 
С(5)Н and С(8)Н), 4.93 and 4.76 (AB spectrum, 2H,^J=12.9 Hz, OCHjPh), 4.67-4.51 (2x X part of 
ABX spectrum, 2H, C(1)H and C(3)H), 4.12 (br s, IH, C(4a)OH (exchangeable)), 2.56-1.88 (m, 4H, 
C(4)H2 and C(1)CH2), 2.39 (s, ЗН, р-СД^СНз)), 1.61 (br s, IH, OH (exchangeable)), 1.34 (s, 6H, 
гхСНзУ 
Compound 26 
A solution of 2,3,4,5,6,6-hexachloro-2,4-cyclohexandien-l-one (22: Janssen Chimica; 38 mg, 0.13 
mmol) in dichloromethane (2 mL) was added dropwise to a stirred solution of 261 (46 mg, 0.12 mmol) 
in СНгСЬ/МеОН, 1/1, v/v (15 mL). After completion of the reaction (30 min) as was monitored by 
TLC (EtOAc) the reaction mixture was washed with IN NaOH and brine. The organic layer was dried 
(N32804) and concentrated to dryness. The residue wss subjected to column chroimtography (CHCU) 
to give 37 mg (73%) of 27. Colourless oil; Rf 0.28 (EtOAc); [a]D +95 0 (c=3.5, methanol); UV 
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(methanol) Xmax 210, 240, 296 nm; EIMS (70 eV) m/z (relative intensity) 427 (M+, 35), 412 (22), 396 
(4), 395 (3), 260 (37), 28 (100); Ή NMR (90 MHz, CDCU) δ 7.00 (d, IH, C(13)H), 6.36-6.17 (m, 2Н, 
С(Ю) and С(12)Н), 5.45 (dd, IH, С(8)Н), 4.40 (dd, IH, C(14a)H), 4.10 (br s, IH, OH), 4.04-3.87 (m, 
IH, C(5a)H), 3.69 (s, 3H, OCHj), 3.53 (s, 3H, OCH3), 3.78-3.29 (m, 2H, C(3)H2), 2.60-1.16 (m, 8H, 
C(14)H2, C(1')H2, C(4)-C(5)H2), 1.36 (s, 6H, 2хСНз). 
Dehydrodipeptide 2 and anhydro base 28 
To a stirred solution of 27 (35mg, 0.082 mmol) in dichloromethane (20 mL) at room temperature 
was added a few drops of trifluoroacetic acid. Stirring was continued for Ih after which the reaction 
mixture was washed with 0.1N МаНСОз and brine. The organic layer was dried (Na^SC^) and 
evaporated to dryness. The residue was subjected to column chromatography (EtOAc) to give 15 mg 
(46%) of 2,15 mg (43%) of starting material 27 and 2 mg (6%) of 28. 
Compound 2: Amorphous yellow-green solid; Rf 0.14 (EtOAc); [a]D +87° (c=1.3, methanol); UV (methanol) \max 227, 254, 363 nm; EIMS (70 eV) 395 (M+, 13), 322 (40), 294 (18), 225 (21), 197 
(27), 57 (100); Ή NMR (90 MHz, CDCI3) δ 9.25 (br s, IH, NH), 7.51 (d, IH, C(13)H), 7.34 (s, IH, 
C(14)H), 6.87 (s, IH, C(IO)H), 6.82 (m, IH, C(12)H), 6,17 (t, IH, C(8)H), 4.22-4.00 (m, IH, C(5a)H), 
3.89-3.54 (m, 2H, СО)Щ), 3.82 (s, 3H, OCH3), 2.53-1.71 (m, 6H, С(Г)Н2, С(4)-С(5)Н2), 2.00 (br s, 
IH, OH), 1.42 and 1.18 (2xs, 6H, 2хСНз) 
Compound 28: Rf 0.43 (EtOAc); UV (MeOH) Xmax 217, 236, 272, 285(sh), 304(sh), 317(sh), 335, 
354 nm; EIMS (70 eV) m/z (relative intensity) 393 (M+, 18), 252 (100), 222 (86); 'H NMR δ 8.38 (s, 
IH, C(14)H), 7.93 (d, IH, C(13)H), 6.96 (s, IH, C(IO)H), 6.90 (d, IH, C(12)H), 4.13 (m, IH, C(5a)H), 
3.98-3.71 (m, 2Н, С(3)Н2), 3.86 (s, ЗН, OCHj), 3.57 and 3.18 (AB spectrum, 2H, 2J=14.5 Hz, 
C(15)H2), 2.23-1.75 (m, 4H, C(4)H2-C(5)H2), 1.61 and 1.24 (2xs, 6H, 2хСНз). 
(-)-Verrucculogen TR-2 (1) 
To a stirred and cooled ((УС) solution of the dehydro compound 2 (5 mg, 0.0127 mmol) in dry 
pyridine (0.5 mL) was added a solution of osmium tetroxide (100 μΐ, 0.0195 M in pyridine). The 
orange solution was stirred at OPC for 2 h and the was treated with saturated aqueous NaHS03 (0.5 
mL), and the mixture was allowed to react at room temperature for 30 min, at which time the aqueous 
layer separated. The mixture was extracted with chloroform and subsequently the organic layer 
washed with brine. The organic layer was dried (Na^SO^ and concentrated to dryness. The residue 
was subjected to column chromatography (СНОз/МеОН, 97/3, v/v) to give 1.2 mg (22%) of 1. oil; Rf 
0.39 (СНСІз/МеОН, 93/7, v/v); [a]D -45° (c=0.55, CH2C12); EIMS (70 eV) 429, (M+· 4), 411 (8), 335 (45), 278 (47), 219 (100); UV (methanol) Xmax 224, 267, 295 nm; 'H NMR (200 MHz, CDCI3) δ 9.04 
(br s, IH, NH), 7.82 (d, IH, C(13)H), 6.86-6.77 (m, 2H, C(10)H and С(12)Н), 5.72 (d, IH, J=2.9 Hz, 
C(14)H), 5.46 (dd, IH, JAX+JBX=11·2 H Z . C(8)H), 4.60 (d, IH, J=2.9 Hz, C(14)OH, 4.45 (m, IH, 
C(5a)H), 4.02 (d, IH, J=2 Hz, C(14a)OH), 3.95 (s, ЗН, OCH3), 3.70-3.61 (m, 2H, C(3)H2), 2.51 and 
2.12-1.65 (m, 7H, С(Г)Н2, C(4)-C(5)H2), 1.55 (s, ЗН, СЩ\ 1.18 (s, ЗН, CH3); (90 MHz, DMSO-dé) 
δ 10.55 (br s, IH, NH), 7.60 (d, IH, J=9 Hz, C(13)H), 6.83 (s, IH, C(10)H), 6.58 (d, IH, J=9 Hz, 
C(12)H), 6.13 (br s, IH, OH), 5.48 (d, IH, C(14)H), 5.32 (m, IH, C(8)H, 5.16 (d, IH, C(14)OH), 4.33 
(m, IH, C(5a)H), 4.17 (br s, IH, OH), 3.70 (s, ЗН, OCH3), 3.55 (m, 2H, C(3)H2), 2.36-1.60 (m, 6H, 
C(1')H2, C(4)-C(5)H2), 1.09 and 0.94 (2xs, 6H, 2x CH3) 
References and Notes 
1. Chapter 4.2 and see also Hermkens, P.H.H.; Plate, R.; Ottenheijm, H.C.J. Tetrahedron, 1988, 
44, 1991. 
2. a) Cole, R.J.; Kirksey, J.W.; Domer, J.W.; Wilson, D.M.; Johnson, J.C.; Johnson, A.N.; Bedell, 
D.M.; Springer, J.P.; Chexal, K.K.; Clardy, J.C.; Cox, R.H. J. Agrie. Food Chem. 1977,25, 826. 
b) Cole, R.J. J. Food Protection 1981, 44, 715. c) Yamazaki, M. In Biosynthesis of Mycotoxins; 
Steyn, P.S., Ed.; Acadenic: Londonn, 1980; p.204. d)Steyn,P.S.; Vleggaar, R.; Rabie, C.J. 
Phytochemistry 1981, 20, 538. e) Cole, R.J.; Cox, R.H. Handbook of Toxic Fungal Metabolites, 
Academic Press, London, 1981, p. 355. 
3. Willingale, J.K.P.W.; Perera, C; Mantle, P.G. Biochem. J. 1983,214, 991. 
4. Plate, R.; Akkerman, M.A.J.; Smits, J.M.M., Ottenheijm, H.C,J. J.Chem.Soc. Perkin Trans I 
1987,2481 and references cited therein. 
5. a) Kodato, S-I; Nakagawa, M.; Hongu, M.; Kawate, T.; Hiño, T. Tetrahedron 1988, 44, 359. b) 
Nakagawa, M.; Kodato, S-I.; Hongu, M.; Kawate, T.; Hiño, T. Tetrahedron Lett. 1986,27, 6217. 
c) Nakagawa, M.; Fukushima, H.; Kawate, T.; Hongu, M.; Kodato, S-I.; Une, T.; Taniguchi, M.; 
88 Chapter 4.3 
Hiño, T. Tetrahedron Lett. 1986,27, 3235. 
6. Oikawa, Y.; Yoshioka, T.; Yonemitsu, О. Tennen Yuki Kagobutsu Toronkai Koen Yoshishu, 
21", 1978,22 (Chem. Abstr. 1979, 90, 152436). 
7. Nakatsuka, S-L; Teranishi, K.; Goto, T.; Tetrahedron Lett. 1986,27,6361. 
8. Boyd, S.A.; Thompson, W.J. J. Org. Chem. 1987,52,1790. 
9. Previero, Α.; Barry, L-G.; Torreilles, J.; Fleury, В.; Letellier, S.; Maupas, B. Tetrahedron 1984, 
40, 221. 
10. Plate, R.; Hermkens, P.H.H.; Smits, J.M.M.; Ottenheijm, H.C.J. J. Org. Chem. 1986,51, 309. 
11. Harrison, D.M.; Sharma, R.B. Tetrahedron Lett. 1986,27, 521. 
12. Seebach, D.; Hungerbuhler, E.; Naef, R.; Schnurrenberger, P.; Weidmann, В.; Zuger, M. 
Synthesis, 1982,138. 
13. The isoxazolidine moiety of 11 is remarkably stable under these catalytic hydrogénation 
conditions, see reference 14. 
14. Reductive ring opening of the isoxazolidine moiety of 16 and 17 by zinc dust in acetic acid at 
50oC gave -after work-up and subsequent addition of the base DBU in chloroform- cyclization 
to the pentacycles 18 and 19 in respectively 87% and 83% yield. Comparison of the ^H NMR 
data of 18 and 19 with those published earlier made the structure assignment possible: Plate, R.; 
Hermkens, P.H.H.; Behm, H.; Ottenheijm, H.C.J. J. Org. Chem. 1987,52, 560. 
15. With ierf-butyl hypochlorite: a) Maindreville, M.D.; Levy, J.; Tillequin, F.; Koch, M. 
J.Nat.Prod. 1983, 46, 310. b) Hershenson, F.M.; Swenton, L.; Prodan, K.A. Tetrahedron Lett. 
1980, 21, 2617. c) Kuehne, M.E.; Roland, D.M.; Hafter, R. J.Org.Chem. 1978, 43, 3705. d) 
Owellen, R.J. J.Org.Chem. 1974,59, 69. Halogination: e) Gassman, P.G.; Campell, G.A.; Mehta, 
G. Tetrahedron, 1972, 28, 2749. f) Gross, E.A.; Vice, S.F.; Dmitrienko, G.I. CanJ.Chem. 1981 
59, 635. 
16. a) Janssen Chimica Acta 1987,5, 3. b) Guy, Α.; Guetté, J-P. Synthesis 1982,1018. 
17. Awang, D.V.C.; Vincent, A. CanJ.Chem. 1980,58,1589 and references cited therein. 
18. Arx, E. von; Faupel, M.; Bruggen, M. J.Chromatogr. 1976,120, 224. 
Chapters 
CHAPTER 5 
Syntheses of 1,3-disubstituted N-hydroxy(alkoxy)-ß-
carbolines by the Pictet-Spengler reactions of N-hy-
droxy(alkoxy)-tryptophan and -tryptamine derivatives. 
C U X = O ^ : - 0 9 Ç Î : OR 
a. 
"Syntheses of 1 J-disubstituted N-oxy-$-carbolines by the Pictet-Spengler reactions of 
N-oxy-tryptophan and -tryptamine derivatives.", Pedro H.H. Hemikens, Jan H. v. 
Maarseveen, Peter L.H.M. Cobben, Harrie C.J. Ottenheijm, Chris G. Kruse, Hans W. 
Scheeren, Tetrahedron (1990), 45, 833. 
90 Chapters 
Chapter 5 
SYNTHESES OF 1J-DISUBSTITUTED N-HYDROXY(ALKOXY)-^-CARBOLINES 
BY THE PICTET-SPENGLER REACTIONS OF N-HYDROXY(ALKOXY)-TRYPTO-
PHANAND -TRYPTAMINE DERIVATIVES. 
The tetrahydro-ß-carboline nucleus is a structural feature present in many indole alkaloids, and the 
Pictet-Spengler reaction (Scheme I) is the most widely used method for synthesizing this tricyclic 
system. Recent examples are the total synthesis of Pyridindolol1, Fumitremorgin-Veiruculogen2 and 
Eudistomins3. For obvious reasons much attention has been focussed on stereochemical11'·2·31'·4·5 and 
mechanistic4b·6 aspects of this reaction. 
CX n4CHO HNR, 
Scheme I 
азссоссс 
1 R^H, Н
г
=СООМ , Вэ=Н 
2. R^H, R2=COOMe, Rg^Bn 
3: R,-H, Rj=CCXDEt, Rj^OH 
4 R^H, Нг-СООЕІ. F^-OBn 
5: R^H, R^H, Rj^DH 
6fc«J 7 (trans) 
Generally, tryptophan methyl ester (1) and aldehydes in aprotic solvents yield both cis and trans 
l,3-disubstituted-l,2,3,4-tetrahydro-ß-carbolines 6 and 7 (Scheme I). It has been demonstrated48 that 
high cii-selectivity can be achieved if the Pictet-Spengler reaction is conducted at low temperatures 
(Ο'Ό). High or complete franj-selectivity was observed when N-benzyl tryptophan methyl ester 2 was 
condensed with aldehydes.4b'4h 
In contrast, Pictet-Spengler reactions of derivatives of N-hydroxytryptophans3b (i.e. 3 and 4) and 
Chart I 
CXJ 
I 
R, 
H N R , 
3: R^H, R^OOEt, R3.OH 
4 R^H, R2=COOEt, Нз-ОВп 
5: R^H. ρζ-Η, KyOH 
8: R^H, R2=Ph. R3=OH 
9: R^H. Н2=СНз. R j ^ H 
10: R^CHj. Rj^CONHMe. R^GM 
11 : R^BOC, ñ^CHp R j^H 
12: R^H. Н
г
=СООЕІ, Рэ=0-І-СзН7 
13: R^H. R2=COOEt. R j j ^ - n ^ H , 
14: R,=H, R2=COOEI, Нд-ОСНз 
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N-hydroxytryptamine3a (i.e. 5) have been investigated only incidentally. The preliminary results of 
these studies indicate a different behaviour with respect to the reactivity and stereochemistry. The 
chemical scope and the stereochemical implications of this reaction for N-hydroxy(alkoxy)-tryptophan 
and -tryptamine derivatives 3-5 and 8-14 (Chart I)7 has now been studied in more detail with different 
aldehydes (R4CHO). 
Pictet-Spengler reactions 
Reaction of the above mentioned N-hydroxy(alkoxy)-tiyptophan and -tryptamine derivatives with 
aldehydes (R4CHO) in dichloromethane at room temperature in the presence of trifluoroacetic acid (1 
Table 1. Influence of the substltuents (IVR4) on the stereochemistry of the Pictet-Spengler reaction. 
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3h 
40oC 24h 
400C. 24h 
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Product ratio6 
compétition between deprotectior 
250C,ih 
3h 
Ih 
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Ih 
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95 
96 
80 
87 
97 
96 
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&7 
7 0 / 3 0 
6 0 / 4 0 
5 8 / 4 2 
7 1 / 2 9 
4 3 / 5 7 
5 8 / 4 2 
5 0 / 5 0 
70/30 
86/14 
45/55 
63/37 
66/34 
0/100 
and condensation 
47/53 
50/50' 
42/58" 
43/57" 
18/82 
21/79 
25/75 
a) based on isolated products b) based on isolated compounds с) see reference 3b d) product ratio determined by means of an 
analytical HPLC-techmque e) see reference 3a 
equiv.) gave a mixture of N-hydroxy(alkoxy)-l,2,3,4-tetrahydro-ß-carbolines 6 and 7 (Table I). With 
the exception of entry 15 all variations of R1-R4 studied resulted in the desired ß-carbolines in 
excellent yields. In order to establish the relative stereochemistry of the C(l) and C(3) protons, NOE 
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difference studies were carried out. Irradiation of C(1)H of compounds 6 resulted in a ca. 10% NOE 
on C(3)H and vice versa. The absence of these NOE differences in compounds 7 indicates that the 
C(l) and C(3) protons in 6 and in 7 have a cis- and a frani-relationship, respectively. It has been 
argued that proton NMR shifts cannot be used for the assignment of the stereochemistry of 
1,3-disubstituted l,2,3,4-tetrahydro-ß-carbolines.4a We found that in all of the 1,3-disubstituted 
N-hydroxy(alkoxy)-ß-carboline derivatives studied however, the chemical shifts of the C(1)H protons 
and the N-hydroxy protons of the 1,3-disubstituted N-hydroxy-ß-carbolines of the rrani-isomers (7) 
are consistently downfield (0.14-1.54 ppm) to the chemical shifts of the corresponding protons of the 
corresponding c/j-isomers (6). 
The influence ofR4. 
The influence of the substituent R4 on the relative stereochemistry (C(l)—»(C(3)) was studied by the 
reaction of 3 with different aldehydes (Table I, Entries 1-7). The tendency is a selectivity for the 
cii-isomer 6. Exceptions are the reactions with benzaldehyde and 3,4,5-trimethoxybenzaldehyde 
(entries 5 and 7). It has been reported4* that when R3=H under reaction conditions similar to those 
using butyraldehyde or benzaldehyde, that the cis product is formed preponderandy (cis/trans=&0/20). 
The decrease of this selectivity observed for N-hydroxytryptophan (R3=OH, entries 2 and 5) is in 
agreement with results obtained for tryptophan derivatives in which Rз=alkyl.4b·c·h 
The observed stereochemistry seems to be the result of a kinetically controlled reaction. Prolonged 
treatment of either the c/j-isomers 6b and 6e or the iranj-isomers 7b and 7e respectively under the 
reaction conditions used for their formation did not cause the formation of the other isomer. Higher 
temperature (650C) led to serious decomposition of the starting materials. In the resulting reaction 
mixtures the only other isomer could be detected, and in less than 5% yield by means of analytical 
HPLC techniques 
Substituent R2. 
The influence of the α-substituent (R2) on the reactivity and relative stereochemistry was studied by 
reaction of the N-hydroxy compounds 3, 5 and 8-9 (R2=COOEt, H, Ph and CH3, respectively) with 
acetaldehyde and benzaldehyde derivatives (Table I, Entries, 1, 5 and 8-13). The substituents 
R2=COOEt and R2=Ph (Entries 1, 5, 8, 11) have a comparable influence on the stereochemistry, 
whereas R2=CH3 (Entries 9, 12, 13) causes a shift towards ds-selectivity. Based on the minimal 
reaction times mentioned in Table I, the reactivities of the compounds with R2=COOEt (Entries 1 and 
5) and R2=Ph (Entries 8 and 11) are also comparable, whereas with R2=H (Entry 10) and R2=CH3 
(Entry 9) a decrease in reactivity is observed. The smooth reaction of N-hydroxyöyptamine (5) with 
acetaldehyde (Entry IO3") is surprising in view of the fact that tryptamine itself (R3=H) cyclizes only 
under much more severe reaction conditions.lb,4d This may be rationalized as follows. 
It is generally excepted that The Pictet-Spengler reaction involves the intermediacy of the imminium 
ion 15 (Chart II), and that the electrophilic character of the C=N bond in this intermediate explains 
differences in reactivity.lb Electron withdrawing groups (R2 e.g. COOR) destabilize the imminium ion 
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Chart II 
077: 
R, R4 R, R4 
15 16 
and accelerate the reaction. Similary the higher reactivity of N-hydroxytryptamine (Яз=ОН) versus 
tryptamine (Яз=Н) can be attributed to the electron-withdrawing ability of the hydroxy group. This 
increased reactivity is also reflected in a lower stereoselectivity. 
Substituent Rj. 
The influence of Rj on the relative stereochemistry was studied by the reaction of the N-hydroxy 
compounds 10-11 with benzaldehyde (Table I, Entries 14-15). Examination of molecular models 
indicated that in the ß-carboline 6 the A(i.2)-strain4a between the substituents I*! (CH3 or BOC) and R4 
(Ph) will be so pronounced that by far mainly the franj-isomer 7 will be formed. Indeed, reaction of 
10 (Кі=СНз) with benzaldehyde gave a single diastereomer of which the relative stereochemistry was 
established as trans (Entry 14). On the basis of this observation, we reasoned that the introduction of a 
protective group at the indole nitrogen could lead to a highly stereoselective approach for trans 
1,3-disubstituted N-hydroxy-1,2,3,4-tetrahydro-ß-carbolines (7: R^H). Treatment of the N-BOC 
protected compound 11 with benzaldehyde under the acidic reaction conditions employed previously 
did not yield however the desired ring closed product. This process is so slow that N-deprotection then 
becomes a competitive reaction. This result can be rationalized by the decreased electron density of 
the indole C(2)-C(3) double bond due to the electron-withdrawing BOC group. 
Substituent R3. 
Of special interest is the influence of R3 on the relative stereochemistry. The reactions of 
N-alkoxytryptophan derivatives 4 and 12-14 with acetaldehyde and benzaldehyde (Table I, Entries 
16-22) were studied. It is noteworthy that the N-alkoxytryptophans are more reactive than their 
N-hydroxy counterpart 3 (entries 1 and 5). This can be rationalized by when R3=OH intermediate 15 
is in equilibrium with the nitrone 16 (Chart II), and in the case of Яз=а1коху such an equilibrium is 
not possible. 
Another interesting feature is that the reaction with acetaldehyde, as well as with benzaldehyde, 
shows a shift of towards trans selectivity in going from NOH to NOR3 derivatives (compare entries 1 
with 16 and 5 with 20). In contrast with the complete irawj-selectivity observed for the reaction of 
N-ben zyltryptophan with benzaldehyde4b, the N-alkoxytryptophans however showed no complete 
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selectivity. This can again be rationalized by the increased reactivity of intermediate 15 as a result of 
the electronic effect exerted by the oxygen atom. 
Conclusions 
In this study on the influence of the substituents R1-R4 on the course of the Pictet-Spengler reaction 
it was found that: 
i) reactions of N-hydroxytryptophan 3 with aldehydes (R4CHO) in general show a moderate 
selectivity for the c/i-isomer. 
ii) the reactivity and stereochemistry is influenced by the α-substituent R2; compounds with 
R2=COOEt or Ph are more reactive than compounds with R2=H or CH3; in the case of 
R2=CH3 the most pronounced cíí-selectivity is observed. 
iii) for R3-substituents the reactivity and the ira/w-selectivity increase in the row H < OH < OR. 
iv) the presence of a substituent other than H at the indole nitrogen (Rj) causes complete trans-
-selectivity. 
Experimental Section 
Melting points were taken on a Koefler hot stage (Leitz-Wetzlar) and are uncorrected. Ultraviolet 
spectra were measured with a Perkin Elmer spectrometer, Model lambda 5. Proton magnetic 
resonance spectra were measured on a Braker WH-90 or on a Bruker AM 400 spectrometer. 
Chemical shifts are reported as δ-values relative to tetramethylsilane as an internal standard; 
deuteriochloroform was used as solvent unless stated otherwise. Mass spectra were obtained using a 
double-focusing VG 7070E spectrometer. Thin-layer chromatography (TLC) was carried out using 
silica gel F-254 plates (thickness 0.25 mm). Spots were visualized with a UV hand lamp, iodine 
vapor, or CI2-TDM.8 For column chromatography Merck silica gel (type 60H) was used. 
General procedure Pictet-Spengler reaction. 
A stirred solution of a N-hydroxy(alkoxy)tryptophan or tiyptamine derivative7 (variation R1-R3, 
see Table I) (1 mmol) and aldehyde (R4CHO, see Table I) (1.25 mmol) in dry dichloromethane (10 
mL) was treated with trifluoroacetic acid (1 mmol) and the reaction allowed to proceed under the 
conditions given in Table I. The mixture was then concentrated in vacuo and the resultant residue 
subjected to column chromatography to yield compounds 6 and 7 (Table I). Spectroscopic data for 
these derivatives are recorded in Table II. 
Table II Sex 
Prod 
6bb 
7ЬЬ 
ec" 
Te­
ed 
7d 
б!" 
71* 
eg" 
ілр 
CC) 
178-181 
141-144 
160-162 
15Я59 
foamc 
loan' 
168-170 
214-217 
225-227 
•ctrosco 
RI 
(Sol.Sf·)1 
0 75 
(0) 
045 
(D) 
0 71 
(B) 
0 57 
(B) 
0 74 
(D) 
0 67 
(D) 
069 
(D) 
0 57 
(D) 
076 
(D) 
pie data ol the ß-carbolmes 6 and 7 
Hass Spectrum 
302 (M*, 36), 285 ([Μ-ΟΗΓ. β), 259 ([М-С
Э
Н7Г, 100), 
229 «M-COOEtJ*, 17). 185 ([Ο,,^Ν^Γ, 51), 169 
((Ο,,Η,Ν/. 42) 
302 (Μ*, 46). 285 ([Μ-ΟΗ1*. 86), 259 (IM-CjH/. 100), 
229 ((M-COOEt)*, 29), 185 ([Ο,,Η,^ΟΓ. 45). 169 
«Ο,,Η,Ν,Γ,βθ) 
350 (Μ*, 5), 277 ([Μ СООЕЦ*, 3), 259 ((М-СуН/, 100). 
ιεθαο,,Η,^ Γ,βδ) 
350 (Μ*. 3), 333 (ΙΜ-ΟΗΓ, 11 ). 277 «МКЮОЕГ. 2). 
259 ([М-С7Н7Г. 100), 169 ([Ο,,Η,ΝϋΓ, 39) 
362 (Μ*, 30), 345 ([Μ-ΟΗΓ, 18), 289 ([M-COOEt]*. 7). 
259 ([M-C^OSr. Κ»). 1β9 ([Ο,,Η,Ν^, 87) 
362 (Μ*. 25), 345 ([Μ-ΟΗΓ, 63), 301 (37), 289 
([MCOOEtr. 9), 259 ([Μΐ4Η703Γ. 74), 169 
([Ο,,Η,Ν/, 100) 
342 (Μ*, 7), 325 ([Μ-ΟΗΓ. 9). 269 ([M-COOEq*. 11), 
251 (Ρ,ϋΗ,,Ν/, 36), 225 (Ι^Η,,ΝΓ. 100). 169 
αΟ,,Η,Ν/. 8) 
342 (Μ*. 7). 325 ([Μ-ΟΗΓ, 35), 269 ([M-COOEt]*, 16), 
251 ([Ο^Η,,Ν/, 71), 22S{lCuHnNr, 100), 169 
αΟ,,Η,Ν/, 14) 
426 (Μ*, 16), 409 ΟΜΟΗΓ. 19), 353 ([»МЮОЕГ. 13), 
335 (34), 309 ([Ο,,Η,,ΝΟ,Γ. 61), 278 αΟ,βΗ,,ΝΟ/, 
е5).2ю^оо)^байс
и
н^^,9) 
Ή NMR 
δ(ρρτπ) 
7 76 (br s, 1 Η,ΝΗ), 7 58-7 04 (m. 4Η. С(5)-С(8)Н), 5 64 (br s, 1 H, NOH), 4 32 (q, 2H, OCHJCHJ), 
4 13 (brs, IH, С(1)Н), 3 86 (t, IH, C(3)H), 3 10 (d, 2Н, 0(4)^). 2 22-1 53 (m, 4H. CflJCHjCt^CHJ, 
1 36 (t. ЗН, OCHjCHj) 1 00 (t, 3H, CfliCHjCHjCHa) 
7èi(brs, 1H.NH). 747-6Sd(m. 4H. C<5)-C(6)H).544(brs, ІН, NOH),4 27(br t, IM, C(1)H). 4 14 
(q, 2H. OCHjjCHj), 3 92 (X part ol ABX speemim, 1 H, C(3)H), 3 11 and 2 97 (AB part o» ABX spectrum, 
2H, 2J=15 4Hz. J=8 1 Hz, J-S 3 Hz, q3)H). 1 9&-1 49 (m, 4H, qi^HjCHjCHj), 1 33 (t, 3H, OCHjCHJ. 
lOOaSH.CflJCf^CHjCHj) 
7 71-6 87(m, 10H, NH. C(5)-C(8)H and CJAJ, 6 11 (brs, IH. NOH), 4 49 (brs, 1H, C(1)H), 4 32 
(q, 2H, ОСНгСНз), 4 (XW 64 (m, 3H. C(3)H and C(1)CH2), 316-2 87 (m, 2H, C(4)H2), 1 33 (t, 3H. 
OCHjCHj) 
7 60« 7Б (m. 10H, NH, С(5)-С(в)Н and CJ1J. 6 40 (br s. IH, NOH), 4 69 (X part of ABX epedium, IH. 
C<1 )H), 4 27 (q, 2H, OCHjCH,), 4 13 (ζ 1 H, C(3)H). 3 67-2 49 (m, 4H, C(4)H2 and AB part of ABX spectrum 
Ol COJHCHj), 1 32 (ζ ЗН, OCHjCty 
8 73 (br s, 1 H, NH). 7 44-7 07 (m, 4H. C(S)-C(8)H), 6 08 (br s, 1 H, NOH), 4 29 (q. 2H, OCHjCH,), 4 12 (br β. 
1 H. C(1 )H,). 3 82 (X part of ABX spectrum. 1 H, C(3)H). 3 24-2.76 (m. 4H. 0 ( 4 ) ^ and CHjS), 2 31 (s. 3H. 
SCOCHj), 2.17-1 78 (m, 2H, C(l)CHj), 1 X (t, ЭН, OCHjCHj) 
8 57 (br s. IH, NH), 7 52-700 (m. 4H, С(5)-С(в)Н), 6 27 (br s, IH, NOH), 4 44 (t, IH. C(1)H). 4 21 (q. 2H. 
OCHjCHj), 4 06 (t, 1 H, C(3)H), 3 41-2.80 (m. 4H, С(4)Н
г
 and CH2S), 2 34 (s, 3H, SCOCH,), 2 34-1 81 
(m, 2H, C(1)CH2), 1 27 (t, 3H, OCHjCH,) 
7 61-6 80 (m, BH, NH, С(5)-С(в)Н and C ^ S ) , 5 83 (br s, IH. NOH), 5 34 (br s, 1H, C(1)H), 4 42 (q. 2H, 
OCHjCHj), 4 00 (t, 1 H, C(3)H), 3 20 (d. 2H. J=7 9Hz, C(4)H2), 1 36 (t, 3H. OCHfiHJ 
7 61 -6 80 (m, BH. NH. C(5)-C(8)H and CAH3S). 5 80 (s, 1 H, C(1)H). 4 22 (q, 2H, OCHjCH,), 4 12 (t, IH, 
C(3)H), 3 44 (m, 2H, C(4)H2), 1 29 (t, 3H, OCHjCHJ 
7 67 (br s, 1 H. NH), 7 60-710 (m, 4H, C(5)-C(8)H), 6 73 (s, 2H, CgH^OMey, 5 50 (s, 1 H, NOH), 4 95 (s, 
1 H. C(1 )H), 4 33 (q, 2H. OCHjCH^, 4 04 (X part of ABX spectrum, 1 H, C(3)H), 3 88 (е. ЗН. р-(ОСНз)). 
3 82 (s. 6H. 2x пЦОСНз». 3 55-3 11 (m. 2H, С{4Щ. 1 34 (t, ЗН, OC^CH^ 
a) A CHCIj В СНСуЬЛеОН, 99/1 С CHCL/MeOH. 97/Э D СНСуМеОН, 93/7 b) Saùstectory mero analyses were obtaned for these compoumfe (C±0 5%, H±0 2%. N±0 4%) 
c) These products resisted oystaizabon attempts d) Anempts to separate these isomers bled <-" 
Table II Spectroscopic data of the ß-carbolines 6 and 7 
Prod 
7gb 
6hb 
7h 
61 
71 
6jb 
бк
ь 
7кь 
61" 
mp 
со 
220-223 
101-10! 
foam0 
loam0 
foam0 
191-193 
191-193 
192-195 
95-97 
M 
(Soh Sy·)' 
060 
(D) 
010 
(B) 
005 
(B) 
028 
(D) 
022 
(D) 
0 17 
(C) 
0 62 
(B) 
029 
(B) 
039 
(B) 
Mas« Spectrum 
426 (M*. 17), 409 ((М-ОНГ, 37). 353 «M-COOEq*. 43), 
309 ([Ο,,Η,,ΝΟ,Γ. 47), 278 «01βΗ1βΝΟ2Γ, 63), 219 
(100),169(tCnH^IJ*,27) 
278 (M*, 20), 263 ((M-CH/, 2). 169 ([Ο,,Η,Ν^*. 5), 
159 (100) 
278 (M*, 21), 263 ([M-CH/, 7), 169 ([C^HjNJ*, 7), 
159 (100) 
216 (M*, 26), 157 ((Ο,,Η,,ΝΓ, 100) 
216 (M*, 25), 157([C1)H1,N]*, 100) 
202 (M*. 42), 157 ((Ο,,Η,,Ν]*, 100) 
340 (M*, 11), 219 ([01βΗ,3ΝΓ, 100) 
340<М*,4),219([С1вН^Г,100) 
278 (M*. 20), 258 ([0,
β
Η|4Ν2Γ. 25), 245 «Ο,,Η,,Ν/, 
Σ^,ΣΙθαΟ,,Η^ΝΓ.ΙΟΟ) 
Ή NMR 
6 (ppm) 
7 64 (br ε, IH. NH), 760-709 (m. 4H, С<5)-С(в)Н). 6 62 (s, 2Н, С
в
Н
г
(ОМе)з), 6 03 (s, 1Н, NOH). 5 69 
(s, 1 H, С( 1 )Н), 4 404 07 (m, ЗН. OCHjC^ and С(З)Н), 3 87 (s. ЗН, ИОСНд)), 3 80 (s, 6Н, 2х ПНОСН3)). 
3 44-3 14 (m, 2Н, С(4)Н
г
), 1 28 (t, ЗН. ΟΟΗ,ΟΗ^ 
7 73 (br s, 1 H, NH). 7 61-6 96 (m, 9H, C(5)-C(8)H and CeH5), 4 73 (br s, IH, NOH). 4 07 (br t, 2H. C(1 )H 
and C(3)H), 3 04 (d. 2H, С(4)Н
г
). 1 62 (d. 3H, C{Ì)CHJ 
7 78 (br s. 1 H, NH). 7 63-7 02 (m, 9H. C(S)-C(8)H and C^, 5 02 (br s, 1 H, NOH), 4 34 (q, 1 H. C(1 )H), 
4 09 (X part of ABX soectrum, IH, C(3)H). 3 38 and 3 08 (AB part of ABX spectrum. 2H. 2J=14 9Hz. J-8 0 
Hz, J=5 1Hz, C(4)Hj), 1 52 (d, 3H, C{\)CH¿ 
7 73 (br s, IH, NH), 7 50-701 (m, 4H, C(5)-C<8)H), 5 08 (br s, 1 H, NOH), 4 06 (br s, 1 H, C(1 )H), 3 14 (m, 
IH, C(3)H), 2 74 (m, 2H C(4)H2). 1 61 (d, 3H, CmCH^, 1 42 (d. ЗН, С(З)СНэ) 
7 70 (br s, IH, NH), 7 52-7 06 (m, 4H, С(5)-С(в)Н), 4 32 (q, IH, C(1 )H), 3 50 (m, 1 H, C(3)H). 2 77 (m, 2H, 
C(4)H2). 1 51 (d, ЗН, С(1)СНз), 1 32 (d, 3H, C{3)CHJ 
7 70 (brs, IH, NH), 7 51-7 06 (m, 4H, C(5)-C(8)H), 6 47 (s, IH, NOH), 4 03 (m, IH, C(1)H), 3 55 (m, 1H, 
С(З)Нд), 3 20 (m, IH, C{,3)H¿), 2 97 (m, 2H, C(4)H2), 1 59 (d, 3H, CflJCHj) 
764-6 91 (m, 15H, NH, C(S)-C(8)H and г х С ^ , 5 10 (brs, IH, C(1)H), 4 59 (brs, IH, NOH), 4 27 (t, IH, 
J=7 5Hz, C(3)H), 3 16 (d, 2H, J=7 5Hz, C(4)H2) 
7 73-702 (m, 15H. NH. C(5)-C(8)H and г х ^ Н ^ , 6 64 (br s. IH. C(1)H), 4 84 (brs. IH, NOH). 4 11 (X part 
of ABX spectnim, IH, C(3)H), 3 42 and 3 14 (AB part of ABX spectnim, 2H, 2J-15 6Hz,J=8 OHz, J=4 8Hz, 
С(4)Н
г
) 
7 53-7 02 (m. 10H. NH. C(5)-C(8)H and С ^ , 4 94 (s, IH, C(1)H), 4 82 (brs, IH, NOH). 3 30 (m. IH, 
C(3)H), 2 86 (m. 2H, C(4)H2), 1 47 (d, ЗН, С(З)СНз) 
a) A CHCI3 В CHCIj/MeOH 99/1 С СНСіуМеОН, 97/3 D CHCIj^teOH, 93/7 b) Sabsfactoiy micro analyses were obtained for these compounds (C±0 5%, H±0 2%, N±0 4%) 
c) These products resisted crystallization attempts d) Attempts to separate these isomers failed 
Table II Spectroscopic data ot the p-carbolmes 6 and 7 
Prod. 
7lb 
6mb 
7mb 
7П Ь 
60 
7o 
7qd 
6г-
71" 
6s 
mp 
(0C) 
230-232 
220-222 
211-223 
oilc 
oil11 
oH« 
of 
of 
Rf 
(StìvSyi)' 
0 19 
(B) 
0 62 
(D) 
0 47 
(D) 
026 
(C) 
046 
(B) 
040 
(B) 
026 
(B) 
0 31 
(B) 
0 76 
(B) 
Mass SpecUum 
278 (M* 24), 258 ([C,eHuN2]\ 19), 245 ([С17Н,зМг]*, 
24),219(IC,eH13NJ\100) 
368 (M*, 24), 350 ([M Hp\\ 43), 335 ( [ C ^ H ^ N ^ / , 
57), 309 ([С,
в
Н1вМОз1*, 100), 278 (|C,eH,6NO ƒ . 94) 
368 (M*, 23), 350 (|M-H2Or. 15), 335 (ΙΟ^Η,,Ν,,Ο/. 
36), 309 ([Ο,,Η,,,ΝΟ/, 100), 278 ([01βΗ,βΝΟ2Γ, 92) 
335 (Μ*. 8), 318 ([Μ-ΟΗ]* 46), 277 ((M-CONHCHJ*. 
18), 259 (|01βΗ,βΝ2Γ, 100), 232 ([017Η,4ΝΓ, 41) 
288 (Μ*. 22), 257 ([M-OCHJ*, 68), 215 ([M-COOEt]*, 
18), 183 ([C^H^NjT, 68), 157 ([Ο,,Η,,Ν]*. 100) 
288 (M*, 21), 257 ((M-OCHJ*, 10), 231 (22), 215 ([M-
COOEtr. 16), ІвЗЦС^Н,,^]*. 24). 157([С1,Н11МГ, 
100) 
316 (M*, 9). 257 ([M-CjHjO]*, 51), 243 ([М-СОО&Г, 
11), 183 ([Ο,,Η,,Ν/. 40), 157 ([Ο,,Η,,ΝΓ, 100) 
330 (M*, 9). 257 ([M-COOEt and M-C4HeOJ*, 25), 183 
([Ο^Η,,Ν/, 18), 157 ((Ο,,Η,,Ν]*. 100) 
350 (M*, 12), 319 ((M-OCH/, 14), 277 ((M-COOEt]*, 
8), 245 ([C17H,3Njr, 12). 219 «Ο,,Η,,Ν]*. 100) 
Ή NMR 
8(ppm) 
7 59-7 08 (m, ЮН, NH, C(5)-C(8)H and Ο,Η^, 5 73 (br s, IH. NOH), 5 18 (s, IH, C(1)H), 3 56 (m, IH, 
C(3)H), 3 03 and 2 81 (AB part of ABX spectrum, 2H, 2J=15 5Hz, J=6 6Hz, J=8 5Hz, C(4)H2), 1 29 (d, 
ЗН, С(З)НСНз) 
7 50-7 03 (m, 5H, NH and C(5)-C(8)H). 6 63 (s, 2H, CilJCjHjtOMey, 4 84 (brs, 2H, C(1)H and 
NOH), 3 89 (s, ЗН, р-ОСНз), 3 83 (s, 6H, 2x m-OCHJ, 3 25 (m, IH, C(3)H), 2 91 (m, 2H, C(4)H2), 
1 48 (d, ЗН. С(З)НСНз) 
7 56-7 06 (m. 5H. NH and C(5)-C(8)H). 6 54 (s. 2H, С(1)С
в
Н2(ОМе)э), 5 50 (brs, IH, NOH). 5 03 (s, IH, 
C(1 )H). 3 84 (s, 3H, POCH.,). 3 78 (s, 6H, 2x m-OCHj). 3 64 (m, 1 H. C(3)H), 3 11 and 2 78 (AB part of 
ABX spectrum. 2H, г.Ы5 5Hz, J=6 3Hz, J-4 5Hz, С(4)Н
г
), 1 29 (d, 3H, C^HCHj, 
7 70-7 10 (m, 4H, C(5)-C(8)H). 6 83 (bf s. 1H, NHMe), 5 57 (s 1 H, C(1)H), 5 26 (br s, 1 H, NOH), 3 78-3 04 
(m, 3H, C(3)H and C(4)H2), 3 41 (s, 3H. indole N-CHj). 2 78 (d, 3H, NHCH3) 
7 73 (br s, 1 H, NH), 7 48-7 05 (m, 4H, C(5)-C(8)H), 4 33 (q, 2H, OCHjCHj), 4 21 (m, 1 H, C(1)H), 3 92-3 57 
(m, IH, C(3)H), 3 76 (s, 3H, NOCH,), 3 40-2 92 (m, 2H, С(4)Н
г
), 1 64 (d, ЭН, CflJHCHj), 1 39 (t, 3H, 
OCHjCHj) 
7 68 (brs, IH, NH), 750-702 (m, 4H. С(5)-С(в)Н), 4 64 (q. IH, CflJHCH,), 4 22 (q, 2H. ОСН^Н^, 4 09 
(X part of ABX spectrum, 1 H, C(3)H), 3 61 (s, ЭН, NOCH,), 3 22 and 3 10 (AB part of ABX spectrum, 2H, 
ZJ=16 0Hz, J=7 5Hz, J=6 2Hz. C(4)H2), 1 49 (t, 3H, OCH^Hj) 
7 50-7 06 (m, ЮН, NH. C(5K;(8)H and С.Н^. 4 96 (s, 1 H, C(1 )H), 4 28 (q, 2H, OCHjCH,), 3 93 (X part 
ol ABX spectrum. IH. С(Э)Н), Э 30-2 96 (m. 2Н. С<4)Н
г
), 3 08 (s. ЗН, OCH,), 1 33 (t, ЗН, OCHjCH,) 
a) A СНСІ, В CHCIj/MeOH, 99/1 С СНСІ^МеОН, 97/3 Ρ СНО/М ОН, 93/7 Ь) Satislactory micro analyses were obtained tor these compounds (C±0 5%, H±0 2%, N±0 4%) vo 
c) These products resisted crystallization attempts d) Attempts to separate these isomers failed 
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Has* Spectrum 
350 (M*. 15), 319 ([M-OCHjT, 68), 277 ([M-COOEtf, 
21), 245 ([Ο,,Η,,Ν/. 52), 219 ([Ο,,Η^ΝΓ, 96), 218 
((Ο,,Η,,ΝΓ. 100) 
178 (M*, 14). 319 ([М-С3Н/ЭГ, 16), 305 «M-COOEt]*, 
)), 245 ( [ С 1 7 Н ^ г ] * , 17), 219 (Ι01βΗ13ΝΓ, 100) 
378 (M*. 16), 319 «M-CjHjOT. 61). 305 ((M-COOEtl*, 
27). 245 αΟ,,Η,,Ν/, 48). 219 ( [ Ο , , Η , ^ . 100) 
392 (M*. 9), 319 QM CCXDEt and Μ-04Η,ΟΓ, 18). 
245 « С 1 7 Н ^ г Г . 13). 219 ([Ο,,Η,,ΝΓ. 100) 
392 (M*, 12), 319 ([M-COOEt and М-С4НвОГ, 72), 
245 ([C17H13N ƒ , 43), 219 ([С1вН,зМ]*. 100) 
Ή NUR 
8(ppm) 
7 58-7 07 (m, ЮН, NH. С<5)-С<8)Н and С,Н5), 5 72 (s, 1 H, C{1 )H), 4 18 (q, 2Н, OCHjCHj), 4 14 
(t, 1 H, C(3)H), 3 47 (s, ЭН, OCH3), 3 28 (d, 2H, 0(4)^), 1 26 (t, 3H, OCHjCHj) 
7 52-7 04 (m, ЮН, NH. C(5)-C(8)H and CJAJ, 5 01 (s, 1 H, C<1 )H), 4 26 (q, 2H, OCHjCHj), 3 98 
(X part of ABX spectrum. 1 H, C(3)H), 3 61-2 96 (m, ЭН, C(4)H2 and NOCHMe2), 1 36 (t, ЭН, OCHjCHj), 
0 87 (d, 3H, J-6 1Hz. ОСЖСНзІдІСНзУ, 0 44 (d, 3H. J=6 1Hz. OCHlCHjJ^CHj^) 
7 56-703 (m. 10H. NH. С<5)-^8)Н and CgH^, 5 73 (s. IH. C<1)H). 4 16(t, IH. C(3)H). 4 14 (q, 2H, 
OCHjCH^, 3 64 (m, 1H, NOCHMe2), 3 28 (d, 2H, J=5 8Hz, C(4)H2), 1 26 (t 3H, OCHjCH^, 
1 08 (d, 3H, J-6 1 Hz, ОСН(СНз)
А
(СНз)
в
), 0 87 (d, 3H, J=e 1 Hz, ОСН(СНз)
А
(СНз)
в
) 
7 55-7/04 (m, 10H, NH, C<5)-C<8)H aid CjHj), 5 00 (s, IH. C(1)H), 4 28 (q, 2H, OCHjCH,), 3 97 
(X part of ABX spectrum, IH, C(3)H), 3 7 4 ^ 42 (m. 2H, NOCH2). 3 40-2 71 (m. 2H. C(4)H2). 1 37 
(t, 3H. ОСН2СНз), 1 21-0 83 (m, 4H, OCHjCHjCHjCHj), 0 69 (br i. ЭН. OCHjC^CHjCHj) 
7 56-7 08 (m, 10H, NH, C(S)-C(8)H and C^HJ, 5 76 (s, IH, C<1)H), 4 19 (t. IH, C(3)H), 4 15 (q, 2H, 
OCHjCH,). 3 78-3 41 (m, 2H, NOCH2), 3 29 (d, 2H, J=6 OHz, C(4)H2). 1 47-1 00 (m. 4H, OCHjCHjCHjCHj). 
1 26 (t, 3H, OCHjCHj), 0 79 (brt, ЭН, OCHjCHjCHjCty 
a) A CHCI3 В CHayMeOH, 99/1 С СНСІуМ ОН, 97/3 0 CHCI/MeOH, 93/7 b) Sauslactoiy micro analyses were obtained for these compounds (C±0 5%, H±0 2%, N±0 4%) 
c) These products resisted crystallization attempts d) Attempts to separate these isomers failed 
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CHAPTER 6 
Intramolecular Pictet-Spengler reaction of N-alkoxy-
-tryptophans and -tryptamines. Synthesis of Corynanthe 
alkaloid derivatives containing a tetrahydro-1,2-oxazine 
as D-ring. 
"Intramolecular Pictet-Spengler reaction of'N-alkoxy'tryptophans and tryptamines ¡I. Synthesis 
of Corynanthe alkaloid derivatives containing a tetrahydro-12-oxazine as D-ring." 
Pedro H.H. Hermkens, Jan H.v. Maarseveen, Harry W. Berens, Jan M.M. Smits, Chris G. 
Kruse, Hans W. Scheeren, J. Org. Chem. in press. 
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Chapter 6 
INTRAMOLECULAR PICTET-SPENGLER REACTION OF N-ALKOXY-TRYPTOPHANS AND 
-TRYPTAMINES. SYNTHESIS OF CORYNANTHE ALKALOID DERIVATIVES CONTAINING 
A TETRAHYDRO-1J-OXAZINE AS D-RING 
Introduction 
In chapter 5 we described the chemical scope and the stereochemical implications of the 
intermolecular Pictet-Spengler reaction of N-hydroxy(alkoxy)-tryptophan and -tryptamine derivatives 
(e.g. 1-3, Chart I) with different aldehydes to give the tricyclic N-hydroxy(alkoxy)-l,2,3,4-tetrahydro-
ß-carbolines1. The therapeutic activity of several tetra- or pentacyclic indole alkaloids which contain 
the tetrahydro-ß-carboline nucleus has been demonstrated, e.g. for the corynantheine, and yohimbine 
(reserpine) group2, respectively. We thought that the N-oxo analogues of these indole alkaloids 
Chart I 
H H I J 7 n = C O O M e . X - C H 2 
1 R=COOEt \ / 8 R=H.X=CH2 
2 R=H 
3 р=снз 
might be of potential interest. The first target structures we settled upon are 4-6 since they contain the 
structural elements of the N-hydroxy compounds 1-3. These molecules are direct analogs of the 
simple corynanthe alkaloids T36,4 and 83·5, containing a tetrahydro-l,2-oxazine as D-ring. 
Strategy 
The standard methods for the construction of the C-ring in the corynanthe alkaloids are the 
Bischler-Napieralski6b and the Pictet-Spengler6b reaction or cyclization via pyridinium salts6b·7. 
Recently, the conversion of 1 into 1,3-disubstituted N(2)-hydroxy-l,2,3,4-tetrahydro-ß-carbolines via 
the Pictet-Spengler reaction has been reported1,8. Therefore our first approach to the compounds 4-6 
consisted of a Pictet-Spengler reaction with 4-chlorobutanal, followed by a cylization to form ring D 
(Scheme I). However, condensation of N-hydroxytryptophan (1) with 4-chlorobutanal did not give the 
desired compound 9 but the N-oxide 10, which has probably been formed by an undesired 
intramolecular cyclization of 9.9(Scheme I). 
We reasoned that an intramolecular Pictet-Spengler reaction should be a better approach to the target 
4 R^COOEI, x=o 
5 R=H, x=o 
ft О-Г.М. -П 
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Scheme I 
COOEt 0 · ^ 
HNOH 
COOEt 
molecules. The intermediate for this synthetic pathway to compounds 4-6, consists of a 
N-alkoxytryptamine derivative such as 11 having a aldehyde function or a masked derivative thereoff 
in δ-position of the alkoxy chain (Scheme Π). Three routes as depicted in Scheme Π might give access 
4-6 
Scheme II 
X 1-3 
to such an intermediate: (1) selective reduction of the O-alkylated oxime function present in 12 
(Route A) (2) selective O-alkylation of the N-hydroxy compounds 1-3 with a properly functionalized 
four carbon substrate (Route B) or (3) selective reduction of the ester function in 13, generated from 
1-3 (Route C)10. 
In this chapter it is highlighted that compounds with the general formula 11 are highly valuable 
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intermediates for the corynanthe Nb-oxo-analogous 4-6, via an intramolecular Pictet-Spengler 
condensation. The most effective approaches are routes В and C, whereas route A gave poor results. 
Results 
Route A 
Alkylation of oxime 14 with the protected 4-chlorobutanals 15 in DMSO with potassium t-butoxide 
as base gave the O-alkylated products 16 in 64-68% yields (Scheme III). Selective reduction of the 
Scheme III 
COOEt 
COOEt 
15a: X-O 
b:X=S 
oxc 
І а: X=0 
b:X=S 
oxime double bond of the dioxolane protected compound 16a failed. Treatment with 
trimethylamineborane in dioxane saturated with HCl gave a mixture of compounds. One of the 
products appeared to be the desired 4a1 1 presumably as a result of reduction of the oxime double 
bond12 and intramolecular cyclization under the acidic conditions. The yield however was too low 
(10%)13 to be of practical value as a result of side-reactions due to cationic ring opening of the 
dioxolane ring. This ring opening was followed by i) reduction of the dioxolane functionality (24%) to 
give a mono-glycolether moiety, partly accompanied by reduction of the oxime function ii) probably 
intramolecular cyclization to give a tetracyclic dihydro-ß-carboline, followed by ring opening of the 
D-ring resulted in the aromatized product 17 (16%). Reaction of 16a under the same reaction 
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conditions with exclusion of the reductive reagent gave 17 quantitatively. 
Reduction of the oxime double bond of the 1,3-oxathiolane protected compound 16b with ТМА:ВНз 
in ethanolic HCl gave the N-alkoxy tryptophan derivative 18b in 56% yield. In this case the previous 
described intramolecular cyclization was not observed. However, deprotection of the oxathiolane 
moiety of 18b failed; the conditions studied were treatment with HgC^/NaOH140, Raney nickel14*·1' 
and various acids. Deprotection with Chloramine-T14c gave the cyclized product 4a but only in 22% 
yield. Attempts to improve these results were unsuccessful. 
Routes В and С 
In both routes В and С we faced the problem of selective O-alkylation of the N-substituted 
hydroxylamines 1-3. In general N.O-disubstituted hydroxylamines are prepared by alkylation of 
N-hydroxyurethanes followed by acidic hydrolysis.15 By adjusting the protective group this method 
could be suitable for our goal. The protective group has to be easily incorporated and removed and has 
to survive the alkylation conditions. For example, the trichloroethoxycarbonyl (TiOC) group satisfied 
Scheme IV 
l^JJ^J HNOH " ЧД-N J TEOCNOH " к Д ^ i TEOCNOR* 
I i I 
H H H 
19 H=COOEI 22 Ρ,-ΟΟΟΕΙ R^CHjCHgCH^HtOMek 
^
3
 20 R-H 23 Η,-Η, Р
г
»СН
г
СН2СНгСН(ОМ ) г 
21 R-CHg 2 4 Ρ,-Η, Н
г
=СН
г
СН2СН2ССОМ 
COOEt Qo HNORj 
30 
26 R,-COOEt R2=CH2CH2CH2CH(OMe)2 
27 R r H , Рг»СНгСНгСНгСН(ОМ )2 
28 Η,-Η. R2=CH2CH2CH2COOMe 
29 R^CHj, R2=CH2CH2CH2COOMe 
¡)TEOC-Clldioxane it)K2C03,R2CVDMSO(R=COOEt)orNaH,RBrlNallDME(R=H,CH3) ш)KOlBuIDUSO tv)Bu4NF 
the first two criteria, but failed with respect to the last one. The protective group of choice which met 
all the criteria is the 2-(trimethylsilyl)ethoxycarbonyl16 (TEOC) group. Treatment of the 
hydroxylamines 1-3 with 2-(trimethylsilyl)ethyl chloroformate in dichloromethane / dioxane17 at 
room temperature gave 19,20 and 21 in 96%, 91% and 80% yield, respectively (Scheme Г ). 
The optimal reaction conditions for the subsequent O-alkylation of these TEOC-protected 
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compounds depend on the α-substituent R in the tryptamine moiety. An N-acyl-N-hydroxytryptophan 
derivative such as 19 is sensitive to elimination reactions under basic conditions. In the absence of a 
nucleophile, rearrangements to the corresponding enamine ester derivative have been reported18·19. It 
occurred indeed that alkylation attempts with 4-bromo-l,l-diniethoxybutane employing 19 using 
DMSO/KOtBU or DME/NaH yielded the dehydro ester 30 almost quantitatively (Scheme IV). 
However, with K2CO3 as the base in DMSO at 450C the desired 22 was obtained in 67% yield. The 
TEOC-protective group was removed with tetrabutylammoniumfluoride (BU4NF) in THF to give the 
N-alkoxytryptophan 26 in 78% yield. Since 20 and 21 are less prone to this elimination reaction these 
compounds could be smoothly converted at room temperature in DME with functionalized 
alkylbromides in the presence of Nal using NaH as the base to give 23-25. These compounds were not 
purified, but immediately deprotected with BU4NF in THF yielding the compounds 27-29 in an overall 
yield of 67%, 74% and 64%, respectively. 
Cyclization (Scheme V) 
It has been demonstrated that dimethoxy acetáis react easily with 1 in the presence of trifluoroacetic 
acid to give N-hydroxy-l,2,3,4-tetrahydro-ß-carbolines.8 So by preparing the compounds 26 and 27, 
which bear all necessary features of intermediate 11, route В seems to be feasible. Indeed, treatment 
of 26 and 27 with trifluoroacetic acid in dichloromethane caused an intramolecular Pictet-Spengler 
reaction and presumably via intermediates 31a,b—*32a,b (Chart П) the cyclized products 4 and 5 were 
R Chart II 
31c: R=CH3 32c: R=CH3 * 
isolated in 97% and 92% yield, respectively. The corynanthe analogue 4 was obtained as a 79/21 
(4a/4b) mixture of the two possible diastereomers, which were readily separated by column 
chromatography. The relative stereochemistry at the C(6) and C(12b) centers were established as 4a 
ciî and 4b trans (Scheme V) (vide infra). 
In order to enlarge the scope of this intramolecular Pictet-Spengler reaction we also studied Route С 
This route implies the selective reduction of the ester function in 28 and 29 in the presence of the 
labile N-O bond. Therefore, we were pleased to find that reduction of the methylester function of 28 
with DIB AL in toluene at -70°^ followed by addition of trifluoroacetic acid gave the cyclised product 
5 in 76% yield. Under the anhydrous acidic conditions intermediate 33a cyclized either via 
31b—32b—5 or via 11 (R=H, X=0)—32—5 (Chart II). 
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Scheme V 
26,27 
28,29 
Oz Гч 1» ^ N . OXÍ: 
I i 51 
4a: R=COOEt, 6Hp, 12bHp (racemic) 4b: R=COOEt, 6Hp, 12ba (racemlc) 
5: R-H (racemic) 
6a: R'CHg, 6Hß, i2bHß (racemic) 6b: В=СНз, 6Hp, 12ba (racemic) 
h 
Л
ССЮЕІ COOEt 
34a 
¡)СН2СІ2ІТРА ii) DIBALf-JCfiC), toluene / TFA iu) Zn I HOAc (8<fC) 
34b 
Reduction of 29 employing the same conditions gave the two diastereomers 6a and 6b (HPLC ratio 
83/17). Separated by column chromatography gave 6a in 68% and 6b in 9% yield. The 
stereochemistry was assigned by extending the line of reasoning employed for 4a and 4b: the major 
isomer was assumed to be the cis diastereomer 6a given that the predominate isomer in the cyclization 
of 26 was unambiguously demonstrated to be 4a {cis) {vide infra). 
The observed stereochemistry seems to be the result of a kinetically controlled reaction. Prolonged 
treatment of either the m-isomers 4a and 6a or the frawi-isomers 4b and 6b, respectively under the 
reaction conditions caused no formation of the other isomer. Higher temperature (650C) led to 
extensive decomposition of the starting materials. In the reaction mixtures the other isomer could be 
only detected in less than 5% by means of analytic HPLC techniques 
Stereochemistry 
The relative configuration of the two diastereomers 4a and 4b was established as follows. Treatment 
of 4a and 4b with zink dust in acetic acid at elevated temperature (80oC) gave the 1,3-disubtituted 
tetrahydro-ß-carbolines 34a and 34b in 85% and 89% yield, respectively (Scheme V). Their relative 
stereochemistry was assigned on basis of 13C NMR data. It has been noted20 that in the 
off-resonance-decoupled 13C NMR spectra of fru/ii-l,3-disubstituted-l,2,3,4-tetrahydro-ß-carbolines 
the chemical shift values for the C(l) and C(3) atoms are upfield of the values of the corresponding 
C-atoms in the cis-isomer. Consequently, structure 34b was assigned trans because of its more 
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shielded C(3) (5=51.90) and C(l) (5=50.30) carbon atoms, compared to C(3) (5=56.38) and C(l) 
(5=52.60) of 34a. Thus the relative stereochemistry at C(12b) and C(6) of the two diastereomers 4a 
and 4b is as depicted in Scheme V. Recendy, Rapoport*5 reported that the cyclization yielding the 
corynanthe alkaloid 8 via an in situ generated iminium ion gave the corresponding diastereomers in 
the same ratio as we observed for the reaction leading to 4a and 4b. So it seems to be reasonable to 
suppose that cylizadon of 26 proceeds via the in situ generation of the intermediate 32a. 
The above discussed assignment of stereochemistry could be confirmed by single crystal X-ray 
analysis of 4a (Figure I).2 1 The stereochemistiy at N(5) is noteworthy. The crystal structure clearly 
shows that the tetrahydro-l,2-oxazine ring D has a chair conformation with the carbon substituents on 
N(5) and C(12b) in an equatorial position. This implies a trans juncture of ring С and D as depicted in 
Scheme V. The ethylester at C(6) is also in an equitorial position. 
Conclusions 
In conclusion, corynanthe analogs 4-6 have been synthesized by an intramolecular Pictet-Spengler 
reaction of 26-29 in excellent yields (Route В and C). The cyclizations occur with high 
stereoselectivity favouring the product with a relative CIJ configuration of the C(6) and C(12b) 
substituents. In general, this method seems to be appropriate for constructing tetracylic indole 
alkaloids of which the D-ring contains an N-0 moiety. Therefore, the natural product Eudistomin22, an 
indole alkaloid with a oxathiazepine as D-ring, will be our next target structure in order to test the 
general applicability of the intramolecular Pictet-Spengler approach (See chapter 7). 
Experimental Section 
Melting points were taken on a Koefler hot stage (Leitz-Wetzlar) and are uncorrected. Ultraviolet 
spectra were measured with a Perkin Elmer spectrometer. Model lambda 5. Proton magnetic 
resonance spectra were measured on a Bruker WH-90 spectrometer or on a Bruker AM 400. Chemical 
shifts are reported as 5-values relative to tetramethylsilane as an internal standard; deuteriochloroform 
was used as solvent unless stated otherwise. Mass spectra were obtained with a double-focusing VG 
7070E spectrometer. Thin-layer chromatography (TLC) was carried out by using silica gel F-254 
plates (thickness 0.25 mm). Spots were visualized with a UV hand lamp, iodine vapor, or CI2-TDM.23 
For column chromatography Merck silica gel (type 60H) was used. Solvent systems used are, A: 
(MeOH/CHClj, 3/97, v/v), В:(МеОН/СНС1з, 7/93, v/v), C:(EtOAc/n-hexane, 25/75, v/v) 
D:(EtOAc/n-hexane, 40/60, v/v). 
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Ethyl a-[3-(l,3-dioxolan-2-yI)propyloximino]-ß-(indol-3-yl)propanoate (16a) 
Potassium t-butoxide (0.74 g, 6.6 mmol) was added portionwise to a stirred solution of 1418 (1.63 g, 
6.6 mmol) and 15a24 (1 g, 6.6. mmol) in DMSO (25 mL). After stirring for 2 hours at S^C the 
reaction was complete. The reaction mixture was diluted with CH2CI2 (100 mL) and most of the 
DMSO was removed by washing three times with 100 mL of water. The resulting organic layer was 
washed with brine and dried with №280,4. Evaporation of the solvent gave an oil which was subjected 
to column chromatography (CHCI3) to give 1.52 g (64%) 16a. Oil: Rf 0.62 (solvent system A); UV 
(MeOH) Xmax 224, 274(sh), 281, 289 nm; CIMS (lOOeV) m/z (relative intensity) 361 ([M+l]+, 30), 
360 (M+, 33), 229 ([CJJHUNPJ]-*-, 26), 130 ([0,Η8Ν]+, 100); lH NMR δ 8.08 (br s, IH, NH), 
7.76-7.04 (m, 5H, indole C(2)H and C(4)-C(7)H)> 4.91 (t, IH, OCHO), 4.32 (m, 4H, ОСН2СНз and 
NOCH2), 4.07 (s, 2H, С(3)СН^, 4.00-3.82 (m, 4Н, OCHjCHjO), 2.04-1.71 (m, 4H, CHzCHjCH), 
1.27(і,ЗН,ОСН2СНз). 
Ethyl a-[3-(l,3-oxathiolan-2-yl)prop}Ioximino]-ß-(indoI-3-yl)propanoate (16b) 
The same procedure was followed as described for 16a. 1418 (10 g, 41 mmol). Potassium t-butoxide 
(4.6 g, 41 mmol) and 15b25 (10 g, 60 mmol) in DMSO (100 mL) gave after column chromatography 
(CHC13) 10.5 g (68%) 16b as an oil. Rf 0.76 (solvent system A); UV (MeOH) Хтгл 224, 274(sh), 
281, 289 nm; CIMS (lOOeV) m/z (relative intensity) 376 (M+, 6), 230 ( [ C n H ^ O j r , 16), 144 
([C1()H10N]+, 48), 130 ([CoHgNr, 100); Ή NMR δ 8.11 (br s, IH, NH), 7.64-7.00 (m, 5H, indole 
C(2)H and C(4)-C(7)H), 5.03 (br t, IH, OCHS), 4.38-4.11 (m, 5H, OCHjCHj, NOCHj and 
SCHOCHA), 4.02 (s, 2H, СО)СЩ\ 3.87-3.51 (m, IH, SCHOCHB), 3.08-2.87 (m, 2H, CHjS), 
2.00-1.70 (m, 4H, CH2CH2CH), 1.23 (t, 3H, OCH2CH3). 
l-(3-Hydroxypropyl)-3-ethoxycarbonyl-ß-carboIine(17) 
Through a stirred solution of 16a (150 mg, 0.42 mmol) in THF (10 mL) was passed a stream of HCl 
for 2 minutes. Stirring was continued for 4 hours. The reaction mixture was washed with saturated 
ЫаНСОз and brine. The organic layer was dried (MgSO^ and concentrated in vacuo. The residue was 
subjected to column chromatography (solvent system A) to give 120 mg (96%) of 17. Crystallization 
attempts were unsuccessful. Rf 0.17 (solvent system B); ELMS (70 eV) m/z (relative intensity) 298 
(M+, 1), 254 ([C15H14N202]+, 19), 169 ( С ц Н , ^ ^ , 14), 69 (100); 'H NMR (CDCI3/CD3OD) δ 11.14 (br s, IH, NH exchangeable), 8.71 (s, IH, C(4)H), 8.14 (d, IH, C(5)H), 7.62-7.22 (m, ЗН, 
C(6)-C(8)H), 4.51 (q, 2Н, ОСН2СН3), 3.76 (t, 2Н, СН2ОН), 3.30 (t, 2Н, С(1)СЩ, 2.24-1.98 (m, 2Н, 
СНгСНгСНгОН), 1.51 (t, ЗН, ОСН2СНз). 
Ethyl a-[3-(l,3-oxathiolan-2-yI)propyloxamino]-ß-(indoI-3-yl)propanoate (18b) 
A solution of HCl in ethanol (2 mL, 7N solution) was added dropwise to a stirred solution of 16b 
(0.5 g, 1.3 mmol) and (СНз)з^ВНз (Aldrich Chemical Co; 300 mg, 4.16 mmol) in EtOH (10 mL) at 
roomtemperature and in an argon atmosphere. Stirring was continued for 5 h. The mixture was then 
concentrated to near dryness. The residue dissolved in CH2CI2. This solution was neutralized with 
NaHC03 and filtered. The filtrate was washed with 0.1 N HCl and dried over N32804. Evaporation of 
the solvent gave an oil which after column chromatography (CHCI3) yielded 273 mg (56%) of 18: oil; 
Rf 0.57 (solvent system A); UV (MeOH) Xmax 224, 274(sh), 281, 289 nm; EIMS (70eV) m/z (relative 
intensity) 378 (M*, 2), 305 ([M-COOEt]+, 4), 227 ([C^H^NjOr, 18), 130 ([G^HgNr, 100); lH NMR 
δ 8.11 (br s, IH, NH), 7.67-7.04 (m, 5H, indole С(2)Н and С(4)-С(7)Н), 5.82 (br s, IH, HNO), 5.07 
(br t, IH, OCHS), 4.40-3.90 (m, 4H, ОСН2СНз, HCCOOEt and SCHOCHA), 3.88-3.60 (m, 3H, 
NOCH2 and SCHOCHB), 3.12-2.92 (m, 4H, C(3)CH2 and CH2S), 2.02-1.55 (m, 4Н, СНгСНгСН), 
1.17 (t, ЗН,ОСН2СНз). 
Ethyl a-[N,N-(2-(trimethylsilyl)ethyloxycarbonyl, hydroxy)amino]-ß-(indol-3-yl)propanoate 
(19) 
2-(Trimethylsilyl)ethylchloroformatei:' (1.08 g, 6 mmol) was added dropwise to a stirred solution of 
I1 (1.0 g, 4 mmol) in CH2Cl2/dioxane, 1/1, v/v (25 mL). The reaction was monitored by TLC (solvent 
system B). Stirring was continued for 2 hours. The reaction mixture was concentrated to near dryness, 
dissolved in CH2C12 and subsequently washed with saturated NaHC03 and brine and dried with 
Na2S04. Evaporation of the solvent gave a crystalline material which was subjected to column 
chromatography (СНСІз/n-hexane, 99.5/0.5, v/v) to yield 1.51 g. (96%) of 19. Crystallization from 
CH2Cl2/n-hexane: mp 101-102.5
 0C; Rf 0.45 (solvent system A); UV (MeOH) Xmax 224, 274(sh), 
281, 289 nm; CIMS (100 eV) m/z (relative intensity) 393 ([M+l]+, 9), 392 (M+, 23), 365 (28), 349 
по 
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(49), 321 (27), 247 ([M-QHnC^Sir, 11), 231 (53), 216 (67), 215 (95), 130 ([CaHgNr, 100);^ NMR 
δ 8.23 (br s, IH, ΜΗ), 7.77-7.19 (m, 5H, indole C(2) and C(4)-C(7)H), 6.53 (br s, IH, NOH), 5.11 (t, 
IH, J=7.8 Hz, HCCOOEt), 4.37 (q, 2H, ОСН2СНз), 3.91 (m, 2H, OCH2CH2Si), 3.51 (d, 2H, J=7.8 
Hz, Indole СОЭСНг), 1.39 (t, 3H, ОСН2СНз), 0.71 (m, 2H, CH2Si), 0.0 (s, 9H, 8і(СНз)з); 
Anal.Calcd. for СХ^ОЦЩО^Х (MW 392.531): С, 58.14; H, 7.19; Ν, 7.14. Found: С, 57.83; Η, 7.14; 
N,7.16. 
3-[2-(NJ4-2-(Trimethylsilyl)ethyloxycarbonyl, hydroxy)aminoethyl]indoIe (20) 
The same procedure was followed as described for 19. 2-(Trimethylsilyl)ethylchloroformate15 (675 
mg, 3.75 mmol) and 21·2 6 (440 mg, 2.5 mmol) gave after column chromatography (EtOAc/n-hexane, 
40/60, v/v) 750 mg (91%) of 20. Crystallization from EtOAc/n-hexane: mp 95-970C; Rf 0.39 (solvent 
system B); UV (MeOH) Xmax 224, 274(sh), 281, 289 nm; EIMS (70 eV) m/z (relative intensity) 320 
(M+, 1), 157 ([QoHçNJ-'-, 11), 130 ([C^HgNr, 100); Ή NMR δ 8.02 (br s, IH, NH), 7.70-7.04 (m, 
5H, indole C(2) and C(4)-C(7)H), 6.25 (br s, IH, NOH), 4.11-3.87 (m, 2H, OCH2CH2Si), 3.90 (t, 2H, 
CH2N), 3.13 (t, 2H, Indole C(3)CH2), 0.89-0.68 (m, 2H, CH2Si), 0.0 (s, 9H, 8і(СНз)з); Anal.Calcd. 
for CjeH^NPjSi (Mw 320469): C, 59.97; H, 7.55; N, 8.74. Found: C,59.91; H,7.62; N, 8.70. 
3-[2-(N,N-2-(Triinethylsilyl)ethyloxycarbonyl, hydroxy)aminopropyl]indole (21) 
The same procedure was followed as described for 19. 2-(Trimethylsilyl)ethylchloroformate15 (1.63 
g, 9 mmol) and З 1 , 2 6 (1.14 g, 6 mmol) gave after column chromatography (СНСІз/n-hexane, 99/1, v/v) 
1.61 g (80%) of 21. Crystallization from CHCyn-hexane: mp 122-125 0C; Rf 0.29 (solvent system 
B); UV (MeOH) Xmax 224, 274(sh), 281, 289 nm; CIMS (100 eV) m/z (relative intensity) 334 (M+, 
2), 291 (14), 230 (9), 158 ([C
n
H 1 2N]+, 100), 130 ([C9HgNl+, 85), 73 ([8і(СНз)з]+, 100); Ή NMR δ 
8.07 (br s, IH, NH), 7.68-7.07 (m, 5H, indole C(2) and C(4)-C(7)H), 6.20 (br s, IH, NOH), 4.53 (m, 
IH, HCCH,), 3.84 (m, 2H, OCHjCH^i), 3.18 and 2.94 (AB part of ABX spectrum, 2H, 2J=14.3 Hz, 
J=8.1 Hz, J=6.0 Hz, indole C(3)CH2), 1.36 (d, 3H, J=7.0Hz, HCCH3), 0.63 (m, 2H, CH2Si), 0.0 (s, 
9H, 8і(СН3)з); Anal.Calcd. for C n H ^ N ^ S i (Mw 334.494): C, 61.04; H, 7.83; N, 8.37. Found: С, 
60.83; H, 7.93; Ν, 8.16. 
Ethyl a-(4,4-dimethoxybutyloxamino)-ß-(indoI-3-yl)propanoate (26) via 19—»22. 
A stirring solution of 19 (1.57 g, 4 mmol), 4-brOmo-l,l-dimethoxybutane27 (1.58 g, 8 mmol) and 
K2CO3 (0.83 g, 6 mmol) in DMSO (25 mL) was kept at 450C for 24 hours. The reaction mixture was 
diluted with CHjC^ (100 mL) and most of the DMSO was removed by washing with water and 0.1 N 
HCl. The resulting organic layer was washed with brine and dried with Na2S04. Evaporation of the 
solvent gave a oil which was subjected to column chromatography (СНСІз/n-hexane, 90/10, v/v) to 
give 1.37 g (67%) of 22. Oil; Rf 0.58 (solvent system A); EIMS (70 eV) m/z (relative intensity) 508 
(M+, 4), 476 ([М-МеОНГ, 5), 215 ([CnH^NOJ-*-, 95), 130 ([CgHgNT, 100); Ή NMR δ 8.07 (br s, 
IH, NH), 7.70-7.10 (m, 5H, indole C(2) and C(4)-C(7)H), 4.98 (X part of ABX spectrum, IH, J=6.0 
Hz, J=8.9 Hz, HCCOOEt), 4.37-3.74 (m, 7H, ОСН2СНз, OCH2CH2Si, NOCH2 and HC(OMe)2), 
3.50-3.30 (AB part of ABX spectrum, 2H, indole C(3)-CH2), 3.30 (s, 6H, 2хОСНз), 1.65 (m, 4Н, 
ОСН2СН2СН2СН), 1.30 (t, ЗН, ОСН2СНз), 0.78 (m, 2Н, СН28і), 0.0 (s, 9Н, 8і(СНз)з. A solution of 
22 (1.35 g, 2.65 mmol) and tetrabutyíammoniumfluoride ( 5.3 mL, IN solution in THF) in THF (25 
mL) was stirred for 2 hours. The reaction mixture was washed with saturated NaHC03 and brine and 
dried with MgS04. Evaporation of the solvent gave crude 26 which was subjected to column 
chromatography (CHCI3) to yield 706 mg (78%) of 26. Oil; Rf 0.33 (solvent system A); UV (MeOH) 
Xmax 224, 274(sh), 281, 289 nm; CIMS (100 eV) m/z (relative intensity) 365 ([M+l]+, 33), 332 
([M-MeOH]+, 41), 301 ([C17H21N203]+, 95), 216 ([C^H^NO^, 94), 130 ([CoHgN]*, 100); 'H NMR 
δ 8.06 (br s, IH, NH), 7.67-7.07 (m, 5H, indole C(2) and C(4)-C(7)H), 5.88 (br s, IH, NbH), 4.35 (br t, 
IH, HC(OMe)2), 4.11 (q, 2H, ОСН2СНз),4.00 (m, IH, HCCOOEt), 3.69 (br t, 2H, NOCH2), 3.28 (s, 
6H, 2xOCH3), 3.13-2.96 (m, 2H, indole C(3)CH,), 1.60 (m, 4H, OCH2CH2CH2CH), 1.46 (t, 3H, 
ОСН2СНз). 
3-t2-(4,4-DimethoxybutyIoxamino)ethyl]indole (27) via 20—>23 
Sodium hydride (41 mg, 1.7 mmol) was added to a cooled (-KTC) stirred solution of 20 (500 mg, 
1.56 mmol) in dry DME (10 mL) in an argon atmosphere. The reaction mixture was allowed to warm 
to room temperature by which H2-evolution occurred. The resulting clear solution was added dropwise 
to a stirred solution of 4-bromo-l,l-dimethoxybutane27 (368 mg, 1.87 mmol) and Nal (260 mg, 1.75 
mmol) in DME (10 mL). After stirring for 24 h. the reaction mixture was diluted with EtOAc (25 mL), 
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washed with 0.1 N HCl and brine and then dried with MgSC^. Evaporation of the solvent gave crude 
23, which was added to a solution of BU4NF (2 eq.) in THF. After stirring the reaction mixture for 2 
hours, the solution was washed with saturated НаНСОз, brine and dried with MgSO^ Evaporation of 
the solvent gave crude 27, which was subjected to column chromatography (СНСІз/МеОН, 99/1, v/v) 
to yield 306 mg (67%) of 27. Oil; Rf 0.28 (solvent system A); UV (MeOH) Xmax 224, 274(sh), 281, 
289 nm; EIMS (70 eV) m/z (relative intensity) 292(M+, 7), 260 ([M-MeOH]+, 14), 229 
(LC^HplSUOr, 16), 216 ([C1 4H1 6N20]+, 14), 130 ([¿HgNT, 100); »H NMR δ 8.08 (br s, IH, indole 
NH), 7.70-7.07 (m, 5H, indole C(2) and C(4)-C(7)H), 5.35 (br s, IH, NH), 4.44 (br t, IH, HCiOMe^), 
3.78 (br t, 2H, NOCHi), 3.36 (s, 6H, 2хОСНз), 3.36-2.93 (m, 4H, indole C(3)CH2CH2), 1.71 (m, 4H, 
ОСН2СН2СН2СНз). 
3-[2-(3-carbomethoxypropyloxainino)ethyl]indole (28) via 20—>24 
The same procedure was followed as described for 27. 20 (640 mg, 2 mmol), methyl 
4-bromobutanoate28 (400 mg, 2.2 mmol), NaH (53 mg, 2.2 mmol) and Nal (300 mg, 2 mmol) gave 
crude 24. Deprotection with BU4NF (2 eq.) in THF gave after column chromatography 
(CHClj/MeOH, 99/1, v/v) 406 mg (74%) of 28. Oil; Rf 0.30 (solvent system A); UV (MeOH) Xmax 
224, 274(sh), 281, 289 nm; EIMS (70 eV) m/z (relative intensity) 276 (M+, 7), 146 ([C6H12N03]+, 26), 
144 ([C1 0H1 0N]+, 11), 130 ([CçHgNr, 100); Ή NMR δ 8.04 (br s, IH, indole NH), 7.64-7.05 (m, 5H, 
indole C(2) and C(4)-C(7)H), 5.56 (br s, IH, NH), 3.73 (t, 2H, NOCH,), 3.68 (s, 3H, OCHj), 
3.31-2.90 (m, 4H, indole С(3)СН2СН2), 2.44 (t, 2Н, СН2СООМе), 1.91 (m, 2Н, ОСН2СН2СН2). 
3-[2-(3-carbomethoxypropyloxainino)propyl]indole (29) via 21—»25 
The same procedure was followed as described for 27. 21 (300 mg, 0.9 mmol), methyl 
4-bromobutanoate28 (180 mg, 1 mmol), NaH (24 mg, 1 mmol) and Nal (150 mg, 1 mmol) gave crude 
25. Deprotection with BU4NF (2 eq.) in THF gave after column chromatography (CHClj/MeOH, 99/1, 
v/v) 167 mg (64%) of 29. Oil; Rf 0.33 (solvent system A); UV (MeOH) Xmax 224, 274(sh), 281, 289 
nm; EIMS (70 eV) m/z (relative intensity) 290 (M+, 14), 223 (34), 160 (165), 131 (85), 130 
(rC9HgN]+, 100); lH NMR δ 8.01 (br s, IH, indole NH), 7.67-7.02 (m, 5H, indole C(2) and 
C(4)-C(7)H), 3.73 (t, 2H, NOCH2), 3.66 (s, 3H, OCH3), 3.34 (m, IH, CHCH3), 2.93 and 2.78 (AB 
part of ABX spectrum, 2H, 2J=14.0 Hz, J=7.0 Hz, J=5.8 Hz, indole C^CH,), 2.41 (t, 2H, 
CH2COOMe), 1.89 (m, 2H, CH2CH2CH2COOMe), 1.56 (br s, IH, NH), 1.13 (d, 3H, CHCH3). 
Ethyl a-[N-(2-(trimethylsilyl)ethyloxycarbonyl)amino]-ß-(indol-3-yI)propenoate (30) 
A solution of 19 (157 mg, 0.4 mmol), 4-bromo-l,l-dimethoxybutane27 (158 mg, 0.8 mmol) and 
KOtBu (67 mg, 0.6 mmol) in DMSO (5 mL) was stirred for 24 h. at room temperature. The reaction 
mixture was diluted with CH2C12 (10 mL) and most of the DMSO was removed by washing with 
water and 0.1 N HCl. The resulting organic layer was washed with brine and dried with Na2S04. 
Evaporation of the solvent gave an oil which was subjected to column chromatography (CHCI3) to 
give 145 mg (97%) of 30. Rf 0.37 (CHCWMeOH, 97/3, v/v); EIMS (70 eV) m/z (relative intensity) 
374 (M+, 18), 287 (9), 258 (8), 155 (15), 73 (100); lH NMR δ 8.73 (br s, IH, indole NH), 7.89 (s, IH, 
indole C(3)CH=C), 7.89-7.71 and 7.50-7.23 (2xm, 5H, indole C(2)H and C(4)-C(7)H), 6.09 (br s, IH, 
ΉΝΤΕΟΓ), 4.35 (q, 2H, ОСН2СНз), 4.24 (m, 2H, OCH2CH2Si), 1.38 (t, ЗН, ОСН2СНз), 1.00 (m, 
2Н, OCH2CH2Si), 0.00 (s, 9Н, 5і(СНз)з); Anal. Caled, for C19H26N204Si (Mw 374.516): C, 60.94; H, 
7.00; N, 7.48. Found: С, 60.98: H, 7.01; Ν, 7.44. 
Cyclization of dimethoxy acetáis under acid conditions. 
rel-(6R,12bR)-6-ethoxycarbonyl-l,23,6,7,12,12b-heptahydro-[l,2]oxazino[2'^':l^]pyrido[3,4-
bjindole (4a) and rel-(6R42bS)-6-ethoxycarbonyl-1^3,6,7,12,12b-heptahydro-íl,2]oxazino[2' 
,3':l,2]pyrido[3,4-b]indole (4b) 
A solution of 26 (650 mg, 1.79 mmol), TFA (228 mg, 2 mmol) in dichloromethane ( 20 mL) was 
stirred for 4 hours. The reaction mixture was monitored by TLC (n-hexane/EtOAc, 75/25, v/v). The 
reaction mixture was washed with 0.1 N КаНСОз and brine and dried with Na2S04. After evaporation 
of the solvent the crystalline material was subjected to column chromatography (n-hexane/EtOAc, 
75/25, v/v) to yield 415 mg (77%) of 4a and 110 mg (20%) of 4b. 
Compound 4a: Crystallized from EtOAc/n-hexane; mp 156-1580C; Rf 0.16 (solvent system C); UV 
(MeOH) Xmax 225, 272(sh), 281, 289 nm; EIMS (70 eV) m/z (relative intensity) 300 (M+, 22), 227 
([M-COOEt]+, 100), 169 ([CnHçNjT, 24), 130 ([(^Η8Ν]+, 48); Ή NMR (400 MHz) δ 7.77 (br s, IH, 
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NH), 7.42 (d, IH, C(ll)H), 7.32 (d, IH, C(8)H), 7.18-7.08 (m, 2H, C(9) and C(10)H), 4.32 (m, 2H, 
ОСН2СНз), 4.15-3.99 (m, 3H, C(12b)H, NOCH2), 3.81 (X part of ABX spectrum, IH, J=5.1 Hz, 
J=10.8 Hz, C(6)H), 3.18 and 3.10 (AB part of ABX spectrum, 2H, 2J=15.1 Hz, J=5.1 Hz, J=10.8 Hz, 
C(7)H2), 2.20 (m, IH, C(l)H), 1.96 (m, 2H, C(1)H and C(2)H), 1.76 (m, IH, C(2)H), 1.34 (t, 3H, 
OCH2CH3); Anal.Calc. for С17Н2()М2Оз (Mw 300.358): C, 67.98; H, 6.71; N, 9.33. Found: C, 68.21; 
H, 6.72; N, 9.25. The structure has been secured by single crystal X-ray crystallography21. 
Compound 4b: Crystallized from EtOAc/n-hexane; mp 145-1470C; Rf 0.21 (solvent system C); UV 
(MeOH) Xmax 225, 272(sh), 281, 289 nm; CIMS (100 eV) m/z (relative intensity) 301 ([M+l]+, 86), 
300 (M+, 52), 256 (34), 231 (75), 227 ([M-COOEt]+, 100), 216(60); lH NMR (400 MHz) δ 7.77 (br s, 
IH, NH), 7.44 (d, IH, C(ll)H), 7.30 (d, IH, C(8)H), 7.16-7.07 (m, 2H, C(9) and C(10)H), 4.99 (d, IH, 
J=10.4 Hz, C(12b)H), 4.35 (X part of ABX spectrum, IH, J=1.25 Hz, J=7.45 Hz, C(6)H), 4.18-4.04 
(m, 4H, ОСН2СНз, NOCH2), 3.36 (A part of ABX spectrum, IH, 2J=16.0 Hz, J=7.45 Hz, C(7)HA), 
3.09 (B part of ABX spectrum, IH, 2J=16.0 Hz, J=1.25 Hz, C(7)HB), 2.21 (m, IH, C(l)H), 1.91 (m, 
IH, C(l)H), 1.74 (m, 2H, C(2)H2), 1.23 (t, 3H, ОСН2СЩ); Anal.Calc. for Cl7H2(^203 (Mw 
300.358): C, 67.98; H, 6.71; N, 9.33. Found: C, 68.16; H, 6.70; N, 9.23. 
l,23,6,7,12,12b-Heptahydro[l^]oxazino[2'^':l^]pyrido[3,4-b]indoIe(5) 
The same procedure was followed as described for 4. 27 (570 mg, 1.95 mmol), TFA (250 mg, 2.2 
mmol) in dichloromethane (20 mL) gave 410 mg (92%) of 5. mp 178-180 0C (ЕЮАс / n-hexane); Rf 
0.49 (solvent system A); UV (MeOH) X.max 225, 273(sh), 281, 289 nm; EIMS (70 eV) m/z (relative 
intensity) 228 (M+, 100), 197 (21), 169 ([СцН^гГ, 81), 156 (34), 144 (26), 130 ([C9H8N]+, 18); lH 
NMR (400 MHz) δ 7.77 (br s, IH, NH), 7.4¿ (d, IH, C(ll)H), 7.31 (d, IH, C(8)H), 7.17-7.08 (m, 2H, 
C(9) and C(10)H), 4.06 (br s, 2H, C(3)H2), 3.86 (br s, IH, C(12b)H), 3.57 (br s, IH, C(6)H), 3.11-2.97 (m, 2H, C(6)H and C(7)H), 2.83 (d, IH, C(7)H)) 2.18 (d, IH, C(l)H), 1.79 (m, 3H, C(1)H and 
C(2)H2); AnaLCalc. for C^H^NjO (Mw 228.295) : C, 73.66; H, 7.06; N, 12.27. Found : C, 73.44, H, 
7.70; N,11.94. 
Reductive ring closure 
l^ó^n.nb-HeptahydroU^loxazinotf'^': 1,2] pyrido [3,4-b]indole (5) 
DIB AL (IN, 3 mL) in toluene was added dropwise to a cooled (-70oC) stirring solution of 28 (390 
mg, 1.4 mmol) in dry toluene (75 mL) in an argon atmosphere. After stirring for 1.5 hours at -70oC, 
TFA (640 mg, 5.6 mmol) in dichloromethane (5 mL) was added carefully. Stirring was continued for 
30 minutes at -70oC. After completion of the reaction as was monitored by TLC (solvent system A), 
the reaction mixture was poured into ice-water (100 mL). The organic layer was separated. The 
neutralized aqueous layer was extracted with ЕЮАс. The combined organic layers were washed with 
brine, dried with MgSO.^ , filtered and the solvent evaporated to give crude 5. Column chromatography 
(СНСЦМеОН, 99/1, v/v) gave 241 mg (76%) of 5. (For spectroscopic data, vide supra). 
rel-(6R,12bR)-6-methyl-l,2,3,6,7,12,12b-heptahydro[l,2]oxazmo[2',3 ':l,2]pyrido[3,4-b]indole 
(6a) and rel-(6R,12bS)-6-methyl-l^,3,6,7,12,12b-heptahydro[l4]oxazino[2'^' :l,2]pyrido-
[3,4-b]indole (6b) 
The same procedure was followed as described for 5. From 29 (165 mg, 0.57 mmol) and DIBAL (2 
eq.) was obtained a mixture of two diastereomers, which were separated by column chromatography 
(CHCI3) to yield 93 mg (68%) of 6a and 13 mg (9%) of 6b. 
Compound 6a: mp 194-1960C (EtOAc/n-hexane); Rf 0.34 (solvent system D); UV (MeOH) Xmax 
224, 273(sh), 281, 289 nm; EIMS (70 eV) m/z (relative intensity) 242 (M+, 100), 227 ([M-CH3]+, 10), 
200 (15), 183 ([С 1 2 Ні^ 2 ] + , 53), 169 ( [ С ц Н ^ Г , 59), 168 ([CUH8N2]+, 45), 156 (28); 'Η NMR (400 
MHz) δ 7.72 (br s, IH, NH), 7.44 (d, IH, J=7.6 Hz, C(ll)H), 7.29 (d, IH, J=7.9 Hz, C(8)H), 7.16-7.07 
(m, 2H, C(9)-C(10)H), 4.12-4.00 (m, 2H, NOCH2), 3.89 (d, IH, J=9.7 Hz, C(12b)H), 3.14-3.06 (m, 
IH, C(6)H), 2.88 and 2.67 (AB part of a ABX spectrum, 2H, 2J=15.6 Hz, J=4.5 Hz, J=10.7 Hz, 
СО)Щ, 2.14 (d, IH, J=9.7 Hz, C(l)H), 1.87-1.71 (m, 3H, C(1)H and С(2)Н2), 1.39 (d, ЗН, J=6.2 Hz, 
СНз);^С NMR (400 MHz) δ 136.33 (C(lla)), 132.92 (C(12a)), 126.70 (C(7b)), 121.51 (C(10)), 
119.53 (C(9)), 118.18 (C(8)), 110.82 (C(ll)), 107.54 (C(7a)), 70.11 (C(3)), 62.35 (C(6)), 57.95 
(C(12b)), 29.82 (C(l)), 28.10 (C((2)), 25.15 (C(7)), 19.46 (CH3); Anal.Calc. for C,5H18N20 (Mw 
242.322): C, 74.35; H, 7.49; N, 11.56. Found: С, 74.34; H, 7.37; N, 11.47. 
Compound 6b: mp 173-1760C (EtOAc/n-hexane); Rf 0.25 (solvent system D); UV (MeOH) Xmax 
224, 273(sh), 281, 289 nm; EIMS (70 eV) m/z (relative intensity) 242 (M+, 100), 227 ([М-СНз]+, 14), 
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200 (18), 183 ([Ο^Η,,ΝΐΓ, 56), 169 ( [ С ц Н ^ Г , 72), 168 ([CnHgNJ*, 51), 156 (36); Ή NMR (400 
MHz) δ 7.76 (br s, IH, NH), 7.46 (d, IH, J=7.6 Hz, C(l 1)H), 7.32 (d, IH, J=7.9 Hz, C(8)H), 7.17-7.08 
(m, 2H, C(9)-C(10)H), 4.03 (br s, 2H, NOCH2), 3.81 (m, IH, C(12b)H), 3.24-3.18 (m, IH, C(6)H), 
2.57 (brd, IH, C(7)H), 2.22-2.18 (m, IH, C(7)H), 1.89-1.67 (m, 4H, C(1)H2 and 0 ( 2 ) ^ , 1.16 (d, 3H, 
J=6.6 Hz, CHj); Anal.Calc. for CuH^NjO (Mw 242.322): C, 74.35; H, 7.49; N, 11.56. Found: С, 
74.16; H, 7.41; Ν, 11.36. 
Cù l-(3-Hydroxypropyl)-3-(ethoxycarbonyl)-l,2^,4-tetrahydro-ß-carb oline (34a) 
Activated zinc dust (100 mg) was added to a stirred solution of 4a (90 mg, 0.3 mmol) in glacial 
acetic acid (20 mL). Subsequendy the reaction mixture was kept at 80oC and monitored by TLC 
(solvent system B). The reaction was completed after 5 hours. The reaction mixture was filtered and 
the filtrate concentrated to dryness. The residue was dissolved in dichloromethane and this solution 
was washed successively with saturated NaHCC^, water, brine and then dried with МагЗОд. The 
solvent was evaporated and the residue subjected to column chromatography (CHCI3/ MeOH, 99/1, 
V/v) to yield 77 mg (85%) of 34a. Rf 0.20 (solvent system B); CMS (100 eV) m/z (relative intensity) 
303 ([M+l]+, 74), 302 (M+, 41), 286 (25), 243 ( [ ^ Η ^ Ν ^ Γ , 100), 233 (40). 202 (37), 169 
([СПНОКІГ, 21); Ή NMR δ 8.57 (br s, IH, N(9)H), 7.52-7.05 (m, 4H, C(5)-C(8)H), 4.24 (q, 2H, 
ОСІЬСНз), 4.24-4.13 (m, IH, C(l)H), 3.74 (X part of ABX spectrum, IH, C(3)H), 3.60 (t, 2H, 
CH2CH2CH2OH), 3.27 (s, 2Н, N(2)H and ОН), 3.08 and 2.78 (AB part of ABX spectrum, 2H, 2J=Í5.8 Hz, J=12 Hz, J=4.1 Hz, C(4)H2), 2.12-1.58 (m, 4H, СН2СН2СНгОН), 1.33 (t, 3H, 
ОСН2СНз); 1 3C NMR (400 MHz) δ 172.85 (COOEt), 136.13 (C(8a)), 134.74 (C(9a)), 127.08 (C(4b)), 
121.74 (C(7)), 119.49 (C(6)), 117.90 (C(5)), 110.91 (CCS)), 108.18 (C(4a))> 62.23 (CH2OH), 61.26 (ОСН2СНз), 56.38 (C(3)), 52.60 (C(l)), 32.26 (C(1)CH2), 28.72 (CH2CH2CH2OH), 25.62 (C(4)), 
14.18 (ОСН2СНз). 
TYans l-(3-Hydroxypropyl)-3-(ethoxycarbonyl)-l,2,3,4-tetrahydro-ß-carboline (34b) 
The same procedure was followed as described for 34a. From 4b (90 mg. 0.3 mmol) was obtained 81 
mg (89%) of 34b. Rf 0.20 (solvent system B); CIMS (100 eV) m/z (relative intensity) 303 ([Μ+ΙΓ, 
100), 302 (M+, 89), 286 (21), 243 ( [ C ^ H ^ C V r , 79), 233 (42), 202 (38), 169 ([СцН^гГ, 26); Ή 
NMR δ 8.28 (br s, IH, N(9)H)( 7.54-7.04 (m, 4H, C(5)-C(8)H), 4.31-4.09 (m, IH, C(l)H), fol (q, 2H, 
ОСН2СНз), 3.94 (X part of ABX spectrum, IH, С(З)Н), 3.68 (t, 2H, CH2CH2CH2OH), 3.29 (s, 2Н, 
N(2)H and OH), 3.12 and 2.92 (AB part of ABX spectrum, 2H, 2J=15.0 Hz, J=5.4 Hz, J=7.6 Hz, 
C(4)H2), 2.06-1.62 (m, 4H, CH2CH2CH2OH), 1.28 (t, 3H, ОСН2СНз); 1 3C NMR (400 MHz) δ 173.35 (COOEt), 135.96 (C(8a)), 135.03 (C(9a)), 126.77 (C(4b)), 121.54 (C(7)), 119.15 (C(6)), 117.87 
(C(5)), 110.84 (C(8)), 106.52 (C(4a)), 62.23 (CH2OH), 61.13 (ОСН2СНз), 51.90 (C(3)), 50.30 (C(l)), 
33.16 (СШСНг), 29.67 (CH2CH2CH2OH), 24.93 (C(4)), 14.04 (ОСН2СНз). 
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CHAPTER 7 
The intramolecular Pictet-Spengler reaction of N-alkoxy-
tryptamine derivatives in the stereoselective syntheses 
of Eudistomin derivatives. 
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"Intramolecular Pictet-Spengler reaction ofN-alkoxytryptamines I. Synthesis of (±)-deamino-
debromoeudistomin L.", Pedro H.H. Hermkens, Jan Η v. Maarseveen, Chris G Kruse, Hans W. 
Scheeren, Tetrahedron Lett. (1989), 30, 5009. 
Intramolecular Pictet-Spengler reaction of N-alkoxytryptamines III. Stereoselective synthesis 
of (-)-debromoeudistomin L, of(-)-l0-O-methyl-debromoeudistomin E and of their stereo­
isomers.", Pedro H.H. Hermkens, Jan H.v. Maarseveen, Harrie C.J. Ottenheijm, Chris G. 
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Chapter 7.1 
INTRODUCTION 
Recently, the intensive research on secondary metabolites with interesting pharmacological activities 
has led to the discovery of the class of indole alkaloids containing a tetrahydro-ß-carboline fragment 
annulated with a oxathiazepine unit These compounds -the Eudistomins (la-Id) (Scheme I)- were 
isolated by Rinehart and Kobayashi from the colonial tunicate Eudistoma olivaceum}. More recently, 
Munro isolated the sulfoxide of eudistomin К (lb) and the unsubstituted eudistomin le from Ritterella 
sigillinoides2. These compounds display potent antitumour activity and antiviral activity against 
Herpes simplex Type 1 (HSV-1) and Polio vaccine Type I viruses1,2. Because of its unique structure 
and its biological activity, this class of compounds constitutes a major challenge for total synthesis. 
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Since the eudistomins are accessible from natural sources in limited amounts, a total synthesis is 
desirable for allowing the preparation of structural analogues and for providing sufficient quantities of 
these compounds for extensive pharmacological studies. 
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Common in the approaches reported so fai3 is the construction of the C-ring of the ß-carboline 2 as 
the first step by an miermolecular Pictet-Spengler reaction of the N-hydroxytiyptamine 3 and a 
cysteinal derivative 4 (Route A, Scheme I). This Pictet-Spengler reaction occurred with high or 
complete stereoselectivity to give the stereoisomer having the desired cii-rclationship between the 
C(l) and C(13b) protons. However, subsequent ringclosure 2—»1 to form the oxathiazepine ring 
appears a difficult task and only recently two total syntheses of eudistomin L (la) employing this 
approach have been reported with low overall yields.4 
In chapter 6 we described5 the synthesis of corynanthe analogs with an 1,2-oxazme as D-ring by an 
inframolecular Pictet-Spengler ringclosure of N-alkoxytryptamine derivatives. The feature of this 
approach is that ring С and D are formed simultaneously. We reasoned that by making use of the 
driving force of the Pictet-Spengler cyclization reaction this methodology could also lead to the 
construction of the unusual 7-membered oxathiazepine ring of eudistomin derivatives. In this chapter 
it is described that this approach is feasable indeed leading in high yields to the target molecules 
(Route B). 
Accordingly the intramolecular Pictet-Spengler reaction of the N-alkoxytryptamine derivative 5 
(Y=COOMe or CH(OMe)2, R1-R4=H) -derived from 3 and 4 (X=CH2C1). gave 
(±)-deamino-debromo-eudistomin L (lg) (Chapter 7.2).6 Further application of this methodology is 
described in chapter 7.3 for the total synthesis of (-)-debromoeudistomin L (le), of 
(-)-O-methyldebromoeudistomin E (If) and their stereoisomers. The approach employed features the 
reaction of the N-alkoxytryptamine derivatives 5, derived from the N-hydroxytryptamine 3 and a 
derivative of chloromethylcysteine (4, X^HjCl, R4=HNBOC, Y=COOMe).7 
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SYNTHESIS OF DEAMINO-DEBROMOEUDISTIMIN L 
Here we report the synthesis of (±)-deamino-debromoeudistomin L (lg) via an intramolecular 
Pictet-Spengler reaction of 2a as well as 2b (Scheme I)1. 
As the retrosynthetic scheme shows the intermediate for the intramolecular cyclization, i.e. 1, should 
be constructed by a coupling reaction of 3a and the corresponding chloromethylsulfides 4. In chapters 
2.1 and 6 it was described that TEOC-protected N-hydroxytryptamine (3b) can be O-alkylated by 
alkylhalogenides in the presence of Nal, followed by deprotection to give N-alkoxytryptamines in 
good yields in a one-pot synthesis. This methodology was employed here also for the synthesis of 
N-alkoxytryptamines 2. 
Scheme I 
•он 
1g 2a: X-CH(OMe)2 
b: X=COOMe 
3a: R=H 
b: R=TEOC 
4a: Х=СН(ОМ ) 2 
b: X=COOMe 
The chloromethyl sulfide 4a could be prepared in 3 steps starting from the thioacetate 5 2 (Scheme 
II). Acetalization of 5 with trimethyl orthofoimate catalyzed by trifluoroacetic acid (TFA) (MeOH, 
24h) occurred smoothly to give the dimethylacetal 6 (81% yield). Dropwise addition of a methanolic 
IN NaOMe solution (1 equiv.) to 6 in methanol gave the thiol 7 (70% yield). A phase-transfer 
alkylation reaction of 7 with bromochloromethane using powdered potassium hydroxide (1.4 equiv.), 
catalyzed by triethylbenzylammoniumchloride (TEBAC; 0.1 equiv.) resulted in the quantitative 
formation of 4a. The chloromethyl sulfide 4b was prepared in an analogous fashion from methyl 
3-mercaptopropionate (98% yield). 
The freshly prepared O-anion of the N-hydroxyurethane derivative 3b (see chapters 2.1 and 6) 
(DME/NaH(l.l equiv.), CC) was added dropwise to the functionalized chloromethylsulfides 4a or 4b 
in the presence of Nal in DME at room temperature. The O-alkylated products were not isolated, but 
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deprotected immediately by adding BU4NF (2 equiv.) to give the compounds 2a and 2b in an overall 
yield of 70% and 81%, respectively. 
The desired intramolecular Pictet-Spengler reaction occurred on treatment of 2a in dichloromethane 
with TFA (2 equiv.). After stirring for 3 days at room temperature, (±)-deamino-debromoeudistomin L 
(Ig) was isolated in 71% yield. The NMR data of Ig show a great resemblance with those of 
debromoeudistomin К (le)3, especially the data of the characteristic AB spectrum of the C(4)H 
protons of the oxathiazepine ring. 
Subsequently we studied the formation of Ig employing the methyl ester 2b as precursor.4 After 
reduction of 2b with DIBAL (2 equiv.) at -IVC in toluene, TFA (3 equiv.) was added to the 
intermediate adduct 8 and intramolecular cylization occurred at -IWC within 15 minutes to give Ig 
(61% yield). The rate of this extremely fast cyclization is much higher than that of the corresponding 
reaction employing 2a, which can be rationalized either by the faster formation of the common aminal 
9 or by the intermediacy of the corresponding aldehyde 10. 
2a-
ig 
In conclusion, it is demonstrated that the intramolecular Pictet-Spengler approach 2—»1 is suitable 
for constructing the 7 membered oxathiazepine ring of the Eudistomin derivatives. 
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Spectroscopic data and Physical constants: 
Compound 6: bp 74-750C/4mm; η 2 5 1.4697; EIMS m/z 178 (M+); Ή NMR δ 4.45 (t, IH, 
HCíOMe)^, 3.34 (s, 6H, 2хОСНз), 2.92 (t, 2Н, CH2S), 2.35 (s, ЗН, COCHj), 1.84 (m, 2H, 
CH2CH2S). 
Compound 7: bp 490C/4mm; η 2 5 1.4571; EIMS m/z 136 (M+); lU NMR δ 4.43 (t, 1, HC(OMe)2), 
3.27 (s, 6H, 2хОСНз), 2.47 (m, 2H, CH2S), 1.92 (m, 2H, CH2CH2S), 1.40 (t, IH, SH) 
Compound 4a: bp 75-78 0C/3.5 mm; η 2 5 1.4970; •H NMR δ 4.73 (s, 2Η, SCH2CI), 4.45 (t, IH, 
HCtOMe)^, 3.30 (s, 6H, 2хОСНз), 2.77 (t, 2Н, CH2S), 1.91 (m, 2H, CH2CH2S). 
Compound 4b: CIMS m/z 184 ([M+2]+), 182 (M+), ^ NMR δ 4.80 (s, 2H, SCH2C1), 3.73 (s, 3H, 
OCH3), 3.18-2.58 (m, 4H, СЩСН^). 
Compound 2a (Preparation procedure analogue to; chapter 6, compounds 26-27): Oil; Rf 0.56 
(CHClj/MeOH, 97/3, v/v); CIMS m/z 325 ([Μ+ΙΓ), 292 ([M-MeOH]+), 261 ([C14H17N2OS]+), 189 ([C11H13N20]+), 130 ([C9H8N]+); Ή NMR δ 8.03 (br s, IH, indole NH), 7.67-7.08 (m, 5H, indole 
C(2)H and C(4)-C(7)H), 5.89 (br s, IH, NH), 4.87 (s, 2H, OCH2S), 4.50 (t, IH, СЩОМе)^, 3.40 (s, 
6H, 2хОСНз), 3.38 (m, 2Н, CH2N), 3.05 (m, 2H, indole C(3)CH2), 2.72 (t, 2H, CH2S), 1.99 (m, 2H, 
CH2CH(OMe),). 
Compound 2b (Preparation procedure analogue to; chapter 6, compounds 28-29) :Oil; Rf 0.51 
(CHCtyMeOH, 97/3, v/v); EIMS 308 (M+), 188 ( [ С ц Н ^ О П , 130 ([CgHgN]*), 86 ([C4H602]+); 
Ή NMR δ 8.03 (br s, IH, indole NH), 7.62-7.00 (m, 5H, indole C(2)H and C(4)-C(7)H), 5.89 (br s. 
IH, NH), 4.83 (s, 2H, OCH2S), 3.64 (s, 3H, OCH3), 3.07 (br t, 2H, CH2N), 3.07-2.56 (m, 6H, indole 
C(3)CH2 and SCH2CH2). 
Compound lg (Preparation procedure analogue to; chapter 6, compounds 4-6): mp 158-160^ 
(EtOAc/n-hexane); Rf 0.59 (n-hexane/EtOAc, 60/40, v/v); UV (MeOH) Xmax 225, 274.5(sh), 281, 
289.5 nm; CIMS (100 eV) m/z (relative intensity) 261 ([M+l]+, 53), 260 (M+, 100), 230 
( [ C u H ^ S r , 34), 144 ([C10H1()N]+, 72), 130 ([<^Η8Ν]+, 86); Ή NMR (400 MHz) δ 7.65 (br s, IH, 
NH), 7.47 (d, IH, 3J=7.7 Hz, C(12)H), 7.31 (d, IH, 3J=7.7 Hz, C(9)H), 7.18-7.08 (m, 2H, 
C(10)-C(11)H), 5.08 and 5.01 (AB spectrum, 2H, 2J=9.9 Hz, C(4)H2), 4.12 (br s, IH, C(13b)H), 3.67 (m, IH, C(7)H), 3.11 (m, IH, C(7)H), 3.09 (m, IH, C(2)H), 3.05 (m, IH. C(8)H), 2.82 (m, IH, 
C(2)H), 2.78 (m, IH, C(8)H), 2.65 (m, IH, C(l)H), 2.10 (m, IH, C(l)H); " C NMR (400 MHz) δ 
136.38 C(12a), 133.07 C(13a), 126.59 C(8b), 121.75 C(ll), 119.65 C(10), 118.31 C(9), 110.78 C(12), 
108.13 C(8a), 73.44 C(4), 63.05 C(C13b), 54.06 C(7), 37.96 C(2), 26.49 C(8), 20.17 C(l); Anal.Calc. 
for C H H J ^ O S (MW 260.360): C, 64.59; H, 6.19; N, 10.76. Found: С, 64.25; H, 6.17; Ν, 10.68. 
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Chapter 7.3 
STEREOSELECTIVE SYNTHESIS OF (-)-DEBROMOEUDISTOMIN L, OF (-)J)-METHYL-
DEBROMOEUDISTOMIN E AND OF THEIR STEREOISOMERS. 
In chapter 7.2 we demonstrated1 by synthesis of deamino-debromoeudistomin К (lg) that the 
intramolecular Pictet-Spengler reaction of N-alkoxytiyptamine derivatives {e.g. 2: Y=COOMe or 
CH(OMe)2, R
r
R4=H) -derived from 3 and 4 (X^HjCl)- is a suitable approach of the 7-inembered 
oxathiazepine ring occurring in the eudistomin derivatives (Scheme I). 
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In this chapter we report the total synthesis of (-)-debronioeudistomin L (le), of (-)-O-methyl-
debromoeudistomin E (If) and of their stereoisomers, by employment of this approach, i.e. the 
intramolecular Pictet-Spengler reaction of N-alkoxytiyptamine derivatives (2), derived from 
N-hydroxytryptamine (3) and chloromethylcysteine derivative (4, X=CH2C1, R4=HNBOC, 
Y=COOMe) (Route B, Scheme I). 
Synthesis of the N-hydroxytryptamine derivatives. 
Compound 9 was prepared via a known procedure2, viz. nucleophilic displacement of the 
quatemarized amino function of gramine 5 with the anion of nitromethane to give 7 and subsequent 
reduction of the nitro group.(Scheme Π). 
5-Methoxy-N-hydroxytryptamine (10) was prepared in an analogous fashion. Reaction of 
5-methoxygramine (6) with nitromethane in the presence of dimethyl sulfate and sodium methoxide 
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gave the nitro compound 8 (98%). Reduction of the nitro group by Al(Hg) in ethyl acetate saturated 
with water gave compound 10 (93%). 
S-(chloromethyl)cysteine derivatives 
From the synthesis of model compound lg we learned that compound 4 should contain the fragments 
X=CH2C1 and Y=CH(OMe)2 or CCXDMe. Thus, to obtain the correct stereochemistry at C(l) as 
present in the naturally occurring enantiomer of the target molecules a chloromethylsulfide derivative 
of D-cysteinal or D-cysteine methyl ester should be employed. Because of the tendency of cysteinal 
derivatives3 to racemization and the high costs of D-cysteine derivatives, we decided to approach 
these compounds from D-serine methyl ester. In order to explore the feasibility of our approach we 
initially started with the more readily available L-serine methyl ester. 
For the cysteinal derivatives (Y=CH(OMe)2) we started with N-[(fm-butyloxy)carbonyl]-0-[(feri-
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-butyl)dimethylsilyl]-L-serine methyl ester4 (11) which was reduced with DIBAL in toluene at -70PC 
to the corresponding serinai derivative (Scheme ΠΙ). The aldehyde was not isolated as such but 
immediately treated with trimethylorthoformiate in methanol and trifluoroacetic acid (TFA), whereby 
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the silyl protective group was removed and the dimethylacetal was formed in one-step giving 13 in 
46% yield in an e.e. of 94% (vide infra). 
The next step is the introduction of the sulphur atom. Recendy, a method for the conversion of 
alcohols into thiols via reaction of the corresponding mesylate with cesium thiocarboxylates was 
published5. This method proved to be successful for our purpose also. Accordingly, the alcohol 13 was 
transformed into the corresponding tosylate 14. Subsequent treatment with cesium thioacetate in DMF 
yielded the thioacetate 15 in 67% yield based on the alcohol 13. This compound was converted 
quantitatively with sodium methoxide into the thiol 16, which immediately was alkylated by a 
phase-transfer reacdon with bromochloromethane using powdered KOH and triethylbenzylammonium 
chloride (TEBAC) to give the chloromethyl sulfide 21 in nearly quantitative yield6. Thus, the overall 
yield 11—21 is 31%. 
In an analogous fashion i.e. 12—»17—18—»19-»20—»22, the 2,2,2-(trichloro)ethyloxycarbonyl 
(ТЮС) protected compound 22 was prepared in an overall yield of 14% (Scheme ΙΠ). In contrast with 
their free aldehyde congeners3, the dimethylacetal derivatives 15 and 19 did not undergo racemization 
during storage. 
СООМ 
To obtain the cysteine methyl ester derivatives (Y=COOMe) the hydroxyl function of 
BOC-L-Ser-OMe and BOC-D-Ser-OMe was converted by the same procedure to the corresponding 
chloromethylsulfides (—23a—24a—25a; 71%) and (—23b—24b—25b; 77%) (Chart I). The 
sequential conversion of the OH into the SH group occurred without loss of enantiomeric purity.8 We 
have no information on the optical purity of 25a and 25b. 
Coupling 
We have demonstrated9 that in a one-pot synthesis the 2-(trimethylsilyl)ethyloxycarbonyl (TEOC) 
protected N-hydroxy tryptamine 269 can be O-alkylated by alkylhalogenides, to give after 
N-deprotection N-alkoxytryptamines in good yields. This methodology was employed here also. 
Accordingly, 10 was treated with 2(trimethylsilyl)ethyl chloroformate10 in dichloromethane / 
dioxane to give 27 in 76% yield (Scheme IV). An efficient method for coupling of the 
chloromethylsulfides 21, 22, 25a and 25b with 26 was only found after several unsuccessful attempts 
(Scheme IV). Application of the basic-systems DMSO/KOtBu, ВМ80/К2СОз, DME/KOtBu or 
benzene/AgNO^tjN11 gave no reaction or unindentified products. The conditions of choice were 
analogous to those used in the preparation of methylthiomethyl ethers12. Compound 26 was treated 
Chart! 
Rj Rj R3 
23a(L) HNBOC H OTs 
23b(D) H HNBOC OTs 
24a(L) HNBOC H SAC 
24b(D) H HNBOC SAc 
25a(L) HNBOC H SCH2CI 
25b(D) H HNBOC SCH2CI 
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with sodium hydride in dimethoxyethane (DME); the anion formed was subsequently coupled with the 
iodomethylsulfide formed in situ from 21 and sodium iodide in DME. The alkylated product 28 was 
not isolated, but N-deprotected immediately by adding tetrabutylammoniumfluoride (TBAF) to give 
the N-alkoxyamine 31 in an overall yield of 75%. The coupling failed however, when the 
TrOC-protected chloromethylsulfide 22 was used. Starting material 26 was recovered quantitatively. 
This failure is due to decomposition of 22 under the basic alkylation conditions used13. 
Following the same procedure employing now the methyl ester 25a the dehydroamino acid 
derivative 34 (35%) (Scheme IV) and the desired thiomethyl ether 29a (34%) were isolated together 
with recovered starting material 26 (59%). This ß-elimination reaction could be prevented by adding 
the anion of 26 very slowly to the in situ prepared iodomethylsulfide of 25a. The thiomethyl ether 29a 
was now isolated in 85% yield. Deprotection with TBAF without isolation of 29a gave 32a in a 
moderate yield (48%). Likewise, deprotection of isolated 29a with TBAF gave 32a in only 61% yield. 
An alternative deprotection method14 with a 'naked' fluoride generated by tetrabutylammonium 
chloride and potassium fluoride dihydrate in acetonitril at бСРС gave 32a in high yield (85%). We do 
not have an explanation for the lower ability of TBAF to remove the TEOC-group of 29a as compared 
to 28. 
In a similar manner the D-cysteine derivative 25b was coupled with 26 and 27 to give 29b (84%) 
and 30 (88%), respectively. Deprotection of these compounds with the above mentioned fluoride 
reagent gave 32b (86%) and 33 (81%), respectively. 
The conversions 25a—»29a and 25b—»29^30 deserve further comment. Despite the application of 
alkaline conditions in the coupling-step we observed only minor losses of enantiomer purity in the end 
products (-)-le and (-)-lf (vide infra). However, we found noticeable racemization when a slight 
excess of sodium hydride was used in the generation of the alkoxide anion. 
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Cyclization 
The intramolecular Pictet-Spengler reaction of the dimethylacetal 31 did not proceed as smoothly as 
the one we observed earlier1·9 for N-alkoxytryptamine derivatives with a dimethylacetal function at 
the end of the alkoxy-chain. Treatment of 31 with TFA gave the two stereoisomers of the cyclic 
urethane 35 as the main products (Chart Π). Apparently, the in situ formed alkoxy-carbenium ion is 
Chart II 
35 36 
quenched intramolecularly by the BOC group15. Unfortunately, the cyclic urethane compounds 
decomposed on further treatment with acid. 
We described earlier1,9 that compound 4 (Y=COOMe, Rj-R^H) cyclized immediately after 
reduction of the methylester with DIBAL at -IQPC and subsequent addition of TFA. The difference in 
reactivity of the intermediate obtained after the DIBAL reduction with that of the dimethylacetal 
derivatives was enormous, indicating a different mechanism in the Pictet-Spengler reaction to follow. 
Consequently, we reasoned that the undesired reaction we observed with the dimethylacetal 31 may be 
avoided by using the methylester derivatives 32 and 33. Indeed, reduction of 32a with DIBAL at 
-Tf^ C in toluene followed by addition of TFA gave the cyclized products 37a and 38a in 52% yield 
(ratio 37a/38a=71/29) (Scheme V and Table I, Entry 1). Presumably, cyclization under acidic 
conditions occurs either via the activated mixed-acetal 36 (Chart II) or via the corresponding free 
aldehyde. 
The 'H NMR data of compound 38a show a great resemblance with those reported by Nakagawa16 
for the compound with а си relationship between the protons of C(l) and C(13b). The characteristic 
differences between the spectra of 37a and 38a are i) the down-field shift of the indole NH proton 8 
9.98 (38a: δ 8.52) propably participating in a Η-bridge with the nitrogen of the HNBOC-group on 
C(l) 1 7 and ii) the AB spectrum of the OCH2S protons at δ 5.26 (38a: δ 4.98) and δ 4.77 (38a: δ 4.83) 
with 2J=11.4 Hz (38a: 2J=9.1 Hz). Therefore, the relative stereochemistry at the C(l) and C(13b) 
centers was tentatively assigned as trans in 37a18 and eis in 38a. 
Although the intermolecular Pictet-Spengler reaction of 9 with cysteinals proceeds with high 
diastereoselectivity yielding predominantly the cis-isomer19, the corresponding intramolecular 
cyclization shows a low diastereoselectivity towards the /ranj-isomer. The complexity of the 
cyclization mechanism20 makes it difficult to give a rationale explanation for this reversal in the 
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Table I. Cyclization o( the N-Alkoxytryptamines 32 and 33. 
Entry 
1 
2 
3 
4 
5 
6 
7 
compound 
32a 
32b 
33 
solvent 
toluene 
toluene 
DME 
CH2CI2 
CH2CI2 
CH2CI2 
CH2CI2 
cyclization TFA 
condition (equiv.) 
-70oC/3h. 5 
RT/1h. 5 
-70oC/3h. 5 
•70oC/3h. 5 
-90oC/0.5h. 15 
-90oC/0.5h. 15 
-90oC/0 5h. 15 
yield0 (%) 
52 
41 
70 
52 
58 
53 
81 
cisnransb 
29/71 
39/61 
13/87 
31/69 
41/59 
34/66 
30/70 
a) These yields are based on starting material and refer to isolated compounds b) Ratos 
are based on isolated compounds These are in agreement with the product ratios determined 
by HPLC 
stereochemical outcome of the reactions. 
We studied the cyclization by varying the solvent, the cyclization temperature and the amount of 
TFA used (Table 1, Entries 1-5). The rano 37a(mwu)/38a(cij) depends slightly on the solvent used. 
Whereas for all the solvents used the major product has a trans relationship between the C(l) and 
C(13b) protons it was observed that toluene and dichloromethane give a higher ratio with respect to 
the cis compound than dimethoxyethane does (Entries 1, 3-4). Raising the temperature to room 
temperature gave a slight improvement of the ratio with respect to the ds-isomer, the yield dropped 
however (Entry 2). The best result was obtained when 15 equivalents TFA were added at once to a 
cooled solution {-9QPC) of the reactant in dichloromethane (Entry 5). Consequently, the compounds 
32b and 33 were cyclized under these conditions to give 37b and 38b in 53% yield (ratio 
37b/38b=66/34) and 39 and 40 in 81% yield (ratio 39/40=30/70), respectively (Scheme V, Table I, 
Entries 6-7). The stereochemistry of 37b, 38b, 39 and 40 was assigned by comparing their 'H NMR 
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spectra with those of 37a and 38a. 
The specific rotations of 38a and 38b arc nearly identical to those reported by Nakagawa19, who 
established the homochirality of these eudistomin derivatives by NMR techniques. 
Deprotection 
The most widely used procedure for removal of the BOC-group involves treatment with TFA at 
(УС21. However, we found that under these conditions 38b gave the desired amine (-)-le in low yield 
only due to decomposition of the latter. The method of choice appeared to be a mild deblocking 
method reported by Stammer22*: it consists of cleavage of the the carbamate by trimethylsilyl iodide 
(TMSI) at room temperature in acetonitrile. Compound 38b was treated for 2 hours with the in situ 
generated TMSI (2 equivalents TMSC1 and Nal)2 2 b at room temperature in CH3CN to give 
debromoeudistomin L ((-)-le) in 94% yield (Scheme V). The deprotections 37a—»41a, 37b—»41b, 
38a-»(+)-le, 39-»(-)-lf and 40-»42 proceeded in an analogous fashion in yields of 95%, 89%, 98%, 
95% and 78%, respectively23. The structure of 42 is verified by a single crystal X-ray analysis24 
(Figure I). Deprotection of the cij-isomers hardly affected their 1H NMR spectra, whereas in case of 
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the fra/u-isomers 41a, 41b and 42 the Ή NMR spectra changed drastically. The differences that 
attract attention are peak-broadening, a single peak for OCH2S at δ 4.94 and the up-field shift of 
C(13b)H. However, the 'NMR spectrum of 41a at -310C showed peak-sharpening and clearly two 
conformations in a ratio of 82/1825. Significant differences between the conformers are the indole NH 
shifts (δ 10.34 versus 9.78) and the AB spectrum of OCH2S (δ 4.99 and 4.97, 2J=9.5Hz versus δ 5.37 
and 4.88, 2J=ll.lHz). The down-field shift of the indole NH proton of the trans compounds is 
probably a result of a Η-bridge with the nitrogen of the amino-group on C(l). 
Conclusion 
In conclusion, we have shown that N-alkoxyöyptamines with a methyl ester at the end of the alkoxy 
chain (32a, 32b and 33) undergo -after reduction with DIBAL and subsequent treatment with TFA- an 
intramolecular Pictet-Spengler reaction to give eudistomin derivatives in reasonable yields. 
Cyclization occurs with a slight diastereoselective preference for the trans-isomn. Removal of the 
BOC group yields (-)-debromoeudistomin L (i.e. (-)-le), its enantiomer (+)-le and the two 
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diastereomers 41a and 41b or (-)-O-methyldebromoeudistomin E (i.e. (-)-lf) and its diastereomer 42. 
This facile approach gives access to all the four possible stereoisomers, and is applicable for the 
preparation of large amounts. Moreover it is sufficiently flexible allowing the prepration of analogues. 
Experimental Section 
Melting points were taken on a Koefler hot stage (Leitz-Wetzlar) and are uncorrected. Ultraviolet 
spectra were measured with a Perkin Elmer spectrometer, Model lambda 5. Proton magnetic 
resonance spectra were measured on a Bruker WH-90 or on a Braker AM 400 spectrometer. 
Chemical shifts are reported as δ-values relative to tetramethylsilane as an internal standard; 
deuteriochloroform was used as solvent unless stated otherwise. Mass spectra were obtained with a 
double-focusing VG 7070E spectrometer. Thin-layer chromatography (TLC) was carried out by using 
silica gel F-254 plates (thickness 0.25 mm). Spots were visualized with a UV hand lamp, iodine vapor, 
or CI2-TDM.27 For column chromatography Merck silica gel (type 60H) was used. 
5-Methoxy-3-[2-nitroethyl]indole(8) 
This synthesis is a modification of Cohen's procedure.2 Sodium methoxide, which was freshly made 
from 1.22 g (53 mmol) sodium in dry methanol (50 mL) was added to a stirred solution of 
5-methoxygramine (6) (9.8 g, 48 mmol), dimethylsulfate (12.1 g, 96 mmol) in nitromethane/methanol, 
2/1, v/v (250 mL). After completion of the reaction (24 h) as was monitored by TLC (CHClj/MeOH, 
99/1, v/v) most of the solvent was removed by evaporation in vacuo at room temperature. The residue 
was dissolved in dichloromethane and subsequently washed with 5% NH4OH, IN HCl and brine. The 
organic layer was dried (N32804) and the solvent evaporated in vacuo. The residue was subjected to 
column chromatography (CHClj/MeOH, 99/1, v/v) to yield 10.34 g (98%) of 8. ; EIMS (70 eV), m/z 
(relative intensity) 220 (M+, 60), 174 ([M-NOj]"1", 69), 173 ([M-HNOJ*. 100), 130 (57); Ή NMR δ 
8.00 (br s, IH. NH), 7.30 (dd, IH, J=8.7 Hz, C(7)H), 7.04-6.81 (m, 3H, C(2)H and C(4)H and C(6)H), 
4.67 (t. 2H, CH2N02), 3.89 (s, 3H, OCH3), 3.47 (t, 2H, indole СОУСИ^. 
5-Methoxy-3-[2-hydroxylamino-ethyl]indole(10) 
To a stiired solution of 8 (9 g, 41 mmol) in EtOAc (saturated with water) freshly prepared Al(Hg) 
was added portionwise. After completion of the reaction (5 h) as was monitored by TLC 
(СНОз/МеОН, 93/7, v/v), the reaction mixture was filtered and the residue dried (MgSCb) and the 
solvent evaporated in vacuo. The residue was crystallized from EtOAc/n-hexane to give 7.83 g (93%) 
of 10. Rf 0.17 (CHClj/MeOH. 93/7, v/v); EIMS (70 eV) m/z (relative intensity) 206 (M+, 21), 160 
([CioHjoNOr, 100); •H NMR δ 7.94 (br s, IH, NH), 7.25 (d, IH, J=9.0 Hz, C(7)H), 7.04-6.74 (m, 3H, 
C(2),C(4) and C(6)H), 5.73 (br, s, 2H, HNOH), 3.84 (s, 3H, OCHA 3.34-2.90 (m, 4H, 
C(3)CH2CH2N); Anal.Calcd. for C1 1H1 4N204 (Mw 206.246): C, 64.06; H, 6.84; N, 13.58. Found: С, 
64.30; H, 6.94; Ν, 13.36. 
N-[(/cri-Butyloxy)carbonyl]-0-[tert-butyldimethylsilyl]-L-Serine Methyl Ester (11) 
To a stirred solution of L-BOC-Ser-OMe (20.9 g, 95.4 mmol) and imidazole (16.2 g, 240 mmol) in 
DMF (200 mL) was added dropwise tert-butyldimethylsilylchloride (15.9 g, 105 mmol). The reaction 
was stirred at 50PC for 5 days after which the solvent was removed in vacuo. The residue was 
dissolved in dichloromethane and successively washed with a IN HCl solution and brine. The organic 
layer was dried (Na2S04) and the solvent evaporated in vacuo to give crude 11. The crude reaction 
product was subjected to column chromatography (CHCI3) to give 28.15 g (89%) of 11. Oil; Rf 0.61 
(CHCI3); [a] 2 2 D +7.5° (c=3.2, methanol); CIMS (100 eV) m/z (relative intensity) 334 ([M+l]+,12), 
278 (28), 260 (LM-OC4H9]+, 13), 234 (49), 220 (43), 49 (100); lH NMR δ 5.32 (br d, IH, NH), 4.33 (m, IH, CHN), 3.95 and 3.76 (AB part ABX spectrum, 2H, 2J=11.4 Hz, J=2.7 Hz, J=8.0 Hz, CH2OSi), 
3.71 (s, 3H, OCH3), 1.43 (s, 9H, С(СНз)з), 0.85 (s, 9H, 5іС(СНз)з), 0.00 (s, 6Н, SKCHj^). 
N-[2¿,2-(Tr¡chIoro)ethoxycarbonyl]-0-[<ert-butyId¡methylsilyl]-L-Serine Methyl Ester (12) 
The same procedure was followed as described for 11. L-TiOC-Ser-OMe (4.15 g, 14.1 mmol), 
imidazole (2.1 g, 31 mmol) and tert-butyldimethylsilylchloride (2.54 g, 16.9 mmol) in DMF (25 mL) 
gave after column chromatography (CHCI3) 5.35 g (92%) of 12: Rf 0.79 (CHCiyMeOH, 97/3, v/v); 
rH NMR δ 5.73 (br d, IH, NH), 4.70 (s, 2H, СН2СС1з), 4.37 (m, IH, СНСН20), 3.92 (m, 2Н, 
СНСН20), 3.71 (s, ЗН, ОСНз), 0.85 (s, 9Н, 5і(С(СНз)з), 0.00 (s, 6Н, SKCHj)^. 
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N-[(fer/-Butyloxy)carbonyl]-L-SerinaI Dimethylacetal (13) 
To a stirred solution of 11 (28 g, 84 mmol) in dry toluene (250 mL) a solution of DIB AL in toluene 
(1.2 equiv.) was added in an argon atmosphere in such a rate that the temperature did not raise above 
-IQPC. After stirring for 2 h. a 10% HCl/EtOH solution was added carefully. The reaction mixture was 
poured into 300 mL 10% aqueous HCl solution. The organic layer was separated and washed with 
brine. The organic layer was dried (MgSO^ and the solvent evaporated in vacuo to give 25 g crude 
serinai derivative. Without further purification the crude reaction product (25 g, 83 mmol) was 
dissolved in methanol (250 mL) and trimethyl orthoformate (75 mL) and trifluoroacetic acid (1 mL) 
were added. After completion of the reaction (24 h) most of the solvent was removed by evaporation 
in vacuo. The residue was dissolved in dichloromethane and successively washed with an aqueous IN 
NaHC03 solution and brine. The organic layer was dried (N32804) and the solvent was evaporated in 
vacuo. The residue was subjected to column chromatography (CHClj/MeOH, 99/1, v/v) to give 9 g 
(46%) of 13 as a colourless oil. The yield is based on the ester 11. Rf 0.31 (CHClj/MeOH, 97/3, v/v); 
[a]22D-202 (c=3.4, methanol); CMS (100 eV) m/z (relative intensity) 236 ([M+l]+, 29), 204 ([M-CH30]+, 11), 180 (20), 162 ([М-С^ОГ, 26), 148 (100); Ή NMR δ 5.16 (br s, IH, NH), 4.42 (d, IH, СЩОМе)^, 4.00-3.50 (m, 3H, NCHCH2), 3.46 (s, 6H, 2хОСНз), 2.61 (br s, IH, OH), 1.46 (s, 
9H, С(СНз)з); Anal.Calcd. for q ^ N O s (Mw 235.283): С, 51.05; H, 9.00; Ν, 5.95. Found: С, 
50.99; Η, 8.89; Ν, 5.88. 
The enantiomeric excess of compound 13 was established by coupling it with 
(+)-a-methoxy-a-trifluoromethylphenylacetyl chloride according to the literature32. The obtained 
MTPA ester ([a]22D-45.30 (c=2,65, methanol); •Η NMR δ 7.51 (m, 2H, С6Н2НЭ), 7.40 (m, ЗН, QHjHj), 4.74 (br d, IH, NH), 4.42 (d, 2H, OCH2), 4.25 (d, IH, CH(OMe)2), 4.10 (br s, IH, 
OCH2CH), 3.53 (q, 3H, CFjCOCHj), 3.37 and 3.35 (2xs, 6H, 2x OCH3), 1.42 (s, 9H, С(СНз)з).) 
showed in the NMR spectrum two signals for 1 9 F at 0.0912 ppm and -0.Ö012 ppm in a ratio of 3/97, 
respectively. Therefore the enantiomeric excess of compound 14 is 94%. A racemic mixture of 14 
showed clearly two signals at 0.0896 ppm and -0.00103 ppm in ratio of 1/1. 
N-[2,2,2-(Trichloro)ethoxycarbonyl]-L-Serinal Dimethylacetal (17) 
The same procedure was followed as described for 13. From 12 (2.85 g, 7 mmol), DIBAL (8.5 
mmol) in toluene (25 mL) the serinai derivative was obtained which was converted without further 
purification with trimethyl orthoformate (7.5 mL), methanol (25 mL) and TFA (0.1 mL) to give after 
column chromatography (CHCyMeOH, 99/1, v/v) 1.20 g (39%) of 17; Rf 0.11 (CHCLa/MeOH, 99/1, 
v/v); Ή NMR δ 5.83 (br s, IH, NH), 4.73 (s, 2H, СН2СС1з), 4.45 (d, IH, CH(OMe)2), 4.03-3.63 (m, 
ЗН, NCHCH2), 3.47 (s, 6H, 2хОСНз), 2.92 (br s, IH, OH). 
General Procedure for the Preparation of the Thioacetates. 
N-IUcri-ButyloxyJcarbonyll-S-tacetyll-L-Cysteinal Dimethylacetal (15) 
To a solution of the alcohol 13 (8.7 g, 37 mmol) in dry pyridine (60 mL) tosylchloride (7.75 g, 40.7 
mmol) was added at -10oC. The reaction mixture was stirred at 4 0C overnight After completion of 
the reaction as was monitored by TLC (СНСІз/МеОН, 99/1, v/v), most of the pyridine was removed 
by evaporation in vacuo at room temperature. The residue was dissolved in dichloromethane and 
subsequently washed two times with a 2N KHS04 solution to remove the pyridine and then with 
water. The organic layer was dried (N32804) and the solvent was evaporated in vacuo to give 13.3 g 
(93%) crude 14. 
To a suspension of CSCO3 (7.06 g, 21.7 mmol) in dry DMF (85 mL) was added freshly distilled 
thioacetic acid (3.3 g, 43.3 mmol). As the CsCOj was dissolved, the crude tosylate 14 (13.3 g, 34.2 
mmol) dissolved in 40 mL of dry DMF was added. The reaction mixture was stirred in the dark 
overnight and was kept under argon atmosphere. After completion of the reaction the solvent was 
evaporated in vacuo. The residue was dissolved in dichloromethane (200 mL) and washed with water. 
The organic layer was dried (N32804) and concentrated in vacuo. The crude reaction product was 
subjected to column chromatography (EtOAc/n-hexane, 20/80, v/v) to give 15 (67%, based on the 
alcohol 13): Rf 0.42 (EtOAc/n-hexane, 40/60, v/v); [a]22D-704 (c=3.55, MeOH); CIMS (100 eV) m/z (relative intensity) 294 ([М+1Г, 5), 262 ([М-СНзО]+, 12), 206 (76), 162 (21), 75 ([CoHjOSr, 100); 
Ή NMR δ 4.78 (br d, IH, NH), 4.27 (d, IH, СЩОМе)^. 4.07-3.76 (m, IH, CHCH2S), 3.44 (s, 6H, 
2хОСНз), 3.19 and 2.94 (AB part of ABX spectrum, 2H, 2J=14.4 Hz, J=4.0 Hz, J=7.8 Hz, CHCH2S), 
2.34 (s, 3H, SCOCH3), 1.43 (s, 9H, С(СН3)з). 
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N-[2^,2-(Tr¡chloro)ethoxycarbonyl]-S-[acetatyl]-L-Cyste¡nalDimethylacetal(19) 
The same procedure was followed as described for 15. Compound 17 (585 mg, 1.88 mmol) gave via 
tosylate 18 after column chromatography (EtOAc/n-hexane, 80/20, v/v) 475 mg (69%) of 19. The 
yield was based on the alcohol 15; Rf 0.38 (EtOAc/n-hexane, 1/1, ν/ν); Ή NMR δ 5.33 (br d, IH, 
Ші), 4.67 (s, 2H, CHjCClj), 4.38 (d, IH, CH(OMe)^, 4.01 (m, IH, CHCH2S), 3.32 (s, 6H, 2хОСНз), 
3.11-2.93 (AB part of ABX spectrum, 2H, CHCH2S), 2.35 (s, 3H, SCOCH3). 
N-[(tert-Butyloxy)carbonyl]-S-[acetatyl]-L-Cysteine Methyl Ester (25a) 
The same procedure was followed as described for 15. (L)-BOC-Ser-OMe (3.8 g, 17.4 mmol) gave 
via tosylate 23a after column chromatography (EtOAc/n-hexane, 25/75, v/v) 3.85 g (80%) of 24a: mp 
46-470C (EtOAc/n-hexane); Rf 0.51 (EtOAc/n-hexane, 50/50, v/v); [a]22D-442 (c=2.6, MeOH); IR (KBr) vícm1) 3360 (NH), 1730 (C=0), 1680 (C=0); CIMS (100 eV) m/z (relative intensity) 278 
([M+l]+, 6), 222 (66), 178 (100), 162 (96); Ή NMR δ 5.23 (br d, IH, NH), 4.61-4.38 (m, IH, 
CHCOOMe), 3.74 (s, 3H, OCH3), 3.52-3.16 (AB part of ABX spectrum, 2H, CH,S), 2.33 (s, ЗН, 
SCOCHj), 1.42 (s, 9H, С(СНз)з); Anal.Calcd. for С ц Н ^ С ^ З (Mw 277.340): С, 47.64; H, 6.90; Ν, 
5.50. Found: С, 47.81; Η, 6.89; Ν, 5.02. 
N-[(tert-Butyloxy)carbonyI]-S-[acetatyl]-D-Cysteine Methyl Ester (24b) 
The same procedure was followed as described for 15. (D)-BOC-Ser-OMe (7.7 g, 35.2 mmol) gave 
via tosylate 23b after column chromatography (EtOAc/n-hexane, 25/75, v/v) 8.2 g (84%) of 24b: 
[a]2 2 D+459 (c=2.7, MeOH). Further spectroscopic data and mp are identical with 24a. 
General Procedure for the Preparation of the Chloromethylsulfides. 
N-[(tert-ButyIoxy)carbonyl]-S-[chloroinethyl]-L-CysteineDiniethylacetal (21) 
To a stirred solution of thioacetate 15 (1.0 g, 3.4 mmol) in ethanol (15 mL) was added dropwise a IN 
NaOEt solution in ethanol (3.5mL). After completion of the reaction, as was monitored by TLC 
(EtOAc/n-hexane, 1/2, v/v) the ethanol was removed by evaporation in vacuo. The residue was 
dissolved in dichloromethane and subsequently washed with 0.1N HCl and brine. The organic layer 
was dried (N32804) and the solvent was evaporated in vacuo to give 860 mg (100%) crude 16. The 
thiol was not further purified but dissolved in bromochloromethane (30 mL) and 
triethylbenzylammonium chloride (TEBAC) (77 mg, 0.34 mmol) and powdered KOH (267 mg, 4.76 
mmol) were added successively. After 15 min. the reaction was complete. The reaction mixture was 
filtered and the filtrate subsequently washed with water, IN HCl, and brine. The organic layer was 
dried (N32804) and the solvent evaporated in vacuo to give 1.0 g (98%) of the chloromethylsulfide 21 
which was not further purified. Oil; Rf 0.54 (EtOAc/n-hexane, 1/2, v/v); ХЯ NMR δ 4.93 (br d, IH, 
NH), 4.78 (s, 2H, SCH2C1), 4.27 (d, IH, HC(OMe)2), 4.13-3.70 (m, IH, CHCH2S), 3.45 (s, 6H, 
2хОСНз), 3.23-2.55 (AB part of ABX spectrum, 2H, CHCH2S), 1.47 (s, 9H, С(СНз)з). 
N-[2¿,2-(TrichIoro)ethoxycarbonyl]-S-[chloroinethyl]-L-CysteineDiinethylacetal(22) 
The same procedure was followed as described for 21. Compound 19 (475 mg, 1.29 mmol) and 
NaOMe (1.35 mL IN methanolic solution) gave via the thiol 20, 244 mg (50%) of 22: Rf 0.44 
(EtOAc/n-hexane, 1/1, v/v); Ή NMR δ 5.44 (br d, IH, NH), 4.78 (s, 2H, SCH2C1), 4.69 (s, 2H, 
СН2СС1з)Л37 (d, IH, НС(ОМе)2), 4.15-3.77 (m, IH, CHCH2S), 3.41 (s, 6H, 2хОСНз), 3.18-2.67 (AB part of ABX spectrum, 2H, CHCHjS). 
N-[(tert-Butyloxy)carbonyI]-S-[chloroniethyl]-L-Cysteine Methyl Ester (25a) 
The same procedure was followed as described for 21. Compound 24a (6.5 g, 23 mmol) gave via the 
thiol derivative, 5.9 g (89%) of the chloromethylsulfide 25a. oil; Rf 0.52 (EtOAc/n-hexane, 1/1, v/v); 
CIMS (100 eV) m/z (relative intensity) 286 ([M+3]+, 3.65), 284 ([M+l]+, 9.72), 230 (17), 228 (40), 
192 (28), 186 (22), 184 (49), 148 (100); Ή NMR δ 5.30 (br d, IH, NH), 4.71 (s, 2H, SCH2C1), 
4.70-4.51 (m, IH, CHCOOMe), 3.78 (s, ЗН, OCH3), 3.29 and 3.15 (AB part of ABX spectrum, 2H, 
2J=14.0 Hz, J=4.9 Hz, J=5.7 Hz, SCH2CH), 1.42 (s, 9H, С(СНз)з). 
N-[(ter/-Biityloxy)carbony!]-S-[chloromethyI]-D-Cysteine Methyl Ester (25b) 
The same procedure was followed as described for 21. Compound 24b (6.5 g, 23 mmol) gave via the 
thiol derivative, 6.0 g (92%) of the chloromethylsulfide 25b. Identical spectroscopic data as for 25a. 
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5-Methoxy-3-[2-(N,N-2-(tr¡methyls¡lyl)ethoxycarbonyI, hydroxy)aminoethyl]indole (27) 
2-(ТгітеиіуІ5І1у1)еиіу1сЫогоГотіаІе™ (8.12 g, 45 mmol) was added at room temperature dropwise 
to a stirred solution of 10 (6.2 g, 30 mmol) in CHjC^/dioxane (150 mL). After completion of the 
reaction ( 2 h), as was monitored by TLC (CHCiyMeOH, 93/7, v/v), most of the solvent was removed 
by evaporation in vacuo. The residue was dissolved in dichloromethane and subsequently washed with 
saturated NaHC03 and brine. The organic layer was dried (N82804) and evaporated in vacuo. The 
residue was subjected to column chromatography (EtOAc/n-hexane, 40/60, v/v) to give 7.94 g (76%) 
of 27. Rf 0.41 (CHCtyMeOH, 93/7, v/v); EIMS (70 eV) m/z (relative intensity) 350 (M+, 15), 233 
([M-CsH^OSi]-1-, 23), 218 (27), 174 ([СцН^КОГ, 26, 173 (60), 160 ([C10H10NO]+, 100); lH NMR δ 
7.96 (br s, IH, NH), 7.26 (d, IH, 3J=9.Ô Hz, C(7)H), 7.11-6.80 (m, 3H, C(2), C(4) and C(6)H), 6.71 
(br s, IH, OH), 4.14-3.80 (m, 4H, CH2N and CH2O), 3.88 (s, 3H, OCH3), 3.12 (t, 2H, C(3)-CH2), 
0.91-0.72 (m, 2H, CH2Si), 0.00 (s, 9H, SiiOtyj). 
General Procedure for the Coupling of TEOC-protected N-hydroxytryptamines with 
Chloromethylsulfides. 
Compound 31 
Sodium hydride was added to a cooled (-K^C) stirred solution of 26 (960 mg), 3 mmol) in dry DME 
(15 mL) in an argon atmosphere. The reaction mixture was allowed to warm to room temperature 
^-evolution occurred). To the resulting clear solution Nal (450 mg, 3 mmol) was added at once and 
then a solution of 21 (1123 mg, 3.75 mmol) in DME (15 mL). After completion of the reaction (5 h), 
as was monitored by TLC (EtOAc/n-hexane, 1/1, v/v) the alkylated product 28 was not isolated but 
BU4NF (9 mL, IN solution in THF) was added. The reaction mixture was stirred overnight, after 
which it was diluted with EtOAc (50 mL) and subsequently washed with saturated NaHC03, IN HCl, 
and brine. The organic layer was dried (MgS04) and the solvent evaporated in vacuo. The crude 
reaction product was subjected to column chromatography (EtOAc/n-hexane, 30/70, v/v) to give 988 
mg (75%) of 31. Oil; Rf 0.44 (EtOAc/n-hexane, 1/1, v/v); [a]22D-236 (c=2.75, methanol); CIMS (100 
eV) m/z (relative intensity) 440 ([M+l]+, 60), 352 ([С 1 6Н 2 1^048+1]+, 67), 189 ([C1 1H1 3N20]+, 37), 
176 (100), 144 ([C10H10N]+, 61), 130 ([0,Η8Ν]+, 70); Ή NMR δ 8.16 (br s, IH, NH), 7.67-7.02 (m, 
5H, indole C(2)H and C(4)-C(7)H), 5.98 (br s, IH, HNO), 5.05 (br d, IH, NHBOC), 4.91 (s, 2H, 
OCHjS), 4.42 (d, IH, CH(OMe)2), 4.09-3.85 (m, IH, CHCH2S), 3.40 (s, 6H, 2x OCH3), 3.40-2.64 (m, 
6H, indole C(3)CH2CH2N and CHO^S), 1.48 (s, 9H, С(СНз)з). 
Compound 29a 
Procedure A 
The same procedure was followed as described for 31. Compound 26 (lg, 3.13 mmol), NaH (82 mg, 
3.34 mmol), Nal (470 mg, 3.13 mmol) and 25a ( lg, 3.5 mmol) gave after column chromatography 
(EtOAc/n-hexane, 35/65, v/v) 248 mg (35%) 34, 610 mg (34%) of 29a, and 593 mg (59%) of starting 
material 26. 
Compound 34: CIMS (100 eV) m/z (relative intensity) 202 ([M+l]+, 70), 146 (100), 102 
([М-ВОС+1Г, 79); Ή NMR δ 7.02 (br s, IH, NH), 6.17 (s, IH, C=CH), 5.77 (d, IH, J=1.5Hz, 
C=CH), 3.83 (s, 3H, OCH,), 1.47 (s, 9H, С(СНз)з). 
Compound 29a: Oil; Rf 0.34 (EtOAc/n-hexane, 1/2, v/v); [a]22D-176 (c=2.1, methanol); CIMS (100 
eV) m/z (relative intensity) 568 ([M+l]+, 1), 567 (M+, 2), 468 (9), 440 (15), 144 ([CioH10N]+, 68), 130 ([C9H8NJ+, 48), 57 ([С4Н9І+, 100); Ή NMR δ 8.04 (br s, IH, NH), 7.68-7.02 (m, 5H, indole C(2)H 
and C(4)-C(7)H), 5.60 (br d, IH, NHBOC), 4.89 (s, 2H, OCH2S), 4.69-4.38 (m, IH, CHCOOMe), 
4.12-3.72 (m, 4H, CH2N and SiCH2CH20), 3.76 (s, ЗН, ОСН3), 3.26-2.90 (m, 4Н, indole С(3)-СН2 
and CHCH2S), 1.41 (s, 9H, С(СНз)з), 1.00-0.68 (m, 2Н, CHjSi), 0.00 (s, 9Н, 8і(СНз)з). 
Procedure В: 
Sodium hydride (356 mg, 14.8 mmol) was added to a cooled (-ІСУС) stinred solution of 269 (5 g, 15.6 
mmol) in dry DME (75 mL) in an argon atmosphere. The reaction mixture was allowed to warm to 
room temperature (H2-evolution occurred). The resulting clear solution was added dropwise to a 
stirred solution of 25a (5.9 g, 20.8 mmol) and Nal (5 g, 33.3 mmol) in DME (75 mL). After stirring 
for 24 hours, the reaction mixture was concentrated in vacuo. The residue was dissolved in EtOAc and 
subsequently washed with 0.IN HCl and brine. The organic layer was dried (MgS04) and evaporated 
in vacuo. The residue was subjected to column chromatography (CHCI3) to give 7.5 g (85%) of 29a. 
Spectroscopic data vide supra. 
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Compound 29b 
Following procedure (B) as described for 29a with 26 (5 g, 15.6 mmol), NaH (356 mg, 14.8 mmol), 
chloromethylsulfide 25b (5.9 g, 20.8 mmol) and Nal (5 g, 33.3 mmol) in DME (150 mL) gave after 
column chromatography (CHCI3) 7.4 g (84%) of 29b. [ a ] 2 2 ^ ! 4 (c=3.7, methanol); Further 
spectroscopic data are identical with 30a. 
Compound 30 
Following procedure (B) as described for 29a with 27 (1.6 g, 4.6 mmol), NaH (105 mg, 4.37 mmol) 
and the chloromethylsulfide 25b (2 g, 6.9 mmol) and Nal (1.5 g, 10 mmol) in DME (30 mL) gave 
after column chromatography (CHCI3) 2.43 g (88%) of 30. Oil; Rf 0.52 (СНСІз/МеОН, 97/3, v/v); 
[ a ] 2 2 D + 1 6 7 (c=3.6, methanol); CIMS (100 eV) m/z (relative intensity) 598 (M+l]+, 0.23), 597 (M+, 
0.22), 543 (0.33), 499 (0.75), 470 (1.3), 57 ([C4H9]+, 100); Ή NMR δ 7.93 (br s, IH, NH), 7.23 (d, 
IH, J=9.0 Hz, C(7)H), 7.03-6.74 (m, 3H, C(2), C(4) and C(6)H), 5.61 (br d, IH, HNBOC), 4.88 (s, 
2H, OCH2S), 4.67-4.42 (m, IH, CHCOOMe), 4.14-3.59 (m, 4H, CH2N and SiCH2CH20), 3.87 (s, 3H, 
indole С(5)-ОСНз), 3.78 (s, 3H, COOCHj), 3.18-2.97 (m, 4H, indole С(3)-СН2 and CHCH2S), 1.40 (s, 9H, С(СНз)з), 1.00-0.64 (m, 2Н, SiOty, 0.00 (s, 9Н, Si(CH3)3). 
General Procedure for the Removal of the TEOC-group. 
Compound 32a 
A solution of 29a (6.2 g, 10.9 mmol), BU4NCI (9 g, 33 mmol) and KF.2H20 (4.1 g, 44 mmol) in dry 
acetonitrile (200 mL) was stirred for 10 h. at 55ο0. The solvent was evaporated in vacuo. The residue 
was dissolved in EtOAc and successively washed with water, saturated NH4CI, and brine. The organic 
layer was dried (MgS04) and the solvent evaporated in vacuo. The crude reaction product was 
subjected to column chromatography (CHC13) to give 3.94 g (85%) of 32a. Oil; Rf 0.38 (EtOAc/n-hexane, 1/1, v/v); [a ] 2 V8 6 (c=1.85, methanol), CIMS 100 eV) m/z (relative intensity) 424 
([Μ+1Γ, 27), 368 (34), 338 (8), 324 (15), 189 ( [ С ц Н ^ О Г , 47), 144 ( [ С щ Н ^ Г , 100), 130 
([CçHgNr, 72), 57 ([C4H9]+, 89); Ή NMR δ 8.06 (br s, IH, NH), 7.63-7.00 (m, 5H, indole C(2)H and 
C(4)-C(7)H), 6.08 (br s, IH, HNO), 5.91 (br d, IH, NHBOC), 4.82 (s, 2H, OObS). 4.71-4.51 (m, IH, 
CHCOOMe), 3.71 (s, 3H, OCH3), 3.37-2.82 (m, 6H, indole C(3)-CH2CH2 and CHCH2S), 1.41 (s, 9H, 
С(СНз)з). 
Compound 32b 
Following the same procedure as described for 32a with 29b (6.2 g, 10.9 mmol), Bu4NCl (9 g, 33 
mmol) and KF.2H20 (4.1 g, 44 mmol) in dry acetonitrile (200 mL) gave after column chromatography (CHCI3) 4.00 g (86%) of 32b: [a]2 2 D+91 (c=3.2, methanol); Further spectroscopic data are identical 
with 32a. 
Compound 33 
Following the same procedure as described for 32a with 30 (2.25 g, 3.75 mmol), BU4NCI (3.07 g, 
11.25 mmol) and KF.2H20 (1.4 g, 15 mmol) gave after column chromatography (CHCtyMeOH, 99/1, 
v/v) 1.38 g (81%) of 33. Oil; Rf 0.42 (CHClj/MeOH, 97/3, v/v); [a] 2 2 D+5 8 (c=4.5, methanol); CIMS 
100 eV) m/z (relative intensity) 454 ([M+l]+, 9), 453 (M+, 3), 398 (18), 354 (12), 219 (28), 191 (33), 
174 ([C
u
H1 2NO]+, 100), 160 ([C1()H10NO]+, 54); 'H NMR δ 8.02 (br s, IH, NH), 7.26 (d, IH, C(7)H) 
7.09-6.80 (m, 3H, C(2), C(4) and C(6)H), 6.11 (br s, IH, HNO), 5.94 (br d, IH, NHBOC), 4.90 and 
4.85 (AB spectrum, 2H, 2J=11.9 Hz, OCH2S), 4.68-4.51 (m, IH, CHCOOMe), 3.86 (s, 3H, OCH3), 
3.71 (s, 3H, COOCH3), 3.41-2.90 (m, 6H, indole C(3)-CH2CH2 and CHCH2S), 1.44 (s, 9H, С(СНз)з). 
Cyclization Attempt of 31 
Compound 35 
A solution of 31 (110 mg, 0.25 mmol), TFA (114 mg, 1 mmol) in dichloromethane (12 mL) was 
stirred for 2 days. The reaction mixture was washed with 0.1 N NaHC03 and brine. The organic layer 
was dried (Na2S04) and evaporated in vacuo. The residue was subjected to column chromatography (CHCI3) to give unidentified products, 28 mg (25%) starting material (31) and 21 mg (24%) 
diastereomer a and 21 mg (24%) diastereomer b of 35. 
diastereomer a: CIMS (100 eV) m/z (relative intensity) 352 ([M+l]+, 23), 320 (56), 189 
([CnH^NjOr, 39), 176 (100), 144 ([CioH10N]+, 65), 130 ([C9H8N]+, 88); »H NMR δ 8.27 (br s, IH, 
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indole NH), 7.67-7.03 (m, 5H, C(2), C(4)-C(7)H), 6.46 (br s, IH, NH), 6.21 (br s, IH, HNO), 5.37 (d, 
IH, J=6Hz, ОСЩОМе)), 4.90 and 4.81 (AB spectrum, 2H, 2J=12Hz, OCH2S), 3.92 (m, IH, 
NCHCH2), 3.49 (s, 3H, OCH3), 3.31 (t, 2H, CH2NO), 3.08-2.68 (m, 4H, NCHCH2, indole Ctfi-CH^. 
diastereomer b: CIMS (100 eV) m/z (relative intensity) 352 ([M+l]+, 18), 320 (41), 189 
([C,iH,3N20]+, 21), 176 (68), 144 ([C10H1()N]+, 88), 130 ([CcHgNr, 100); 1Н NMR δ 8.24 (br s, IH, 
indole NH), 7.64-7.05 (m, 5H, C(2), C(4)-C(7)H), 6.29 (br s, IH, NH), 5.93 (br s, IH, HNO), 5.11 (d, 
IH, J=2.2Hz, OCH(OMe)), 4.88 (s, 2H, OCH2S), 3.71 (br t, IH, NCHCH,), 3.49 (s, 3H, OCH3), 3.32 (t, 2H, CH2NO), 3.04 (t, 2H, indole C(3)-CH2), 2.82-2.51 (m, 2H, NCHCH2). 
General Procedure of Cyclization 
(IR, 13bS)-l-[(tert-Butyloxycarbonyl)ammo]-l,2,7,8,13,13b-hexahydro-[l,6,2]oxathiazepino-
[2',3':l,2]pyrido[3,4-b]indole (37a) and (IR, 13bR)-l-[(icft-Butyloxycarbonyl)amino]-
-l^,7,8,13,13b-hexahydro-tl,6,2]oxathiazepino[2',3,:l^]pyrido[3,4-b]indoIe(38a) 
To a cooled {-IQPC) stirring solution of 32a (2 g, 4.73 mmol) in dichloromethane (200 mL) in an 
argon atmosphere was added dropwise DIB AL (6.5 mL of a 1.5M solution in toluene, diluted with 20 
mL dichloromethane) in 30 min. After completion of the reaction (30 min.) as was monitored by 
HPLC (Waters RCM 8x10, reverse phase, CH3CN/H20, 60/40), the reaction mixture was cooled to 
-90oC and TFA (8 g, 70 mmol) was added at once. After stirring the reaction mixture for 30 minutes it 
was poured into 250 mL of a 0.5 N aqueous HCl solution. The organic layer was separated and the 
water layer washed with dichloromethane. The combined organic layers were washed with water and 
brine. The organic layer was dried (N32804) and the solvent evaporated in vacuo. The residue was 
subjected to column chromatography (EtOAc/n-hexane/ 20/80, v/v) to yield 604 mg (34%) of 37a and 
425 mg (24%) of 38a. 
Compound 37a: Amorphous white solid, crystallization attempts failed; Rf 0.56 (EtOAc/n-hexane, 
1/2, ν/ν); [a]22n+74 (c=2.15, methanol); CIMS (100 eV) m/z (relative intensity) 376 ([M+l]+, 3), 375 
(M+, 6), 344 (7), 232 (10), 202(31), 137(32), 135 (97), 133 (100); 'H NMR (400 MHz) δ 9.98 (br s, 
IH, NH), 7.45-7.42 (m, 2H, C(9)H and C(12)H), 7.18-7.05 (m, 2H, C(10)-C(11)H), 6.24 (br d, IH, 
J=8.6 Hz, HNBOC), 5.26 (d (A part of AB spectrum), IH, 2J=11.4 Hz, C(4)HA), 4.77 (dd,(B part of 
AB spectrum), 2H, 2J=11.4 Hz and J=1.6 Hz, C(4)HB), 4.52-4.49 (m, IH, C(l)H), 4.13 (br s, IH, 
C(13b)H), 3.78 (br d, IH, 2J=14.8 Hz, C(7)H), 3.54 (m, IH, C(2)H), 3.07 (m. IH, C(2)H), 2.96 (m, 
IH, C(7)H), 2.82 (m, IH, C(8)H), 2.77 (m, IH, C(8)H), 1.52 (s, 9H, С(СНз)з); l 3 C NMR (400 MHz) δ 
156.28 (C=0), 136.59 C(12a), 132.57 C(13a), 126.00 C(8b), 121.61 C(ll), 119,21 C(10), 118.00 
C(9), 111.52 C(12), 107.49 CiSa), 80.45 (ОС(Ме)з), 74.84 C(4), 73.44 C(13b), 54.89 C(l), 54.59 
C(7), 32.79 C(2), 28.40 С(СНз)з, 21.14 C(8). 
Compound 38a: mp 214-2160C (EtOAc/n-hexane); Rf 0.40 (EtOAc/n-hexane, 1/2, v/v); [a] 2 2 D +938 (c=1.6, methanol); UV (MeOH) Xmax 224, 273.5(sh), 282, 289.5 nm; CIMS (100 eV) m/z (relative 
intensity) 376 ([M+l]+, 19), 375 (M+, 26), 320 (44), 276 (54), 232 (35), 202 (24), 186 (100), 149 (45), 
57 (50); ХП NMR (400 MHz) δ 8.56 (br s, IH, NH), 7.42 (d, IH, 3J=7.7 Hz, C(12)H), 7.27 (d, IH, 
J=7.7 Hz, C(9)H), 7.10-6.98 (m, 2H, C(10)-C(11)H), 5.69 (br d, IH, J=10.4 Hz), 4.94 and 4.81 (AB 
spectrum, 2H, 2J=9.1 Hz), 4.66 (m, 2H, C(l)H), 4.15 (br s, IH, C(13b)H), 3.60 (m, IH, C(7)H), 3.32 
(d, IH, J=14.5Hz, C(2)H), 3.15 (m, IH, C(7)H), 2.97 (m, IH, C(8)H), 2.83-2.76 (dd, 2H, C(2)H and 
C(8)H), 1.17 (s, 9H, С(СНз)з); Anal. Caled, for C ^ H ^ O j S (Mw 375.427): C, 60.78; H, 6.71; N, 
11.19. Found : C, 60.62; H, 6.60; N,11.02. 
(IS, 13bR)-l-[(/ert-ButyIoxycarbonyl)amino]-l
v
2,73,13,13b-hexahydro-[l,6,2]oxathiazepino-
[2',3':l,2]pyrido[3,4-b]indole (37b) and (IS, 13bS)-l-[(/err-Butyloxycarbonyl)amino]-
-l,2,7,8,13,13b-hexahydro-[l,6,2]oxathiazepino[2',3':l^]pyrido[3,4-b]indole(38b) 
In an analogous fashion 32b (2 g, 4.73 mmol), DIBAL (2 equiv.), and TFA (8 g) gave after column 
chromatography (EtOAc/n-hexane/ 20/80, v/v) 621 mg (35%) of 37b and 327 mg (18%) of 38b. 
Compound 37b: Amorpous white solid; [a] 2 2 D -8 y (c=3.75, methanol). Further spectroscopic data 
are identical with 37a. 
Compound 38b: mp 214-2160C (EtOAc/n-hexane); [a]22D-942 (c=3.8, methanol). Further 
spectroscopic data are identical with 38a. 
(IS, 13bR)-l-[(№rf-Butyloxycarbonyl)amino]-10-methoxy-l^,7,8,13,13b-hexahydro-[l,6,2]oxa-
thiazepino[2',3':l,2]pyrido[3,4-b]indole (40) and (IS, 13bS)-l-[(iert-Butyloxycarbonyl)amino]-
-10-methoxy-l,2,7,8,13,13b-hexahydro-[l ,6,2]oxathiazepino[2'3':l^]pyrido[3,4-b]indole (39) 
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In an analogous fashion 33 (1.25 g, 2.76 mmol), DIB AL (2 equiv.) and TFA (5 mL) gave after 
column chromatography (CHCI3) 637 mg (57%) of 40 and 268 mg (24%) of 39. 
Compound 40: mp 145-1460C (CH^yn-hexane); Rf 0.78 (CHCWn-hexane, 97/3, ν/ν); [α}22
ΰ
-Τί
ι 
(c=5.1, methanol); CIMS (100 eV) m/z (relative intensity) 406 ([M+l]+, 83), 405 (M+, 47), 374 
([M-CH3O]4·, 12), 350 (51), 320 (29), 306 (36), 262 (27), 232 (65), 216 ([C l 2H 1 2N 20]+, 100); »H 
NMR δ 9.82 (br s, IH, NH), 7.32 (dd, IH, J=9.0Hz, C(12)H), 6.89 (s, IH, C(9)H), 6.81 (dd, IH, 
J=9.0Hz, C(ll)H), 6.22 (br d, IH, J=9.1Hz, HNBOC), 5.26 (d (A part of AB spectrum), IH, 
2J=11.4Hz, C(4)HA), 4.80 (dd (B part of AB spectrum), IH, 2J=11.4Hz, J=1.8Hz, C(4)HB), 4.62-4.37 (m, IH, C(l)H), 4.12 (br s, IH, C(13b)H), 3.84 (s, 3H, OCH3), 3.77-3.34 (m, 2H, C(7)H and C(2)H), 
3.22-2.61 (m, 4H, C(7)H, C(2)H and С{%)Щ, 1.49 (s, 9H, CíCH,),); Anal. Caled, for C^^NjC^S 
(Mw 405.518) :C, 59.24; H, 6.71; N, 10.36. Found: С, 59.11; H, 6.74, Ν, 10.31. 
Compound 39: mp 184-220oC (decomp.); Rf 0.53 (CHClj/MeOH, 97/3, v/v); [ccpu-SS3 (c=4.05, 
methanol); CIMS (100 eV) m/z (relative intensity) 406 ([M+l]+, 57), 405 (M+, 44), 350 (51), 320 (17), 
306 (50), 262 (32), 232 (17), 216 ( [ ^ , Η , ^ Ο Γ , 100);^ NMR δ 8.46 (br s, IH, NH), 7.17 (d, IH, 
J=9.0Hz, C(12)H), 6.91-6.71 (m, 2H, C(9)H and C(ll)H), 5.70 (br d, IH, HNBOC), 4.97 and 4.81 ( 
AB spectrum, 2H, 2J=9.0 Hz, C(4)H,), 4.72-4.56 (m, IH, C(l)H), 4.14 (br s, IH, C(13b)H), 3.86 (s, 
3H, OCH3), 3.61 (m, IH, C(7)H), 3.34 (m, IH, C(2)H), 3.13 (m, IH, C(7)H), 2.94 (m, IH, C(8)H), 
2.83-2.76 (m, 2H, C(2)H and C(8)H), 1.20 (s, 9H, С(СНз)з); Anal. Caled, for C20H27N3O4S (Mw 
405.518) :C, 59.24; H, 6.71; N, 10.36. Found: C, 58.99; H, 6.62, N, 10.27 
Removal of the BOC-group 
(lR,13bS)-l-Amino-l,2,7,8,13,13b-hexahydгo-[l,6,2]oxath¡azepίno[2',3, 
:l,2]pyrido[3,4-b]indole (41a) 
A solution of 37a (604 mg, 1.61 mmol), chlorotrimethylsilane (351 mg, 3.22 mmol) and Nal (483. 
mg, 3.22 mmol) in acetonitrile (200 mL) was stirred at room temperature during 3 hours. The solvent 
was evaporated in vacuo, the residue was dissolved in dichloromethane and subsequently washed with 
water and brine. The organic layer was dried (NajSO^ and the solvent evaporated in vacuo. The 
residue was subjected to column chromatography (EtOAc/n-hexane, 1/1, v/v) to yield 423 me (95%) 
of 42a. mp 147-1490C (CH2Cl2/n-hexane); Rf 0.24 (СНСІз/МеОН, 97/3, v/v); [ a ] 2 2 ^ * (c=1.7 
.methanol); CIMS (100 eV) m/z (relative intensity) 276 ([M+l]+, 27), 275 (M+, 20), 232 (21), 203 
(27), 202 (32), 186 (91), 172 (40), 171 (100), 169 (35), 144 (35); Ή NMR (400 MHz) δ 10.05 (br s, 
IH, NH), 7.46 (d, IH, J=7.7 Hz, C(12)H)), 7.32 (d, IH, J=8.1 Hz, C(9)H), 7.15-7.04 (m, 2H, 
C(10)-C(11)H), 4.93 (br s, 2H, C(4)H2), 3.71-3.60 (br d, 3H, C(13b)H, C(1)H and C(7)H), 3.13-2.77 (m, 5H, C(2)H2, C(7)H and C(8)H2), 1.59 (br s, 2H, NH2); 1 3C NMR (400 MHz) δ 135.78 C(12a), 
133.73 C(13a), 126.08 C(8b), 121.28 C(ll), 118.98 COO), 118.06 C(9), 110.98 C(12), 106.79 C(8a), 
73.08 C(4), 69.02 C(13b), 59.70 C(l), 54.98 C(7), 37.97 C(2), 20.81 C(8); Anal. Caled, for 
C ^ H j ^ O S (Mw 275.374): C, 61.06; H, 6.22; N, 15.26. Found: С, 60.99; H, 6.10; Ν, 15.11. 
(-)-Debromo-eudistomin L ((-)-le) 
Following the same procedure as described for 37a with 38b (327 mg, 0.87 mmol), 
chlorotrimethylsilane (190 mg, 1.74 mmol) and Nal (260 mg, 1.74 mmol) gave after column 
chromatography (СНСІз/МеОН, 98/2, v/v) 225 mg (94%) of le.: Amorphous white solid; 
Crystallization attempts were unsuccessful; Rf 0.06 (СНСІз/МеОН, 97/3, v/v); [a]22p -1153 (c=3.0, 
methanol); UV (MeOH) Xmax 223, 273.5(sh), 282, 289 nm; CIMS (100 eV) m/z (relative intensity) 
276 ([M+l]+, 3), 275 (M+, 1), 232 (11), 231 (14), 212 (19), 211 (21), 203 (82), 202 (100), 186 (34), 
172 (22), 171 (32), 169 (37), 144 (44); ГН NMR (400 MHz) δ 8.33 (br s, IH, NH), 7.47 (d, IH, J=7.6 
Hz, C(12)H), 7.32 (d, IH, J=8.0 Hz, C(9)H), 7.17-7.13 (m, 2H, C(10)-C(11)H), 4.92 and 4.80 (AB 
spectrum, 2H, 2J=9.0 Hz, C(4)H2), 4.08 (br s, IH, C(13b)H), 3.57 (m, IH, C(7)H), 3.51 (br s, IH, 
C(l)H), 3.31 (d, IH, 2J=14.4Hz, C(2)H), 3.13 (m, IH, C(7)H), 2.94 (m, IH, C(8)H), 2.84 (dd, IH, 
2J=14.3Hz, J=5.7Hz, C(2)H), 2.81 (m, IH, C(8)H), 1.85 (br s, 2H, NH2); l 3 C NMR (400 MHz) δ 
136.90 C(12a), 130.67 C( 13a), 126.32 C(8b), 122.13 C(ll), 119.82 CÜO), 118.26 C(9), 111.16C(12), 
110.96 C(8a), 71.36 C(4), 69.93 C(13b), 53.98 C(7), 50.73 C(l), 33.99 C(2), 20.67 C(8). 
(lS,13bR)-l-Amino-l,2,7,8,13,13b-hexahydro-[l,6,2]oxathiazepino[2',3' 
:U]pyrido[3,4-b]mdole (41b) 
Following the same procedure as described for 37a with 37b (621 mg, 1.66 mmol), 
chlorotrimethylsilane (362 mg, 3.32 mmol) and Nal (500 mg, 3.32 mmol) gave after column 
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chromatography (EtOAc/n-hexane, 1/1, v/v) 404 mg (89%) of 41b. mp 146-1490C 
(СН2СІ2/п-Ьехапе); [α]22]} +232 (c=3.8, methanol). Further spectroscopic data are identical with 41a. 
(+)-Debromo-eudistomin L ((+)-le) 
Following the same procedure as described for 37a with 38a (425 mg, 1.13 mmol), 
chlorotrimethylsilane (246 mg, 2.26 mmol) and Nal (340 mg, 2.26 mmol) gave after column 
chromatography (СНСІз/МеОН, 98/2, v/v) 303 mg (98%) of (+)-le. Amorphous white solid; 
Crystallization attempts were unsuccessful; [ a p o + l l l 4 (c=2.1 .methanol). Further spectroscopic data 
are identical with (-)-le. 
(IS, 13bS)-l-Amino-10-methoxy-l,2,7,8,13,13b-hexahydro-[l,6^]oxathiazepino[2'3':l
r
2]-
pyrido[3,4-b]indole ((-HO 
Following the same procedure as described for 37a with 39 (155 mg, 0.38 mmol), 
chlorotrimethylsilane (83 mg, 0.76 mmol) and Nal (114 mg, 0.76 mmol) gave after column 
chromatography (CHCtyMeOH, 99/1, v/v) 111 mg (95%) of (-)-lf·; Amorphous white solid; 
Crystallization attempts were unsuccessful; Rf 0.36 (CHClj/MeOH, 93/7, v/v); [a]22D-766 (c=2.7, 
methanol); CIMS (100 eV) m/z (relative intensity) 306 ([M+l]+, 13), 276 (37), 232 (100), 216 
([Ci2H1 2N202]+, 19), 201 (49), 200([C12H12N2O]+, 22), 199 (20), 174 (30); Ή NMR (400 MHz) δ 
8.22 (br s, IH, NH), 7.19 (d, IH, J=9.0Hz) C(12)H), 6.92-6.76 (m, 2H, C(9)H and C(ll)H), 4.93 and 
4.81 (AB spectrum, 2H, 2J=9.0 Hz, C(4)H2), 4.06 (br s, IH, C(13b)H), 3.83 (s, 3H, OCHj), 3.56 (m, 
IH, C(7)H), 3.42 (m, IH, C(l)H), 3.27 (m, IH, C(2)H), 3.09 (m, IH, C(7)H), 2.95 (m, IH, C(8)H), 
2.83 (dd, IH, C(2)H), 2.81 (m, IH, C(8)H), 1.87 (br s, 2H, NH2). 
(ÍS, 13bR)-l-Amino-10-methoxy-l,2,7,8,13,13b-hexahydrHl,6,2]oxathiazepino[2'r3':l,2]-
pyrido[3,4-b]indole (42) 
Following the same procedure as described for 37a with 40 (110 mg, 0.27 mmol), 
chlorotrimethylsilane (59 mg, 0.54 mmol) and Nal (81 mg, 0.54 mmol) gave after column 
chromatography (EtOAc/n-hexane, 40/60, v/v) 65 mg (78%) of 42. Crystallized from 
CH2Cl2/n-hexane: mp 104-105oC; Rf 0.24 (CHClj/MeOH, 93/7, v/v); [a]22D+3o(c=2.0, methanol); 
CIMS (100 eV) m/z (relative intensity) 306 ([M+l]+, 48), 262 (30), 233 (38), 232 (54), 216 
([C12H12N202]+, 100), 201 (95), 200([C12H12N2O]+, 51), 199 (35); Ή NMR (400 MHz) δ 9.87 (br s, 
IH, NH), 7.23 (d, IH, J=9.0Hz, C(12)H)), 6.94-6.73 (m, 2H, C(9)H and C(ll)H), 4.94 (br s, 2H, 
C(4)H2), 3.87 (s, 3H, OCH3), 3.77-3.51 (br m, 3H, C(13b)H, C(1)H and C(7)H), 3.13-2.77 (m, 5H, 
C(2)H2, C(7)H and C(8)H2), 1.69 (br s, 2H, NH2). 
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CHAPTER 8 
Structure -activity relationship (SAR) studies 
"Structure-activity relationship studies ofN-hydroxy(alkoxy)tryptamine derivatives on the serotonin-
and tryptamine receptors.", Pedro H.H. Hermkens, Jan H. v. Maarseveen, Martin Th. M. Tulp, Hans 
W. Scheeren, Chris G. Kruse, in preparation. 
"Structure-actvity relationship studies of eudistomin derivatives on antitumour and antiviral activities. 
Pedro H.H. Hermkens, Jan H. v. Maarseveen, Peter Lelieveld, Eric De Clercq, Jan Balzarmi, Chris G. 
Kruse, Hans W. Scheeren, in preparation. 
138 Chapter 8.1 
Chapter 8.1 
STRUCTURE-ACTIVITY RELATIONSHIP (SAR) STUDIES OF N-OXY-TRYPTAMINES 
AND N-OXY-^-CARBOLINES ON BENZODIAZEPINE-, SEROTONIN- AND TRYPTAMINE-
RECEPTORS 
8.1.1 Introduction 
Tetrahydro-ß-carboline (THBC) and ß-carboline derivatives have been detected in human and rat 
tissues and body fluids1. In man they were mainly found in plasma and platelets. Considerable 
differences in concentration of some ß-carbolines were reported, even by the same group of 
investigators, which could be due to artifactual formation of ß-carbolines during the work-up 
procedures. Some doubt still exists as to their physiological occurrence, because these compounds 
are very easily formed from formaldehyde and indoleamines. Anyhow, despite the question whether 
the ß-carbolines are endogenous substances, they are interesting because they show a very broad 
pharmacological profile. 
Monoamine oxidase (MAO) is the principal enzyme concerned with the inactivation of serotonin 
(5-HT) and other neurotransmitters. It has been demonstrated2 that ß-carbolines and THBC are 
potent and selective MAO-inhibitors. It has also been observed3 that ß-carbolines increase 5-HT 
concentrations probably by 5-HT reuptake inhibition. Furthermore, ß-carbolines show variable 
affinity for the benzodiazepine-4, serotonin-5 and tryptamine6 receptors. 
It is obvious that these compounds are of major pharmacological interest. Because virtually nothing 
is known about the pharmacology of N(2)-hydroxy(alkoxy)-tetrahydro- and N(2)-oxo-ß-carboline 
derivatives and the corresponding N-hydroxy(alkoxy)tryptamines, from which they are prepared, it 
was interesting to subject these compounds to a first pharmacologocal screening. In our view the 
benzodiazepine-, serotonin- and tryptamine-receptors were the most logical choice. 
Benzodiazepine receptor 
It is generally accepted that the postsynaptic (γ-aminobutyric acid) GABAA-receptor is a tetrameric 
membrane protein complex, consisting of very similar protomers (subunits). The quaternary 
structure enables the formation of a CI* ionophore that can close and open in response to small 
conformational changes in the subunits. The subunits are proposed to have at least three domains 
with different functions i.e. GABA-binding sites, binding sites for benzodiazepines (BZ) or 
ß-carbolines and sites which bind picrotoxin and barbiturates (Figure I)7·8. At receptor level in vitro 
studies have shown that BZ agonists enhance the binding of GABA to its receptor, inverse agonists 
inhibit GABA binding while antagonists, which reverse both of these effects, have no influence on 
GABA binding. The reverse effect, that is binding of the ligands to the BZR in the presence of 
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agonists 
antagonists 
inverse agonists' 
chloride channel 
barbituratesi 
BARBI picrotoxinin ί 
chloride channel agents 
GABA agonists 
GABA antagonists 
Fig 1 Schemabc model of a subumt of the postsynaptic ОАВАд receptor 
The mam funbon of the complex is the GABA-induced gating (opening) of the CI" 
channel (large arrow), with the regulaton of this gating process by BZ agonists 
and inverse agonists (medium arrow), and regulation of CI channel properties 
by ligands like Picrotoxin and barbiturates (dotted arrow) 
GABA, follows the same pattern; the affinity of agonists is enhanced by GABA, the affinity of 
inverse agonists is decreased in the presence of GABA, and there is no effect of GABA on the 
affinity of antagonists. Some barbiturates and other agents, likewise thought to interact directly with 
chloride channels, enhance the affinity of agonists to the BZR9. It has been postulated that these 
differences in activity are due to conformational changes effected at the BZR by the various ligands 
(Figure 2)7·8 '1 0·1 1. Stimulation of the GABA receptor induces a conformational change which 
inverse agonist 
CONFORMATION 1 
positive efficacy 
a) activated 
open CI channel 
b) enhances GABA 
c) anxiolytic 
CONFORMATION 2 
a) no conformational 
changes from BZR 
b) no effect on GABA 
c) no biological effect 
CONFORMATION 3 
negative efficacy 
a) actvated 
dosed CI channel 
b) inhibits GABA 
c) anxiogène 
Fig. 2 Proposed model for interactions of Agonist, Antagonist 
and Inverse Agonist Ugands at the BZR 
triggers the opening of chloride channels; the benzodiazepine receptor is suggested to operate as a 
coupling unit between the GABA receptor and the chloride channel. Benzodiazepine agonists 
enhance, inverse agonists reduce the coupling function. 
The BZR ligands are thought to comprise a continuous spectrum of agents with a graduated range 
of pharmacological efficacies at the receptor: (1) full inverse agonists (negative efficacy; 
anxiogenic/convulsant), (2) partial inverse agonists (intermediate negative efficacy; proconvulsant), 
(3) pure antagonists (nil efficacy; antagonism toward the other classes), (4) partial agonists, and (5) 
full agonists (positive efficacy; anxiolytic/anticonvulsant)11,12. This spectrum of differing efficacy 
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has been most clearly demonstrated in the ß-carbolines (Chart I)12"14. It was proposed that such 
Chan I 
COOR3 
1 
a 
b 
с 
d 
β 
Ra 
Et 
Et 
Et 
Et 
Me 
R4 
CHJOCHJ 
СН2ОСНз 
Me 
Η 
Et 
n5 
Η 
OBn 
ОСН(М )
г 
Η 
Η 
Re 
OBn 
Η 
Η 
Η 
OMe 
R7 type of efficacy 
Η 5 
Η 4 
Η 3 
Η 2 
OMe 1 
ß-carbolines, which were isolated from human urine and brain tissue compose part of the 
endogenous ligand structure of the BZR4·15·16. 
So the ß-carboline structure might become an important basis for the design of new 
benzodiazepine-related drugs. Studies on structure-activity relationships (SAR)17 have demonstrated 
that 3,4-dihydro-, or tetrahydro-ß-carbolines showed decreased activity compared to the 
corresponding fully aromatic compounds. Introduction of functionalities at positions C(l) and/or 
N(9) results in loss of activity. At position 3 the presence of ester groups is fundamental for an 
optimal drug-receptor interaction. The 3,4-dihydro-N(2)-oxide analogue of Id causes a drop in 
activity, though the fully aromatic analogue still preserves an appreciable affinity towards the 
receptor18. 
In order to study the effect of the presence of functional groups at C(l) and/or N(2) on the activity 
of ß-carbolines we prepared 1,3-disubstituted N(2)-oxy-l,2,3,4-tetrahydro-ß-carbolines (chapters 5 
and 6) and 1, and/or 3-substituted N(2)-oxo-3,4-dihydro-ß-carbolines (chapter 3) and investigated 
their affinity towards the benzodiazepine receptor. 
Serotonin receptor 
Appetite, memory, thermoregulation, sleep, sexual behaviour, anxiety, depression, and 
hallucinogenic behaviour are some of the processes that have been linked with the neurotransmitter 
serotonin (5-hydroxytTyptamine=5-HT;2, Chart II). With the recent discovery of multiple 
populations of central serotonin binding sites (i.e. 5-HT1A, 5-HT1B, 5-НТ1С, 5-HT1D, 5-HT2 and 
5-HT3 sites) has come a renewed interest in this neurotransmitter, particularly in light of the 
possibility that its interaction with different types of central sites might explain its various actions.19 
One of the most significant problems facing serotonin research today is a lack of site-selective 
agonists and antagonists; a continued lack of such tools will surely retard further advances in this 
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Xx NH, MeO. 
X 
2: R,=H, ^ O H 5: β-ΟΗ-DPAT 6: mCCP 7 : X-l (DOI) 
3: R,=CH3, R2=OH 8 : X=Me (DOM) 
4 R^H, R2=CH2S02NHMe 9:X=Br(DOB) 
EXjfiOC Co .o-
° ОЗУ 
CHj 
11 : Ketanserin 12 : Ondanselron 
field. By adapting the chemical struture of 5-HT, scientists have synthesized analogous molecules, 
which act by triggering or blocking only specific types of receptors. This selectivity of 5-HT drugs 
means that they have no apparent side-effects. Some of the structural classes currently being 
explored as central 5-HT agonists and antagonists are indolylalkylamines (e.g. 5-HT;2, 
2-Me-5-HT;3, sumatriptan^), aminotetralins (e.g. 8-OH-DPAT;5), arylpiperazines (e.g. mCCP;6), 
phenylalkylamines (e.g. DOI;7, DOM;8, and DOB;9), ergolines (e.g. LSD;10), alkylpiperidines (e.g. 
ketanserin; 11) and carbazole derivatives (e.g. ondansetron; 12) (Chart II)1 9. 
Our first goal is to compare the indolylalkylhydroxyl(alkoxy)amines (chapter 2) with 
indolylalkylamines in order to study the influence of the oxygen adjacent to the nitrogen. Secondly, 
because the ß-carbolines are composed of an indolylalkylamine backbone, and because several 
derivatives (harmine, harmaline and related compounds e.g. 13)5 showed moderate affinity for the 
R2=OH, OMe 
Ring C'Aromatic 
or Not-Aromatic 
13 
5-HT receptor we also studied the affinity and selectivity of several N-oxy-l,2,3,4-tetrahydro-ß-
carbolines (chapters 5 and 6). 
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Tryptamine receptor 
The functional role of tryptamine in the CNS is not clearly defined at the present time. Recently it 
has been suggested that the most consistent feature of this amine is the potentiation of 5-HT, 
presumably via a postsynaptic action. However, a synaptic action independent from 5-HT cannot be 
excluded at this time. It has been clearly demonstrated by competition experiments that the 
tryptamine binding sites are distinct from 5-HT or catecholamine receptors. 
ß-Carbolines of the harman-famile (e.g. 13) showed a high affinity for the tryptamine receptor*. 
Therefore, it was of interest to examine whether N(2)-oxy-ß-carbolines (chapters 5 and 6) has any 
affinity for this receptor. 
8.1.2 Receptor Binding Assays 
Receptor binding assays were performed as reported earlier (see Table I) at Duphar Research 
Table I. Receptor binding methodology. 
Receptor 
benzodiazepine 
5-HT1A 
5-HT1B 
5-HT1c 
5-HT1D 
5-HT2 
5-HT3 
tryptamine 
GABAA 
Tissue» 
total brain 
frontal cortex 
frontal cortex 
chonod plexusb 
n.caudatec 
frontal cortex 
nb-g cellsd 
cerebal cortex 
cerebellum 
[3H]-Llgand 
diazepam 
8-OH-DPAT 
serotonin6 
serotonin 
serotonin9 
spiperone 
GR 38032F 
tryptamine 
DH-Muscimol 
Reference 
20 
21 
22 
23 
24 
25 
26' 
27 
28 
a) Rat b) Pig c) Bovine d) Cultivated mouse neuroblastoma-glioma cells 
e) In these assays 3 IO"8» unlabelled 8-OH-DPAT and 3 10""M DOI are added to 
the incubation medium in order to block 5-HT1A and 5-HT1c receptors, respectively 
I) Method identical to this reference, except [3H] GR 38032F was used as ligand, 
rather than (3H] ICS205.930 
Laboratories, Weesp. Ability of the compounds to displace the [3H]-ligand from the tissue 
homogenates was than measured, as an indication of their affinity for the corresponding receptors. 
N-oxy-tryptamines 
Over the past two decades, considerable synthetic and pharmacological effort has been directed to 
'fine-tuning' studies of hallucinogenic phenethylamines and tryptamines. 
The basic goal of this research was to gain a better understanding of the structure-activity 
relationships of these substances with respect to the serotonin- and tryptamine-receptors. Within the 
indolylalkylamine family the major chemical alterations have involved changes in the amine alkyl 
substituents. This has been partly due to the relative ease of synthetic manipulations at this site and 
also because substantial biological differences can be attributed to even minor changes in these 
substituents. Only recently a new selective drug has been introduced, which is an 5-HT analogue 
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with a different, aromatic substituent. Sumatriptan (4), a 5-HTj-like agonist, looks promising in 
treatment of migraine29. 
In contrast, little is known about N-oxy tryptamine derivatives. Earlier publications reported that 
l-(3-mdolyl)-2-hydroxylaminopropane causes no significant inhibition of monoamine oxidase while 
l-(3-indolyl)-2-aminopropane is a potent inhibitor of this enzyme30. However, the observation that in 
the rabbit and the guinea-pig liver, tryptamine was converted in ß-(3-indolyl)ethylhydroxylaniine31 
promted us to investigate the N-oxy tryptamines. For this reason we measured the affinity of several 
N-hydroxy- and N-methoxytryptamine derivatives (chapter 2) for the serotonin- and 
tryptamine-receptors and compared these values with those of the corresponding tryptamine- and 
N-methylated tryptamine-derivatives (Table II). We considered three classes i.e. N-substituted 
tryptamines (entries 1-5), N-substituted 5-methoxytryptamines (entries 6-9) and α-substituted 
tryptamines (entries 10-13). 
Table II. Radioligand Binding Data for tryptamine and N-oxy-tryptamme derivatives8. 
Entry 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
«1 
H 
H 
H 
H 
H 
OH 
OMe 
OMe 
OMe 
H 
H 
H 
H 
R2 
H 
H 
H 
H 
H 
H 
H 
H 
H 
Me" 
Meb 
Meb 
Phb 
Rs 
H 
Me 
Me 
H 
H 
H 
H 
Me 
H 
H 
H 
H 
H 
R v ^ ^ 
Y jr 
H 
R4 
H 
H 
Me 
OH 
OMe 
H 
H 
Me 
OH 
H 
OH 
OMe 
OH 
^ 
^ Ra 
r-"2 I 
1 affinity, ρΚι | 
5-HT1A 
710 
7.21 
6 85 
5 4 
483 
8 38 
8 51 
8 20 
7 00 
5 78 
<6 2 
<6 2 
<6 2 
5-HT1B 
7 32 
6 95 
6 36 
619 
464 
8 61 
7 98 
7.07 
5 65 
<6 2 
<6 2 
5-НТ1С 
7.78 
6 69 
6 47 
711 
4.12 
8 37 
8 05 
7 69 
7 20 
7 27 
5 23 
444 
<6 3 
5-HT10 
7 24 
7 18 
634 
<6 2 
368 
8 46 
8 30 
7.41 
6 90 
5 40 
<6 2 
<6 2 
5-HT2 
5 5 4 
5 69 
5 80 
<6 2 
4 19 
S 69 
5 94 
564 
<5 2 
5 42 
<5 2 
<6 2 
4 59 
5-НТэ 
<5.14 
4.78 
5.43 
<6 11 
<611 
644 
<514 
<5 14 
<61 
5.13 
<6 11 
<61 
trypt 
8 21 
6 08 
5 50 
6 66 
5 25 
5 81 
6 42 
<5 09 
<61 
7 50 
4.66 
4 1 
<61 
a) Ail values represent the mean of two or three determinations b) racemic mixtures 
In the first class, methyl substitution at the nitrogen of tryptamine reduces the affinity for the 
tryptamine receptor substantially, while for the serotonin 5-HTj receptors there is a moderate 
decrease in affinity (entnes 1-3). Therefore the decrease in affinity of N-hydroxytiyptamine for the 
tryptamine receptor (entry 4) can be ascribed to steric hindrance. Since the affinity of the 5-HT1A, 
5-HT1B and 5-HT1D receptors is significant lower than the affinity of the N-methyl analogues 
electronic influences must play an important role. Surprisingly, the affinity for the 5-HT,
c
 receptor 
is hardly affected and therefore N-hydroxytryptamine is a relatively selective ligand for the 5-HTIC 
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receptor. At this moment it is not known whether this ligand has agonistic or antagonistic properties 
at this receptor. N-methoxytryptamine (entry 5) has no affinity for the serotonin and tryptamine 
receptors. Especially, the lost in affinity for the 5-HTlc receptor is of interest, because electronic 
rather than steric effects must be the reason for this. 
In the second class, serotonin and 5-methoxytiyptamine show high affinities for the 5-HT1 
receptors (entries 6,7). Nitrogen alkylation (entry 8) has no influence on the affinity for the 5-HT1A 
receptor, while there is a noticeable decrease in affinity for the remaining S-HTj receptors. The 
decrease in affinity of S-methoxy-N-hydroxytryptamine (entry 9) for the 5-HT1A receptor and for the 
remaining 5-HT! receptors is probably the result of electronic effects. Selectivity for this ligand is 
out of the question, because the affinities for the S-HTj receptors are comparable. 
In the third class, we see that ct-methyltryptamine (enöy 10) has a selectivity for the 5-HTlc- and 
the tryptamine receptor. For the N-Hydroxy- and N-methoxy analogues the affinity for these 
receptors is abolished (entries 11-12). Whether electronic or steric factors are responsible for this 
decrease is yet unknown. a-Phenyl-N-hydroxytryptamine (entry 13) likewise shows no affinity for 
the serotonin- and tryptamine-receptors. 
In conclusion, it can be said that introduction of a hydroxy or methoxy function at the nitrogen 
decreases the affinity for the tryptamine receptor due to steric factors. For the 5-HT! receptors there 
is a decrease of affinity due to electronic factors. These effects are stronger for the 5-HT1A, 5-HT1B 
and 5-HT1D than for the 5-НТ1С receptor. The electron density on the nitrogen decreases in the row 
N-methyltryptamine > tryptamine » cc-methyltryptamine > N-hydroxytiyptamine > 
N-methoxytryptamine32. With decreasing electron density also the net contribution of this nitrogen 
for receptor binding will decrease, though the 5-HT l c receptor is the least critical. 
N-hydroxytryptamine is a relatively selective substrate for this receptor. 
N(2)-Oxo-1 -and/or 3-substituted-3,4-dihydro-fi-carbolines (Table III). 
The earlier observed18 considerable affinity of 2-oxo-3-(ethoxycarbonyl)-3,4-(iihydro-p-carboline 
(Entry 1) for the BZR did us decide to study this class of compounds (chapter 3.1) in more detail. 
Therefore we prepared the 5-chloro- and 6-chloro analogues of this compound (Entries 2,3). The 
observed affinities (pKi's of 7.67 and 7.81, respectively) were very high for this type of not-aromatic 
dihydro-ß-carbolines. Because of an inconsistency in the SAR of the nitrile cycloadducts (vide infra) 
we studied these compounds in more detail. It had already been reported33 that these nitrones very 
easily decompose to 3-(ethoxycarbonyl)-ß-carboline (ß-CCE; ld) of which it is known that it is a 
potent inhibitor of the specific binding of [3HJ-diazepam to its brain receptors. Therefore it seemed 
obvious to determine if ß-CCE formation might take place during the formulation of the samples. By 
means of a quantitative TLC determination method we were able to establish that decomposition of 
the nitrones (entries 1-3) takes place indeed and that the resulting ß-CCE analogues were responsible 
for the observed affinity and not the parent compounds. 
The 3-methyl nitrones (entries 4,5) did not decompose to the corresponding aromatic ß-carbolines 
and no affinity was observed for the BZR. This is in agreement with known SAR for this receptor 
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Table III. Radioligand Binding Data (ot N(2)-oxo-3,4-dihydro-ß-carbolines 
R2fì ^ 
H R, 
Entry 
1 
2 
3 
4 
5 
Ri 
H 
H 
H 
H 
Ph 
R2 
H 
5-CI 
6-CI 
H 
H 
a) All values represent the mean о 
is a result ol formation of the cone 
«3 
COOEt 
COOEt 
COOEt 
CH3 
CHg 
BZ 
6.68b 
7.67b 
7.81 ь 
<6.1 
<6.1 
iftinitV DKi 
5-HT1A 
<6.2 
<6.2 
<6.2 
<6.2 
S-HT2 
<6.3 
<5.3 
<5.3 
<5.2 
<5.2 
two or three determinations b) The observed altinity 
spending aromatic ß-carbolme during the formulation. 
a 
i.e. the aromatic character and the presence of an ester group at position 3 are essential. 
All the nitrones (entries 1-5) showed no specific inhibition of the binding of the [3H]-ligand to the 
5-HT1A and 5-HT2 receptor. 
Nitrile cycloadducts (Table IV). 
Initially, very high affinities for the BZR were found for some of the nitrile cycloadducts (chapter 
3.2)(entries 1-16). However, an inconsistency in the SAR made us suspicious. Therefore we 
examined the adducts on their stability. We found that that the cycloadducts partially decomposed to 
give ß-CCE and the corresponding amides when they were kept at вСУС for 2 days (Scheme I) 3 4 . By 
Scheme I 
H N = / 
COOEt a_ ^ C O O E t c 
means of a quantitative TLC determination method we established that ß-CCE formation took also 
place during the formulation of the samples. We were able to measure that the decomposition of the 
cycloadducts resulting in ß-CCE analogues was responsible for the observed affinity and not the 
parent compounds. 
All the adducts (entries 1-16) showed no affinity for the 5-HT1A and 5-HT2 receptor (pKi<6.2 and 
pKi<5.3, respectively). 
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Table IV. Nitrile cvcloadducls 
Entry 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
^ 4 
Ri 
H 
H 
H 
H 
H 
H 
H 
H 
SMe 
Ph 
H 
^ ^ ^ .COOR, 
Vts 
H 
R2 
Ph 
Ph 
Ph 
p-CI-Ph 
p-F--Ph 
Ph 
Ph 
Ph 
SMe 
Ph 
2-furanyl 
"V' 
NC Rj 
Ra 
H 
9-OMe 
H 
H 
H 
H 
7-CI 
e-ci 
H 
H 
H 
R4 
El 
Et 
Bn 
Et 
Et 
Me 
Et 
Et 
Et 
Et 
Et 
Entry 
12 
13 
14 
15 
16 
" ^ N u ^^v^COOEt 
-AK 
H N = / 
Ri 
Me 
Bn 
Me 
Me 
R2 
Me 
Bn 
Me 
Me 
-(CH2)4-
Ra 
CN 
CN 
EtOOC 
NO, 
CN 
1- and/or S-Substimted N-oxy-1,2,3,4-mrahydro-$-carboIines (Table V). 
Subsequently, we investigated the hitherto unknown N(2)-oxy-l,2,3,4-tetrahydro-ß-carbolines 
(chapter 5) presented in Table V on their receptor affinity. 
For all the compounds tested (entries 1-27) there was no high affinity for the binding-sites of the 
benzodiazepine (pKi<6.1), 5-HT1A (pKi<6.2), 5-ΗΤ1Β (pKi<6.2), 5-HT2 (pKi<5.2) and tryptamine 
receptor (pKi<6.1). No specific inhibition of [3H]-serotonin binding at the 5-HT lc receptor was 
observed in the case of entries 2, 10 and 11. 
Although no specific inhibition was observed for [3H]-diazepam binding, we observed that some of 
the ß-carbolines with a phenyl group at position 1 (entries 3, 4, 5 , 10 and 11), caused a potentiation 
of binding of this ligand (See Figure 3). This is a known phenomenon in the presence of a GABA 
agonist. Although, the level of stimulation of the compounds of entry 3, 4, 5 and 10 is mediate, that 
of trans l-phenyl-2-hydroxy-3-phenyl-l,2,3,4-tetrahydro-ß-carboline (entry 11) is comparable with 
that of GABA (see figure 3). This potentiation of a BZ agonist by ß-carbolines has not been 
described before. Our first hypothesis was that these types of ß-carbolines therefore should act as 
GABA agonists. However, they did not show any specific inhibition of [3H]-DH-muscimol binding, 
the ligand of the the GABA receptor. Therefore the affinity site must lay somewhere else. A 
possibility is that this type of ß-carbolines have an affinity for the barbiturate receptor, as some 
barbiturates are known to enhance the affinity for agonists to the BZR9. Another rational is that they 
directly interfere with the chloride channel protein or picrotoxinin sites. Although, the mechanism of 
action at this point is uncertain yet, we believe that a more detailed study is of interest. 
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Table V. 1- and/or 3-Substituted-N-oxy-
Entry 
1 
2 
3 
4 
5 
6 
7 
β 
9 
10 
11 
12 
13 
14 
Ri 
Η 
Me 
Η 
R2 
COOEt 
СОМНСзН5 
CONHMe 
Ph 
Me 
COOEt 
Из 
Η 
Me 
i-Pr 
n-Bu 
Η 
,2,3,4-tetrahydro-p-carbolines. 
^Р^ 
Осе 
Ri 
R4 
Ph 
2-lhienyl 
0,-0, 
els 
trans 
trans 
trans 
cis 
trans 
cis 
trans 
trans 
els 
trans 
cis 
trans 
cis 
- ^ ^ " г 
Y V0R3 
R4 
Entry 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
Ri 
H 
R2 
COOEt 
Me 
COOEt 
Ph 
H 
R3 
H 
П4 
2-thienyl 
3.4,5-С6Нг(ОМв)э 
Me 
n-Pr 
Benzyl 
Me 
Me 
с,-Сэ 
trans 
cis 
trans 
cis 
trans 
cis 
trans 
cis 
trans 
cis 
trans 
cis 
% specific binding 
[3H]-diazepam 
seo 
200 
160 
100 
• diazepam 
+ GABA 
* entry 11 
• entry 10 
Fig. 3 Potentiation curve of [3H]-diazepam binding 
- 4 - 2 0 
—»- log (drug concentration) 
An application of this observed potentiation might be that the doses of the benzodiazepine 
constituent in a combination-drug of these ß-carbolines and bezodiazepines, would lead to a decrease 
of the required amount of the tranquilizer. 
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Tetracyclic N-oxo-$-carbolines (Table VI) 
Although, the N-carbon tetracyclic-ß-carbokne is a structural feature present in many indole 
alkaloids (j e yohimbine (17) and corynantheine (18)), with interesting pharmacological activities, 
the N-oxo analogues 14-16 show no specific inhibition of the [3H]-ligand binding at the 
Chart II 
14: R=COOE1, H(6)a, H(12b)a 
15: R=COOEt, H(6)a, H(12b)ß 
16: R=H 
MeOOC 
17 
MeOOC 
18 
Table VI Tetracyclic N-oxo ρ carbolmes 
Compound 
14 
15 
16 
affinity, pKi 
Benzod 
<61 
<61 
<61 
ь н і 1 А 
5 0 
4 47 
512 
ь-ні
ів 
<6 2 
<6 2 
<6 2 
5 H T 1 C 
<6 3 
<6 3 
5 H T 1 D 
<6 2 
<6 2 
<6 2 
5 H T 2 
<5 2 
<5 2 
<5 2 
5НТз 
<6 1 
<6 1 
<6 1 
tryptamine 
<6 1 
<6 1 
<6 1 
benzodiazepine, 5-HT1A, 5-HT1B, 5-HT lc, 5-HT1D, 5-HT2, 5-HT3 and tryptamine receptors (Table 
VI) A direct companson between the N-oxo and N-carbon analogues is at this point impossible, 
because the activities of the N-carbon analogues of 14-16 are unknown 
As it is possible now to prepare this class of tetracyclic N-oxo compounds (see chapter 6), η is of 
importance that N-oxo compounds will be prepared from which the N-carbon analogues have 
interesting pharmacological activities For instance yohimbine (17) exerts a complex pattern of 
pharmacological actions that include blockade of α-adrenergic and serotonin (5-HT) receptors 
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STRUCTURE ACTIVITY RELATIONSHIPS OF EUDISTOMIN ANALOGUES WITH REGARD 
TO THEIR ANTITUMOUR AND ANTIVIRAL ACTIVITY 
8.2.1 Introduction 
It is of great importance to enrich the current chemotherapy, in particular the antiviral and 
antitumour drugs with new chemical structures. Hereby are of special interest compounds which 
derive their action from new and specific points of interaction with the biological substrate. Recently, 
a new class of compounds -eudistomins- has been isolated which has a realistic possibility to reach 
this goal. 
Eudistomins A-Q were extracted from the colonial tunicate Eudistoma olivaceum, collected in the 
shallow water in Mexico, Belize and Florida1. Crude extracts of all the E. olivaceum samples collected 
displayed activity against Herpes Simplex virus, type I (HSV-1). Four groups of eudistomins have 
been isolated, including simple ß-carbolines (D, J, N, and O), pyrrolyl-ß-carbolines (A, B, and M), 
pyrrolinyl-ß-carbolines (G, Η, I, Ρ, and Q) and tetrahydro-ß-carbolines containing an oxathiazepine 
ring (C, E, F, K, and L). The latter group displayed the strongest activity against HSV-1 and among 
Eudistomin L 
К 
С 
E 
a: 
b: 
с: 
d: 
: 
Ri 
Η 
Η 
Η 
Br 
Η 
^ Br 
Η 
он 
он 
Η 
Ra 
Η 
Br 
Br 
Η 
Η 
these the order of antiviral activity observed was E (ld) (25 ng/disk) > С (le) (50 ng/disk)> L (la) = 
К (lb) (250-400 ng/disk). The potent antiviral eudistomins С and E were active against RNA viruses 
(Coxsackie A-21 virus and equine rhinovirus) as well as DNA viruses (HSV-1, HSV-2, and Vaccinia 
virus). Acetylation of the amine function of eudistomin С (eudistomin F) abolished the antiviral 
activity. Antiviral activity has been assayed by using a standard procedure involving monkey kidney 
cells (CV-1 line).2 More recently the isolation of eudistomin С, О, К and the new debromoeudistomin 
К (le) and eudistomin К sulfoxide from the unrelated New Zealand ascodian Ritterella sigillinoides 
has been reported.3 The activity levels and trends of these compounds were similar to those described 
above, i.e. eudistomin С and К (40-50 ng/disk) > debromoeudistomin К and eudistomin К sulfoxide 
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(400 ng/disk). These eudistomins exhibited also antiviral activity against Polio vaccine Type 1 virus. 
These compounds not only display antiviral activity, but as was recently found3c for eudistomin К 
also in vitro and in vivo antitumour activity against L1210, A549, HCT-8 and P388 cell lines. For 
P388 the in vitro Ю50 was 0.01 μg/πll whereas an in vivo assay gave a T/C value of 137% at 100 
mg/kg. 
The eudistomins attracted also considerable attention because of their unique chemical structure in 
combination with their exceptional potent biological activity. The 7-membered oxathiazepine ring 
-especially the N-O-CH2-S moiety- is believed to play an important role in this respect. This ring is 
rarely encountered in natural products and the synthesis of it appeared to be a real challenge. Although 
the eudistomins were accessible from natural sources in limited amounts, a total synthesis was 
desirable in order to provide sufficient quantities of the compounds for extensive pharmacological 
studies and for allowing the preparation of structural analogues. It was not until recently that the total 
synthesis of the eudistomins was accomplished; two different approaches were reported: the groups of 
Nakagawa4 and Still5 reported an intermolecular Pictet-Spengler reaction as the key-step and the 
intramolecular approach is described in this thesis (Chapter 7). In addition we were able to synthesize 
analogues in order to carry out SAR studies. Based on these results attempts will be made to develop a 
molecule with a higher selectivity for either the antiviral or the antitumour activity. Moreover, we 
hope to acquire more information about the site of interaction of the title compounds and their 
working mechanism at a molecular level. 
Scheme I 
1h:R=H 
1l:R=OMe 
As a first contribution to the realization of these aims, we wish to report here the antitumour activity 
of le-lg and Ij (Scheme I) against P388 cells in vitro and the antiviral activity of le-lk against a wide 
variety of viruses including the human immunodeficiency virus (HIV). It should be bom in mind that 
the compounds le-lk tested are not optically pure. Compound If is a racemic mixture and the 
compounds le and Ig-lk contain minor amounts (5-7%) of their enantiomers as a result of a low level 
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of racemization in the reaction sequence (Chapter 7.3). 
8.2.2 Antitumour activity. 
For a first evaluation of the relation between structure and antitumour activity of the eudistomin 
derivatives le-lg and Ij, we used an in vitro clonogenic assay of P388 (leukemia) cells.6 This test is 
believed to have a high predictive power for in vivo activity of the positive compounds. The assyas 
were performed by P. Lelieveld, TNO-CIVO institutes, Zeist (Netherlands). 
Inhibition of P388 colony formation by eudistomins or analogues was determined at several 
concentrations and the dose causing 50% inhibition of colony formation (Ш50) relative to untreated 
control cells was calculated. The results are collected in Table I. 
Table I. Inhibition of P388 Colony Formation. 
Comp. 
i e a 
i f 
v 1JC 
Юм 
(ng/ml) 
42 
.d 
3.8 
=1000" 
μΜ 
0.15 
-
0.012 
=3.6 
a) Ratio l e / 1 | = 94 5 / 5 5 b) Ratio tg/enantiomer o M g = 
9 3 / 7 b) Ratio 1| / l e - 93 / 7 d) The highest dose tested 
(729 ng/ml) caused no inhibition e) Predicted value based 
on the highest tested dose ID 2 5 • 527 ng/ml 
Discussion 
Comparison of the Ш ^ values of the both enantiomers tested (le and Ij) unambigeously 
demonstrates that only le -the compound with the "natural" configuration at C(l) and C(13b)- is 
active. The minor activity observed by Ij is rather the result of the presence of the enantiomeric 
impurity (le) which is known to be active. The lower ГО50 value of the analogue lg, which differs 
from le in having an additional methoxy group at C(10), clearly demonstrates that placing substituents 
in the indole ring affects the activity of the resulting analogues. This is confirmed by the observed 
high in vitro ГОзд value (10 ng/ml)3c in the P388 assay of eudistomin К (lb), which has a bromine 
Scheme II. Antitumour activity of eudlstomln-analogues. 
+ Important for activity 
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atom at the C(10) position of the eudistomin skeleton. Comparison of the IDs0 value of lg (3 8 ng/ml) 
with that of the well known antitumour compound adnamycine (20 ng/ml)7 is an indication for the 
high potency of the eudistomin compounds The lack of activity of If in comparison with le, clearly 
demonstrates the importance of the amino function at C(l) The results of this preliminary SAR study 
are summarized in Scheme II. 
8.2.3 Antiviral activity 
The development of a flexible synthesis for eudistomins allows us to study the structure-activity 
relationships in some detail The SAR studies on antiviral activity, which have appeared so far1·3 were 
hampered by the absence of a total synthesis 
This preliminary SAR study focusses on the influence on the activity of the stereochemistry at C(l) 
and C(13b) and on small alterations of the essential structural moieties 
The eudistomins le-Ik were evaluated for their inhibitory effects on the replication of a number of 
viruses, including influenza virus A and influenza virus В in MDCK cells (Table II), respiratory 
syncytial virus, vesicular stomatitis virus, Coxsackie virus B4 and Polio virus-1 in Heia cell cultures 
(Table ΙΠ), parainfluenza-3 virus, reovirus-1, Sindbis virus, Coxsackie virus B4 and Semliki forest 
virus in Vero cell cultures (Table IV), herpes simplex virus type 1 (HSV-1) (strains KOS, F, 
Mclntyre), HSV-2 (strains G, 196, Lyons), the thymidine kinase (TK) deficient (TK ) HSV-1 (strain 
B2006), vaccinia virus and vesicular stomatitis virus in primary rabbit kidney cell cultures (Table V), 
HIV-1 and HIV-2 in human MT-4 cells (Table VI) The antiviral assays were performed by Prof E. 
DeClercq, Rega Institute, Leuven (Belgium) Human immunodeficiency virus (HIV) infection was 
earned out with the HTLV-IIIB strain The virus was prepared from the culture supernatant of a 
persistently HTLV-IIIB-infected HUT-78 cell line The antiviral assays were based on inhibition of 
HIV-induced cytopathogenicity in human MT-4 lymphocytes as described previously 8 The other 
antiviral assays were based on the inhibition of virus induced cytopathogenicity in either MDCK, 
HeLa, Vero or primary rabbit kidney cell cultures, following established procedures 9 
Table II Cytotoxic and Antiviral Activity of eudistomin derivatives in MDCK cell cultures 
Compound 
l e 
I f 
i g 
1h 
11 
1J 
1k 
Ribavirin 
mm cytotoxic 
concn(MCC)a, цд/ті 
8 
80 
0 8 
15 
3 
40 
8 
>200 
mm inhibitory 
influenza 
vims A 
(Ishikawa) 
08 
>40 
>0 32 
>8 
>1 6 
3 
>16 
15 
concnb(MIC), цд/ті 
influenza 
virus В 
(Singapore) 
0 8 
>40 
>0 32 
>8 
>1 6 
3 
>1 6 
15 
a) Required to cause a microscopically detectable alteration of normal cell morphology b) Required to reduce 
virus induced cytopathogenicity by 50% Virus induced cytopathogenicity was recorded ar day 5 after infection 
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As general rule it is accepted that a compound is called antivirally active when the minimal 
inhibition concentration (MIC) is at least ten-fold lower then the minimal cytotoxic concentration 
(MCQ. 
Only, compounds le and Ij show a ten-fold MIC/MCC ratio and further none of the eudistomin 
compounds show marked anti-influenza A or influenza В activity at a concentration that is 
significantly below their toxicity threshold (Table II). 
From the eudistomin derivatives, lg is effective (MCC/MIC ratios of 13-67) against respiratory 
syncytial virus, vesicular stomatìs virus, Coxsackie virus B4 and polio virus-1 and le against vesicular 
stomatis virus (MCC/MIC ratio of 20) (Table Ш). 
Table III. Cytotoxic and Antiviral Activity of eudistomin derivatives in Heia cell cultures. 
Compound 
l e 
1f 
is 
I h 
11 
1] 
Ik 
Ribavirin 
min. cytotoxic 
concn(MCC)a 
(цд/ті) 
24 
¿30 
2 
12 
4 
40 
3 
2400 
min. inhibitory concnb(MIC), цд/ті 
Respiratory 
syncytial 
vims (Long) 
0.8 
>β 
0.15 
>8 
>1.6 
3 
>1.6 
3 
Vesicular 
stomatitis 
vims 
0.2 
>10 
0.03 
>10 
>2.5 
4.5 
>1 
20 
Coxsackie 
virus B4 
0.55 
>10 
0.045 
>10 
>2.5 
>β.5 
>2.5 
70 
Polio 
virus-1 
0.7 
>10 
0.045 
>10 
>1 
>8.5 
>2.5 
110 
a) Required to cause a microscopically detectable alteration of normal cell morphology, b) Required to reduce 
virus-induced cytopathogenioty by 50%. The data represent average values of two separate expenments 
Compound lg is also specific (MCC/MIC ratios of 10-22) against reovirus type 1, Sindbis virus, 
Coxsackie virus B4 and Semliki forest vims and le (MCC/MIC ratios of 10-11) against reovims type 
1 and Sindbis vims (Table IV). 
Table IV. Cytotoxic and Antiviral Activity of eudistomin derivatives in Vero cell cultures. 
ПлтплппіЧ 
i e 
If 
13 
I h 
11 
IJ 
1k 
Ribavirin 
min. cytotoxic 
concn(MCC)a'c 
(цд/ті) 
24 
240 
21 
25 
22.5 
25 
210 
>400 
parainfluenzal 
virus 
>0.6 
>10 
0.55 
>7 
>1 
7 
>4 
135 
Minimum inihibitory concn.b'e (MIC) (цд/ті) 
Reovirus-1 Sindbis 
vims 
0.4 0.35 
>10 >10 
0.045 0.045 
>10 >10 
>0.3 >0.85 
20 14 
>4 >4 
125 >235 
Coxsackie Semliki 
virus B4 forest virus 
0.55 0.45 
>25 >25 
0.07 0.11 
>10 >10 
0.55 >1 
7 13 
7 >4 
>300 >300 
a) Required to cause a microscopically detectable alteration of normal cell morphology b) Required to reduce virus-induced 
cytopathogenicity by 50% c) The data represent average values of two separate experiments 
Table V. Cytotoxic and Antiviral Activity of eudistomin derivatives in primary rabbit kidney (PRK) cell cultures. 
Compound 
l e 
11 
i g 
1h 
11 
if 
Ik 
Ribavirin 
min. cytotoxic 
concn.tMCC)3·0 
(мд/ті) 
225 
2:120 
¿2.5 
¿25 
¿7 
S40 
27 
2400 
Нефез 
simplex 
virus-1 
(KOS) 
1.35 
>70 
0.045 
>4 
>11 
>7 
>200 
Herpes 
simplex 
virus-1 
(F) 
0.25 
>70 
0.039 
10 
>4 
5.4 
>3 
>200 
Herpes 
simplex 
virus-1 
(Mclnyre) 
0.2 
>70 
0.013 
>10 
>4 
4.5 
>4 
>200 
mininimum inhibitory concn.(MIC 
Нефез 
simplex 
virus-2 
(G) 
0.2 
>120 
0.012 
>25 
>4 
4.5 
>5.5 
>200 
Herpes 
simplex 
virus-2 
(196) 
0.2 
>70 
0.014 
>10 
4.5 
3 
2 
>200 
Нефез 
simplex 
virus-2 
(Lyons) 
0.38 
>70 
0.023 
>2.5 
4.5 
>2.8 
>200 
Vaccinia 
virus 
0.25 
>70 
0.012 
>10 
>4 
4.5 
>4 
30 
ь
'
с
, рд/пИ 
Vesicular 
stomahtis 
vims 
0.2 
>70 
0.015 
>25 
>4 
4.5 
>4 
>400 
Herpes 
simplex 
virus-1 
(B2006) 
CI 58/77 
0.7 
>70 
0.023 
>10 
>4 
>8.5 
>4 
>200 
Нефез 
simplex 
virus-1 
(B2006) 
C137/101 
0.7 
>70 
0.0085 
>10 
>4 
14 
>4 
>200 
Herpes 
simplex 
virus-1 
(B2006) 
*3 
0. 5 
>70 
0.055 
>10 
>2.5 
14 
>4 
>200 
a) Required ID cause a microscopically detectable alteration of normal сей morphology b) Required to reduce virusHnduced cytopathogenraty by 50% 
c) The dala represent average values of two experiments. 
1Л 
(л 
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The eudistomin derivatives le, lg and Ij are endowed with a marked activity against herpes simplex 
virus type 1 and 2 (Table V). Especially lg shows activies well below the cytoxicity threshold 
(MCC/MIC ratios of 56-294). 
It should be bom in mind that the foregoing activities observed for Ij are rather the result of the 
presence of the enantiomer impurity (le, 5.5%), which is known to be active. 
The anti-Ш -І and anti-HIV-2 activities and cytotoxicities of the eudistomin analogues are shown 
in Table VI. Although, in the preceeding tests, le and lg proved to be promising antiviral remedies, 
they failed to give a satisfying therapeutic index against anti-НГ -І and -2. 
Table VI. Anti-HIV-1 and -HIV-2 activity and cytotoxic activity of eudistomin derivatives 
in human T-lymphocyte (MT-4) 
Compound 
l a 
if 
i g 
1h 
I I 
1] 
ík 
AZT10 
EDso 
HIV-1 
>0.116 
г154 
>0.0066 
>5.β 
>5.2 
>5.8 
>5.8 
0.003 
cells. 
8(μΜ) 
HIV-2 
>0.116 
112+65 
>0.0066 
>29 
>5.2 
>5.8 
>5.β 
СОеДіМ) 
0.27±0.025 
370±122 
0.0131 
16.4±0.25 
6.52±3 84 
13.02±0.04 
2.79І0.85 
4.8 
therapeutic index 
(ratio IDco/EDgn) 
HIV-1 
<2.3 
<2.4 
<1.98 
<2.8 
<1.25 
<2.25 
<0.48 
1600 
HIV-2 
<2.3 
3.33 
<1.98 
<0.57 
<1.25 
<2.25 
<0.48 
a) Effective dose of the compound, achieving 50% protection of MT-4 cells against cytopathic effect of HIV 
b) Cytotoxic dose of compound, required to reduce the viability of normal uninfected MT-4 cells by 50% 
In conclusion, the general outcome of this study is that for the antiviral activities other than the 
anti-HIV-1 and -2 activity, we observed that: i) only the stereoisomers with the same configuration on 
C(l) and C(13b) as the natural products are active, ii) the presence of the amino function at C(l) is of 
importance. Hi) substitution in the indole nucleus alters the potency of the compound. For anti-HIV-1 
and -2 activity our results indicate that the therapeutic index of the active compounds is unfavourably 
low. 
The results of this preliminary SAR study are summarized in Scheme III. 
Scheme III. Antiviral activity of eudlstomln-analogues. 
+ important for activity 
«b N . 
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8.2.4 Epilogue 
The strategy for new drug discovery involves two phases: lead identification and 
structure-activity/toxicity fine tuning. For the eudistomins lead identification is now completed and a 
start with the second phase has been made. The synthesis developed for the eudistomins enables us 
to prepare sufficient quantities for further biomedical studies. In addition, more elaborate 
structure-activity relationship studies will be performed to develop compounds with more selective 
biochemical and pharmalogical properties. 
No data on pharmakinetics or metabolism of eudistomins have been published so far. For further 
preclinical studies of the eudistomins and analogues evaluation of their pharmacodynamic and 
biopharmaceutical properties -like metabolism, distribition, excretion, toxicity- in animals is 
essential. 
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SAMENVATTING 
Tryptamines (1: R ^ I ^ H ) en tryptofaan derivaten (1: R^H, R2=COOH) spelen een belangrijke 
rol in tal van biologische processen, zowel als neurotransmitter in het centraal zenuwstelsel als ook 
als bouwsteen voor ingewikkelde chemische strukturen, zoals de ß-carbolines (3)(zie schema I). 
ß-Carbolines staan in de belangstelling vanwege hun breed farmacologisch profiel, zoals blijkt uit de 
gevonden affiniteit voor tryptamine, serotonine en benzodiazepine receptoren. 
'Όςη; 
Schema 
Rj Η XX ~OR, 
Dit proefschrift handelt over de synthese van N-hydroxy(alkoxy)-tryptaniine (2: R]=R2=H) en 
-tryptofaan (Ri=H, R2=COOEt) derivaten en hun toepassing in de synthese van N-oxy analoga van 
ß-carbolines (4) en natuurproducten (zie schema I). 
Chemische modificatie van tryptamine- en carboline-structuurfragmenten is onderwerp van 
intensieve studie. Een snel groeiend aantal derivaten wordt toegepast in de farmacotherapie, met 
name op het gebied van het centraal zenuwstelsel. De bovengenoemde N-hydroxy- en 
N-alkoxy-derivaten openen een nieuwe lijn in dit farmacochemisch onderzoek. 
Omdat het zesring N-atoom een sleutelrol vervult bij de farmacodynamische interactie met 
receptoren, zal het sterk electronegatieve O-atoom de farmacologische eigenschappen van dit type 
structuren op verrassende wijze kunnen beïnvloeden. Veranderingen in basiciteit, nucleofiliciteit, 
polarisatie, sterische hindering en extra H-brug vorming moeten in ogenschouw worden genomen. 
Dit kan enerzijds leiden tot meer informatie op moleculair nivo aangaande de kritische parameters 
die betrokken zijn bij de receptor affiniteit, en anderzijds tot de ontwikkeling van nieuwe 
farmacotherapeutica. 
In hoofdstuk 2 t/m 7 worden de syntheses beschreven van de N-oxy-tryptamine, -tryptofaan en 
-ß-carboline analoga en in hoofdstuk 8 wordt de biologische activiteit van deze verbindingen in tal 
van in vifro assays vermeld. 
In hoofdstuk 2 wordt een efficiënte route naar derivaten van N-hydroxytryptofaan (7: RpH, 
R2=COOEt) en -tryptamine (8: R^H, R2=H, Me, Ph) beschreven. Sleutelstap is de reactie van 
160 
gramine (5) met nitromethaan derivaten, welke resulteert in de corresponderende nitroverbindingen 
6. Reductie van de nitrogroep met Al-amalgam geeft de N-hydroxy verbindingen in hoge 
opbrengsten (Schema Π, Route A). 
Schema II 
NMe. 
Route A' 
0 s L J 
η, 
12 
\ ^ 
1 
HNOR3 
Route A R2=H, CH3, Ph, COOEt 
Route B. R2=Ph, COOEt, COO(R*) 
Een tweede benadering vía de oxim verbindingen 11, welke verkregen werden uit een cycloadditie 
reactie van indool-derivaten 9 en nitroso-alkenen 10 (Schema Π, Route B), was reeds eerder 
beschreven. Echter, deze route bleek alleen efficiënt te zijn wanneer sterk electron-zuigende groepen 
(R2) in 10 aanwezig zijn. Deze route werd gebruikt in een poging om optisch actief 
N-hydroxytryptofaan te maken. Een diastereoselectieve reductie van de oxim functie van chiraal 
gesubstitueerde menthol ester derivaten (R2=COO(-)-8-fenylmenthyl en COO(-)-8-naftylmenthyl) 
werd gerealiseerd. Helaas was het tot nu toe niet mogelijk om de chirale hulpstof te verwijderen. 
N-alkoxy-tryptofaan en -tiyptamine derivatives (12) zijn gesynthetiseerd door middel van 
selectieve alkylering van de N-hydroxy verbindingen 7 en 8 (Route A') of door middel van 
selectieve alkylering van de oxim functie van 11 (Route B'). 
kJ^J HNOH 
7,8 
Schema III 
N=C —Rj I 
4 ^ ^ N V 
H N = / 
14 ^ 
Hoofdstuk 3 gaat over de synthese van 3,4-dihydro-ß-carboline nitronen 13, waarbij wordt 
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uitgegaan van de corresponderende N-hydroxy-tryptofaan of -tryptamine derivaten (Schema Ш). 
Vervolgens wordt de 1,3-dipolaire cycloadditie besproken van deze nitronen met nitnllen, een 
reactie die resulteert in de A4-l,2,4-oxadiazolines (14). 
In hoofdstuk 4 wordt de toepassing van isoxazolidine 15 besproken in de totaal-synthese van 
fumitremorgine С (16). In het tweede gedeelte van dit hoofdstuk wordt de totaal-synthese van een 
tweede lid van deze familie van mycotoxines besproken d.w.z. verruculogen TR-2 (19). In deze 
synthese werd de formele dehydrogenering van tetrahydro-ß-carbolines 15 tot 
3,4-dehydro-ß-carbolines (18) bewerkstelligd waarbij 3-alkoxyindolenine derivaten (17) als 
tussenproduct optreden. De ds-diol functie in 19 werd verkregen door hydroxylering van de dubbele 
band met osmium tetroxide (Schema IV). 
Schema IV 
o 
I 1 
MeO 
ι I II u 
In hoofdstuk 5 wordt de invloed besproken van de substituenten Rj-Rs in N-oxy-tryptofaan en 
-tryptamine derivaten op hun reactiviteit in de intermoleculaire Pictet-Spengler reactie met 
aldehydes (R4CHO) resulterend in cij- (21) en franj-ß-carbolines (22) (Schema V). Aandacht werd 
Scheme IX 
k X J »K R'CHO 
Ρ 
LI Ι Τ 
^ ' Ч - ' ' ^
М
-ОНз 
R, R^ U _J 
7,8,12 20 21 -.cis 2 2 : « « 
besteed aan factoren die de cis/trans verhouding beïnvloeden. Tengevolge van het toegenomen 
clectrofiele karakter van de C=N dubbele band in intermediair 20, verloopt de reactie sneller en 
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minder specifiek dan de reactie met de deoxy analoga. 
Hoofdstuk 6 behandelt de synthese van tetracyclische N-oxo-ß-carboIines 23 (R=H, CH3, COOEt), 
analoga van indoolalkaloiden van het corynantheine type. Deze doelmoleculen weiden verkregen 
door middel van een nieuwe intramoleculaire Pictet-Spengler reactie van tussenproduct 24 (Schema 
VI). Dit belangrijke tussenproduct is een N-alkoxytryptamine met een aldehyde functie of een 
gemaskeerd aldehyde functie op de δ-positie van de alkoxy zijketen. De toegankelijkheid van dit 
intermediair werd langs drie wegen bestudeerd: 
i) Reductie van een O-gealkykeerde oxim functie aanwezig in 25 (Route A). 
ii) Selectieve O-alkylering van de N-hydroxy-functie van verbindingen 7 of 8 met een 
gefunctionaüseerd vier-koolstof substraat (Route B). 
Ui) Selectieve reductie van de ester functie aanwezig in 26, verkregen uit 8. 
Het meest efectief waren route-B en -C, terwijl route-A slecht verliep. 
In hoofdstuk 7 worden resultaten beschreven verkregen door toepassing van de intramoleculaire 
Pictet-Spengler reactie in de synthese van een eudistomine derivaat en enkele analoga daarvan. 
Intramoleculaire reactie van 28 (RpH of OMe, R2=H of NHj, Y=CH(OMe)2 of COOMe) 
-verkregen uit 8 en het chloormethylsulfide derivaat 29- gaf toegang tot de eudistomines 27 (Schema 
VII). 
Hoofdstuk 8 gaat over structuur-activiteit relatie studies. Het eerste gedeelte van dit hoofdstuk 
beschrijft de affiniteiten van de N-hydroxy(alkoxy)-tryptofaan en -tryptamine derivaten, de 
3,4-dihydro-N-oxo-ß-carbolines, de N-oxo-tetrahydro-ß-carbolines en de tetracyclische 
N-oxo-tetrahydro-ß-carbolines voor de tryptamine-, serotonine - en benzodiazepine-receptoren. In 
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Schema VII 
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het algemeen is de affiniteit van de N-oxo-verbindingen minder dan die van de overeenkomstige 
desoxo verbindimg, maar daar tegenover staat dat sommige van de eerstgenoemde verbindingen een 
verhoogde selectiviteit bezitten. 
Het tweede gedeelte van dit hoofdstuk beschrijft de structuur-werkingsrelatie van de 
gesynthetiseerde eudistomines met betrekking tot antivirale en andtumor activiteit. 
Deze eerste SAR-studie beperkt zich tot het belang van de stereochemie der chirale centra C(l) en 
C(13b) voor de antivirale activiteit. Bovendien wordt de invloed van twee andere structurele 
parameters bestudeerd. Zeven gesynthetiseerde eudistomine-analoga (27) werden getest op hun 
vermogen de replicatie van tal van virussen te remmen, waaronder de "human immunodefiency virus" 
НГ -1епШ -2. 
Voor alle virussen, met uitzondering van Ш -l en НГ -2 werd gevonden dat i) alleen 
stereoisomeren, die dezelfde configuratie op C(l) en C(13b) bezitten als het natuurproduct zelf actief 
zijn ii) de aanwezigheid van de aminofunctie op C(l) van belang is /il') door het aanbrengen van 
substituenten in de indoolkem de activiteit van de resulterende verbinding verandert. 
Vier van de gesynthetiseerde eudistomine-analoga werden onderzocht op hun activiteit tegen tumor 
cellen (P388 leukemie) in een in vitro assay. Onze voorlopige gegevens lieten een grote overeenkomst 
zien met de gegevens verkregen in de bepaling van de antivirale activiteit der stoffen, inzovene het 
gelijke structuurparameters betreft. De resultaten van beide SAR-studies zijn schematisch 
weergegeven in schema VIII. 
Schema Vili. Antivirale en antitumor activiteit van eudlstomlne analoga 
FL + belangrijk voor de activiteit 
De actiefste stof is verbinding 27 waarin R1=OMe en R2=NH2. Dit analogen is vijf maal actiever, in 
de gebruikte assay, dan de bekende antitumorverbinding adriamycine. 
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